The Development of an Automated, Fluorescent, Quantitative Three-Dimensional In Vitro Organotypic Invasion Assay by Patel, Ketan Vinodbhai
 
The Development of an Automated, 
Fluorescent, Quantitative Three-




Ketan Vinodbhai Patel 
 
This thesis is submitted for the degree of  
Doctor of Philosophy 
 
Centre for Tumour Biology, Barts Cancer Institute 
Barts and The London School of Medicine & Dentistry 








Declaration of Originality 
I, Ketan Vinodbhai Patel, confirm that the research included within this thesis is my 
own work or that where it has been carried out in collaboration with, or supported by 
others, that this is duly acknowledged and my contribution indicated. Previously 
published material has also been acknowledged in the correct manner.  
 
I attest that I have exercised reasonable care to ensure that the work is original, and 
does not to the best of my knowledge break any UK law, infringe any third party’s 
copyright or other Intellectual Property Right, or contain any confidential material.  
 
I accept the College has the right to use plagiarism detection software to check the 
electronic version of this thesis.  
 
I confirm that this thesis has not been previously submitted for the award of a degree 
by this or any other university.  
 
The copyright of this thesis rests with the author and no quotation or information 
derived from it may be published without the prior written consent of the author.  
 
This study was sponsored and supported by the Biotechnology and Biological 












The work presented in this thesis would not have been possible without the 
contribution and support from others. I would like to extend my gratitude to those who 
have assisted me throughout this journey. 
Firstly, a very special mention to my supervisor, John Marshall. Thank you for not 
only for giving me the opportunity to work on such a fascinating project within your 
group, but also for your unwavering enthusiasm, guidance and support. Thank you 
for supervising me through this PhD with continued patience and opportunities. Not 
many PhDs involve drinking whisky until 2am, whilst sat in a roof top swimming pool 
in Singapore after a week-long conference. It has been a pleasure to work with you 
during the past four years. 
This project would not have been possible without the contributions and support of 
my sponsors BBSRC and AstraZeneca. Thank you to Simon Barry and Cath Eberlein 
of AstraZeneca, for all of your advice and the insightful discussions throughout my 
project. I am incredibly appreciative to members of the High-Content Biology group 
at AstraZeneca led by Beverley Isherwood. Thank you for all of your advice and 
guidance, but also making me feel welcome and part of the team from the very 
beginning. Additionally, thank you to Cerith Pierce, for his persistent willingness to 
help me during my visits to AstraZeneca. I further extend my gratitude to Sam Peel, 
thank you for your constant assistance and positive approach during the last four 
years, but also for all of your help in the lab at Alderley Park and Cambridge and for 
getting me out of my room to join for beers with everyone.  
To the past and present β6 group members; I would like to thank you all for welcoming 
me in to the group from day one. I’ve enjoyed the many laughs we’ve had during our 
group meetings and the β6 group retreat. I am truly grateful for all of your professional 
guidance over the past four years.  
I am thankful to those at the BCI who have helped me during my project. Thank you; 
Yasmine and Ed C for your knowledge and help with lentiviral particles; Bakhouche, 
King of the West(ern blots); Joseph Brook, for that amazing mathematical brain of 
yours; Beta, Claire and Zareen for your kind words of advice with writing; Debbie for 
running the lab; Linda for helping me with the microscopes and George for his 





Thank you Claire, Caroline, Zareen, Banu and Ami for always being available to help 
and support me in the lab but also for the great laughs and fun times we all shared. I 
further extend my gratification to Claire and Caroline for all the support during writing. 
For those who have not had ‘the PhD experience’; it can be laborious days, late nights 
and long weekends and then you realise the experiment didn’t work! However, I am 
grateful to have shared such challenging and frustrating times with the tumour biology 
lab members who kept spirits high and provided more than a few laughs along the 
way.  
Special thanks to ar’ kid - Prabhu, for never failing to make me laugh with your 
humorous antics. Thank you Yasmine, for being there to support and help me, but 
more importantly for all the countless little things that you did to cheer me up, from 
kindly bringing me treats, always making me laugh and going for spontaneous cake 
and pint breaks with me. Bakhouche, thank you for the stimulating debates on world 
politics, the education system, Brexit and countless other topics, but most importantly 
for your help, support and laughter during writing. Thanks to the brewing squad who 
provided many enjoyable evenings, in particular to Fulford and Ed W, for always being 
up for a laugh, supportive and good friends throughout.  
Thanks to my friends outside of the lab, Adam, Arthur, James, Nacho and Rushen for 
all of your advice and support during the last years. 
It’s not very common to call your dad’s best friend ‘uncle’, however I do. Not only out 
of respect, but because to me he is family. Sunil, you have been a constant presence 
in my life and I cannot thank you enough for all of the advice and support you have 
given me over the years. 
I consider myself privileged to have a very caring and involved family. Firstly, to my 
uncles Vinod and Kishor and my aunties Gita and Mina. I cannot thank you enough 
for all of the encouragement and guidance you have continually given me and more 
importantly all of the delicious food that I have been lavished with over the last four 
years. I give my deepest gratification to my grandparents Ram Dada and Sita Baa, 
you are the pillars of hard work and strength for me and installed the importance of 
education into my life. To my late-grandmother Rukhi Baa, your care, encouragement 
and love will always be with me. To my siblings Anant, Rushina, Rashmi, Amish and 
Janak, thank you for the boundless support, not just during this PhD but also 
throughout my life. Adding to that, Janak, you have been supportive and helpful at 





movie nights and providing me with a place to stay in the most crucial of times. I am 
truly grateful to all of you. 
I am incredibly thankful to my brother Kumul, who has never stopped showing care 
and reassurance. Thank you for your endless support and most importantly all of the 
continued laughs we’ve had. 
None of this would have been remotely possible without the two most important 
people in my life. There are not enough words to describe how grateful I am for 
everything that you have done for me. I am eternally grateful for the continuous care, 
guidance, love and support you have infinitely given me during this PhD but also 
throughout everything I have chosen to pursue. Thank you for believing in me and 
guiding me through life.  













I do not know what I may appear to the world; but 
to myself I seem to have been only like a boy 
playing on the seashore and diverting myself in 
now and then finding a smoother pebble or a 
prettier shell than ordinary, whilst the great ocean 
of truth lay undiscovered before me. 







Tumour metastasis is a complex multi-step biological process, which involves 
dispersion of cancer cells to various organ sites within the body. The tumour-stroma 
interface plays an important role within cancer progression and is a major area of 
focus within cancer research. It is imperative that we are able to understand what 
mechanisms the tumour cells use in order to achieve maximum invasive potential. 
Fibroblasts are one of the major host cell types that are usurped by the tumour cells 
to promote invasion. Thus, we must understand the molecular mechanisms by which 
fibroblasts are transformed by the tumours into tumour-promoting fibroblasts, thus 
enabling cancer progression. 
Over 10 years ago our laboratory developed a quantitative image analysis 
methodology for analysing tumour and stromal fibroblast-interactions using 1ml 
collagen type I based three-dimensional (3D) organotypic gels. The assay is 
expensive, slow and can take 3-4 weeks before results are available.  
In this study I have developed two smaller versions of this assay that enable 
drug/gene screening in 3D, that are quicker to analyse and affordable; mini-
organotypics (100µl) and micro-organotypics (50µl). Using fluorescently labelled 
tumour (red) and fibroblast (green) populations, it is possible to view the invasive 
process live and in situ, using confocal microscopy. Analysis of fluorescent 
organotypic gels after 72 hours, showed that the fibroblasts are the principal invading 
cell type that commence invasion and are followed by the tumour cells. 
For a proof-of-principle study I transfected human dermal fibroblasts with a 
customised SMARTpool siRNA library targeting proteases. Data collection was 
automated, thus allowing results within three days instead of three weeks. Relative to 
siRNA control treated fibroblasts, 16 out of 60 targeted proteases significantly 
reduced fibroblast and tumour cell invasion. Moreover, re-analysis of five lead 
proteases using individual siRNA for each gene identified that fibroblast MMP-17 and 
TMPRSS-13 is required by dermal fibroblasts to support invasion of cancer cells 
within this 3D assay.  
I believe this novel 24-well 3D fluorescent mini-organotypic invasion assay will allow 
drug/gene screens to be conducted affordably on multiple different tumour-stroma 
cell combinations. Moreover, the 96-well 3D fluorescent micro-organotypic invasion 
assay is almost ready for use in high-throughput screening and thus will be of great 
value in both academia and industry. 
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CHAPTER I: INTRODUCTION  






1.1 Approximately 38,630 new cancer cases worldwide each day 
Data from the GLOBOCAN project, led by the World Health Organisation (WHO), 
estimated that in 2012 there were approximately 14.1 million new cancer cases of 
which 8.2 million deaths occurred worldwide (Torre et al., 2015). The causes of 
cancer are complex, diverse and only partially understood. 
Tumour invasion and metastasis are the prime cause of death within cancer patients. 
The biological processes involved in metastasis are a series of very complex 
molecular mechanisms that consist of cells absconding from a primary tumour 
through loss of cohesion with their neighbouring cells, followed by local invasion into 
the surrounding matrix and ultimately formation of tumours at secondary sites. 
Secondary tumour sites develop as migrating cancer cells intravastate the lymphatic 
and vascular system, thus circulating and extravasting into a niche environment within 
the body that can support tumour growth (Hart, 1982; Hart and Fidler, 1980b). 
 
1.2 Origins of cancer metastasis  
In 1889 British surgeon, Stephen Paget, examined post mortem data from 735 
women, all of whom died from breast cancer and noted that the distribution of tumour 
metastases was non-random. Interestingly, he described that tumour cells (the ‘seed’) 
grew preferentially within the surrounding vicinity of select organs (the ‘soil’) (Paget, 
1889). This idea was challenged in 1928 by American pathologist, James Ewing, who 
proposed the idea that circulatory patterns between a primary tumour and specific 
secondary organs were sufficient in accounting for organ-specific metastasis (Ewing, 
1928).  




1.2.1 Defining metastasis 
Metastasis, is regarded as an inefficient process due to the inability of most circulating 
tumour cells to grow at distant sites (Luzzi et al., 1998; Weiss, 1990).  Metastasis is 
commonly defined as the ability of cancer cells to disperse from one tumour site to 
organs and tissues beyond where they originated and form new tumours (Chambers 
et al., 2002; Jiang et al., 2015) (Figure 1.1). 
The process is a series of complex steps, driven by an accumulation of DNA 
mutations, that include; (1) the initial loss or disruption of the cell-cell adhesion 
molecules, such as epithelial (E)-cadherin (important for cell polarity and epithelial 
organisation (van Roy and Berx, 2008)). Thus, reduced adhesion may enhance the 
potential for metastasis through loss of contact and promotes uncontrolled 
proliferation (Cavallaro and Christofori, 2004). Tumour cells acquire an invasive and 
migratory phenotype, thus enabling penetration into surrounding tissue (Wells et al., 
2013). This instigates; (2) invasion of tumour cells, degradation of basement 
membrane (BM) and extracellular matrix (ECM) and a transition from in situ to 
invasive carcinoma (Liotta et al., 1980). Tumour cells then migrate and intravastate 
the lymphatic or vascular system (Clark and Vignjevic, 2015); (3) tumour cells 
circulate and survive within the circulatory system until they arrest in microvascular 
beds (Fidler, 2003); (4) next, the tumour cells form adhesions to the endothelial cells, 
causing them to retract or die and thus begin to penetrate into the surrounding stromal 
microenvironment, known as extravasation (Liotta and Rao, 1986); (5) tumour cells 
acclimatise and thrive within the stroma, displaying increased levels of proliferation 
and angiogenesis leading to the development of a secondary foci and ultimately 
formation of micro-or macrometatasis (Fidler, 2003).   













Figure 1.1: Steps in metastasis 
During metastasis, cancer cells form an overt secondary tumour site through a 
series of complex processes. A) Cancer cells begin to loose cohesive properties 
with neighbouring cells and detach from the primary tumour site. B) Cancer cells 
invade through the basement membrane and migrate into the vasculature rich-
stroma. This process is known as intravastation. C) Cancer cells cause endothelial 
retraction, thus breaching the vasculature system. D) Cells then begin migrating 
through the circulatory system, E) before arresting at microvascular beds. F) 
Cancer cells cause retraction of endothelial cells and extravastate into the 
surrounding microenvironment before G) forming secondary tumour sites, where 
cancer cells not only survive, but thrive and proliferate. (Image adapted from 
(Schroeder et al., 2011)). 
 
  




1.2.2 Models of metastasis 
The debate whether cancer metastasis is an early or late event in tumour progression 
is still ongoing and remains elusive (Friberg and Nystrom, 2015). Two distinct 
systematic progression models exist. The linear progression model is based on Leslie 
Fould’s description of a stepwise progressive tumour development, by means of a 
permanent or irreversible qualitative change in one or more the tumours 
characteristics (Foulds, 1954). 
On the contrary, the parallel progression model suggests a stepwise tumour 
development via morphological abnormalities and accumulation of genetic alterations 
that cause the cancer cells within a primary tumour to pass through multiple rounds 
of mutation and selection, before disseminating to form secondary sites (Cairns, 
1975; Klein, 2009). 
In line with linear progression, Olivier and colleagues reported an increase in mutation 
frequency for the tumour suppressor TP53, during advanced stages of breast cancer 
when compared to smaller earlier stage tumours (Olivier et al., 2006). On the other 
hand, the parallel progression model claims that tumour cell dissemination occurs 
early due to genetic alterations, thus leading to early separation and independent 
development of tumour cells (van Zijl et al., 2011).  
Paget’s ‘seed and soil’ theory describing an organ-specific pattern of metastasis has 
been reported by others. For example, the brain, bone, liver and lungs are the most 
assaulted organs for breast cancer metastasis (Chambers et al., 2002). Bone and 
lungs being the most common site of occurrence for metastasis (Langley and Fidler, 
2011) and  early tumour cell dissemination and formation of micrometastasis in these 
sites were reported for HER2 mutant breast cancer cells (Husemann et al., 2008). In 
addition, Hiratsuka and colleagues suggested that some primary tumours may 
transmit pro-metastatic signals to the lung, thus priming the metastatic soil for the 
arrival of the tumour cells (Hiratsuka et al., 2002). 
 
1.2.3 Mechanisms of cancer cell invasion 
Cancer cells can invade and migrate through tissues by moving collectively as 
epithelial sheets, detached clusters or as single cells via mesenchymal or amoeboid 




cell migration; these invasion and migration modalities are themselves associated 
with cellular behaviours such as adhesion (Friedl and Wolf, 2003).  
Collective cell migration is characterised by groups of cells which retain cellular 
adhesions and display a high correlation in directional movement between 
neighbouring cells and feature three distinct hallmarks; (1) cell-cell junctions remain 
intact during movement, resulting in cohorts of migrating cells (Friedl et al., 2004); (2) 
multicellular polarity and organisation of the actin-cytoskeleton generate traction 
forces that are required for collective cell movement (Hegerfeldt et al., 2002); and (3) 
collective cell migration requires rearrangement of the BM and remodelling of the 
ECM (Wolf et al., 2007). Collective cell migration includes movement of  cells either 
as narrow linear strands which can occur by two-dimensional (2D) sheet migration or 
the formation of broad layered multicellular strands through three-dimensional (3D) 
tissues (Friedl et al., 2004; van Zijl et al., 2011). Collective cell migration was reported 
to occur during embryogenesis (Davidson and Keller, 1999) and branching 
morphogenesis (Simian et al., 2001). 
Collective cell migration is typically known as the slowest form of migration and has 
been reported in wound closure during skin (Poujade et al., 2007)  or corneal 
epithelium repair (Zelenka and Arpitha, 2008) after injury. Additionally, collective cell 
migration has been reported in breast cancer (Giampieri et al., 2009) and fibroblast-
led collective invasion of oral squamous cell carcinoma (OSCC) (Gaggioli et al., 
2007). 
Single cell migration is characterised by the lack of cell-cell interactions with 
neighbouring cells. Tumour cells can apparently interconvert between various 
migratory strategies in response to a changing microenvironment. Thus, suggesting 
that suppression of single cell migration may require inhibition of mesenchymal or 
amoeboid-like migration (Valastyan and Weinberg, 2011). In vitro studies have 
reported that individually migrating cancer cells display increased contractility under 
control of the Rho-pathway and favours an amoeboid-like migration pattern (Sahai 
and Marshall, 2003), whereas lower contractility (or increased adhesion) favour more 
mesenchymal-like properties (Wolf et al., 2003).   
Mesenchymal (or fibroblast-like) cell migration employs a five step cycle, including; 
(1) pseudopod protrusions at the leading edge; (2) formation of focal contacts; (3) 
focalised proteolysis; (4) actomyosin contraction; and (5) detachment of the trailing 




edge (Friedl and Wolf, 2003). Cells that go through mesenchymal migration possess 
a fibroblast-like spindle shape that have been reported to be dependent on α6β4 and 
α2β1 integrin mediated adhesions. Mesenchymal migration takes place on cells from 
within the connective tissue of tumours, such as fibrosarcomas (Wolf et al., 2003) and 
gliomas (Paulus et al., 1996). 
Amoeboid cell invasion hallmarks include, loss of polarity and loose attachment to the 
ECM, thus making it the fastest type of invasion (Condeelis and Segall, 2003). Cancer 
cells may acquire these characteristics through inhibition of integrin β1, leading to 
collective-to-amoeboid transition (CAT), where tumour masses invading surrounding 
tissues collectively dissociate into single migrating cells using amoeboid-like 
movement (Friedl, 2004). The transition from mesenchymal to amoeboid-like cells 
(MAT) was reported to be dependent on Rac and Rho/ROCK signalling and is 
independent of protease activities (Friedl and Wolf, 2003). Valastyan and colleagues 
reported that the microRNA, miR-31, inhibits breast cancer mesenchymal migration 
through concurrently supressed integrin α5 and amoeboid migration through RhoA 
suppression (Valastyan et al., 2009).  
Furthermore, single-cell invasion pathways maybe incompatible without the loss of 
epithelial tissue organisation molecules, specifically E-cadherin (Jensen et al., 2015). 
Thus, tumour cells can undergo a cell-programmed transition, known as epithelial-
mesenchymal transition (EMT) in order to become invasive. EMT is a normal process 
during development whereby epithelial cells obtain mesenchymal, fibroblast-like 
properties and are often identified by downregulation of E-cadherin and upregulation 
of vimentin (Larue and Bellacosa, 2005) as well as loss of apical-basal polarity 
(Thiery, 2002).  
EMT contributes not only to tissue repair and embryonic development but also organ 
fibrosis and can promote cancer progression through loss of cell-cell adhesion 
molecules, such as E-cadherin (Thiery et al., 2009). Brabletz and colleagues reported 
that EMT occurs at the invasive front in colon carcinoma and produces single 
migratory cells that lose E-cadherin (Brabletz et al., 2001). In addition, transforming 
growth factor-beta (TGF-β) has been reported to promote EMT via blocking 
expression of E-cadherin, thus leading to increased expressions of mesenchymal 
proteins (vimentin and fibronectin) (Miyazono, 2009). The reversal of EMT is referred 
to as epithelial to mesenchymal transition (MET) and can be characterised by 




epithelial reorganisation and also described as individual to collective transition 
(Thiery et al., 2009). During MET, mesenchymal cells regain their epithelial cell-cell 
junctions, thus, able to colonise at secondary tumour sites (Kalluri and Weinberg, 
2009).  
Circulating tumour cells (CTCs) (or tumour microemboli) are suggested to be a 
precursor to metastatic cancer and were first proposed in 1869 by Australian 
pathologist, Thomas Ashworth (Ashworth, 1869). CTCs must detach from tumours, 
probably through loss of cell-cell adhesions and intravastate in small groups of 
collectively-migrating tumour cells (Clark and Vignjevic, 2015).  Studies have reported 
that clusters of CTCs are present in the circulatory system and blood of patients with 
invasive cancers, such as, breast (Cristofanilli et al., 2004), colon (Choy and 
McCulloch, 1993), lung (Hou et al., 2012), prostate (Makarovskiy et al., 1997) and 
renal cancer (Kats-Ugurlu et al., 2009). Identifying CTCs in the peripheral blood has 
become a valuable diagnostic tool and a predictor of clinical outcomes in patients with 
solid tumours (Pantel et al., 2008). 
Intervention, but ideally prevention of metastasis pathways would provide a promising 
clinical therapy for cancer patients with or at risk of metastatic disease. Thus, 
development of a preclinical model to validate potential anti-metastatic therapies is in 
high demand. 
  




1.3 Two-dimensional vs three-dimensional cultures 
Currently the in vitro screening of synthetic and natural product compound libraries 
for anticancer agents focuses on cytotoxicity data using established cancer cell lines. 
The majority of these cell based assays are performed on 2D substrates (i.e. tissue 
culture plastic). Cell-based assays are an important pillar of the drug discovery 
process, providing a fast, repeatable and cost effective tool, thus avoiding large scale 
and cost intensive animal testing.  
2D cell based assays have proven to be a reliable tool for drug discovery, especially 
within cancer research, for example, identifying small molecules for colorectal cancer 
treatment (Bialkowska and Yang, 2012) or when developing and validating functional 
cell-based assays (Sadikot et al., 2013). However, their limitations prohibit 
translational studies to be performed. In particular, the lack in capability of 2D cultures 
to accurately mimic the complexity and heterogeneity of tumours as observed in vivo. 
Consequently this leads to the loss of numerous signalling pathways being 
expressed, changes in cellular processes and changes in cell shape when grown on 
a 2D substrate (Lee et al., 2007).  
Cellular behaviour, such as proliferation, differentiation, metabolism, motility, gene 
and protein expression and response to stimuli are all strongly influenced by the 
surrounding microenvironment. Evidently, it has been reported that these factors can 
be impeded and in some cases not present whatsoever within 2D environments 
(Chen et al., 1997; Itano et al., 2003; McBeath et al., 2004; Singhvi et al., 1994). It 
has been suggested that in 2D cultures, cell attachment onto planar surfaces occurs 
on one side of the cell, thus becoming flatter (von der Mark et al., 1977), and losing 
their differentiated phenotype (Petersen et al., 1992). Conversely, in 3D cultures, cell 
attachment occurs around the entire surface of the cell, thus regaining their 
physiological form and function (Baker and Chen, 2012). In general, cell attachment 
and spreading on 2D substrates occurs within a few minutes or hours, however in 3D 
this process can take several hours and even days (Khetan et al., 2013). Table 1.1 
summarises the advantages and disadvantages of both culturing methods.  
Several studies have reported the use of 3D culture models over the commonly used 
2D monolayer culture format (Ghajar and Bissell, 2010; Lee et al., 2007; Pampaloni 
et al., 2007; Rizki et al., 2008; Santiago-Walker et al., 2009) specifying their evident 




advantages in providing a more physiological milieu and being able to recapitulate 
the architecture of living tissue.  
3D cultures can be specifically synthesised using various substrates and scaffolds, 
thus providing environmental conditions that closely mimic those observed in vivo 
(Edmondson et al., 2014). The addition of the third dimension is a crucial feature, not 
only having an influence on the spatial organisation of the cells, but also inducing 
physical constraints. These spatial and physical constraints have a direct impact on 
the interactions between cells and their environment thus influencing various 
processes, such as differentiation (Weaver et al., 1997), proliferation (Bhadriraju and 
Chen, 2002) and cell-cell and cell-matrix signalling pathways, all which may not be 
observed in 2D (Baker and Chen, 2012; Hubbell, 1995; Kim et al., 2004).  
  




Table 1.1: Summary of the advantages and disadvantages of 2D & 





Cost effective Cells only form monolayers 
Ease of use 
Reduced cell-cell and 
biomechanical interactions 
Fast results Reduced signalling 
3D 
More accurate representation of 
in vivo environment and cell 
morphology & signalling 
Complex culture system 
Lack vasculature and normal 
transport of small molecules 
Cells can grow in multiple layers Increased expense 
Cell-cell and cell-ECM signalling 
present 
Require sophisticated imaging 
platforms 
 
1.3.1 Two-dimensional in vitro models 
Historically cell migration experiments were performed via in vitro scratch assays, as 
described (Liang et al., 2007), whereby a wound is inflicted on a confluent monolayer 
of cells and the ability of the wound to close is assessed by capturing images at 
various time points using a phase contrast microscope. The simplicity and low cost of 
the assay allows us to study movement of cell populations, thus producing 
quantitative migration value. However the scratch assay does not permit the study of 
chemotactic (chemical) or haptotactic (substrate) agents; for this, a commonly used 
migration assay system, based on that developed by Boyden (Boyden, 1962) to study 
neutrophil migration, is employed. Often documented as the Boyden Chamber Assay, 
in this method, a cell suspension is placed in an upper chamber of a sterile plastic 
insert, allowing cells to migrate through a cell-permeable membrane towards a 
chemotactic or haptotactic agent placed below the membrane.  
However, while this assay measures migration, it still does not accurately depict the 
migration of cells within an in vivo environment, where invasive and metastatic cells 
must pass through cross-linked fibrillar-based matrices including the BM and 
underlying stroma in order to disseminate. BMs are thin (20-300nm (Laurie et al., 
1982)) sheets of continuous of ECM that separate epithelial tissues from adjacent 
stroma (Vracko, 1974). The BM is composed of large structural proteins, such as 




laminin-5 (laminin-332), heparin sulphate and collagen type IV. These proteins form 
an organised scaffold to provide structural support to epithelial tissue but also offer 
functional input to modulate cellular and thus tissue function (Laurie et al., 1982; 
LeBleu et al., 2007; Timpl et al., 1979). BMs act as a physical barrier to the passage 
of cells and macromolecules unless it becomes more permeable, as occurs during 
tissue development, wound repair and at inflammatory sites (Liotta, 1984).  
For many years it has been know that BM can be degraded by specific enzymes 
secreted from invasive cells such as cancer cells, thus allowing them to cross the BM 
towards lymphatic or vascular systems (Nicolson, 1982). As I will show later, it may 
be that many tumour cells can invade due to the invasive behaviour of host cells 
native to the stroma. 
The Boyden Chamber Assay has been modified to assess the ability of cells to invade 
across a reconstituted BM. In these assays the upper membrane of the sterile insert 
is usually coated with a gel-matrix, such as Matrigel® derived from the secretions of 
Engelbreth-Holm-Swarm sarcoma (EHS) (Orkin et al., 1977).  
Matrigel® is meant to represent the physical barrier of the BM and also the 
glycoprotein component. Whilst Matrigel® does include laminin within its composition, 
it is laminin-1 not laminin-5. Moreover, the Matrigel® does not form a cross-linked 
fibrillar matrix like a BM, but does have numerous growth factors and proteases 
embedded within it, unlike a BM (Kleinman and Martin, 2005). Despite the fact that it 
imperfectly replicates a natural BM, Matrigel® has been used to assess invasion 
through a physical matrix barrier (Moutasim et al., 2011; Nystrom et al., 2005; 
Tolboom and Huizinga, 2007). Thus cells must now destroy the gel in order to invade 
through towards the chemoattractant below within the lower chamber (Albini and 
Benelli, 2007).  
Today commercially available plastic inserts, for multi-well plates contain a porous 
permeable membrane permitting cellular invasion. Transwell® inserts possess varying 
pore sizes (ranging 3.0-8.0µm) which can be blocked with gel in order to mimic the in 
vivo invasion process in vitro. Migration of invasive cells is determined by counting 
the cells that have navigated through the gel and the 10µm thick permeable 
membrane (as described (Marshall, 2011)). Additionally, Kenny and colleagues 
developed a 8.0µm pore sized Transwells® model to understand the adhesion and 




invasion of ovarian cancer cells to the omentum, using primary human mesothelial 
cells and primary human omental fibroblasts (Kenny et al., 2007). 
The assays described have many advantages, such as the ease of repetition and low 
cost, but a major disadvantage is that they do not take into consideration the complex 
process of invasion and the dynamic interactions with other host cells which occurs 
within the ECM. Therefore using a 3D in vitro organotypic method to inspect and 
quantify invasion considered a superior representation of the in vivo 
microenvironment. 
  




1.4 3D cell culture techniques 
It is recognised that flat and hard plastics or glass substrates commonly used for cell 
culture are not representative of the ECM environment found in multicellular 
organisms. In fact, tissue specific architecture, homeostasis, mechanical and 
biochemical cues and cell-cell communications are lost under such simplified 
conditions (Bissell et al., 2003; Cukierman et al., 2001; Cukierman et al., 2002; Nelson 
and Bissell, 2006). Cells cultured in a 3D organisation have been reported to exhibit 
biochemical and morphological features similar to their corresponding tissues in vivo, 
such as formation of actin-rich podosomes and invadopodia on migrating and 
invading cells (Artym et al., 2006; Gligorijevic et al., 2012).  
3D culturing methods have been used widely and proved to not only aid the drug 
discovery process but also increase the understanding of mechanical, chemical and 
physical behaviours of cells in vivo. These complex systems are employed by tissue 
engineers, stem cell scientists, cell biologists and cancer researchers (Cairns et al., 
2016; Fong et al., 2014; Wang et al., 2014). Establishing 3D culture systems requires 
the development of precise protocols, new cell lines, well suited 3D imaging platforms 
and sophisticated quantitative analysis techniques.  
Approaches to 3D culture can be broadly categorised as scaffold-based and scaffold-
free platforms; with innovative new materials and a greater understanding of the in 
vivo microenvironment, scientists can now incorporate these discoveries into 
designing novel experimental systems. 3D cultures are not just limited to cancer 
invasion studies, they have been reported in the development and engineering of 
cardiac tissue (Zimmermann et al., 2006) and used to establish an in vitro tool for 
monitoring the process of hippocampal neurogenesis (Usui et al., 2017). Overall, one 
of the most fundamental aspects of in vitro 3D models is the need to mimic the in vivo 
microenvironment as accurately as possible, thus allowing a prediction of cellular and 
tissue response to various stimuli.  
There is no panacea or individual technology that fulfils the needs of all 3D cell culture 
requirements. All tissues are different and therefore users have an array of materials 
and fabrication techniques to develop the most appropriate model for their cell-based 
assays needs.  Several types of 3D culture methods have been developed and can 
be grouped into different formats; (1) cells embedded within a natural or synthetically 
produced matrix; (2) cells cultured in sterile plastic inserts; and (3) cells cultured as 




multicellular aggregates without the use of matrix based substrates.  These different 










Table 1.2: Summary of the different 3D cell culture systems 
3D culture 
system 
Advantages Disadvantages Matrix material needed References 
Spheroids 
Easy and quick to produce 
Cost effective 
HTS compatible 
Easy to image 
Easy to track nanoparticles 
Limited spheroid size 
Lack of matrix interaction 
Potential unrealistic 
particle uptake  
Cells native ECM 
(Kramer et al., 2013; Kunz-
Schughart et al., 2004; Lee 
et al., 2016; Vinci et al., 






Physical, mechanical and 
biochemical environment 
achieved  
Ready to use 
Variety of size formats  




Difficult to image/harvest 
Expensive materials 










(Caicedo-Carvajal et al., 
2011; Hofmann et al., 2008; 
Loessner et al., 2010; 
Tolboom and Huizinga, 2007; 




Precise control of environment 
Real time analysis  
Very sophisticated model 
Skill intensive 
Very expensive materials 
Difficult to reproduce 
exact conditions 
Micro fluid chip 
(Bhise et al., 2014; Huh et 
al., 2011; Hwang et al., 2008; 





*Natural polymers: Collagen, fibrin, elastin, gelatin, fibronectin, vitronectin, hyaluronic acid (HA), alginate, glycosaminoglycan, chitosan, keratin 
+Synthetic polymers: polyglycolic acid (PGA), polylactic acid (PLA), polycaprolactone (PCL), polyethylene glycol (PEG), polyvinyl alcohol (PVA), 
polyhydroxyalkanoate(PHA), polypropylene fumarate (PPF), polyacrylic acid (PAA) synthetic peptides, synthetic DNA and the co-polymers of any of 
these. High-throughput screening (HTS) (Table modified from (Leong and Ng, 2014)). 
3D culture 
system 
Advantages Disadvantages Matrix material needed References 
Organotypic 
cultures 
Built from relevant cells to 









Natural* or synthetic+ 
polymers 
Scaffold inserts 
(Froeling et al., 2009; 
Fusenig et al., 1983; 
Mackenzie, 2004; Mueller et 
al., 2014; Nystrom et al., 
2005; Vorsmann et al., 2013; 
Worst et al., 1982) 
Explant 
cultures 
Native matrix  
Realistic cell-cell interactions 
Study histotypic relationship 
between various cell types 
within an organ/tissue 
Limited supply of sample 
Short experiment time 
Large genetic variations 
Low throughput 
Difficult to image 
None 
(Brandenburger et al., 2012; 
Jain et al., 2009; Meng et al., 
2007) 




1.4.1 Scaffold based 3D culture methods 
Scaffold-based 3D cultures are generated by using either of two techniques; (1) 
seeding cells on to an acellular 3D matrix (e.g. Alvetex® polystyrene scaffold 
(Reinnervate Ltd, UK,  acquired by ReproCELL, Japan) or AlgiMatrix™ alginate 
sponge (ThermoFisher Scientific)); (2) dispersion of cells in a liquid matrix material. 
Commonly used scaffold matrix materials includes biologically derived constituents 
that provide a support for the growth of cells and mimic the ECM environment, such 
as Matrigel® from Corning. Matrigel® (product of EHS mouse sarcoma cells) provides 
additional ECM proteins (laminin type I, enactin and collagen type IV) and an 
abundance of growth factors, such as epidermal growth factor (EGF), fibroblast 
growth factor (FGF), insulin-like growth factor (IGF) and TGF-β (Corning, 2016).  
Other commercially available matrices include; (1) Cultrex® (Trevigen, USA) a BM 
extract, also obtained from purified EHS tumours; (2) Geltrex® (ThermoFisher 
Scientific) a reduced growth factor EHS gel product; and (3) synthetically formed 
hydrogels (polyethylene glycol (PEG)) mixed with naturally occurring ECM 
components (e.g. collagen, heparin, hyaluronan). The BM mimetic matrices can be 
integrated with sterile plastic inserts with cell-permeable supports such as 
Transwells® (Corning) and ThinCerts™ (Greiner Bio-one). 
Hydrogels and ECM mimetic matrices are comprised of networks of cross-linked 
polymer chains or complex protein molecules, that when combined in the optimum 
formula produce a complex nanoscale architecture resembling the native ECM tissue 
environment. Hydrogels serve as highly effective matrices for 3D cell culture due to 
their significant hydrophilic structure, which allows them to retain large amounts 
water, thus making them similar to natural tissue (Ahmed, 2015). Furthermore, 
hydrogels can be used as stand-alone 3D matrices or combined with other 
technologies, such as, a coating reagent for various solid scaffolds (Alvetex® or 
AlgiMatrix™) (Andersen et al., 2015), encapsulating cells plated on to permeable 
supports (Transwell® or ThinCert™) (Torisawa et al., 2011), or within microfluidic 
devices (Sung et al., 2009). 
  




The ECM components of Matrigel® have been reported to activate numerous 
signalling pathways in cancer cells controlling motility (Carpenter et al., 2009) and 
angiogenesis (Languino et al., 1989; Zhou et al., 2004). However such natural 
hydrogels do present the disadvantage of batch-to-batch variation in composition due 
to their isolation from animal-derived sources.  
To circumvent some of the issues related to animal-derived biomaterials, matrices 
have been developed that are animal-free. One such example is the use of hyaluronic 
acid (HA) as a biologically derived matrix (David et al., 2008; Pan et al., 2015), which 
can be modified by the addition of ECM components, such as collagen (Suh and Lee, 
2002) for improving cell proliferation and attachment (Lam et al., 2014a).  
Hydrogels comprised entirely of synthetic polymers and non-natural molecules are 
PEG hydrogels and have been used to form bioerodible hydrogel film coatings at 
wound sites in animals (Sawhney et al., 1994). PEG gels provide structural support 
for a variety of cell types however they are biologically inert. Moreover they have been 
shown to maintain viability of encapsulated cells whilst allowing for ECM deposition 
as the hydrogel degrades (Bryant and Anseth, 2002). 
 
1.4.2 Scaffold-free 3D culture methods 
Scaffold free cultures have existed since the 1970’s, when Robert Sutherland 
successfully cultured spheroids using spinner flasks (Sutherland et al., 1970) and 
shortly after cultured multicellular spheroids using Chinese hamster v79 lung cells 
resembling the nodules observed in several animal and human carcinomas 
(Sutherland and Durand, 1984; Sutherland et al., 1971). Scaffold-free models 
primarily consist of multicellular aggregates, often referred to as spheroids.  
Cellular spheroids are relatively simple to culture and an easy way to make 3D models 
that can be generated from different of cell types, such as the formation of single 
celled cancer spheroids using non-small cell lung carcinoma (NSCLC) A549 (Zanoni 
et al., 2016) or Colo-699 lung cancer cells (Amann et al., 2014), and furthermore 
formation of neuro-spheroids using pluripotent stem cells for Alzheimer’s disease 
(Lee et al., 2016).   




Tumour spheroids have become a very commonly used and versatile scaffold-free 
method, due to their availability and ability to mimic the heterogeneous population of 
cells with areas of proliferation and quiescent centre’s (Ware et al., 2016) (Mehta et 
al., 2012).  
Multicellular spheroids can be generated using a variety of techniques; (1) forced-
aggregation suspension technique obtains a homogenous population of uniform sized 
spheroids (Yamada and Cukierman, 2007) (Baraniak and McDevitt, 2012); (2) the 
hanging droplet technique, whereby cells are cultured in an aliquot of suspended 
media and incubated under the correct physiological conditions until 3D spheroids 
are formed (Ware et al., 2016) (Foty, 2011); (3) agitation-based approaches include 
gyratory rotation techniques and stirred suspension culture systems to regulate 
spheroid formation through cell-cell collisions. (Breslin and O'Driscoll, 2013; Serra et 
al., 2012).  
Multicellular spheroids can be custom made, using a range of cell lines and varying 
in final spheroid size (150-500µm in diameter). Spheroids, much like tumours, usually 
contain a heterogeneous population of cells that are proliferative at the periphery and 
less or non-proliferative within core. A situation that resembles tumour edges adjacent 
to capillaries in vivo. Also similar to some tumours, the inner-most cells gradually 
become quiescent and eventually die by apoptosis or necrosis, thus forming a 
necrotic core (Ryan et al., 2016). These changes occur in both spheroids and 
tumours, due in part to the limited inward and outward diffusion of nutrients and 
oxygen, resulting in hypoxia, accumulation of waste products and changes in pH 
(Acker et al., 1987; Carlsson and Acker, 1988; Vinci et al., 2012). 
 
1.4.3 Limitations of 3D cell culture models 
Several categories of 3D culture methods have been developed and are summarised 
in Table 1.3. Cells cultured within a 3D mimetic architecture have been shown to 
exhibit similar biochemical and morphological features corresponding to tissues in 
vivo. For example, the ability of breast cancer cells to form invadopodia (membrane 
protrusions specialised in degrading ECM) via upregulation of EGF (Yamaguchi et 
al., 2005) and the formation of functional acini as observed in vivo when mammary 




epithelial cells were cultured on 3D collagen type I: laminin-1 gels (Gudjonsson et al., 
2002).  
Development of new materials and technologies has been driven by scientists to 
incorporate experimental systems that better represent the in vivo physiological 
microenvironment into their research. Establishing 3D cultures as a mainstream 
approach holds great promise for drug discovery, however requires the development 
of precise protocols, new cell lines, well suited 3D imaging platforms and 
sophisticated quantitative analysis techniques.  
3D cultures possess specific limitations and disadvantages, for instance, most of the 
existing models only represent the biochemical characteristics of in vivo tissue during 
static conditions (Mathes et al., 2010). Additionally, using scaffold-based systems 
introduces reproducibility issues due to batch variation from commercially purchased 
matrices. Importantly use of animal-derived products potentially increases the risk of 
transmitting infections or disease (Raghunath et al., 2007).  
Furthermore, 3D spheroid cultures may bring additional drawbacks with increased 
drug resistance possibly due to geno- and phenotypical changes induced by 
spheroids (Karlsson et al., 2012). Moreover, not all systems are imaging-friendly due 
to their opacity or contain auto-fluorescent component, thus generating high 
background fluorescence.  
Another major limitation is cost; the simple fact that 3D culture systems are expensive 
is one of the main reasons why it has not yet been fully integrated and utilised within 
industry and drug discovery platforms. Maturity of sophisticated technology platforms, 
expensive consumables (plates, reagents etc.) and data storage facilities all add to 
the cost element. Apart from these reasons 3D cell culture models can be very 
complex, technically challenging and may require specialised consumables, 
equipment or detection techniques. These limitation are however, being overcome 
with improved 3D assays and emerging technology platforms. 
Numerous 3D models within academia have been developed to focus on specific 
applications. Examples include, development of 3D prostaspheres to model growth, 
invasion and drug response using 29 different prostate cancer cell lines (Harma et 
al., 2010). Additionally, Loessner and colleagues reported that ovarian cancer cells 
(OV-MZ-6 and SKOV-3) formed and sustained 3D spheroids when cultured on PEG-




based hydrogels and showed mRNA expression of the cell surface receptors 
α3/α5/β1 integrins and the protease matrix metalloproteinase-9 (MMP-9) were 
increased in cells within the 3D spheroids compared to 2D monolayer cultures 
(Loessner et al., 2010). Furthermore, the development of a human lung ‘small airway-
on-a-chip’ was reported to identify new therapeutics for chronic respiratory diseases 
(Benam et al., 2016).  
By contrast the pharmaceutical industry are in search of a standardised 3D cell culture 
model which fits their stringent assay requirements. Such assays are required to be; 
(1) cost efficient; (2) reliable; (3) reproducible; (4) built into a standardised automated 
work flow; and (5) informatics integrated. Therefore the pharmaceutical industry aim 
to identify potential therapeutic targets by combining biological relevance with 
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1.5 Organotypic culture models 
The term ‘organotypic’ describes tissue, removed from an in vivo host organ, placed 
and cultured in vitro in the hope that it continues to function physiologically and 
develop as it would within the original organ. The removed tissue is immediately 
placed into an in vitro substrate, supplemented with the necessary growth medium 
and maintained under physiological conditions. 
During the last 47 years organotypic cultures have immensely advanced and been 
widely reported for their use within the dermatology, neuroscience and oncology 
research fields. The first detailed description of an in vitro brain tissue culture was 
published using an organotypic cerebellum model in the early 1970’s (Hauw et al., 
1972; Wolf, 1970). Followed by the breakthrough made by Gähwiler, who cultured 
organotypic rat brain slices using the roller tube technique to model functional 
synaptic connections, neuronal differentiation and the effects of slowly acting 
neurotoxins on synaptic transmission (Gahwiler, 1981a, b, 1988).  
 
1.5.1 Organotypic skin cultures 
Organotypic skin culture (OSC) models have been utilised for the in vitro growth of 
complex biological tissues to replicate normal and diseased function and physiology 
(Bernerd and Asselineau, 2008; Carlson et al., 2008; Coleman et al., 2014b; Froeling 
et al., 2010; Igarashi et al., 2003; Mackenzie, 2004; Mackenzie and Fusenig, 1983; 
Mueller et al., 2014; Nystrom et al., 2005; Schneider et al., 2008; Vorsmann et al., 
2013). Commonly used models are probably those of skin, consisting of keratinocytes 
grown on top of a collagen rich matrix populated with embedded dermal fibroblasts 
that are then fed from below using specialised growth medium (creating an important 
air-liquid interface) and exposed to humidified air. This tissue-air model has the ability 
to reproduce the 3D stratified organisation of normal skin in vivo.  
Before the practice of using animal derived collagen lattices, split-thickness human 
allografts, derived from cadaveric donors, were commonly used to temporarily cover 
and treat wounds from thermal burns (Macmillan, 1962). 
  




During the early 1970’s German oncologist, Norbert Fusenig, started what lead to a 
series of influential discoveries that have moulded the way OSCs are executed in the 
laboratory today. In 1971, Fusenig successfully isolated epidermal cells from mouse 
skin and continued to culture them on collagen lattices (Fusenig, 1971). A few years 
later, he and his group grafted intact cultures of epidermal cells, grown on collagen 
gels, back onto the mouse recipient, thus investigating the function of epidermal skin 
grafts (Worst et al., 1974).  
This led to further investigations; from using dermal equivalents (native collagen type 
1 extracted from rat tail tendons) for organotypic co-cultures, whereby mammalian 
cells were isolated, and cultured in vitro and either re-implanted or used to study 
geno- and phenotypic characteristics from human skin carcinomas (Boukamp et al., 
1982; Fusenig et al., 1983). To the development of epidermis dissociated cells 
originally from neonate mouse skin (Mackenzie and Fusenig, 1983; Worst et al., 
1982) and furthermore, to the cultivation of skin grafts, grown on collagen lattices, 
embedded with fibroblasts exhibiting vascularisation and wound healing 
characteristics (Bell et al., 1981). 
Similarly In 1979 a group at the Massachusetts Institute of Technology (MIT) used 
OSC’s to study skin cell function and would healing. They observed that fibroblast 
cells were capable of interacting with collagen fibrils to produce a denser 
arrangement, thus having a direct impact on the rate and extent of lattice contraction 
(Bell et al., 1979).  
These breakthroughs have since increased the usage of this particular style of 3D 
model to; (1) successfully culture acceptable artificial skin in the treatment of 
extensive burn injuries (Burke et al., 1981; Tompkins and Burke, 1990); (2) perform 
mechanistic studies of skin physiology for pharmacotoxicologic keratinocytes studies 
(Stark et al., 1999); (3) improve experimental designs to assess cutaneous skin 
photo-reaction, photo-damage and photo-protection for use within the cosmetic 
industry (Bernerd and Asselineau, 2008; Dreher et al., 2002); and (4) construct large 
organotypic cultures of oral mucosa and skin as potential tissue grafts to repair oral 
wounds (Igarashi et al., 2003). 
  




1.5.2 Organotypic culture models in cancer 
An organotypic cancer model must have the capability to emulate, as closely as 
possible, the physiological tumour-stromal microenvironment as seen in vivo. 
Engineered organotypic models are expected to recapitulate the natural features of 
tumour progression, which include cell invasion through basement membranes, 
oncogenic signalling and mimicking of the spatial organisation as well as the 
elaborate architecture of the ECM. 
Achieving all of these parameters for all of the various types and stages of cancer is 
a near impossible task. Consequently, many groups have designed unique tailor-
made organotypic cancer models addressing a specific investigative question. For 
example, to investigate the behaviour of melanocytes and of human melanoma cells, 
Eves and colleagues, used reconstructed de-epidermised human dermis (DED) 
composite in order to determine if pigmentary and invasiveness are influenced by 
interaction with co-cultured keratinocytes and fibroblasts (Eves et al., 2000). 
Additionally, Caswell and colleagues used a scaffold-based model (8.0µm pore size 
Transwell® inserts) to report the interaction between the cytodomain of the β1 integrin 
and Rab25 (a GTPase linked to tumour aggressiveness and metastasis) that strongly 
promotes an invasive mode of cell migration through a 3D fibronectin-containing ECM 
(Caswell et al., 2007). 
 
1.5.3 Large organotypic gel cultures 
In 1979 Bell and colleagues showed that skin fibroblasts seeded into collagen lattices 
severely contracted and also noted that contraction was cell and protein concentration 
dependent (Bell et al., 1979). In addition, suspensions of epidermal cells that were 
applied to the contracted lattices rapidly covered the entire surface and produced a 
differentiated phenotype (Bell, 1979). Demonstrating that collagen and isolated 
fibroblasts support an in vitro skin-like model. Our laboratory regularly and 
continuously uses the organotypic skin culture model developed by Fusenig and 
colleagues (Fusenig et al., 1983). In their study, Nystrom and colleagues, developed 
a method to quantify squamous cell carcinoma (SCC) invasion using an organotypic 
gel culture model (Nystrom et al., 2005). Human fibroblasts were embedded within a 
collagen gel and aliquoted into a 24-well plate (1ml per well) before being placed in 




an incubator for 18 hours to polymerise. The next day keratinocytes were added on 
top of the polymerised fibroblast-containing gel. The following day, gels were removed 
from the 24-well plate and placed on to the individually collagen coated nylon squares 
which were rested on steel grids, housed in a 6-well plate. Sufficient media were 
added to reach the under surface of the gel allowing the cells to grow at an air-liquid 
interface. The gels were then fixed in formalin at specific time points and processed 
to paraffin for histological staining (Figure 1.2). Furthermore, Nystrom and colleagues 
grew organotypic gels in vitro for seven days before grafting the gel under the skin of 
nude mice. An invasion index was calculated from cytokeratin stained sections based 
on a the product of average depth of invasion, number cell colonies invaded and the 
total area of cells invaded below the overlying ‘epithelium’ providing a quantitative 
tumour invasion value (described in detail (Nystrom et al., 2005)).  
Fusenig’s model has since been widely used as 3D physiomimetic model to assess 
skin keratinocyte and fibroblast form and function (Parenteau et al., 1992), as well as 
being used to study the variation within growth rates and patterns of different OSCC 
cell lines, thus providing an in vitro model to assess tumour cell behaviour 
(Mackenzie, 2004). 
In addition, Marsh and colleagues used the organotypic skin culture method to identify 
that the integrin αvβ6 is expressed at significantly higher levels in aggressive 
morphoeic basal cell carcinomas (Marsh et al., 2008). Similarly, adaptions of this 
model have been utilised within our department to study the role and mechanisms of 
cell-cell interactions (E-cadherin, β-catenin and Ezrin) in modulation of pancreatic 
cancer progression. In this adaption of the model, Froeling and colleagues, firstly 
isolated normal and cancer-associated pancreatic stellate cells (PSCs) and co-
cultured with pancreatic cancer cells (capan-1 and PaCa-3) (Froeling et al., 2010; 
Froeling et al., 2009).  
Additionally, retinoic acid treated organotypic gels were reported to induce 
quiescence and reduce motility of PSCs, thus resulting in reduced levels of pancreatic 
cancer cell proliferation (Froeling et al., 2011). Furthermore, the use of organotypic 
gels revealed that the nuclear translocation of fibroblast growth factor receptors within 
pancreatic stellate cells mediates invasion of cancer cells (Coleman et al., 2014a). 
Moreover, Kadaba et al, demonstrated that tumour-stroma interactions within the 




pancreas altered cell cycle, motility, proliferation and signalling in addition to changing 








Figure 1.2: Development of organotypic gels 
A) Gels composed of collagen type I (5.25 volumes) and Matrigel® (1.75 volumes), DMEM 10x, (1 volume), standard DMEM (1 
volume) and of FBS (1 volume). 5 x 105 fibroblasts cells (green) are embedded within the gel. 1ml of gel solution aliquoted into 
a 24-well plate and incubated at 37°C for 18h (Day 0). B) The next day 5 x 105 tumour cells (red) are placed on top of the gel 
and placed in the incubator (start of day 1). Meanwhile the same day, a fibroblast-free collagen gel is made to coat sterile nylon 
sheets. C) The following day, the gels are lifted out of the 24-well plate using a sterile spatula and placed on top of a collagen 
coated nylon square and elevated on a metal grid (2.5cm2 squares of stainless steel mesh with edges bent down to form 4-5mm 
legs). The steel grids are placed in a 6-well dish and a sufficient volume of serum-containing medium is placed underneath the 
grid. The medium coats the under surface of the nylon square creating an air-liquid interface. 
 
  




1.5.4 Limitations of large organotypic gel cultures 
As previously discussed, the practice of organotypic gel culture methods within 
cancer research provides a reliable and reproducible model, which has been used to 
quantify the growth and invasiveness of numerous cancer cell lines using standard 
pathology. It is highly adaptable and enables the user to incorporate different cell lines 
or matrices enabling a broad range of questions to be answered and allows for 
implantation in vivo. Thus creating a unique and customisable 3D modelling 
technique. However there are several drawbacks of this particular 3D in vitro model; 
(1) large numbers of cells are required for each experiment (5 x 105)  fibroblast and 
tumour cells for one gel); (2) large volumes culture media and expensive reagents 
(collagen and Matrigel®) are required to sustain and construct the gels; (3) the assay 
lasts 2-3 weeks followed by several days of histological processing before samples 
are available for analysis; (4) due to the low-throughput assay format drug or gene 
screening cannot be supported without incurring heavy expenditure; and (5) the final 
data are generated from tissue sections of the organotypic gels, thus only producing 
2D data after going to great lengths to create an elaborate 3D microenvironment. For 
these reasons it is necessary to create a cheaper and faster model. 
 
1.5.5 Miniaturising organotypic gel cultures 
With consideration to the limitations witnessed in the large organotypic gel cultures, 
our laboratory has miniaturised and optimised this assay to recapitulate the tumour-
stroma interface as observed in the conventional model. With the use of sterile plastic 
Transwell® inserts, similarly used for inverse cell invasion studies (Caswell et al., 
2008; Caswell et al., 2007), our laboratory employ inserts of 0.4µm pore size to 
guarantee cells do not traverse the permeable membrane. By coating the membrane 
with a collagen: Matrigel® rich gel, we have generated a physiologically biomimetic 
system that attempts to recapitulate the in vivo tumour-stroma microenvironment. The 
Transwell® inserts, possess a 6.5mm diameter polycarbonate translucent membrane 
with an approximate growth area of 0.33cm2. Each Transwell® rests inside a 24-well 
plate and is approximately elevated 5mm above the bottom of the well, thus creating 
the air-liquid interface (Figure 1.3). A detailed description of the protocol is described 
in Section 2.3.1. 




The 3D mini-organotypic invasion assay has several major advantages over the 
conventional large organotypic model, namely; (1) requiring only 1/10th of the volume 
of gel (100µl per well); (2) the gel is plated directly into the Transwell® insert and 
remains inside for the duration of the assay; (3) each gel requires only a total of 105 
cells, in a 2:1 ratio of fibroblast to tumour cells (ratio was determined by a previous 
PhD student, data not shown); (4) increased speed and ease of experimental 
configuration; (5) requires less media and reagents, therefore reducing costs; and (6) 
miniaturisation enables flexibility and diversity in experimental design, permitting drug 









Figure 1.3: Development of mini-organotypic gels 
A) 100μl of collagen: Matrigel® mix plated into a 6.5mm diameter, 0.4μm pore size Transwell® permeable support housed in a 
24-well plate. Gel is incubated at 37°C for 45-60 minutes until set. B) 200μl suspension containing a known number of fibroblasts 
and tumour cells in a 2:1 ratio respectively is placed on top of the gel. 600μl of serum-containing media is added in the outer 
well. C) After 10-14 days gels are then fixed in formalin overnight and processed to paraffin. Histological sections can be cut 
and stained for quantitative 2D analysis. 
 
  




1.5.6 Limitations of 3D mini-organotypics 
Whilst no model has been yet developed to perfectly recapitulate the tumour 
microenvironment. This novel 3D mini-organotypic invasion assay allows us, at least 
in part, to mimic the stromal microenvironment, thus permitting the early stages of 
metastasis and cancer progression to be monitored. This intricate yet robust model 
allows the user to customise the organotypic gel composition to produce the desired 
tissue microenvironment. Additionally any cell type can be embedded within or on top 
of the gel and observations regarding, invasion and cell morphology can be measured 
on the histological stained sections of the fixed gels. Furthermore, with the use of 
Transwell® permeable supports, users now benefit from 10 mini-organotypic gels for 
the same volume required to make one large organotypic gel.  
However, the limitations of the miniaturised model is the cost of the inserts 
(£170/case) and the lengthy fixation and histological processing required at the end 
of the assay. Additionally, staining, imaging and analysis, is slow, similar to the large 
organotypic gel system. Therefore performing functional screening or validation tests 
would require pro-longed periods of time before any analysis and conclusions can be 
examined. Furthermore, the same Transwell® cannot be monitored repeatedly over a 
set period of time and the user has to rely on technical repeats follow a process over 
time.  
Therefore, it would seem imperative to design and develop a 3D mini-organotypic 
invasion assay that could permit functional screening as well as providing a means 
for faster delivery of results.   




1.6 Tumour-stromal microenvironment 
The composition of the tumour-stromal microenvironment is a complex mixture of 
connective tissue and extracellular space, filled with cellular (immune, endothelial, 
fibroblast, dendritic, macrophage, T and B cells) and non-cellular (ECM) components 
which facilitate homeostasis of normal tissue (Li et al., 2007a). The supporting role of 
the microenvironment towards metastasis was originally asserted by Paget’s ‘seed 
and soil’ hypothesis (Paget, 1989). Paget’s theory has led to the premise that survival 
of cancer cells within the tumour-stroma microenvironment depends, not only on their 
ability to adhere and attach, but also to infiltrate, receive sustenance and thrive within 
the ECM. 
 
1.6.1 The Extracellular Matrix (ECM) 
Once thought of as an inert scaffold, the ECM, is a multi-component, proteinaceous 
network, containing reservoirs of growth factors and intricate structural architectures, 
which is essential for supporting tissue organisation and cellular survival (Hynes, 
2009).  
The non-cellular component of connective tissue is formed of two main classes of 
macromolecules; (1) large linear polysaccharide chains, named glycosaminoglycans 
(GAGs) (e.g. HA, chondroitin sulphate (CS), dermatan sulphate (DS), heparan 
sulphate (HS) and keratin sulphate (KS)) which are covalently attached to a protein 
in the form of proteoglycans (PGs) (e.g. aggrecan, brevican, decorin, keratocan, 
lumican, neurocan, perlecan, syndecans and versican); and (2) fibrillar proteins (e.g., 
collagen, elastin, fibronectin and laminins) (Alberts et al., 2002). GAGs provide 
mechanical support to the ECM and maintain gel integrity by drawing in copious 
amounts of water due to their negative charge and hydrophilic properties. Whereas, 
the fibrous proteins (produced and secreted mostly but not exclusively by fibroblast 
cells) provide structural support to the 3D architecture of the connective tissue.  
The ECM provides multi-functional biochemical and biomechanical cues that can; (1) 
function as an adhesive substrate to track and direct migrating cells; (2) provide a 
scaffold upon which tissues are organised yet also provides integrity and elasticity to 
developing organs; and (3) facilitate crosstalk between growth factors and their 




cellular receptors in order to control spatial distribution of ECM molecules (Frantz et 
al., 2010; Pickup et al., 2014). 
A non-component, but an important mediator receptor protein between the ECM and 
the cells are the adhesion molecules called integrins. Integrins are a fundamental 
family of heterodimeric cell membrane adhesion receptors that mediate cell-to-cell or 
cell-to-matrix interactions and facilitate cell adhesion, invasion, migration and survival 
(Barczyk et al., 2010; Hynes, 1992). Since their original discovery in 1987 (Hynes, 
1987) integrin recognition has become widely expressed and to date there 24 different 
functional integrins formed in humans (Hynes, 2002) composed of 18α and  8β  paired 
subunits. Each heterodimer has a different pattern of ligand specificity, for example, 
αvβ3 binds to fibronectin, vitronectin and more weakly to collagen and laminin, 
whereas α5β1 selectively binds predominantly to fibronectin (van der Flier and 
Sonnenberg, 2001). Integrin α6β4 is a laminin binding integrin that is an essential 
component of hemi-desmosomes anchoring keratinocytes to the BM (Geuijen and 
Sonnenberg, 2002; Wilhelmsen et al., 2006).  
Additionally, integrins are able to transduce signals bi-directionally sending 
intracellular signals following ligand binding (known as outside-in signalling) or when 
talins or kindlins bind to cytoplasmic β tails resulting in integrin activation (known as 
inside-out signalling) (Bledzka et al., 2012; Harburger et al., 2009). Integrins in cancer 
have been reported to facilitate various functions, examples include, αvβ3 and αvβ5 
Integrins were reported to inhibit tumour angiogenesis in animal models (Kumar et 
al., 2001) and have been reported to play key roles in vascular development (Hynes 
et al., 1999). Additionally, loss of α6 and/or β4 in basal cells coincides with loss of BM  
proteins in oral carcinomas (Downer et al., 1993). Furthermore, in 2001 our laboratory 
retrovirally infected a population of αv-negative oral SCC (H357) with β6 cDNA, 
creating the high αvβ6 expressing cell line (VB6) (Thomas et al., 2001a). Thomas and 
colleagues reported that expression of αvβ6 promoted invasion of the SCC cells 
through up-regulation of MMP-9 (Thomas et al., 2001c). More recently Moore and 
colleagues reported that simultaneous targeting of αvβ6 in combination with 
trastuzumab may potentially be effective against human epidermal growth factor 
receptor 2 (HER2) positive breast cancer (Moore et al., 2014). 
  




1.6.1.1 Components of the ECM 
Collagen is the most abundant fibrous protein in the body and is an essential 
structural element of all connective tissue. The majority of interstitial collagen is 
secreted by fibroblast cells that reside within the ECM or are recruited by 
neighbouring tissues. Collagen fibres are intricately interwoven with carbohydrate 
molecules called proteoglycans, producing resistant, strong fibril bundles within the 
tissue stroma that provide tensile strength, regulate cell adhesion, support migration 
and tissue development (Gelse et al., 2003; Ricard-Blum, 2011). To date 28 types of 
the collagen superfamily have been identified in vertebrates (Gordon and Hahn, 
2010), of which, fibrillar collagens (type I, II and V) are most abundant in humans 
(approximately 90% of all collagens). Forming densely packed long (200-300nm) thin 
(15-50nm) fibrils and are prevalent in bone, cartilage, connective tissue, ligaments, 
skin and tendons (Gelse et al., 2003; Miller, 1985). Despite the large structural 
diversity amongst the different collagen types, all members of collagen have a 
common triple helix composed of three distinct α-polypeptide chains. Each chain 
containing an amino acid sequence of poly-L-proline (aka polyproline type II helix) 
(Shoulders and Raines, 2009) which itself contains a glycine residue in every third 
position of the chain resulting in multiple triplet sequences of a (Gly-X-Y)n  repeat, 
where X and Y are often proline and 4-hyrdoxyproline respectively (Adzhubei et al., 
2013). 
Some collagens have restricted expression and functions, for example, type IV 
collagen, with its more flexible triple helix, can assemble into an intricate meshwork 
and expression is restricted to the basement membrane forming a sheet-like structure 
(Laurie et al., 1982). Similarly to type II, type IX collagen was reported in the formation 
articular cartilage in adults and type V associated with corneal formation (Ricard-
Blum, 2011). It is common in many cancers including breast, pancreatic and skin to 
observe high levels of collagen type I deposition in vivo, thus forming a fibrotic (aka 
desmoplastic) stroma (Barsky et al., 1982; Ibbetson et al., 2013; Imamura et al., 
1995). Breast cancers are often first detected as a collagen-dense shadow on X-rays 
and their growth and metastasis is shown to correlate with progression in collagen 
density (Levental et al., 2009; Provenzano et al., 2008). Thus collagens are major 
controllers of cellular behaviour. 
 




Elastin, an associate of collagen and another major ECM protein, serves an important 
role, by providing elasticity to tissues that undergo repeated bending, stretching and 
recoil (Frantz et al., 2010). Elastin stretch capability is highly important and has been 
reported to be limited by its associations with collagen fibres (Wise and Weiss, 2009). 
Elastin provides crucial resilience to many tissues including, arteries, lung, tendons 
and skin. These resilient fibres are comprised of two components, the elastin protein 
and microfibrils (such as fibrillin). Elastin is rapidly assembled during cross-linking 
and polymerisation of its soluble precursor, tropoelastin, thus forming elastic fibres   
(Mecham, 2008; Wagenseil and Mecham, 2007).  
Fibronectin mediates not only organisation of the ECM but also cellular adhesion, 
growth and migration (Pankov and Yamada, 2002). Fibronectin, is a large 
glycoprotein found in all vertebrates that binds to cell surface receptors (such as 
integrins) during ECM development. HT1080 cells were reported to attach through 
the integrin α5β1 when plated on a fibronectin-coated substrate (Friedland et al., 
2009). Fibronectin contains multiple splice variants, which are classified into type I 
(12 domains), type II (two domains) and type III (15-17 domains) (Pankov and 
Yamada, 2002). Additionally, fibronectins importance has also been linked to cell 
migration during development and has been implicated in cardiovascular diseases 
(Astrof et al., 2007).  
Laminin, a large multi-domain glycoprotein was discovered in 1979 as a product of 
EHS cells (Timpl et al., 1979). Together with collagen type IV, nidogen and perlecan, 
laminins are a major component of the ECM. Laminins are extracellular proteins of 
which, 16 known isoforms are produced from combinations of α, β and γ chains (as 
reviewed by (Aumailley et al., 2005; Tzu and Marinkovich, 2008)). Laminins have 
been reported to have a range of important roles, examples include; (1) laminin-5 (or 
-α3β3γ2) play a significant role in BM assembly and providing structural support to 
the ECM (Nishiyama et al., 2000); (2) laminin-211 (previously known as laminin-2 or 
laminin-α2β2γ1) was found predominantly in skeletal muscle tissues and serves as 
an anchor between glycoprotein complexes that lie at the surface of muscle cells and 
the surrounding ECM (Helbling-Leclerc et al., 1995); and (3) implications in the role 
of cell migration and motility. Zhang and Kramer demonstrated that for maximal cell 
motility, human foreskin keratinocytes secrete laminin-332 (laminin-5 or -α3β3γ2) 
when plated on to collagen type I or fibronectin coated substrate (Zhang and Kramer, 
1996). Thus, it is not surprising that laminins have also been implicated with the 




tumour invasion process. For example, high levels of laminin-γ2 chains were 
expressed at the leading invasive edges of human cervical (Noel et al., 2005),  colon 
(Pyke et al., 1995) and lung cancers (Maatta et al., 1999). 
Tenascins, another large ECM glycoprotein family member, are comprised of 
tenascin-C, -R, -W and –X all of which contribute to structure and physiology of 
connective tissue. Three of the four (-C, -X and –R) have been characterised in 
mammals (Chiquet-Ehrismann, 1995; Erickson, 1993). The first and best described 
member of the tenascin family (tenascin-C) was discovered in 1983 (Bourdon et al., 
1983) and is hexameric protein highly expressed in connective tissues which 
surround inflamed tissues, tumours or wounds, where it may regulate cell growth and 
migration via intracellular signalling (Chiquet-Ehrismann and Tucker, 2004; Orend 
and Chiquet-Ehrismann, 2006). Tenascin-C has been reported to be involved in 
tumour invasion (De Wever et al., 2004), migration (Herold-Mende et al., 2002) and 
stimulate tumour angiogenesis (Ishiwata et al., 2005; Tanaka et al., 2004). Whereas, 
Tenascin-R is expressed and plays an important role within the central nervous 
system (as reviewed by (Anlar and Gunel-Ozcan, 2012)). Tenascin-X, the largest of 
the tenascin family members, is the only member to exert crucial architectural 
functions and is located in loose connective tissue during both development and 
adulthood (Valcourt et al., 2015). Tenascin-W, the last member of the tenascin family 
to be discovered was first described in zebrafish (Weber et al., 1998) and similar to –
C, is highly expressed within connective tissue (Martina et al., 2010) but also been 
linked as an efficient biomarker for human breast (Degen et al., 2007) and colorectal 
cancer (Degen et al., 2008). 
The ECM components discussed above are all involved with the matrix scaffold, 
either as a structural constituent (collagen, elastin) or as a molecular adhesive 
between the matrix and cells (integrins). PGs however, are also essential to the ECM 
of connective tissues, their major biological function is derived from the GAG 
component of the molecule, which is to provide hydration and swelling pressure to fill 
extracellular tissue and enable it to withstand compressional forces (Yanagishita, 
1993). PGs (such as aggrecan, brevican, decorin, keratocan, lumican, neurocan, 
perlecan, syndecans and versican) are glycosylated proteins which have highly 
anionically charged GAGs attached to them. GAGs are large (4-8000 kDa), linear 
sulphated (except HA which is non-sulphated), polysaccharide chains, with an 
alternating repeating disaccharide unit, comprised of an acetylated amino sugar 




group with uronic acid (CS, DS, HS and KS) (Gandhi and Mancera, 2008; Perrimon 
and Bernfield, 2001). The simplest non-sulphated GAG, HA, abundant in the ECM 
and cell surfaces has been implicated during important functional roles, including 
embryonic development (Camenisch et al., 2002), wound healing (West et al., 1997) 
and deposition of HA in tumour tissue was associated with malignant progression of 
colorectal cancers (Ropponen et al., 1998). The resulting PG/GAG complexes form 
a variety of combinations, the most common being perlecan and aggrecan. Perlecan 
or heparan sulphate proteoglycan (HSPG), which has been linked to angiogenesis 
and blood coagulation (Sarrazin et al., 2011). Aggrecan or chondroitin sulphate 
proteoglycan (CSPG) is essential for providing hydration to articular cartilage via its 
link to HA and resistant, smooth surfaces via its link to collagen type II (Kiani et al., 
2002). 
 
1.6.2 Changes in the ECM during cancer 
The ECM, under normal physiological conditions provides a multi-functional service 
to maintain and organise the cellular dynamics, intercellular signalling and structural 
integrity of the connective tissue (Alberts et al., 2002). However, the ECM can and 
does change, gradually becoming disorganised and deregulated over time as a result 
of miscues. Dysregulation of matrix composition and structure can contribute to 
pathological conditions such as organ fibrosis and cancer (Lu et al., 2011) and 
pathological destruction of cartilage ECM  in osteoarthritis (Dean et al., 1989). A main 
contributor of altered ECM are stromal cells; during normal wound healing, resting 
fibroblasts differentiate and secrete structural proteins (collagens) to form granulation 
tissues mediated through TGF-β stimulation (McAnulty, 2007). However, during 
altered conditions, copious amounts of TGF-β are released from platelets leading to 
increased trans-differentiation of normal fibroblasts to contractile myofibroblasts 
which in turn can lead to excess collagen deposition resulting in fibrosis and increased 
cancer risk (Bissell and Hines, 2011). In addition, ECM remodelling may promote 
intravastation of cancerous cells residing within the tumour-stroma microenvironment 
(Condeelis and Segall, 2003).  
The structural architecture of the tumour-associated ECM is fundamentally different 
to that of normal ECM. For example, tumour cells may undergo morphological 
changes via regulation of Rho GTPases and RhoA and RhoC have been observed in 




human cancers associated with invasiveness (Croft et al., 2004). Therefore initiating 
the Rho-associated kinase (ROCK) pathway to mediate actin-myosin contractility of 
collagen fibres was reported change the orientation of tumour cells and facilitate 
invasion (Han et al., 2016; Provenzano et al., 2006). Furthermore changes in ECM 
stiffness, induced by increased collagen cross-linking and disposition can contribute 
to cancer progression and stiffer matrix of cancerous tissue when compared to normal 
tissue (Paszek et al., 2005).  
It appears that successful metastasis requires a local niche to support tumour cell 
growth but also an environment whereby cancerous cells can disseminate, thus 
allowing them to colonise, proliferate and survive (Chambers et al., 2002; Hart, 1982; 
Hart and Fidler, 1980a, b; Luzzi et al., 1998). Therefore targeting the ECM and its 
enzymes could be a promising potential therapeutic target. 
  




1.7 Fibroblast biology 
Fibroblasts are elongated, spindle-shaped cells that are ubiquitously distributed within 
all human tissue. Fibroblasts are a very resilient cell type and can survive stress-like 
conditions that would be lethal to other cells (Kalluri, 2016). One of the main roles of 
fibroblast cells is to maintain and organise the structural architecture and biological 
integrity of connective tissue by synthesising and depositing ECM components 
(collagens, fibronectins, laminins tenascins and PGs) (Kalluri, 2016).  
For example, fibroblasts have been reported to secrete various type of collagen (type 
I, III & IV) (Li et al., 2007b), which are dragged along the fibrillar matrix of the 
connective tissue and re-modelled by fibroblast movement, thus forming elongated 
fibres. The fibres are subjected to a constant pulling in a magnitude of directions, 
therefore leading to contraction and re-organisation of the tissue.  In addition, 
fibroblasts have been reported in regulating degradation of the ECM through 
production and secretion of enzymes known as MMPs (Baum and Duffy, 2011; Lu et 
al., 2011; Rhee, 2009). 
 
1.7.1 Fibroblasts in wound healing 
Fibroblasts that reside within the ECM are usually quiescent but play an important 
role in the restoration of injured tissue, for example during wound healing. In brief, 
this process is defined by three processes; (1) the inflammatory phase upon the 
inflicted wound; damage to the capillaries activates circulating platelets and triggers 
formation of blood clots consisting of fibrin (Li et al., 2007b). Consequently, the 
platelets release chemotactic and cytokine factors, such as TGF-β and platelet-
derived growth factor (PDGF) which recruit inflammatory cells, including 
macrophages and neutrophils that in turn result in the migration of fibroblasts and 
endothelial cells to the wound site (Darby et al., 2014); (2) formulation of granulation 
tissue involves the migration of keratinocytes over the injured dermis, followed by 
angiogenesis, which is critical for delivery of nutrients to the wound (Darby et al., 
2014). Importantly, it’s at this stage differentiation of the recruited fibroblasts into an 
activated ‘myofibroblast’ phenotype occurs. The most defining physical features that 
distinguish fibroblasts to myofibroblasts is the development of actin stress fibres into 
organised microfilaments, allowing the cells to adopt a contractile phenotype 




(Gabbiani et al., 1971). An additional feature that has been predominantly used as a 
marker of fibroblast differentiation is the expression of alpha-smooth muscle actin (α-
SMA, also known as ACTA2) (Hinz et al., 2012). Myofibroblasts secrete ECM proteins 
(such as fibronectin and collagen type I and III) to form granulation tissue (the scab, 
rich in collagen type III) and provide a scaffold for collagen type I fibrils which mediate 
wound contraction (Li et al., 2007b); (3) resolution of the ECM;  extracellular 
degradation is regulated through myofibroblast secretions of MMPs and tissue 
inhibitors of metalloproteinases (TIMPs), myofibroblasts cells are removed via 
apoptosis and the non-differentiated fibroblasts may exhibit a more quiescent, non-
contractile phenotype (Li et al., 2007b; McAnulty, 2007). Interestingly, in vitro cultured 
fibroblasts are being used commercially as augmentations for tissue repair for a 
variety of conditions, such as acute and chronic wound injuries (Griffiths et al., 2004) 
and healing of extensive burns (Waymack et al., 2000). 
 
1.7.2 Cancer associated fibroblasts (CAFs) 
In 1986 Harold Dvorak published an article entitled, “Tumours: wounds that do not 
heal” (Dvorak, 1986). The article discussed the many similarities between wound 
healing and solid tumours, such as, the excess production of proteins (fibronectin and 
fibrinogen) and the fibrin-fibronectin clot that serves as a provisional stroma to 
surround ECM components (Dvorak, 1986). The novelty of Dvorak’s article was 
based upon two relevant findings; firstly, the discovery of vascular permeability factor 
(VPF, later renamed vascular endothelial growth factor (VEGF)) as a tumour product 
(Senger et al., 1986) and secondly the recognition that chronic vascular 
hyperpermeability (CVH) induced by VPF accounts for the fibrin deposition in solid 
tumours in early stages of wound healing (Dvorak et al., 1979). 36 years later Dvorak 
defended and evaluated the principal relationship between tumours and wound 
healing in light of subsequent research, stating that tumours strongly require stroma 
and depend on their host for survival (Dvorak, 2015). These seminal discoveries from 
the late 1970s have led to a greater understanding of the similarities between wound 
healing and tumour-microenvironment during tumour progression. 
Similar to the myofibroblasts present during wound healing, fibroblasts in the 
presence of cancer cells have also been reported to adopt an ‘activated’ phenotype, 




displaying traits similar to those of myofibroblasts, such as formation of elongated 
collagen fibres and expression of α-SMA (Hanley et al., 2016).  
CAFs are present within the tumour-microenvironment and play an important role in 
promoting tumour growth, angiogenesis and invasion (Gaggioli et al., 2007; Pietras 
et al., 2008). CAFs have also been reported to alter expression of certain growth 
factors, such as, IGF I and II (Yee et al., 1991), PDGF (Ponten et al., 1994) and TGF-
β  (Frazier and Grotendorst, 1997) in breast cancer. In addition, introduction of CAFs 
isolated from head and neck SCC appeared to promote invasion of SCC cells into 3D 
organotypic gels (Gaggioli et al., 2007). Furthermore, Orimo and colleagues showed 
that CAFs extracted from human breast carcinoma promote growth of admixed breast 
carcinoma cells more than with normal mammary fibroblast (Orimo et al., 2005). Both 
examples suggest that CAFs may possess a more activated phenotype than normal 
fibroblasts, thus proposing they have increased ability to remodel ECM over normal 
fibroblasts.  
CAFs are a critical component of the tumour-stroma microenvironment, and an 
important area of research within cancer (Kalluri, 2016; Kalluri and Zeisberg, 2006; 
Shiga et al., 2015). CAFs are highly recognised as a valid therapeutic target and 
academia and industry are actively looking for new CAF-selective drugs. However, 
the underlying molecular mechanisms of how CAFs regulate tumour progression are 
not fully understood. 
  




1.8 Drug Discovery 
Historically, new drugs were discovered through the identification of an active 
compound, however, there are examples in history where drugs have been identified 
through serendipitous events. From Alexander Fleming’s accidental discovery of 
penicillin (Fleming, 1929) to Pfizer’s’ mid 90’s blockbuster, Sildenafil, which was 
primarily targeted for treating patients with pulmonary arterial hypertension, but now 
is the most common treatment for erectile dysfunction in the world (Boolell et al., 
1996). 
 
1.8.1 The drug discovery process 
Normal drug discovery is a series of complex processes through which potential new 
therapeutic targets and drugs can be identified. The identification process follows a 
general pattern for antibody, drug and gene discovery.  
Specifically, the drug discovery pipeline consists of several stages, which include; (1) 
target identification – which involves early stage research and development of the 
disease pathway and initial genomic and proteomic data of the target; (2) discovery 
– starts with chemical synthesis of compounds specific to the target, followed by 
assay development to optimise the screening process concluded by performing HTS 
of compound libraries to identify hits; (3) lead validation – begins with analysing the 
effect of the identified hits and trying to improve their structure-activity relationship 
(SAR) to try and increase their potency before re-screening to validate the hits; (4) 
pre-clinical study – efficacy and potential risks are evaluated before human trials can 
begin, therefore in vitro and then in vivo experiments are performed to provide efficacy 
and toxicity data from lead compound candidates; (5) clinical trials – involve human 
participants and are normally split into four phases. The primary purpose of phase I 
trials is to evaluate drug safety, metabolism and side effect (cohort of 20-80 patients). 
Phase II trials sees the drug or treatment administered into a larger cohort of patients 
(between 100-300) and further determines drug effectiveness and safety in 
conjuncture with a placebo. Phase III trials further evaluate the efficacy, dosage and 
safety in a much larger population of patients (between 1000-3000). This phase also 
compares efficacy of existing treatments as well as different dosages and interactions 
with other combination therapies; finally (5) approval and launch – takes place if a 




selected drug candidate is effective in clinical trials. The compound is submitted to 
regulating bodies for approval by the Food and Drug Administration (FDA). The drug 
is marketed and then released to the public however still monitored for side effects 
(also known as phase IV trials). The process to fully develop a drug from concept to 
shelf costs approximately £2 billion and take around 12-15 years (Hughes et al., 2011; 
Orloff et al., 2009; Strovel et al., 2004). 
 
1.8.2 High-throughput screening (HTS) in drug discovery 
Today, large pharmaceutical companies perform HTS of compound libraries (usually 
containing up to 1 million compounds which include various natural products, extra- 
and intracellular targets and even whole genome) as an initial step in the drug 
discovery and lead validation process. HTS is an approach to drug discovery that 
incorporates a broad range of robust automated technologies and advanced 
instruments, comprised of; (1) robotic arms programmed to efficiently and precisely, 
transport barcoded multi-welled plates from storage/incubator carousels to integrated 
liquid dispensing units and plate centrifuges/readers; (2) high-content image 
capturing machines such as microscopes and spectrophotometers; and (3) non-
contact, tipless compound transfer machines which use acoustic energy, capable of 
transferring solutions ranging in volume from 25nl to 50µl (Echo, Labcyte, USA). 
Fluorescence imaging microscopy within biomedical research has become an integral 
part of all cell biology studies. Many research institutes use advanced high powered 
fluoresce imaging technologies for a wide variety of biological studies. Examples 
include the use of laser scanning confocal microscopy to visualise detailed 3D adult 
Drosophila anatomy (McGurk et al., 2007). In addition, spinning disk confocal 
microscopy has been used to capture live imaging of neutrophil migration in zebrafish 
(Lam et al., 2014b). Furthermore, two-photon microscopy can image through thick 
sample specimens producing high quality 3D images and was used to detect breast 
cancer cell bone colonisation from frozen bone samples (Allocca et al., 2016).  
These are just a few of the examples supplied through high-end companies, namely; 
Carl Zeiss, Leica, Nikon and Olympus. All of the mentioned technologies provide high 
quality of specimen imaging, however image capture via these techniques if often 
slow and normally samples have to be manually exchanged. 




The pharmaceutical industry have adopted the use of high-content automated image 
capturing microscopes. These systems include the IN Cell Analyser 6000 (GE 
Healthcare Life Sciences, USA), Operetta (Perkin Elmer, USA), Cell Voyager 7000 
(CV7000) (Yokogawa, Japan) and the Cell Discoverer 7 (Carl Zeiss, Germany) (Li et 
al., 2016). These high-spec machines use laser-based or light-emitting diode (LED) 
technology (Cell Discoverer 7) for live cell imaging and scientific complementary 
metal-oxide semiconductor (sCMOS) cameras for high-resolution imaging capture. 
The microscope systems are often large cabinet-like units that are sterile and 
environmentally controlled. The units contain built in microscopes with automated 
stage and objective turrets, thus no user intervention is required. Additionally, each 
system contains barcode readers and plate docking stations, thus enabling 
integration within a HTS platforms. Furthermore, one of the most important aspects; 
the speed of image acquisition in 2D and 3D for these systems is much faster 
compared with the conventional fluorescence laser scanning microscopes mentioned 
previously.  
However, these high-end, full-spec systems are costly (approximately ranging from 
£500K – £1M) and also require elaborate data management systems to allow tracking 
of entire HTS campaigns as well as perform high-content data analysis (Buchser et 
al., 2004). 
Additionally, advances in multi-welled plate technology has been reported to increase 
high-throughput capacity from screening 10,000 compounds a month using 96-well 
plates (200µl max working volume/well), to 10,000 a day using 384-well plates (100µl 
max working volume/well) and now ultra-HTS using 1,536-well plates (10µl max 
working volume/well) whereby 100,000 compounds a day can be screened (Klumpp 
et al., 2006; Mayr and Fuerst, 2008). 
Some groups have also attempted the use of 3,456-well plates (Aurora Microplates, 
USA) (2.5µl max working volume/well), for example, Brandish and colleagues 
screened for inhibitors against D-amino acid oxidase, screening approximately 
170,000 compounds a day (Brandish et al., 2006). However, such small working 
volumes and surface area will inevitably lead to technical limitations, therefore 
currently HTS laboratories within academia and industry favour the 384- and 1,536-
well plate formats assays as they stay within the ‘magic triangle of HTS’ ; time, cost 
and quality of process (Mayr and Fuerst, 2008). 




HTS can and does identify compounds which go through clinical trials and regulations 
to become FDA approved drugs. For example, Gefitinib an AstraZeneca drug (trade 
name Iressa) (Wakeling et al., 2002), is an oral epidermal growth factor receptor 
(EGFR) tyrosine kinase inhibitor for EGFR mutation-positive NSCLC, which was 
processed by HTS in 1993 before being FDA approved in 2003 (Macarron et al., 
2011).  
However, several postulations regarding the drug discovery industry have pointed to 
HTS as the sole benefactor of blame, such as HTS; (1) contributes to the decline of 
creativity within drug discovery; (2) data is of poor quality; (3) is expensive and time 
consuming; (4) fails to find leads for targets (Macarron et al., 2011). Nevertheless, 
many companies still do and will continue to use HTS technologies to perform primary 
and hit validation high-content screening, thus, driving engineers, scientists and 
technology companies to innovate and design faster and smarter automation 
platforms that can reduce and refine process flow and assay timelines (Hughes et al., 
2011). 
  




Aims of this study 
As previously described in Section 1.3, 3D culture systems provide an in vitro model 
allowing the study of biological responses in an in vivo physiomimetic 
microenvironment. Data have reported that 3D culture systems not only allow cells to 
differ morphologically from 2D cultured cells, but also the 3rd dimension is a crucial 
feature adding to the spatial organisation in which cellular cues and responses are 
similar to those in vivo (Chen and Yoon, 2017; Gudjonsson et al., 2002; Harma et al., 
2010; Haycock, 2011; Huh et al., 2011; Kimlin et al., 2013; Kramer et al., 2013; Lee 
et al., 2008a; McBeath et al., 2004; Nyga et al., 2011; Ryan et al., 2016; Thoma et 
al., 2013).  
3D organotypic cultures adapted from the original Fusenig model (Fusenig et al., 
1983) have been widely utilised not only in our laboratory (Froeling et al., 2010; 
Nystrom et al., 2005; Thomas et al., 2006) but also globally (Bernerd and Asselineau, 
2008; Igarashi et al., 2003; Mueller et al., 2014; Schneider et al., 2008; Vorsmann et 
al., 2013). Moreover, data from our laboratory has demonstrated the importance and 
value of such 3D organotypic models in promoting migration and invasion of cancer 
cells (Moore et al., 2014; Nystrom et al., 2005). However the organotypic gel invasion 
assay is a slow experiment and it is not possible to examine the cells within the gel 
over time. Fibroblasts are implicated in tumour progression but they are often ignored 
in the analysis of organotypic gels largely because they are hard to see. Thus while 
the organotypic gel is an excellent tool, it still has several limitations. In this study I 
will attempt to resolve some of these limitations. 
 
This study will aim to: 
1) Develop a novel fluorescent 24-well mini-organotypic Transwell® invasion 
assay that can be examined automatically over time in 3D via confocal laser 
scanning microscopy. Data collection in situ will eliminate the need for 
histology before obtaining initial data. 
 
2) Establish that the new assay will work with and support a variety of tumour 
and fibroblast cell combinations from different tissues. 
 




3) Use the new assay to screen a library of small interfering RNA (siRNA) 
targeting proteases to determine if any affect the invasion of tumour cells. 
Moreover, I shall target the fibroblasts, not the tumour cells, since less is 
known about the molecular mechanisms of fibroblast invasion and this will 
examine further whether targeting fibroblasts can supress cancer growth and 
invasion. 
 
4) Miniaturise the 24-well assay to suit a 96-well format enabling higher-












CHAPTER II: MATERIALS AND 
METHODS 
  




2.0 Materials and Methods 
 
2.1  Cell culture 
2.1.1 Routine cell culture and conditions 
All cells were cultured as adherent monolayers in sterile tissue culture flasks of 
various sizes (Corning, 25cm2 (430639), 75cm2 (430641U) and 175cm2 (431080)) in 
a humidified atmosphere of 37°C and 8% CO2. Cells were routinely examined for the 
presence of mycoplasma using the polymerase chain reaction (PCR) method 
(detailed in Section 2.7). Cancer and fibroblast cells were grown using different 
growth media (detailed below). 
 
2.1.1.1  Passaging cells 
When cells reached 70-80% confluency, medium was carefully removed and cells 
were washed with sterile phosphate buffered saline (PBS) before adding trypsin 
(0.5%) – Ethylenediaminetetraacetic acid (EDTA) (0.2% w/v) (Sigma Aldrich, 
59418C) for 2-5 minutes (dependant on cell type) at 37°C. Once detached from the 
surface of the culture flask, trypsin was inactivated by addition of medium containing 
10% foetal bovine serum (FBS) (Gibco, 10500-604), the cell suspension was then 
centrifuged at 1200 revolutions per minute (rpm) for three minutes (ALC International, 
PK121). Cell pellets were re-suspended in the appropriate medium, if cell counting 
was required, 10µl of cell suspension were pipetted into a FastRead counting 
haemocytometer (Immune Systems, BVS100) and cells were manually counted 
under a phase-contrast light microscope (Olympus, IMT-2, Japan). Cells would then 
be prepared for experimental purposes or placed back into the desired culture flasks 
at various dilutions (1:3 to 1:20) dependant on their growth rates and needs. 
 
2.1.1.2  Cryopreservation of cells 
For cell preservation, cell pellets were re-suspended in 90% FBS and 10% dimethyl 
sulphoxide (DMSO) (Fisher Scientific, D/4120/PB08). A total volume of 1ml cell 
suspension (containing approximately 106 cancer cells or 2 x 106 fibroblast cells) was 
transferred to Corning 1.5ml cryovial (Corning, 430489). Cryovials were placed in a 
Mr Frosty™ freezing vessel (ThermoFisher Scientific, 5100-0001) at -80°C for 24 




hours before being transferred to liquid nitrogen (-196°C) long-term cryogenic 
storage.  
2.1.1.3 Thawing cryopreserved cells 
Frozen cryovials were transferred directly to a 37°C water bath until thawed 
(approximately 90 seconds). Once thawed, the contents of the cryovials were 
transferred to a 15ml Falcon™ tube (Corning, CLS430791) containing pre-warmed 
culture medium, centrifuged (1200rpm for three minutes) and the pellet was re-
suspended in fresh medium and immediately plated into the appropriate tissue culture 
flasks. 
 
2.1.2  Human fibroblasts 
Three types of fibroblasts were used in this study (Table 2.1); neonatal human 
foreskin fibroblasts (FSF), adult derived human dermal fibroblasts (HDF) and Medical 
Research Council cell strain 5, a human foetal isolated lung fibroblasts (MRC5). HDF, 
FSF and MRC5 were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Sigma Aldrich, D6429), supplemented with 10% FBS. 
 
Table 2.1: Details of human primary fibroblasts used 
Cell Strain Donor detail Tissue type Provider 
FSF – skin strain 1 Male, 28 days Foreskin 
Dr Su Marsh (Blizard 




MRC5 – lung strain 
Male, 14 week 
gestation 
Lung 
Dr Zareen Khan (Barts 
Cancer Institute, QMUL) 
 
  




2.1.3 Human cancer cells 
Three cancer cell lines were used in this study (Table 2.2). Oral squamous cell 
carcinoma (OSCC) VB6 (derivation described in (Thomas et al., 2001b)) cells were 
cultured in keratinocyte growth medium (KGM) comprised of α-Minimum Essential 
Medium (α-MEM) (Invitrogen, 22571-020), supplemented by 10% FBS, 18mM 
adenine (Sigma Aldrich, A2786-2SG), 1% L-glutamine (Sigma Aldrich, G7513), 
0.5µg/ml hydrocortisone (Sigma Aldrich, H4001), 10µg/ml insulin (Sigma Aldrich, 
I1882), 10ng/ml epidermal growth factor (EGF) (Sigma Aldrich, E9644) and 10-10M 
cholera toxin (Calbiochem, 227035). MD Anderson (MDA)-MB-468 cells are a breast 
adenocarcinoma line, isolated from the right mammary gland of breast cancer 
patients. MDA-MD-468 cells were cultured in DMEM supplemented with 10% FBS 
(Cailleau et al., 1978). National Cancer Institute (NCI)-H1299 cells are a human non-
small cell lung carcinoma (NSCLC) line derived from a lymph node metastasis of a 
lung cancer patient. H1299 cells were cultured in Roswell Park Memorial Institute 
(RPMI-1640) (Sigma Aldrich, R8758) medium supplemented with 10% FBS (Phelps 
et al., 1996). 
 
Table 2.2: Details of human cancer cells used 
Cell line Donor detail Cell details Reference 
VB6 (OSCC) - 
Differentiated, retroviral 
infection to overexpress 
β6 integrin 








metastasis, PTEN, RBI1, 
SMAD4, TP53 mutations 
(Cailleau et al., 1978; 
Mu et al., 2002) 
H1299 
Lung carcinoma 
Male, 43 years 
Non-small cell, lung 
cancer, lymph node 
metastasis, NRAS 
mutation 









2.2 Western blotting 
2.2.1 Cell lysis 
Fibroblast cells were grown to 80% confluency prior to two washes with sterile ice 
cold PBS. Cells were lysed for 15 minutes on ice in lysis buffer (Nonidet-P40 (NP40), 
Invitrogen, FNN0021) containing 1:100 dilution of protease inhibitor cocktail 1 stock 
(Calbiochem, 539131) and 1:100 phosphatase inhibitor (Calbiochem, 524625)) 
(200µl/well in a 6-well plate). Cell lysates were collected and transferred into 1.5ml 
microcentrifuge tubes on ice and vortexed every five minutes for three cycles. After 
centrifugation (13,000rpm for 10 minutes at 4°C), supernatants were carefully 
removed and transferred to pre-labelled, chilled, 1.5ml microcentrifuge tubes for 
immediate protein concentration determination. Protein concentration was quantified 
in a 96-well plate (Corning, #3599) using Bio-Rad DC Protein Assay reagents 
according to manufacturer’s instructions (Bio-Rad Laboratories, Reagent A – 500-
0113, Reagent B – 500-0114, Reagent S – 500-0115), alongside a series of pre-
prepared known bovine serum albumin standards (BSA) (0.0-5.0mg/ml). The 
absorbance of each lysate samples were measured at 550nm using a microplate 
reader (Tecan, Infinite F50, Switzerland). Once sample concentration was 
determined, lysates were subsequently diluted in an appropriate volume of 2x 
Laemmli sample buffer (Sigma Aldrich, S3401) to the desired final protein 
concentration. Samples were stored at -20°C if not immediately used. 
 
2.2.2 Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Samples were thawed then briefly centrifuged to collect any residual contents from 
tube walls before heating to 95°C for five minutes to denature proteins. Gel cassettes 
(ThermoFisher Scientific, NC2010) were inserted into SDS-PAGE tank 
(ThermoFisher Scientific, EI0001) with 10x tris-glycine SDS-PAGE buffer (Severn 
Biotech, 20-6300-100) diluted in distilled water. Protein samples and Amersham ECL 
Rainbow Protein Ladder (10µl) (GE Healthcare Life Sciences, RPN800E)  were 
loaded into gel cassettes containing freshly made 12% polyacrylamide gels (Table 
2.3) and run at 120 volts (V) for 95 minutes. 
  




2.2.3 Western blotting 
Proteins were transferred on to Hybond nitrocellulose membranes (GE Healthcare 
Life Sciences, 10600002), using an Invitrogen wet transfer chamber inside the SDS-
PAGE tank. Proteins from the gel were transferred at 35V for 95 minutes. The 
nitrocellulose membrane was removed and incubated in 20ml of Ponceau S (0.1% 
(w/v) in 5% acetic acid) (Sigma Aldrich, P7170) for 10 minutes to confirm efficient 
protein transfer. Nitrocellulose membranes were subsequently washed four times in 
PBS to remove the Ponceau S, before non-specific protein binding was blocked by 
incubation for 45 minutes, in 5% w/v non-fat milk (Sigma Aldrich, 70166),  0.1% 
Tween-20 (Sigma Aldrich, P9416) and tris-buffered saline (TBS) (Severn Biotech, 20-
7301-10) (TBS-T) at room temperature. Membranes were rinsed in TBS-T four times 
before being placed inside a 50ml Falcon™ tube (Corning, 430290)  and incubated 
with a specific dilution of primary antibody (Table 2.4) in TBS-T containing 5% BSA 
(5ml final volume) and left rotating overnight at 4°C. 
The next day membranes were washed thoroughly for one hour with TBS-T, 
replenishing the washing solution every five minutes, before being incubated with 
species-specific secondary horseradish-peroxidase (HRP) conjugated antibody for 
40 minutes at room temperature, followed by an additional one hour wash step with 
TBT-T. Specific proteins were detected using an Enhanced Chemiluminescence 
detection reagent kit (ECL) (GE Healthcare Life Sciences, RPN2106) and visualised 
using the ChemiDoc Imager 600 (GE Healthcare Life Sciences). 
 
2.2.4 Densitometry analysis 
Densitometric analysis of protein bands was performed using Image J Software 
(National Institutes of Health, USA). Protein band densities were normalised to the 
loading control housekeeping protein, Heat-shock chaperone-70 (HSC-70, Santa 
Cruz Biotech, SC-7298). 
  




Table 2.3: Formulation of 12% polyacrylamide gels 
Resolving gel Stacking gel 
dH2O 5.3ml dH2O 2.7ml 








Tris-HCL (1.5M, pH 8.8) 3.75ml Tris-HCL (1M, pH 6.8) 0.5ml 
10% SDS  
(Fisher Scientific, BP1311-1) 
0.15ml 
10% SDS  
(Fisher Scientific, BP1311-1) 
0.05ml 
10% Ammonium persulphate 
(APS) (Sigma Aldrich A3678) 
0.075ml 
10% Ammonium persulphate 
(APS) (Sigma Aldrich A3678) 
0.05ml 
TEMED 
(National Diagnostics, EC503) 
0.0075ml 
TEMED 
(National Diagnostics, EC503) 
0.005ml 
APS - ammonium persulphate; dH2O - distilled water; SDS - sodium dodecyl sulphate; TEMED - 
tetramethylethylenediamine 
 
Table 2.4: List of primary and secondary antibodies used for western 
blotting 
Target Type Host/Isotype Clone Supplier Concentration 




TMPRSS-13 Primary Rabbit/IgG - 
ThermoFisher Scientific  
(PA5-30935) 
1:1000 
HSC-70 Primary Mouse/IgM B-6 





Secondary Mouse/IgG - Dako (P0260) 1:2000 
Anti-Rabbit 
HRP 
Secondary Donkey - 











2.3 Organotypic cultures 
Organotypic cultures are so-called as they are in vitro attempts to recreate and 
recapitulate part of a normal 3D tissue. Norbert Fusenig originally developed the 
organotypic model by culturing a solid squamous cell carcinoma in vitro and then 
plating these cells onto collagen gels prepared in silicon chambers. Once cell 
attachment was achieved, the collagen gels were lifted to an air-liquid interface, thus 
nourishment of gels occurred from below whilst the surface of the gel was exposed 
to air (Boukamp et al., 1982). The addition of cancers cells and stromal fibroblasts 
enables the study of invasion using the organotypic gel model. 
 
2.3.1 Preparation of mini-organotypic cultures – 24-well assay 
The mini-organotypic assays are miniaturised versions of the organotypic gels, which 
have previously been published by our laboratory (Nystrom et al., 2005). This 
miniaturised version recreates the organotypic gel in a hanging basket-like sterile 
Transwell® insert. 
0.4µm-pore size, optically clear polyethylene terephthalate (PET) Transwells® 
(Corning, #3470) were coated using a 300µl solution of ice cold collagen type I – rat 
tail (Corning, #354236) diluted 1:100 with cold sterile PBS and placed inside a sterile 
plastic 24-well plate (Corning, #3524). In the meantime a collagen: Matrigel® mixture 
was prepared in cold sterile 15ml Falcon™ tubes. To produce 1ml of organotypic gel 
mixture, the following volumes were used, all reagents were kept on ice; 525µl 
collagen type I, 175µl Matrigel® (Corning, #354234), 100µl 10x DMEM (Sigma, 
D2429), 100µl cell culture media, 100µl sterile FBS and neutralised using 1M sterile 
sodium hydroxide (NaOH) solution (80µl/ml). When mixed together correctly, the gel 
should produce a straw like colour until addition of the NaOH, which rapidly 
transforms the solution to a bright pink colour.  
All reagents must be kept on wet ice at all times during assembly of the gels. The 
Falcon™ tube containing the bright pink gel mixture was buried within the wet ice. 
Next the excess collagen: PBS solution was carefully removed from the Transwell®, 
before 100µl of collagen: Matrigel® organotypic gel mixture was added (dropwise) and 
placed in an incubator at 37°C for 1.5 hours, thus allowing the proteins to cross link 
and polymerise. Fibroblasts and tumour cells were counted and plated on top of the 
mini-organotypic gels in a 200µl cell suspension, either alone (105 in total) or in a 2:1 
co-culture ratio of fibroblast (6.7 x 104) and tumour cells (3.3 x 104). Next, 600µl of 
cell culture medium was added underneath each Transwell®. The following day the 




medium below each Transwell® was replaced with 350µl of fresh medium and the 
medium above the gel was carefully removed (not disturbing the top surface of the 
gel) and replaced with 200µl serum-free medium (only for cultures containing MDA-
MD-468 and H1299 cells, VB6 were left exposed). To maintain a chemotactic gradient 
this process of changing medium was carried out every two days, until samples were 
fixed or analysed by microscopy and then fixed. 
 
2.3.2 Fixation, harvesting and processing 
Transwells® were fixed in 10% v/v neutral buffered formalin (Cellstor, BAF-0010-25A) 
for 24 hours and the following day transferred to 70% v/v ethanol for at least three 
hours. Gels were removed from the Transwell® by use of scalpel to cut the membrane 
before being placed into a histology embedding cassette. The fixed gel was 
processed to paraffin wax and 4µm thick sections were cut and stained with 
haematoxylin and eosin (H&E) by Mr George Elia (Histopathology Department, Barts 
Cancer Institute). 
 
2.4 Transient labelling of cells with fluorescent dyes 
CellTracker™ Red (C34552) and CellTracker™ and Green (C7025) (50μg aliquots, 
ThermoFisher Scientific) were dissolved in anhydrous DMSO to produce 5mM and 
10mM stock concentrations respectively. CellTracker™ Red and Green were diluted 
1:1000 in serum-free α-MEM or DMEM producing 5μM and 10μM final concentrations 
respectively. Cell culture media were removed from the desired flasks and the cells 
were washed once with sterile PBS. The serum-free medium containing the 
fluorescent dyes were added to the appropriate flasks and incubated at 37°C for 45 
minutes. Subsequently, the serum-free medium containing the fluorescent dye was 
removed, cells were then washed with sterile PBS before serum-containing media 
were added to each flask and incubated at 37°C for a further 40 minutes. 
 
2.4.1 Use of IncuCyte™ ZOOM® to determine optimal exposure 
time 
To determine the time required for each fluorescent dye to internalise to a maximum, 
cells labelled with CellTracker™ within their flasks were immediately placed inside an 
IncuCyte™ ZOOM® imaging system (Essen BioScience). The IncuCyte™ ZOOM® 
consists of a microscope gantry that resides within a cell incubator and can obtain 




real time live cell imaging. Images were captured at various time points and 
fluorescence intensity was measured over time. 
 
2.5 Live image acquisition, rendering and quantification of mini-
organotypic gels 
The mini-organotypic gels contain fluorescently labelled cancer (red) and fibroblast 
(green) cells. The Transwells® used have an optically clear membrane, thus enabling 
imaging through the insert. Obtaining live, in situ images of cancer and fibroblast cell 
invasion, at various time points was performed using a Confocal Laser Scanning 
Microscope (CLSM) 710 (Carl Zeiss GmbH, Germany). This was the most suitable 
imaging platform available at the time. However in January 2017 Barts Cancer 
Institute purchased a Nikon Eclipse Ti-E spinning disk confocal microscope (Nikon 
Instruments, Europe BV). Going forward, this system would be better suited to image 
3D gels, specifically, for the speed of acquisition, but also for ease of use of the 
software. 
 
2.5.1 Live image acquisition 
In initial studies, Transwells® were removed with tweezers from the plastic 24-well 
plate and placed onto a 35mm-diameter glass coverslip-bottomed dish (MatTek, 
USA, P35G-1.0-14-C). This was positioned inside a heated 35mm dish-holder on an 
automated x-y scanning stage. The confocal was equipped with a heated chamber 
set to 37°C, supplied with 5% CO2 and a humidifier to simulate the same conditions 
present in an incubator. In situ optical overlapping sections in the z-axis were obtained 
using a 568nm excitation line and 602nm emission for the CellTracker™ Red dye and 
488nm excitation line and 517nm emission for the CellTracker™ Green dye.  
Series of x-y-z images of 700μm square (in the x-y plane) were collected along the z-
axis at 4μm intervals with a 1μm overlap to approximately 1400μm depths throughout 
the gel using a 20x air objective. Scanning through one gel of approximately 1400μm 
thickness, in two colour channels, took 20-23 minutes. During the image acquisition, 
the sample needed to be removed from the 24-well plastic plate and was not in 
contact with any cell culture medium. While this method allowed for imaging, it was 
slow and cumbersome. After three months of optimising the gel system, I tested 
several glass bottomed 24-well plates so that imaging could take place within the 
plate. I chose the black polystyrene 24-well sterile SensoPlate™, fitted with a 0.17mm 




thick glass bottom coverslip (Greiner Bio-one, 662892), I also purchased a scanning 
stage designed for multi-welled plates (Carl Zeiss, 0496-315) and a long working 
distance 20x air objective (Carl Zeiss, Objective LD Plan-Neofluar 20x/0.4 Corr M27). 
Programming the microscope’s automated positioning system, ensured that each 
Transwell® was imaged in the same position every time. These changes to the image 
acquisition process made collection of the z-stack images increasingly swifter. 
Additionally the samples remained inside a sterile environment and were always in 
contact with cell culture media. Before imaging, Transwells® were removed from the 
24-well plastic host plate and transferred into the Greiner 24-well glass bottomed plate 
by use of sterile tweezers under a lamina flow hood. 
 
2.5.2 Image rendering using Imaris 
The raw laser scanning microscope (.lsm) z-stack data files obtained from the CLSM 
710 were imported to the image analysis software Imaris (Bitplane AG, Switzerland). 
The base software enables rendering and removal of background noise of the image; 
providing smooth surfaces, higher resolution and sharper 3D images. A wide range 
of additional add-ons can be purchased allowing for multi-purpose and in-depth 
quantification and analysis.  
 
2.5.3 Image quantification using Imaris XT 
After purchasing Imaris XTensions (XT), an add-on, that calculates and quantifies cell 
movements; depth of invasion from the base of the Transwell® (defined as point ‘0’) 
to the centre of each cell within a 700μm x 700μm x 1400μm volume were measured. 
Comma-separated value (.csv) files were generated for a wide range of parameters 
in both channels (including, area, intensity, position, sphericity, and volume) thus 
allowing high content data analysis to be performed. 
  




2.6 Small interfering RNA (siRNA) transfection 
The optimised 24-well fluorescent mini-organotypic assay has become more 
affordable and justified as a 3D invasion assay for many reasons, in particular, due 
to reductions in the required volumes of costly reagents (collagen and Matrigel®). The 
use of Transwells® has permitted the assay to be easily repeated using a variety of 
experimental conditions, thus increasing the ease of attaining triplicate results and 
varying plate conditions. As a direct result of these improvements it has now become 
achievable and affordable to perform siRNA transfections. Described below are the 
procedures used to transfect HDF cells with a customised pooled library of siRNA 
(Table 2.5) and the deconvoluted individual validation screen from specifically chosen 
hit targets (Table 2.7). 
 
2.6.1 SMARTpool siRNA screen 
A custom library of 60 SMARTpool siGENOME siRNA (Dharmacon, GE Healthcare) 
was purchased. The 60 siRNA’s (0.5nmol) used for the primary gene screen are listed 
in Table 2.5. 25µl of 1x siRNA buffer (300mM KCl, 30mM HEPES-pH 7.5 (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid), 1.0mM MgCl2) was added to each 
siRNA when needed, producing a 20µM stock solution and stored at -20C until use. 
Due to the amount of time required to manually perform this screen, the 60 
SMARTpool siRNAs were analysed in 15 groups (Table 2.6). Meaning, four siRNAs 
were tested, in triplicate, at one time, alongside a non-targeting (NT) siRNA control 
and a non-siRNA treated control, shown in Figure 2.1. 
This proof-of-principle screen targeted genes in fibroblasts. HDF cells were seeded 
into 6-well plates (1.5 x 105 cells per well) in serum-containing DMEM. Subsequently, 
24 hours later the 70% confluent HDF cells were transfected with the SMARTpool 
siRNA. Briefly, in a labelled microcentrifuge tube, the target siRNA were added with 
the transfection reagent (INTERFERin®, Polyplus, 409-10) to serum-free DMEM, 
producing a 20nM final concentration according to the manufacturer’s instructions.  
The microcentrifuge tubes were vortexed and incubated at room temperature for 10 
minutes. The vehicles and siGENOME NT siRNA controls (Dharmacon, GE 
Healthcare, D-001206-14-05) were prepared similarly. During incubation of the siRNA 
and INTERFERin® complexes, cells were washed once with sterile PBS. The 
transfection reagent mixture (1.224ml) was added to triplicate wells at 400μl volumes 
per well, dropwise and mixed gently by rocking the 6-well plate back and forth before 
being incubated. 72 hours post transfection, media were removed from the 6-well 




plates and gently washed once with sterile PBS (not disturbing the cell layer). 
CellTracker™ Green was administered to the siRNA transfected HDF cells (as 
described in Section 2.4). During the incubation time, mini-organotypic gels were 
prepared. Fluorescently labelled green HDFs were trypsinised, counted and plated in 
co-culture with fluorescently labelled red VB6 cell on top of mini-organotypic gels and 
imaged via confocal microscopy. 
 
2.6.2 Deconvoluted siRNA 
The SMARTpool siRNA system mixes four different siRNAs to the same gene target. 
A standard practice when screening pooled siRNA is to conduct a deconvolution 
screen, where each of the individual siRNA sequences of the top scoring hits are 
screened independently, thus, providing a technical validation of the reagents (Chia 
et al., 2010; Falkenberg et al., 2014; Simpson et al., 2008). The primary SMARTpool 
siRNA screen yielded 16 gene hits that induced significant (p<0.05) changes versus 
a NT siRNA control (Figure 4.7). Five of the 16 SMARTpool hits were selected for a 
validation screen; these were tested using the four individual constituent siRNAs of 
each SMARTpool (Table 2.7). Transfection of HDF cells were carried out as 









Figure 2.1: Timeline of siRNA transfection protocol 
The figure displays the timeline and processes undertaken to perform one of the 15 groups of the 60 siRNA experiments. 
 
 




Table 2.5: List of SMARTpool siRNAs used for primary screen 





































Serine protease inhibitor 
Serpin peptidase inhibitor, clade A(alpha 
1 antiproteinase, antitrypsin) member 1 & 
3 
Deficiency results in:- 




Serpin peptidase inhibitor, clade B 
(ovalbumin) member 2,12 
Plasminogen activator inhibitor-2 
Deficiency results in :- 
- Inflammatory disease 
SERPIN-D1 
Heparin cofactor II 
Serpin peptidase inhibitor, clade D 
member 1 
Thrombin inhibitor 




Serpin peptidase inhibitor, clade E (nexin, 
plasminogen activator inhibit type 1) 
Endothelial plasminogen activator 
inhibitor 






Serpin peptidase inhibitor, clade F (alpha 
2 antiplasmin) 
Pigment epithelium-derived factor (PEDF) 
Antiangiogenic 
Antitumourigenic 
SHH Sonic Hedgehog  
Vertebrate organogenesis 
Proliferation of adult stem cells 
TMPRSS-11A Transmembrane protease, serine 11A 
Overexpression: - 
- Inhibits cell growth 
- G1 cell cycle arrest 
Diseases: - 
- Oesophageal cancer 
- Avian influenza 
TMPRSS-
2,3,4,5,6,9,13 
Transmembrane protease, serine 
2,3,4,5,6,9,13 
Deficiency results in: - 
- Tumourigenesis 
- Infection 
- Prostate cancer 
- Ovarian cancer 
- Deafness 
 




Table 2.6: Identity of siRNAs tested in experimental subgroups 
siRNA experiments siRNA Appendix Figure 
1 CAPN-5, MMP-15, CASP-4, CASP-8 7.1 
2 SERPIN-E1, MMP-3, CAPN-10, CASP-1 7.2 
3 CASP-9, MMP-7, MMP-19, SHH 7.3 
4 CAPN-11, CASP-10, MMP-1, MMP-2 7.4 
5 CASP-14, CAPN-13, MMP-8, TMPRSS-11A 7.5 
6 CASP-6, MMP-10, SERPIN-A1, TMPRSS-13 7.6 
7 MMP-24, CASP-2, TMPRSS-3, MMP-21 7.7 
8 MMP-20, TMRPSS-2, CAPN-3, CASP-3 7.8 
9 MMP-12, CAPN-2, SERPIN-A3, MMP-11 7.9 
10 MMP-17, MMP-13, MMP-25, CAPN-1 7.10 
11 SERPIN-B12, TMPRSS-4, CAPN-6, CASP-5 7.11 
12 MMP-14, MMP-26, SERPIN-B2, TMPRSS-5 7.12 
13 CAPN-7, MMP-9, CAPNS-1, MMP-27 7.13 
14 SERPIN-D1, TMPRSS-6, CAPN-9. CASP-7 7.14 
15 MMP-16, MMP-28, SERPIN-F1, TMPRSS-9 7.15 
 
  












































2.7 Polymerase chain reaction (PCR) primer design 
All primers were manually designed using the National Centre for Biotechnology 
Information (NCBI) primer design tool (https://www.ncbi.nlm.nih.gov/tools/primer-
blast/) and specificity was validated using the online Basic Local Alignment Search 
Tool (BLAST) (https://blast.ncbi.nlm.nih.gov/Blast.cgi). When designing primers, 
criteria included that primer should span exon-exon junctions to avoid transcription of 
genomic DNA and that the primer pair should be separated by at least one intron on 
the corresponding genomic DNA. In addition, guanine-cytosine content in each primer 
was approximately 50% to regulate primer melting temperature and PCR product size 
was measured between 90-150 base pairs to ensure an efficient reaction. All primers 
(Sigma Aldrich) used are detailed in Table 2.8. 
 
Table 2.8: Primer details 
Primers Primer Sequence 
Calpain-10: 
CAPN-10 – Forward (F) 





CASP-8 – F 





MMP-17 – F 




Serpin peptidase inhibitor clade F: 
SERPIN-F1 – F 




Transmembrane protease serine 13: 
TMPRSS-13 – F 










2.8 RNA extraction & cDNA synthesis 
To extract RNA from the HDF cells at the end of each transfection period, cells were 
first trypsinised, centrifuged, washed with PBS and lysed at 4°C using lysis buffer 
(RLT buffer) provided with the RNeasy Mini kit (Qiagen, 74104). Total RNA was then 
extracted according to the manufacturer’s protocol and quantified using a NanoDrop 
1000 spectrophotometer (ThermoFisher Scientific), resulting HDF RNA was stored at 
-80°C. Total RNA (0.5-1.0µg) was reverse transcribed according to the 
manufacturer’s protocol in a 20µl reaction volume using QuantiTech Reverse 
Transcription kit containing random primers (Qiagen, 205311). The resulting cDNA 
was then diluted 1:40 in RNAase-free water (Sigma, W4502) and stored at -20°C, 
ready for qPCR. 
 
2.9 Quantitative real-time polymerase chain reaction (qPCR) 
qPCR was performed in a 96-well plate format (Applied Biosystems, 4346906). The 
qPCR was completed in triplicate wells using 20µl total reaction volumes with SYBR 
Green (Qiagen, 204145), 0.5µM primers and executed using the StepOne Plus 
system (Applied Biosystems, 4376598). The cycling conditions were; one cycle for 10 
minutes at 95°C, 40 cycles for 15 seconds at 95°C, one minute cycle at 60°C, 30 
seconds at 72°C and one cycle for 15 seconds at 95°C.  
An additional melt curve analysis step was included which ran for one minute at 60°C 
and 15 seconds at 95°C. At the end of each PCR run, a cycle threshold (Ct) value 
was generated, which is the number of cycles that were required for the fluorescence 
signal to cross the threshold/exceed background levels. These values were used for 
data analysis. Hypoxanthine phosphoribosyltransferase-1 (HPRT-1) housekeeping 
gene was required to act as an internal control to ensure that the quality and quantity 
of the cDNA was similar to each of the samples. The 2-ΔCt equation was used to 
determine the housekeeping gene produced similar Ct values between vehicle and 
siRNA treated samples. Data were analysed by normalising the siRNA induced and 
vehicle induced fibroblasts against the housekeeping gene Ct. Fold changes between 
only 0.5-1.5 in the siRNA treated samples relative to vehicle were considered 
appropriate. Fold change = 2-[(siRNA Ct – housekeeping Ct)-(vehicle Ct – 
housekeeping Ct)]. Summarised by the equation 2-ΔΔCt, as described (Livak and 
Schmittgen, 2001). 
  




2.10 96-well micro-organotypic invasion assays 
One of the aims of this project was to develop and optimise a novel 3D organotypic 
based invasion model which could be integrated into a laboratory automation 
platform, permitting higher-throughput of samples and would allow industry to perform 
HTS.  
Miniaturisation would obviously have the financial advantages of reducing assay 
volumes, allowing higher throughput, faster data acquisition time and most 
importantly, permit automated robotic screening of drugs and genes. However the 
optimisation presents its own challenges, trials and developments, such as, 
discovering a suitable plate type, optimising cell numbers and reagent volumes, 
sourcing an appropriate imaging platform and finally, analysing large amounts of data 
to deduce valuable conclusions. 
 
2.10.1 Procurement the correct plate type 
Corning produce HTS 96-Transwell® insert permeable support plates, covering a 
series of various pore sizes, ranging from 0.4-8.0µm (Corning, 0.4µm - #3391, 1.0µm 
- #3392, 3.0µm - #3386, 5.0µm - #3388, 8.0µm - #3384). The product includes; a 
Transwell® unit (1 integral insert with 96-wells), a reservoir plate and a receiver plate. 
The 96-well Transwell® insert possess large apical and basolateral access ports for 
ease of medium exchange. Additionally the receiver plate has oval, rather than 
circular, shaped wells which are better suited for the addition of reagents or cell 
culture medium via liquid handling systems. For invasion studies pore sizes of <1.0µm 
were of interest to our laboratory.  
A single free sample plate of Corning #3391 (0.4µm pore size) was requested for 
optimisation. However the porous membrane material is synthetic polycarbonate, an 
opaque material, as seen in Figure 2.2A, which not suitable for imaging platforms. 
Furthermore a case of plates (five plates per case) costs £1245.99. During a 
secondment at AstraZeneca in 2014, I contacted Corning requesting a unique 
prototype 96-Transwell® insert containing 0.4µm pore size and a PET membrane 
(transparent material). I received 10 free sample plates to use for development and 
optimisation of the micro-organotypic invasion assay (Figure 2.2B). These 
membranes are optically clear and suitable for 3D imaging. These plates are now 
commercially available (Corning, #7369, Figure 2.2C), at a cost of £884.61 per case 
(five plates). 




Due to the high cost of the plastic consumables and absence of automated liquid 
handling systems I also investigated alternative assay formats that would fit the 
following criteria; (1) affordability to perform screening (e.g. RNAi or compound 
screens); (2) can be performed manually but also integrated into an automated work 
flow process using laboratory automation; (3) remain consistent in mimicking the 3D 
microenvironment as observed with the large and mini-organotypic invasion assay; 
(4) produce high content phenotypic data for multi parameter analysis; (5) 
undemanding experimental procedure and reproducibility.  
In 2008 Christopher Marshall’s group described a 96-well invasion assay whereby, 
cells of interest were suspended in collagen type I and dispensed into 96-well 
ViewPlates (Perkin-Elmer) coated with BSA. Plates were then centrifuged and 
incubated before addition of FBS. After 24 hours of incubation, cells were fixed in 
formaldehyde and stained with Hoechst before confocal z-slices were collected via 
an INCELL3000 imager (GE Healthcare). Nuclear staining was quantified to produce 
an invasion index (Sanz-Moreno et al., 2008).  
On the foundation of this assay I have developed a multicellular, live, 3D organotypic 
invasion assay that recapitulates the microenvironment and does not require the use 
of Transwell® Inserts. However I also investigated the use of the 96-well Transwell® 
insert with 0.4µm PET optically clear membranes. 
 
2.10.2 96-well Transwell® insert 
Organotypic gel was prepared as described in Section 2.3.1. However the collagen: 
PBS pre-coating step was not performed, due to the difficulties when removing this 
solution. This step can be performed with great care and precision, nonetheless, 
without use of liquid handling systems to remove the solution, it is not advised. Even 
using a manual multichannel pipette risks piercing the membrane.  
The plate was placed into a small polystyrene box containing ice. This was to ensure 
the plastic and the overall plate temperature was as low as possible. Consequently 
50µl of organotypic gel mixture was pipetted into each well. The plate was then placed 
in a pre-chilled (4°C) centrifuge and spun for 45 seconds at 1500rpm, forcing any 
residual gel attached to the inside wall to the bottom of each well. The plate was 
swiftly removed from the centrifuge and immediately incubated at 37°C for one hour. 
During the incubation step cells were labelled with CellTracker™ Red and Green as 
described in Section 2.4. Fibroblast and tumour cells were then counted and plated 




on top of the polymerised organotypic gels in a 50µl cell suspension in serum-free 
medium, either alone (5 x 103), or in a 2:1 co-culture ratio of fibroblast (3.3 x 103) and 
tumour cells (1.6 x 103). Next, 150µl of serum containing media were added to the 
96-well receiver plate. The following day the media below each Transwell® was 
replaced with 150µl of fresh media. The process of changing medium was carried out 
every two days, thus maintaining a chemotactic gradient. 
  
























Figure 2.2: 96-Transwell® insert plates produced by Corning 
A) Shows the 0.4µm pore size, 96-well Transwell® insert plate with a polycarbonate 
membrane (Corning #3391). The inner 60 wells contain 40µl of organotypic gel which 
were manually pipetted into each well. The outer wells are empty and the opaque 
porous membrane can be recognised. The insert possess large access ports for 
addition of reagents of media exchange via liquid handling robotics (identified by blue 
arrows). B) Displays the 0.4µm pore size, 96-well Transwell® insert plate with a PET 
membrane (Corning #7369). The transparent membrane can be seen. C-D) Screen 
shot from Corning online website displaying unit price of 1 case of plates (C - #3391 








2.10.3 96-well reverse organotypic invasion assay 
Following a similar method as described by Sanz-Moreno and colleagues, I devised 
a method whereby fluorescently labelled cells were embedded within the collagen: 
Matrigel® mixture and then forced to the bottom of the plate by centrifugal force. 
A sterile black 96-well glass bottom microplate (Greiner Bio-One, 655892) was placed 
on ice to ensure the surface of the plate was kept cold. Organotypic gel was prepared 
as described previously in Section 2.3.1, with the exception of omitting the 10% cell 
culture media. The mixture was divided into the appropriate aliquots for each 
corresponding condition (i.e. fibroblast cells alone, cancer cells alone and fibroblast: 
cancer cells co-culture). Fluorescently labelled fibroblast and cancer cells were 
counted, re-suspended in growth medium and added to each condition aliquot in 
place of the absent 10% cell culture volume. Cell numbers per well were, 7.5 x 103 
cells if plated alone, or if plated as a 2:1 co-culture, 5.0 x 103 fibroblasts and 2.5 x 103 
cancer cells. The organotypic gel was gently mixed, avoiding development of bubbles 
to produce a homogenous cell suspension. 50ul of the organotypic gel containing 
cells was added to each well. 
The plate was then placed in a pre-chilled (4°C) centrifuge and spun for three minutes 
at 1500rpm, forcing the cells to the bottom of the gel. The plate was removed from 
the centrifuge and immediately incubated at 37°C for one hour. After polymerisation 
of the gel, the plate was viewed under a light microscope and cells were observed at 
the bottom of each well. Subsequently 100µl of serum-containing media were added 
on top of the gel, thus creating a chemotactic gradient to drive invasion upwards. 
Media were exchanged manually every second day. 10µl of sterile polystyrene 
microsphere blue fluorescent beads (10µm diameter) (ThermoFisher Scientific, 
F8829) were added to each well before imaging via confocal microscopy to determine 
the top surface of the gel. 
During these initial experiments, fibroblast and cancer cells did not appear to invade 
upwards through the organotypic gel. When viewed under a light microscope 48 hours 
after plating, cells remained at the bottom of the plate, adhered and spread on to the 
glass substrate. After further investigation, the assay plate was changed to a sterile, 
black 96-well ultra-clear (µClear®) non-binding microplate (Greiner Bio-One, 655906). 
The non-binding surface from Greiner are achieved through stable chemical 
modification. The surface substrate forms a hydrostatic layer preventing binding to 




the microplate, thus, cells can no longer adhere, forcing them to settle in the 
organotypic gel. 
 
2.11 Generation of stably transduced fluorescent cell lines using 
lentiviral particles 
2.11.1 Lentiviral particle production 
Use of CellTracker™ dyes permits any cells to be used in organotypic gels, however 
once inside the cell, the cell permeant dyes are modified into cell-impermeant reaction 
products. Thus although the dye does not leak out of the cells, each proliferation cycle 
halves the fluorescence intensity per cell. Also I noted that by 72 hours, the 
distribution of the dye was not uniformly distributed within individual cells. 
To establish cells with a more stable and uniform fluorescence I employed a lentivirus 
expression systems. The lentivirus transduction system is based on the human 
immunodeficiency virus (HIV) and utilises a packing, vehicle and vector plasmid (Dull 
et al., 1998). The plasmids are combined and simultaneously transfected into virus-
producing cells (human embryonic kidney 293T (HEK293T)), that in turn generate 
and release an abundance of viral particles into the cell culture medium. The medium 
is then collected and used to infect the desired cell lines.  
 
2.11.1.1 Production of lentiviral particles encoding: 
histone H2B-GFP 
HEK293T cells were plated into a 6-well plate (105 cells/well) and grown to 80% 
confluency. Prior to viral transfection cell culture medium was replaced with fresh 
DMEM supplemented with 10% FBS. Packaging plasmids pMD2.G (1.75µg, 
Addgene, #12259) and pCMVR8.74 (3.25µg, Addgene, #22036) with pLV-H2B-GFP 
vector (5.0ug, Addgene, #11680) was added with 30µl FuGENE HD (Promega, 
E2311) transfection reagent. The lentiviral construct was added to Opti-MEM 
(ThermoFisher Scientific, 31985070) and incubated at room temperature for 20 
minutes. The resulting complex was carefully added dropwise to the HEK293T cells 
and incubated at 37°C in a 5% CO2 incubator. After 48 hours, the resulting viral 
containing cell culture medium was collected, centrifuged at 2000rpm for five minutes 
to remove cellular debris, divided into 1ml aliquots and stored at -80°C until required. 




2.11.1.2 Lentiviral particle production: histone H2B-RFP 
The same procedure as described above using the vector pLV-H2B-RFP (5.0ug, 
Addgene, #26001) was used. 
 
2.11.1.3 Lentiviral particle production: enhanced green 
fluorescent protein (EGFP) 
The same procedure as described in Section 2.11.1.1 using the vector PL-SIN-PGK-
EiP EGFP (5.0ug, Addgene, #21312) was used. 
 
Both packaging plasmids and the EGFP vector were kindly donated by Yasmine 
Tanner & Dr Ed Carter (Grose group, Department of Tumour Biology, Barts Cancer 
Institute). The H2B-GFP and -RFP vectors were kindly donated by Dr Pedro Monteiro 
(Godinho group, Department of Molecular Oncology, Barts Cancer Institute).  
 
2.12 Fluorescence activated cell sorting (FACS) 
VB6 cells infected with H2B-RFP and HDF cells infected with H2B-GFP were 
trypsinised and collected into 15ml Falcon™ tubes before centrifugation at 1200rpm 
for three minutes. Medium containing trypsin was carefully removed not disturbing the 
cell pellet and replaced with 10ml of sterile serum-free DMEM. Prior to cell sorting 
using BD FACSAria™ II (BD Bioscience, USA) 1ml of the cell suspension was placed 
into a 5ml round bottom polystyrene test tube (Corning, #352235). Cells were gated 
based on forward scatter (FSC) and side scatter (SCC) to exclude debris and a 
second gate was set to exclude doublets on a dot plot of pulse area (FSC-A) versus 
height (FSC-H). H2B-RFP was detected using a yellow laser at 610nm bandpass filter 
and H2B-GFP was detected using a blue laser at 525nm bandpass filter. 
  
2.13 Statistical analysis 
All quantitative statistics were performed using Prism 5 (Graphpad, USA) software, 
unless otherwise stated. Descriptive statistics are presented as a mean or median ± 
standard deviation (s.d). Comparisons between two samples used Students t-tests 
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A vast amount of evidence suggests that cellular cues, functions, homeostasis, 
invasion, migration, phenotype, shape, structural complexity and protein and gene 
expression may all be modified within 3D spatial architecture (Baker and Chen, 2012; 
Brock et al., 2003; Chen et al., 2013; Chen et al., 1997; Hess et al., 2010; Lee et al., 
2007; Moutasim et al., 2011; Nyga et al., 2011; Petersen et al., 1992; Thomas et al., 
2001c; von der Mark et al., 1977). Thus, it would seem imperative that we design 
assays that allow analysis of cell biology within relevant 3D environments. In this 
chapter I will describe the optimisation steps that were undertaken in order to achieve 
an elegant, robust, yet reproducible and quantifiable 3D mini-organotypic invasion 
assay that could be analysed in situ by measuring cell fluorescence. The steps 
included; (1) fluorescently-labelling cells to be used in the assay; (2) identifying and 
optimising a suitable imaging platform; (3) optimising the length of the assay time; (4) 
accumulating multi-parameter 3D phenotypic data from the mini-organotypic gels; (5) 
image processing and data analysis of the 3D images. 
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3.2 Optimising CellTracker™ labelling using IncuCyte™ ZOOM® 
To develop the fluorescent mini-organotypic invasion assay, I chose the VB6 OSCC 
cell line that had been previously studied in mini-organotypic gels (Nystrom et al., 
2005) and used HDF’s as tissue-matched fibroblasts. I sought to develop an assay 
that could be executed by most modern cell and molecular biology research 
laboratories using their own cells. Thus initially, rather than using genetically-labelled 
fluorescent cells I chose to use membrane permeable fluorescent dyes.  
To determine how long VB6 and HDF cells had to be exposed to the dyes to achieve 
maximal fluorescence, the cells were labelled in vitro with fluorescent CellTracker™ 
Red and Green dyes, respectively (detailed in Section 2.4). Briefly, DMSO was 
added to CellTracker™ Red and Green dyes (50µg aliquots), producing a stock 
concentration of 5mM and 10mM respectively. CellTracker™ Red and Green were 
diluted 1:1000 in serum-free medium producing 5µM and 10µM solutions 
respectively. Subsequently, VB6 and HDF culture media were replaced with 
CellTracker™-treated serum-free medium. The flasks containing CellTracker™-
treated cells were placed into an IncuCyte™ ZOOM® system, where the microscope 
obtained 2D fluorescent images every four minutes over a period of 44 minutes. At 
the end of the experiment the images were analysed using the IncuCyte™ ZOOM® 
Analyser 2015A and were data plotted as a function of average object intensity 
against time (Figure 3.1 and Figure 3.2). This experiment was conducted during a 
secondment at AstraZeneca (Alderley Park, UK). 
Figure 3.1A and Figure 3.2A display overlapping phase contrast and fluorescence 
images of VB6 and HDF cells treated with CellTracker™ Red and Green respectively. 
Figure 3.1B and Figure 3.2B display the average object intensity over a 44 minute 
period. VB6 cells appear to internalise around eight minutes and fluorescence 
intensity continues to increase steadily during the 44 minute period. However, HDF 
cell internalisation is initially slower and then rapidly increases almost three-fold 
between 16-20 minutes. Both cell types appear vibrantly labelled and healthy after 44 
minutes. 








Figure 3.1: Fluorescence internalisation and average object intensity 
data from IncuCyte™ ZOOM® – VB6 cancer cells 
The figure displays CellTracker™ Red internalisation within VB6 cancer cells. A) 
Displays overlapping phase contrast and red fluorescence time lapse images of 
VB6 cells exposed to the red dye over a period of 44 minutes. B) Displays the 
average object intensity over time (red calibrated units (RCU)). Scale bar 100µm, 
4x objective. One set of representative images and data from three independent 
experiments. 








Figure 3.2: Fluorescence internalisation and average object intensity 
data from IncuCyte™ ZOOM® – HDF cells 
The figure displays CellTracker™ Green internalisation within HDF cells. A) 
Displays overlapping phase contrast and green fluorescence time lapse images 
of HDF cells exposed to the green dye over a period of 44 minutes. B) Displays 
the average object intensity over time (green calibrated units (GCU)). Scale bar 
100µm, 4x objective. One set of representative images and data from three 
independent experiments. 
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3.2.1 Fluorescently labelled VB6 & HDF cells 
VB6 and HDF cells were labelled with fluorescent CellTracker™ Red and Green dyes 
respectively and observed by confocal microscopy to confirm fluorescence 
internalisation (Figure 3.3). Figure 3.3A shows rounded red (VB6) and green (HDF) 
cells after 15 minutes incubation with fluorescent dyes at 37°C (T0). Figure 3.3B 
shows VB6 and HDF cells 24 hours after exposure to fluorescent dyes (T24). Both 
cell types have adhered and spread out on to the glass substrate and exhibit whole 
cell fluorescent at a high intensity. After a period of four days the fluorescence 




Figure 3.3: Fluorescently labelled VB6 & HDF cells 
VB6 and HDF cells were labelled with CellTracker™ Red (5µM) and CellTracker™ 
Green (10µM), respectively, for 45 minutes at 37°C. After labelling, cells were 
washed with PBS then mixed in a 2:1 ratio of tumour to fibroblasts (105 cell/ml) 
and co-cultured into a MatTek 35mm-diameter glass coverslip-bottomed petri 
dish. The MatTek dish was imaged at two time points using a CLSM 710 
microscope. A) Time point 0 (T0) shows high intensity internalisation of 
fluorescent dyes into both cell types imaged 15 minutes post labelling. B) T24 
shows appearance of cells 24 hours after plating. Both cell types exhibit whole cell 
fluorescence and have adhered and spread out on to the glass substrate. Scale 
bar 50µm, 10x objective. One set of representative images from one experiment. 
 
  
A       T0 B      T24 
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3.3 Confocal laser scanning microscopy of mini-organotypic gels: 
preliminary studies 
To obtain high resolution images from these experiments I chose confocal laser 
scanning microscopy. The term ‘Confocal’ is described as having one focus point, 
directed at a small spot on the specimen, thus giving greater resolution. In confocal 
microscopy this is achieved by the introduction of an adjustable pinhole that functions 
as a versatile iris placed between the specimen and the detector. The function of the 
pinhole is to reject out of focus light and select information from a single focal plane, 
producing a sharply focussed optical slice through the specimen.  
However if the pinhole size is significantly reduced, so too are the number of photons 
arriving at the detector from the specimen (Denis Semwogerere, 2005). This is 
achieved by excluding as much external light away from the specimen as possible 
thus improving contrast and reducing haze. Obtaining true confocality and high optical 
resolution for samples using CLSM, the following must be considered; (1) the 
numerical aperture of the optical system; (2) the wavelength of light used to detect 
the image; (3) selecting the optimum diameter for the pinhole. 
In situ z-stacks were acquired using the Zeiss CLSM 710 system. The mini-
organotypic gels that were created in optically-clear Transwells® were removed from 
their 24-well source plate and placed onto a MatTek glass coverslip-bottomed 35mm-
diameter dish. The dish was transferred to the microscopes heated (37°C), gassed 
(5% CO2) and humidity-controlled chamber. A series of x-y-z images of 700μm square 
(in x-y plane) were collected along the z-axis at 4μm intervals with a 1μm overlap to 
approximately 1400μm depths throughout the mini-organotypic gel. This required the 
use of a Zeiss long working distance 20x objective (LWD 20x). Fluorescence images 
were generated using 568nm excitation line and 602nm emission for detection of 
CellTracker™ Red and 488nm excitation line and 517nm emission for detection of 
CellTracker™ Green.  
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3.3.1 Fluorescently labelled VB6 cancer cells in mini-
organotypic gels imaged at 24, 48 & 72 hour time points 
To investigate whether VB6 cells invade through mini-organotypic gels, the cells were 
labelled with CellTracker™ Red (5µM) and plated alone on top of mini-organotypic 
gels (105 cells total). 24 hours post plating, KGM medium underneath each Transwell® 
was exchanged and excess medium from the surface of the gel was carefully 
removed leaving the gels exposed for the remainder of the assay. 
3D z-stack images were obtained over a period of 72 hours via CLSM (Figure 3.4). 
The solid red square (700µm x 700µm in the x-y plane) seen in the images represents 
the PET membrane at the bottom of the Transwell®, which auto-fluoresces red.  VB6 
cancer cells appear attached and evenly spread on the surface of the gel forming 
layers. Over the course of 72 hours, the cells do not appear to invade through the gel, 
the gel appeared to maintain integrity and composition, however the gel does appear 
to shrink vertically over time. This is possibly due to evaporation within the incubator 
as the top of the gel was exposed (not protected by a serum-free medium layer). 
  




Figure 3.4: Fluorescently labelled VB6 cancer cells in mini-
organotypic gels imaged at 24, 48 & 72 hour time points 
The above images display VB6 cancer cells labelled with CellTracker™ Red 
(5µM) and plated on top of mini-organotypic gels. The same Transwell® was 
imaged every 24 hours for a total period of 72 hours. Live 3D z-stack images were 
achieved via confocal microscopy. A) 24 hours post plating; VB6 cells adhere and 
spread on to the surface of the mini-organotypic gel. Gel thickness approximately 
1400µm. B) 48 hours post plating; VB6 cell layer appears to be denser, no 
definitive signs of invasion, however a cluster of cells or single cell appears to 
have progressed away from the main keratinocyte layer (indicated by white arrow). 
To confirm whether this is in fact a cell or an artefact within the gel, image analysis 
and image rendering was performed. Gel thickness contracts to approximately 
1200µm. C) 72 hours post plating; VB6 cells show no evident signs of invasion 
through mini-organotypic gels. Level of fluorescence intensity appears to be 
reduced compared with that of the 24 and 48 hour time point. Gel thickness further 
contracts to approximately 1100µm. One representative image for each time point 
from triplicate gels belonging to one of three independent experiments. 
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3.3.2 Fluorescently labelled HDF cells in mini-organotypic gels 
imaged at 24, 48 & 72 hour time points 
To examine the behaviour of HDF cells in mini-organotypic gels, HDF cells were 
labelled with CellTracker™ Green (10µM) and plated alone on top of mini-organotypic 
gels (105 cells total). 24 hours post plating, fibroblast growth medium underneath each 
Transwell® was exchanged with fresh serum-containing media and excess medium 
from the surface of the gel was carefully removed and replaced by serum-free 
medium. 3D z-stack images were obtained over a period of 72 hours (Figure 3.5). 
Interestingly, after 24 hours (Figure 3.5A), HDF cells appear to become polarised, 
change their morphology and orientation (compared with the 2D observations seen 
in Figure 3.3B). Additionally, at the 24 hour time point the mini-organotypic gel has 
contracted considerably compared to that of Figure 3.4A (reduced from a height of 
approximately 1400µm to 600µm). After 48 hours a population of HDF cells have 
invaded deeper further through the gel which is now approximately 500µm thick. At 
the 72 hour time point the HDF cells within the gel have reached the bottom of the 
Transwell®, which has now contracted to a height of approximately 400µm. 
  





Figure 3.5: Fluorescently labelled HDF cells in mini-organotypic gels 
imaged at 24, 48 & 72 hour time points 
The above images display HDF cells labelled with CellTracker™ Green (10µM) 
and plated on top of mini-organotypic gels. The same Transwell® was imaged 
every 24 hours for a total period of 72 hours. A) After 24 hours post plating, HDF 
cells become polarised and invade vertically through the mini-organotypic gel 
(indicated by red arrows), consequently instigating drastic gel shrinkage. Gel 
thickness ca. 600µm. B) 48 hours post plating, HDF cells invade further through 
the mini-organotypic gel. Gel thickness contacts to approximately 500µm. C) 72 
hours post plating, HDF cells invade the entirety of the mini-organotypic gel. Gel 
thickness further contracts to approximately 400µm. Furthermore, there does not 
seem to be any significant increase in the total number of fibroblast cells. One 
representative image for each time point from triplicate gels belonging to one of 
three independent experiments. 
  
A B C 24 Hours 48 Hours 48 Hours 
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3.3.3 Fluorescently labelled HDF & VB6 cancer cells in mini-
organotypic gels imaged at 24, 48 & 72 hour time points 
To examine the effects of fibroblast and cancer cell invasion simultaneously, HDF 
and VB6 cells were fluorescently labelled with CellTracker™ Green (10µM) and Red 
(5µM) and admixed in a 2:1 ratio of fibroblast (6.7 x 104 cells) to tumour (3.3 x 104 
cells) and plated on top of mini-organotypic gels (Figure 3.6). This ratio was chosen 
because in previous work performed by our laboratory this gave the maximal invasion 
(data not shown). 24 hours post plating, growth medium underneath each Transwell® 
was replaced with fresh media and excess medium from the surface of the gel was 
carefully removed leaving the gels exposed.  
3D z-stack images displayed enhanced cell invasion patterns and striking gel 
contraction. It is likely that the fibroblasts remodel the collagen: Matrigel® substrate 
by secreting enzymes that destroy matrix proteins. Thus invading into the gel, forcing 
their way down towards the chemoattractant. Closely behind, a mass of cancer cells 
appears to pursue the fibroblast trail. Figure 3.4, Figure 3.5 and Figure 3.6 are 
product of the Zen 2009 Software 3D Compiler Tool (Carl Zeiss, Germany), images 
were saved as tagged image file format (.tiff) files. 





Figure 3.6: Fluorescently labelled VB6 cancer and HDF cells in mini-
organotypic gels imaged at 24, 48 & 72 hour time points 
The above images display HDF and VB6 cancer cells labelled with CellTracker™ 
Green (10µM) and Red (5µM) respectively and plated on top of mini-organotypic 
gel. The same Transwell® was imaged every 24 hours for a total period of 72 
hours. A) After 24 hours post plating, HDF and VB6 cells form multi-cell layers on 
top of the mini-organotypic gel. Gel height is approximately 1400µm. HDF and 
VB6 cells do not appear to invade, however what appear to be single cells or 
artefacts within the gel are observed (indicated by white arrows). B) 48 hours post 
plating, it is clear that both the VB6 cells and the HDF cells have polarised. A 
population of HDF cells appear to have invaded further in to the gel than the VB6 
cells. The HDF cells probably remodel the mini-organotypic gel, creating channels, 
though which the VB6 cells follow closely behind (indicated by yellow arrow). 
HDFs appear to be the primary invading cell type, however what appear to be 
single cells or artefacts within the gel are observed (indicated by white arrows) 
and will be identified via image analysis. Gel contracts to approximately 800µm. 
C) 72 hours post plating, HDF cells continue to invade ahead of the VB6 cells, 
followed by an increased population of VB6 cells (indicated by yellow arrows). Gel 
further contracts to approximately 400µm. One representative image for each time 
point from triplicate gels belonging to one of three independent experiments. 
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3.4 Image analysis & construction of 3D volumes from raw data 
In order to analyse the 3D z-stack results it was necessary to find; (1) a suitable 
software that could handle 3D data; (2) a software that would accept .lsm files; (3) a 
commercially available and affordable program; (4) a software that was 
uncomplicated, easily operated and user friendly. I discussed using Definiens with 
their technical sales representatives (Definiens AG, Germany), however, the costs 
were prohibitive (totalling over £14,000 for the base software, annual licence and a 
custom made CPU workstation), moreover, 3D image analysis modules would have 
been an additional cost. As discussed below, I eventually chose the image analysis 
software Imaris (Bitplane AG, Switzerland) on account of its ease of use and 
moderately priced software (£10,000). 
Confocal imaging accumulates distortion and image quality is therefore directly 
affected by signal-to-noise background; consequently raw data files were rendered 
and smoothened using Imaris 8.2 image analysis software (basic software, Bitplane 
AG). Imaris is a modular software tool purposely suited for multi-dimensional data 
from the confocal imaging variety, regardless of the method used for image capturing. 
The software provides a variety of modules to inspect the 3D arrangement of various 
cell types and other components native to tissue. Multiple spots, surfaces and 
volumes can be segmented and rendered to customised specifications set by the 
user.  
Sections were acquired at different z-positions and assembled into a 3D volume of 
data. Each pixel from the 2D section becomes a voxel (a 3D pixel) and computer 
aided 3D reconstruction of the gels enables visualisation of the fluorescently labelled 
cells throughout each of the individual focal planes.  
 
3.4.1 Quantification of 3D volumes 
In order to validate and quantify 3D cell distribution, I purchased an additional module 
called Imaris XTensions (XT) (Bitplane AG, Switzerland). This module is a 
programmable interface that contains a package of add-on plug-ins that enable 
quantitative analysis data from 3D volumes. Imaris XT is interfaced with MatLab® 
(Matrix Laboratory, MathWorks Inc, USA) and uses custom algorithms for image 
processing and segmentation. This permits the 3D measurement of cells without a 
Chapter III: Results Part I 
93 
 
pre-defined shape or with inconsistent fluorescent components. Imaris XT segments 
objects and generates data for every single particle within the obtained field of view 
(defined by user). 
Data for individual cells or cell clusters were exported as .csv files into Microsoft Excel 
for further quantification. The organotypic specimens (typically a volume of 700μm x 
700μm x 1400μm) were examined regarding number of projections, fluorescence 
intensity and position via Distance Transformation measurements. Data were 
exported into Microsoft Excel software and processed using Prism 5. The z-position 
of each fluorescent particle within the gels, in relation to the bottom membrane of the 
Transwells® was extrapolated and plotted. Creating a ‘bee swarm’ plot displaying the 
collective invasive depth of the each cell population within the 3D field of view. 
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3.5 Imaris image analysis at 24, 48 & 72 hour time points 
Mini-organotypic gels containing fluorescently labelled red VB6 cells alone, green 
HDF cells alone and HDF: VB6 co-cultures were observed over a 72 hour time period. 
Confocal z-stack images were acquired at 24, 48 and 72-hour time points post 
seeding from the same Transwell®. The raw .lsm data files were processed and 
rendered using Imaris XT image analysis software (Figure 3.7A-C, Figure 3.8A-C 
and Figure 3.9A-C). 
A pre-written MatLab® algorithm within Imaris XT called ‘Distance Transformation’ 
allows the quantification of distances between objects in different channels. This is 
performed by the creation of a new channel measuring distances from the centre of 
spots to the edge of additional volumes within the field of interest. The invasive depth 
data were collect and plotted in Prism (Figure 3.7D, Figure 3.8D and Figure 3.9D). 
Mini-organotypic gels were fixed in formalin and processed to paraffin before sections 
were stained with H&E (Figure 3.7E-G, Figure 3.8E-G and Figure 3.9E-G). 
 
3.5.1 Construction of 3D volumes and distance quantification: 
VB6 cancer cells alone at 24, 48 & 72 hour time points 
VB6 cells were labelled with CellTracker™ Red (5µM), plated alone on top of mini-
organotypic gels and imaged every 24 hours for three days via CLSM 710, producing 
z-stack volumes (Figure 3.4). Using Imaris XT image analysis software a rendered, 
smoothened 3D representation of the raw .lsm confocal z-stack was generated for 
the 24, 48 and 72-hour time points (Figure 3.7A-C). Distance Transformation analysis 
was performed on the rendered 3D volumes producing .csv data files. Graphical plots 
of invasive depth were generated in Prism using data extrapolated from the .csv files 
(Figure 3.7D). Mini-organotypic gels containing VB6 cells were fixed in formalin and 
processed to paraffin before sections were stained with H&E (Figure 3.7E-G). 
After 24 hours the VB6 cells appear adhered and homogeneously spread on to the 
surface of the gel. At the 72 hour time point the VB6 cells do not exhibit signs of 
invasion into the collagen: Matrigel® substrate. Figure 3.7D shows a graphical bee 
swarm plot displaying distance away from the PET membrane in micrometres (y-axis) 
against time in hours (x-axis).  
The z-positions of each particle (in this case a cell) were generated in relation to their 
distance away from the red porous PET membrane at the bottom of the Transwell® 
(Position 0). The graph suggests that after 72 hours VB6 cells are invading through 
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the gel towards the bottom of the Transwell®, however this does not appear to be the 
circumstance when observing the images in Figure 3.7A-C. The reduction in gel 
height from approximately 1400µm at the 24 hour time point, to 1100µm by the 72 
hour time point, may possibly be due to evaporation. As the surface of the gel was 
left exposed, evaporation during incubation may be a result of gel contraction. The 
VB6 cells maintain a tightly packed layer arranged within a proximity of <100µm of 
each other. To confirm the data obtained by fluorescence in situ imaging at each time 
point, a gel from each time point was fixed and stained with H&E. The image in Figure 
3.7E-G show the VB6 cells growing on the surface of the gel. At 72 hours the cells 
look less healthy than at the earlier time points, possibly due to desiccation. For 
similar reasons evaporation of the gels during incubation is highly likely to be 
responsible for the change in gel height.  









Figure 3.7: 3D rendered and quantified z-stacks of fluorescently labelled VB6 
cancer cells plated alone on top of mini-organotypic gels with H&E stained 
sections 
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Figure 3.7; 3D rendered and quantified z-stacks of fluorescently 
labelled VB6 cancer cells plated alone on top of mini-organotypic gels 
with H&E stained sections 
The figure displays Imaris XT rendered and analysed mini-organotypic gels plated 
with CellTracker™ Red labelled VB6 cancer cells (5µM). Samples were fixed in 
formalin, processed to paraffin and H&E stained were sections obtained. The 
confocal microscope z-stacks data files were segmented, rendered and analysed 
by Imaris XT. Images were rendered using a surface segmentation tool that 
accurately detects particles of specific diameters and intensity. Distance 
Transformation calculations were performed via Imaris XT and plotted in Prism. A, 
B, C) 24, 48 and 72 hour time point rendered images. VB6 cells appear vibrant 
with colour and are easily identifiable. VB6 cells do not invade throughout the mini-
organotypic gel over a 72 hour period. However the average height of the gels 
reduces. This contraction is probably due to evaporation during incubation. Serum-
free medium was not placed above each gel when incubated, thus exposing the 
upper surface of the gels. D) Graphical depiction of individual VB6 cells z-position 
in relation to the PET membrane (position 0). Each red dot represents one cell 
within the 700µm square field of view. The cells stack tightly together and on top 
of each other in a layer that is <100µm in depth. E-G) H&E stained sections of VB6 
cells plated on top of mini-organotypic gels and harvested at 24, 48 and 72 hour 
time points. Scale bar: 100µm. One representative image for each time point from 
triplicate gels belonging to one of three independent experiments. 
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3.5.2 Construction of 3D volumes and distance quantification: 
HDF cells alone at 24, 48 & 72 hour time points 
HDF cells were labelled with CellTracker™ Green (10µM), plated alone on top of mini-
organotypic gels and imaged every 24 hours for three days via CLSM 710, producing 
z-stack volumes (Figure 3.5). Using Imaris XT image analysis software a rendered, 
smoothened 3D representation of the raw .lsm confocal z-stack was generated for 
the 24, 48 and 72-hour time points (Figure 3.8A-C). Distance Transformation analysis 
was performed on the rendered 3D volumes producing .csv data files. Graphical plots 
of invasive depth were generated in Prism using data extrapolated from the .csv files 
(Figure 3.8D). Mini-organotypic gels containing HDF cells were fixed in formalin and 
processed to paraffin before sections were stained with H&E (Figure 3.8E-G).  
Image analysis revealed invasion of HDF cells after 24 hours. I also observed 
dramatic gel contraction at this time point (Figure 3.8A). By 48 hours post plating, 
HDF cells have fully polarised, changed their morphology and orientation to favour a 
vertically downward invasion through the gel, presumably toward a serum derived 
gradient (Figure 3.8B). This invasive behaviour has advanced further by the 72 hour 
time point and a large population of HDF cells invade through the gel at different 
positions, filling the entirety of the field of view (Figure 3.8C). 
The gels appeared diminished and withered compared with observations of VB6 cells 
alone (Figure 3.7). The possible reason for this occurrence are several fold; (1) 
enzymes secreted from the HDFs may have degraded the ECM within the mini-
organotypic gel, thus facilitating rapid invasion of the HDF cells; (2) as with VB6 gels, 
evaporation of exposed gel surface during incubation may have resulted in increased 
gel shrinkage; (3) the HDFs may have physically contracted the collagen: Matrigel® 
substrate. 
Figure 3.8D displays the distance between the centres of each cells in relationship 
to the bottom of the Transwell®; over a 72 hour period the HDF cells produce a much 
steeper invasive gradient to that observed with VB6 cells (Figure 3.7D). Additionally 
the cells are not as tightly packed together as with VB6 cells. Furthermore the HDF 
cells are spread throughout the span of the gel, ranging an invasive depth between 
600-200µm. This could imply that HDF cells are more invasive than VB6 cells over a 
72 hour period and that some HDF cells within a population could be more invasive 
than others. Interestingly, in 24 hour time point image (Figure 3.8A) the gel height is 
around 600µm, and remains consistent throughout the course of the 48 and 72 hour 
time points (Figure 3.8B and C) whereas the VB6 gels contract over time. 








Figure 3.8: 3D rendered and quantified z-stacks of fluorescently labelled HDF 
cells plated alone on top of mini-organotypic gels with H&E stained sections 
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Figure 3.8: 3D rendered and quantified z-stacks of fluorescently 
labelled HDF cells plated alone on top of mini-organotypic gels with 
H&E stained sections 
The figure displays Imaris XT rendered and analysed mini-organotypic gels plated 
with CellTracker™ Green labelled HDF cells (10µM). Samples were fixed in 
formalin, processed to paraffin and H&E stained sections were obtained. The 
confocal microscope z-stacks data files were segmented, rendered and analysed 
by Imaris. Images were rendered using a surface segmentation tool that 
accurately detects particles of specific diameters and intensity. Distance 
Transformation calculations were performed via Imaris XT and plotted in Prism. 
A) After 24 hour post cell seeding, HDF cells are vibrant with colour and easily 
identifiable. Cells become polarised, changing their morphology and orientation to 
favour a vertical downward invasion approach (indicated by blue arrows). At this 
time point we observe the dramatic gel contraction, possibly due in part to 
evaporation of the mini-organotypic gel during incubation. Additionally, the 
fibroblasts may have physically contracted the collagen: Matrigel® substrate, thus, 
further reducing overall gel height. Furthermore, additional contraction may be 
caused by degradation of the ECM proteins by enzymatic secretions from the HDF 
cells. Gel thickness is approximately 600µm. B) After 48 hours the mini-
organotypic gel housing the HDF cells is approximately the same height as the 24 
hour time point (ca 600µm). However the leading invasive cell reaches a depth of 
around 300µm. interestingly a mass of cells are seen invading vertically through 
the gel toward the bottom of the Transwell® (indicated by blue arrows). It is 
assumed that this invasion is driven by chemotaxis from the serum underneath 
the Transwell®. C) At the 72 hour time point a battalion of HDF cells has invaded 
the entirety of the mini-organotypic gel. The gel height remains at 600µm. D) 
Graphical depiction of individual HDF cells z-position in relation to the PET 
membrane (position 0). Each green dot represents one cell within the 700µm 
square field of view. The cells vastly spread throughout the gel, however still within 
close enough proximity to transmit and receive signalling information. E-G) H&E 
stained sections of HDF cells plated on top of mini-organotypic gels and harvested 
at 24, 48 and 72 hour time points. The blue arrows indicate HDF cells invading 
vertically through the mini-organotypic gels. Scale bar: 100µm. One 
representative image for each time point from triplicate gels belonging to one of 
three independent experiments. 
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3.5.3 Construction of 3D volumes and distance quantification: 
HDF: VB6 cells co-cultured cells at 24, 48 & 72 hour time 
points 
HDF and VB6 cells were labelled with CellTracker™ Green (10µM) and Red (5µM) 
respectively and co-cultured in a 2:1 ratio on top of mini-organotypic gels. CLSM z-
stacks images were acquired every 24 hours for three days (Figure 3.9). Using Imaris 
XT image analysis software a rendered, smoothened 3D representation of the raw 
.lsm confocal z-stack was generated for the 24, 48 and 72-hour time points (Figure 
3.9A-C). Distance Transformation analysis was performed on the rendered 3D 
volumes producing .csv data files. Graphical plots of invasive depth were generated 
in Prism using data extrapolated from the .csv files (Figure 3.9D). Mini-organotypic 
gels containing VB6 admixed with HDF cells were fixed in formalin and processed to 
paraffin before sections were stained with H&E (Figure 3.9E-G). 
The 24 hour image revealed both cell types appear to have attached and spread 
uniformly on the surface of the gel and display no signs of invasion at this time point. 
The data in Figure 3.8 indicated that, when plated alone, HDFs are highly invasive, 
changing their polarity and appointing a vertical invasive position. This suggests that 
the rate of invasion of the HDF cells when co-cultured with VB6 is affected and results 
in a slower initial rate of invasion. After 48 hours I observed both populations of cells 
invading through the collagen: Matrigel® substrate and at the same time noticed gel 
contraction. I consistently observed that the most advanced invasive cell type was a 
fibroblast often followed closely behind by VB6 tumour cells. 
The data appear to suggest the VB6 cells migrate into remodelled matrix channels 
generated by the fibroblasts. Again, H&E analysis of fixed and section samples of 
these mini-organotypic gels confirm that some tumour cells have invaded almost to 
the PET membrane. However the H&E images fail to reveal that the fibroblasts are 
truly the invasive phenotype. 
  









Figure 3.9: 3D rendered and quantified z-stacks of fluorescently labelled HDF & 
VB6 cells plated in co-culture on top of mini-organotypics gels with H&E 
stained sections 
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Figure 3.9: 3D rendered and quantified z-stacks of fluorescently 
labelled HDF & VB6 cells plated in co-culture on top of mini-
organotypics gels with H&E stained sections 
The figure displays Imaris XT rendered and analysed mini-organotypic gels co-
cultured with CellTracker™ Green and Red labelled HDF (10µM) and VB6 (5µM) 
respectively. Samples were fixed in formalin, processed to paraffin and H&E 
stained sections were obtained. The confocal microscope z-stacks data files were 
segmented, rendered and analysed by Imaris. Images were rendered using a 
surface segmentation tool that accurately detects particles of specific diameters 
and intensity. Distance Transformation calculations were performed via Imaris XT 
and plotted in Prism. A) After 24 hour post cell seeding, HDF and VB6 cells are 
vibrant with colour and easily identifiable. Gel thickness is approximately 1400µm. 
Both cell populations appear to be settled and spread on to the surface of the gel. 
B) After 48 hours the mini-organotypic gel housing the HDF and VB6 co-cultures 
is approximately 850µm thick. However a population of HDF cells closest to the 
surface of the gel appear to become polarised and as observed previously, 
change their morphology and orientation, thus beginning to invade through the 
gel. the leading invasive cell (HDF) reaches a depth of around 600µm. HDF cells 
appear to be the leading invasive cell type as observed in Figure 3.8, however 
VB6 cells can be identified within the HDF invasive layer (indicated by yellow 
arrows). C) At the 72 hour time point a mass of HDF cells has arrived at the bottom 
of the Transwell® accompanied by VB6 cells. At this stage I also observed drastic 
gel contraction thus producing a gel thickness of approximately 400µm. D) 
Graphical depiction of HDF and VB6 cells z-position in relation to the PET 
membrane (position 0). Each dot represents one cell within the 700µm square 
field of view. E-G) H&E stained sections of VB6 admixed with HDF cells in a 1:2 
ratio plated on top of mini-organotypic gels and harvested at 24, 48 and 72 hour 
time points. VB6 cells are observed invading through the gel with HDF cells 
(indicated by yellow arrows). Scale bar: 100µm. One representative image for 
each time point from triplicate gels belonging to one of three independent 
experiments. 
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3.6 Fibroblasts embedded within mini-organotypic gels 
Throughout the previous experiments, HDF cells were always plated on top of the 
mini-organotypic gel. The organotypic invasion protocol described by Nystrom and 
colleagues states that stromal fibroblasts were embedded within the gel prior to 
polymerisation (Nystrom et al., 2005). This enables fibroblasts to become settled, 
creating a comfortable niche within a 3D environment prior to addition of cancer cells. 
Other groups within our institute similarly adopted the ‘pre-embedding’ step, for 
example, embedding pancreatic stellate cells to produce a pancreatic organotypic 
model (Coleman et al., 2014b; Froeling et al., 2009).  
In the mini-organotypic assay used here, fibroblast cells are cultured on the same day 
as cancer cells and both cell types are plated on top of a polymerised gel. This method 
does not allow fibroblast cells to settle within the 3D environment. Therefore, 
fibroblast cells were labelled with CellTracker™ Green (10µM) and embedded into 
the mini-organotypic gel and plated into the Transwell® prior to polymerisation. Once 
polymerised, VB6 cells labelled with CellTracker™ Red (5µM) were plated on top of 
the mini-organotypic gel and imaged over a 48 hour period via CLSM 710.  
Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated for the 24 and 48 hour time points 
(Figure 3.10A & B). Distance Transformation analysis was performed on the 
rendered 3D volumes producing .csv data files. Graphical plots of invasive depth were 
generated in Prism using data extrapolated from the .csv files (Figure 3.10C). Mini-
organotypic gels embedded with HDF cells and surface plated VB6 cells were fixed 
in formalin and processed to paraffin before sections were stained with H&E (Figure 
3.10D & E). 
The results obtained display interesting outcomes, suggesting that HDF cells 
descend to the bottom of the gel during the pre-embedding step, possibly whilst the 
gel is polymerising. Furthermore, the morphology of the HDF cells remains spherical 
and the cells do not exhibit the same degree of polarisation and spreading as 
previously observed. One possibility of this occurrence, may be due to the 
mechanisms involved during the formation of collagen fibrils. The gel probably 
polymerises slowly during incubation, thus, the embedded cells descend to the 
bottom instead of being dispersed throughout the entire gel.  The VB6 cells attach 
and spread to the surface of the gel 24 hours post seeding and appear to proliferate.   
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However invasion of VB6 cells through the mini-organotypic gel was not observed. 
This may be due to the fact that the fibroblast cells have not remodelled or degraded 
the upper part of the gel, but rather sunk down during gel cross-linking. Note that the 
gel height continued to shrink over the 48 hour period as previously observed, but to 
a lesser degree than observed when cells were co-cultured on top of the gels (see 
Figure 3.9). For these reasons I chose not to embed fibroblasts within the mini-
organotypic gels for the remainder of my studies. 










Figure 3.10: 3D rendered and quantified z-stacks of fluorescently labelled HDF 
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Figure 3.10: 3D rendered and quantified z-stacks of fluorescently 
labelled HDF cells embedded within mini-organotypic gels with H&E 
stained sections 
The figure displays Imaris XT rendered and analysed mini-organotypic gels 
embedded with CellTracker™ Green labelled HDF cells (10µM) and CellTracker™ 
Red labelled VB6 cancer cells (5µM). HDF cells were embedded within mini-
organotypic gels and incubated until polymerised. Red labelled VB6 cells were 
plated on top of the solidified gel surface. Samples were fixed in formalin, 
processed to paraffin and H&E stained sections were obtained. A) 24 hours post 
cell seeding, HDF cells appear rounded and do not exhibit the previously observed 
polarised morphology (as displayed in Figure 3.8 and Figure 3.9). Additionally 
the HDF cells have dispersed throughout the mini-organotypic gel. However 
mostly accumulating at the bottom of the gel. VB6 cells were plated once the gel 
had polymerised, the cells appear adhered and spread on to the surface of the 
gel. VB6 cells are vibrant with colour, easily identifiable and exhibit no signs of 
invasion. Gel thickness was approximately 1500µm. B) After 48 hours the mini-
organotypic gel housing the embedded HDF cells has shrunk approximately to 
900µm thick. The HDF population appears to have clustered closer together, 
possibly as a result of gel shrinkage. Their morphology remains spherical, where 
as previously; observations to their morphology and orientation were clearly 
evident.  At this stage I can only make suggestion as to why the HDF cells gather 
at the bottom of the gel, do not take shape and do not appear to invade. Gel 
shrinkage appears to be a common factor observed here and in previous 
experiments, possibly due to evaporation during incubation. C) Graphical 
depiction of HDF and VB6 cells z-position in relation to the PET membrane. Each 
dot represents one cell within the 700µm square field of view. D, E) H&E stained 
sections of HDF cells embedded into gel prior to polymerisation step and VB6 
plated on top of gels. HDF cells are observed at the bottom of the gel and VB6 
remain at the surface. Scale bar: 100µm. One representative image for each time 
point from duplicate gels belonging to one of two independent experiments. 
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3.7 Investigating the invasiveness of different fluorescently labelled 
cell types within mini-organotypic gels 
I have confirmed that the new in situ invasion assay works reliably, reproducibly and 
that the software can generate 3D images and quantitative data allowing suitable 
analysis. However the previous results have only examined one fibroblast: tumour 
pair; HDFs and VB6 cells. To investigate the invasive capability of different cell types 
within the mentioned 3D assay, three cancer cell lines; (1) VB6 – OSCC; (2) NCI-
H1299 – human NSCLC (denoted as H1299 from this point forward); and (3) MDA-
MB-468 – human breast adenocarcinoma (denoted as MDA-468 from this point 
forward) and three human fibroblast cell lines; (1) HDF – adult derived human dermal 
fibroblasts; (2) FSF – neonatal human foreskin fibroblasts; and (3) MRC5 – human 
foetal isolated lung fibroblasts were plated alone (Figure 3.11 and Figure 3.12 
respectively) and co-cultured in combinations of; (1) HDF, FSF and MRC5 with H1299 
(Figure 3.13); (2) HDF, FSF and MRC5 with MDA-468 (Figure 3.14); (3) HDF, FSF 
and MRC5 with VB6 (Figure 3.15).   
H1299 and MDA-468 cancer cell lines were fluorescently labelled using the same 
concentration of CellTracker™ Red previously used for labelling the VB6 cancer cells 
(5µM). Similarly, FSF and MRC5 fibroblast cell lines were fluorescently labelled using 
the same concentration of CellTracker™ Green used for labelling the HDF cells 
(10µM). Once labelled, cells were plated on top of mini-organotypic gels in a 2:1 ratio 
of fibroblasts to tumour cells. Transwells® were imaged 72 hours post plating to 
determine which cell line pairs invaded the furthest by this time point. A preliminary 
time lapse fluorescence internalisation study (as displayed in Figure 3.1 and Figure 
3.2) was not performed on the H1299, MDA-468, FSF or MRC5 cell lines, as an 
IncuCyte™ ZOOM® microscope was not available. 
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3.7.1 Investigating the invasiveness of fluorescently labelled 
cancer cell lines; H1299, MDA-468 and VB6 in mini-
organotypic gels 
To investigate whether the cancer cell lines; H1299, MDA-468 and VB6 invaded 
through mini-organotypic gels; all three cell lines were fluorescently labelled with 
CellTracker™ Red (5µM) and plated on top of mini-organotypic gels. 24 hours post 
plating, growth medium underneath each Transwell® was exchanged and excess 
medium from the surface of the gel was carefully removed. Mini-organotypic gels 
containing H1299 and MDA-468 cells had their upper surface covered with a layer of 
serum-free medium, whereas, gels containing VB6 cells were left exposed. 
Transwells® were imaged at an end point of 72 hours via CLSM 710 (Figure 3.11). 
Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated for each cancer cell line at the 72 hour 
time point (Figure 3.11A-C). Distance Transformation analysis was performed on the 
rendered 3D volumes producing .csv data files. Graphical plots of invasive depth were 
generated in Prism using data extrapolated from the .csv files (Figure 3.11D). 
At the 72 hour time point, H1299, MDA-468 and VB6 cells appear to remain at the 
surface of the gel, homogeneously adhered and spread. None of the cell lines 
exhibited signs of invasion into the collagen: Matrigel® substrate. Previous 
observations from Figure 3.7 (VB6 alone) suggested that mini-organotypic gels with 
an exposed surface contract over time, the initial gel height at the 24 hour time point 
was approximately 1400µm and contracted to approximately 1100µm by the 72 hour 
time point. This may be due to evaporation of the exposed gel surface during 
incubation. However all three samples in (Figure 3.11) display signs of gel contraction 
to a similar degree, despite H1299 and MDA-468 containing an  overlay of serum-
free medium. These data suggest that the serum-free layer in this instance made no 
or very little difference. Perhaps the serum-free layer needed to be replaced 
frequently at regular intervals.  





Figure 3.11: 3D rendered and quantified z-stacks of fluorescently labelled cancer 
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Figure 3.11: 3D rendered and quantified z-stacks of fluorescently 
labelled cancer cell lines; H1299, MDA-468 and VB6 in mini-
organotypic gels imaged 72 hours post plating 
The figure displays Imaris XT rendered and analysed 3D z-stack images of 
fluorescently labelled red VB6, MDA-468 and H1299 cancer cells. Images were 
obtained via CLSM 710 72 hours post plating on top of mini-organotypic gels. After 
72 hours post cell seeding, all cells type have adhered and spread out on to the 
surface of the gel. A) H1299 cells do not appear to invade through mini-
organotypic gels. Gel thickness is approximately 1100µm. B) MDA-468 cells also 
show no signs of invasion after 72 hours post plating. Gel thickness is 
approximately 1140µm. C) VB6 cells display no signs of invasion. Gel thickness 
approximately 1100µm. D) Graphical bee swarm plot of invasive depth of all three 
cell types after 72 hours. Each dot represents one cell within the 700µm square 
field of view. One representative image for the 72 hour time point from triplicate 
gels belonging to one of two independent experiments. 
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3.7.2 Investigating the invasiveness of fluorescently labelled 
fibroblast cell lines; HDF, FSF and MRC5 in mini-
organotypic gels 
To determine whether the fibroblast cell lines; HDF, FSF and MRC5 invaded through 
mini-organotypic gels; all three cells were labelled with CellTracker™ Green (10µM) 
and plated on top of mini-organotypic gels. 24 hours post plating, growth medium 
underneath each Transwell® was exchanged and excess medium from the surface of 
the gel was carefully removed before being replaced with a serum-free medium layer. 
Transwells® were imaged via CLSM 710 and z-stacks were obtained at an end point 
of 72 hours (Figure 3.12). Using Imaris XT image analysis software a rendered, 
smoothened 3D representation of the raw .lsm confocal z-stack was generated for 
each fibroblast cell line at the 72 hour time point (Figure 3.12A-C). Distance 
Transformation analysis was performed on the rendered 3D volumes producing .csv 
data files. Graphical plots of invasive depth were generated in Prism using data 
extrapolated from the .csv files (Figure 3.12D).  
Image analysis revealed, when plated alone, that all three fibroblast cell lines invade 
through mini-organotypic gels, however, all at variable rates. In Figure 3.12A the HDF 
cells appear to have polarised and become activated at a faster rate, invading deeper 
into the gel by the 72 hour  time point, in comparison to FSFs and MRC5s (Figure 
3.12B and C). A large population of HDF cells are observed invading though the gel 
at different positions, filling the entirety of the field of view, presumably toward a serum 
derived gradient. Interestingly, the FSF and MRC5 cells do appear to become 
invasive, however, at a slower rate than the HDF cells.  
A large population of both FSF and MRC5 cells are observed attached at the surface 
of the gels. A small population of FSF cells have begun to polarise and change their 
morphology, invading vertically downward through the mini-organotypic gel. 
Furthermore, an even smaller population of MRC5 cells are observed displaying signs 
of early invasive behaviour. Additionally, the gel containing the HDF cells 
(approximately 600µm thick) appears to be diminished and withered compared with 
observations of FSF and MRC5 gels (both approximately 800µm thick). The possible 
reasons for these occurrences may be due to; (1) enzymes secreted by the HDF cells 
may have degraded the collagen: Matrigel® substrate faster than the secretions from 
the FSF and MRC5 cells, thus, invading deeper through the gel; (2) the HDF cells 
may possess a more activated phenotype compared to the FSF and MRC5 cells, also 
leading to an increase in invasive activity and matrix degradation; (3) the FSF and 
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MRC5 cells may be slower at activating on 3D substrata, therefore, require more time 
to become fully activated and polarised. 
Figure 3.12D displays the distance between the centres of each cell in relationship 
to the bottom of the Transwell®. Over a 72 hour period the HDF cells produce a much 
steeper invasive gradient to that observed of the FSF and MRC5 cells. Additionally 
the HDF cells are not as tightly packed as the FSF and MRC5 cells. In fact, the HDF 
cells are spread through the span of the gel, ranging and invasive depth between 
600-200µm, on the contrary, FSF and MRC5 cells appear to be stacked on top of 
each other, producing a cell layer of 200µm in depth with only a small population of 
each cell line invading into the gels. This implies that the HDF cells are more invasive 
than FSF and MRC5 cells when plated alone over a 72 hour period and that some 
HDF cells within a population could be more invasive than others. Interestingly all 
three fibroblast cell lines display varying signs of activation and all appear to have 
changed their morphology to favour a vertical downward invasion through the mini-
organotypic gel, albeit at different rates. 
  




Figure 3.12: 3D rendered and quantified z-stacks of fluorescently 
labelled fibroblasts cell lines; HDF, FSF and MRC5 in mini-
organotypic gels imaged 72 hours post plating 
The figure displays Imaris XT rendered and analysed 3D z-stack images of 
fluorescently labelled green HDF, FSF and MRC5 fibroblast cells. After 72 hours 
post cell seeding, all cells type are vibrant with colour and easily identifiable. A) At 
the 72 hour time point a large population of HDF cells has invaded the entirety of 
the gel. HDF cells have changed their polarity and morphology, favouring a 
downward vertical invasion. Ranging and invasive depth between 600-200µm. Gel 
thickness is approximately 600µm. B) FSFs appear attached and very much 
settled on the surface of the gel. A small population of FSF cells can be observed 
initially invading. The level of invasive depth reached is far less than the HDF cells. 
Perhaps with more time the FSF cells would invade further through the gel. Gel 
thickness is approximately 800µm. C) MRC5 cells also appear to be settled on the 
surface of the gel. Similar to that of the FSF cell, some MRC5 cells appear to have 
begun invading. Gel thickness is approximately 800µm. D) Graphical bee swarm 
plot of invasive depth of all three cell types after 72 hours. Each dot represents 
one cell within the 700µm square field of view. One representative image for the 
72 hour time point from triplicate gels belonging to one of two independent 
experiments. 
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3.7.3 Investigating the invasiveness of fluorescently labelled 
HDF, FSF, and MRC5 fibroblast cells co-cultured with 
H1299, MDA-468 or VB6 cancer cells in mini-organotypic 
gels 
To identify which fibroblast: tumour cell pair displayed the maximum invasion after 72 
hours post plating; HDF, FSF and MRC5 fibroblast cells were labelled with 
CellTracker™ Green (10µM) and co-cultured with fluorescently labelled 
CellTracker™ Red; H1299, MDA-468 or VB6 cancer cells (5µM) (Figure 3.13, Figure 
3.14 and Figure 3.15). Transwells® were imaged via CLSM 710 and z-stacks were 
obtained at an end point of 72 hours. Using Imaris XT image analysis software a 
rendered, smoothened 3D representation of the raw .lsm confocal z-stack was 
generated for each fibroblast and tumour cell line pair at the 72 hour end point (Figure 
3.13A-C, Figure 3.14A-C and Figure 3.15A-C). Distance Transformation analysis 
was performed on the rendered 3D volumes producing .csv data files. Graphical plots 
of invasive depth were generated in Prism using data extrapolated from the .csv files 
(Figure 3.13D, Figure 3.14D and Figure 3.15D). 
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3.7.3.1 Investigating the invasiveness of fluorescently 
labelled HDF, FSF and MRC5 fibroblast cells: co-
cultured with H1299 lung cancer cells in mini-
organotypic gels 
To determine which fibroblast cell line displayed maximum invasion after 72 hours 
when co-cultured with lung H1299 cells, HDF, FSF and MRC5 cells were labelled with 
CellTracker™ Green  and plated in co-culture on top of mini-organotypic gels with 
CellTracker™ Red labelled H1299 cells. 24 hours post plating, growth medium 
underneath each Transwell® was exchanged and excess medium from the surface of 
the gel was carefully removed before being replaced with serum-free medium. 
Transwells® were imaged via CLSM 710 and z-stacks were rendered, smoothened 
and quantified at an end point of 72 hours post plating (Figure 3.13). 
Image analysis revealed, when H1299 cells were plated in co-culture with three 
different fibroblast cell lines, cell invasion in to the mini-organotypic gels was diverse 
in each combination. Figure 3.13A displays fluorescently labelled HDF and H1299 
cells 72 hours post plating. Both cell types appear to have adhered and spread 
homogeneously on the surface of the gel.  HDF cells appear to have become 
polarised, changed their morphology and orientation and invaded into the gel, as 
similarly observed in Figure 3.12A (HDF cells alone). However, the HDF cells have 
not reached the same invasive depth when co-cultured with H1299 cells compared to 
when plated alone. The bee swarm plot suggests that the H1299 cells have settled 
on the surface of the gel and produced a layer, approximately 80µm in depth. 
Interestingly, the plot also reveals a small population of H1299 cells residing beneath 
this layer, located deep within the core of the invading HDFs, with a secondary wave 
following closely behind. This may be a result of the H1299 cells migrating closely 
behind the HDFs, possibly through the channels produced by the fibroblasts. 
Conversely, observations from Figure 3.11A, suggested H1299 cells do not migrate 
through mini-organotypic gels when plated alone. 
Figure 3.13B displays fluorescently labelled populations FSF and H1299 cells 
attached and evenly spread on the surface of the gel 72 hours post plating. The bee 
swarm plot suggest that the H1299 cells produce a cell layer approximately 80µm in 
depth. A small cluster of FSF cells have begun to polarise and change their 
morphology, invading vertically downward through the gel. Similar observations were 
noted in Figure 3.12B (FSF cells alone).  
Chapter III: Results Part I 
121 
 
However in that experiment, FSF cells expand over an invasive depth between 700-
550µm, whereas when co-cultured with H1299 cells, the rate of invasion appears to 
have decreased, with FSF cells only ranging an invasive depth between 850-750µm. 
This reduction in invasive capability may be due to the presence of the H1299 cells, 
competing for space or potentially supressing, temporarily, the FSFs capability to 
polarise and invade.  
Figure 3.13C displays large populations of fluorescently labelled MRC5 and H1299 
cells attached and uniformly spread to the surface of the gel 72 hours after plating. 
Neither cell type are seen invading through the gel. The MRC5 cells do not appear to 
become polarised or change their morphology, unlike the observations displayed with 
the HDF and FSF cells (Figure 3.13A and B respectively). 
In Figure 3.13A, the mini-organotypic gel appears to have contracted to 
approximately 600µm in depth. In comparison, gels in Figure 3.13B and C appear to 
have contracted less and appeared more robust (approximately 850µm and 1200µm 
respectively). This may be due to enzymatic secretions from the HDF cells increasing 
the rate of gel degradation and remodelling, compared to the gels containing FSF and 
MRC5 cells. 
The 3D rendered images and bee swarm plot data suggest that HDF cells polarise 
and invade further into the gel after 72 hours compared to FSF and MRC5 fibroblast 
cells when co-cultured with H1299 cancer cells. These data suggest that H1299 cell 
migration may be co-dependant on the fibroblasts ability to invade and remodel the 
mini-organotypic gels, and additionally, the invasive capability of fibroblast cells may 
be due to specific genotypes. 
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Figure 3.13: 3D rendered and quantified z-stacks of fluorescently labelled HDF, 
FSF and MRC5 cells co-cultured with fluorescently labelled H1299 cells in mini-










Figure 3.13: 3D rendered and quantified z-stacks of fluorescently 
labelled HDF, FSF and MRC5 cells co-cultured with fluorescently 
labelled H1299 cells in mini-organotypic gels imaged 72 hours post 
plating  
The figure displays Imaris XT rendered and analysed 3D z-stack images of 
fluorescently labelled green HDF, FSF and MRC5 fibroblast cells co-cultured with 
fluorescently labelled red H1299 lung cancer cells. After 72 hours post cell 
seeding, all cells type are vibrant with colour and easily identifiable. A) At the 72 
hour time point HDF cells have changed their polarity to that favouring a downward 
vertical invasion. H1299 cells appear attached and spread on the surface of the 
gel. A small population of H1299 cells can be observed migrating in to the gels. 
Gel thickness is approximately 600 µm. B) FSFs appear attached and very much 
settled on the surface of the mini-organotypic gel. A small population of FSF cells 
can be observed initially invading. The level of invasive depth reached is far less 
than the HDF cells. H1299 cells appear attached and spread on the surface of the 
gel, with no signs of invasion after 72 hour. Gel thickness is approximately 850µm. 
C) Large populations of MRC5 and H1299 cells appear to be settled, attached and 
spread on the surface of the mini-organotypic gel. Both cell types appear densely 
packed together in a layer no more than 90µm in thickness. Overall gel thickness 
is approximately 1250µm. One representative image for the 72 hour time point 
from triplicate gels belonging to one of two independent experiments. 
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3.7.3.2 Investigating invasiveness of fluorescently 
labelled HDF, FSF and MRC5 fibroblast cells: co-
cultured with MDA-468 breast cancer cells in mini-
organotypic gels 
To determine which fibroblast cell line displayed maximum invasion after 72 hours 
when co-cultured with MDA-468 cells, HDFs, FSFs and MRC5s were labelled with 
CellTracker™ Green and plated in co-culture on top of mini-organotypic gels with 
CellTracker™ Red; labelled MDA-468 cells. 24 hours post plating, growth medium 
underneath each Transwell® was exchanged and excess medium from the surface of 
the gel was carefully removed before being replaced with serum-free medium. 
Transwells® were imaged via CLSM 710 and z-stacks were rendered, smoothened 
and quantified at an end point of 72 hours post plating (Figure 3.14). 
Image analysis revealed, when MDA-468 cells were plated in co-culture with three 
different fibroblast cell lines, cell invasion into mini-organotypic gels was different in 
each combination, as previously observed (Figure 3.13). Figure 3.14A displays 
fluorescently labelled HDF and MDA-468 cells 72 hours post plating. Both cell types 
appear to have attached and spread equally on the surface of the gel. The HDF cells 
appear to have become polarised, changed their morphology and invaded into the 
gel. However, HDF cells co-cultured with MDA-468 cells have not reached the same 
invasive depth as when plated alone (Figure 3.12A) or when plated with H1299 cells 
(Figure 3.13A). This could imply that the MDA-468 cells may have decreased the 
rate at which HDF cells become polarised and activated, thus, slowing down the depth 
of invasion reached by the 72 hour time point. The bee swarm plot suggests that the 
MDA-468 cells have formed a cell layer approximately 80µm in depth.  
Additionally, a small number of MDA-468 cells are residing underneath this layer 
buried deep within the invading fibroblasts, as previously observed in Figure 3.13A 
(HDF cells co-cultured with H1299). Suggesting that a small population of MDA-468 
cells may have migrated into the channels in the gel, created by HDF cells, during 
matrix remodelling. Interestingly, observations from Figure 3.11B, suggest that MDA-
468 cells do not migrate through mini-organotypic gels when plated alone. 
Figure 3.14B displays fluorescently labelled populations of FSF and MDA-468 cells 
attached and homogenously to the surface of the gel 72 hours post plating. FSF cells 
appear to have become polarised, changed their morphology and started to invade 
downward through the mini-organotypic gel. The level of invasive depth reached by 
the FSF cells in Figure 3.14B (between 800-650µm) resembles similar observations 
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identified in Figure 3.12B (FSF cells alone, invasive depth between 700-550µm). The 
MDA-468 cells appear to have formed a layer of cells at the surface of the gel 
approximately 50µm thick. The bee swarm plot suggests that three individual MDA-
468 cells have drifted away from the main layer and possibly migrated into the 
channels created by the FSF cells. Potentially with more time FSF cells could invade 
further through the mini-organotypic gels, thus, enabling MDA-468 cells to follow 
closely behind. 
Figure 3.14C displays a large population of fluorescently labelled MRC5 and MDA-
468 cells attached and spread evenly on the surface of the gel 72 hours post plating. 
As observed in Figure 3.13C (MRC5 co-cultured with H1299), neither cell type are 
seen invading through the gel. The MRC5 cells do not appear to become polarised 
or change their morphology however a few rounded cells have started to invade. 
The 3D rendered images and bee swarm plot data suggest that HDF and FSF cells 
become polarised and invade through mini-organotypic gels when co-cultured with 
MDA-468 cells. Contrarily, MRC5 cells displayed no signs of invasion when co-
cultured with MDA-468 cells, as similar previous observations (Figure 3.13C). All gels 
appear to experience some level of contraction, Figure 3.14B and C display greater 
contraction compared with observation of Figure 3.14A.    
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Figure 3.14: 3D rendered and quantified z-stacks of fluorescently labelled HDF, 
FSF and MRC5 cells co-cultured with fluorescently labelled MDA-468 cells in 















Figure 3.14: rendered and quantified z-stacks of fluorescently 
labelled HDF, FSF and MRC5 cells co-cultured with fluorescently 
labelled MDA-468 cells in mini-organotypic gels imaged at 72 hours 
post plating 
The figure displays Imaris XT rendered and analysed 3D z-stack images of 
fluorescently labelled green HDF, FSF and MRC5 fibroblast cells co-cultured with 
fluorescently labelled red MDA-468 breast cancer cells. After 72 hours post cell 
seeding, all cells type are vibrant with colour and easily identifiable. A) HDF and 
MDA-468 cells appear attached and spread on to the surface of the gel. HDF cells 
have changed their polarity to that favouring a downward vertical invasion. The 
bee swarm plot displays a small population of MDA-468 cells migrating in to the 
gels. Gel thickness is approximately 900 µm. B) FSF and MDA-468 cells appear 
attached and spread on the surface of the gel. A small population of FSF cells 
appear to become polarised and can be observed initially invading. The bee 
swarm plot displays three MDA-468 cells migrating away from main cell layer in 
to the gel. Gel thickness is approximately 800µm. C) Large populations of MRC5 
and MDA-468 cells appear to be settled, attached and homogenously spread on 
the surface of the gel. Neither cell type display signs of invasion. Both cell types 
appear densely packed together in a layer no more than 100µm in thickness. 
Overall gel thickness is approximately 1250µm. One representative image for the 
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3.7.3.3 Investigating invasiveness of fluorescently 
labelled HDF, FSF and MRC5 fibroblast cells; co-
cultured with VB6 OSCC in mini-organotypic gels 
To examine which fibroblast cell line displayed maximum invasion after 72 hours 
when co-cultured with VB6 cells, HDFs, FSFs and MRC5s were labelled with 
CellTracker™ Green and plated in co-culture on top of mini-organotypic gels with 
CellTracker™ Red labelled VB6 cells. 24 hours post plating, growth medium 
underneath each Transwell® was exchanged and excess medium from the surface of 
the gel was carefully removed leaving the surface of the gels exposed for the 
remainder of the assay. Transwells® were imaged via CLSM 710 and z-stacks were 
rendered, smoothened and quantified at an end point of 72 hours post plating (Figure 
3.15). 
Image analysis revealed, when VB6 cells were plated in co-culture with three different 
fibroblast cell lines, cell invasion into mini-organotypic gels was uniquely different in 
each combination, as previously observed (Figure 3.13 and Figure 3.14). Figure 
3.15A displays fluorescently labelled HDF and VB6 cells 72 hours post plating. Both 
cell types appear to have attached and spread on the surface of the gel. The HDF 
cells appear to have become polarised, changed their morphology and invaded 
deeply into the gel. Interestingly, the HDF cells co-cultured with VB6 cells reached an 
invasive depth, similar to that observed when HDF cells were plated alone (Figure 
3.12A) and greater than when plated with H1299 cells (Figure 3.13A) and MDA-468 
cells (Figure 3.14A). The bee swarm plot suggests that the VB6 cells have formed a 
cell layer approximately 100µm in depth. Additionally, a population of VB6 cells are 
residing underneath this layer buried deep within the invading fibroblasts, as 
previously observed in Figure 3.13A (HDF cells co-cultured with H1299). Again, as 
indicated previously, this suggests that a small population of VB6 cells probably 
migrate into the channels in the gel, created by HDF cells. Interestingly, observations 
from Figure 3.11C, suggest that VB6 cells do not migrate through mini-organotypic 
gels when plated alone. After 72 hours I observed both populations of cells invading 
through the collagen: Matrigel® substrate and at the same time notice gel contraction.  
Figure 3.15B displays fluorescently labelled populations of FSF and VB6 cells 
attached and homogenously to the surface of the gel 72 hours post plating. FSF cells 
do not appear to show the same levels of polarity or invasiveness as observed in 
Figure 3.15A.  
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Additionally the gel appear more robust. The bee swarm plot suggests that the FSF 
and VB6 cells are tightly packed together in an area no greater than 50µm in depth.  
Figure 3.15C displays large population of fluorescently labelled MRC5 and VB6 cells 
attached and spread evenly on the surface of the gel 72 hours post plating. Similar 
observation in Figure 3.13C (MRC5 co-cultured with H1299) and Figure 3.14C 
(MRC5 co-cultured with MDA-468) were seen with neither cell type invading through 
the gel. The MRC5 cells do not appear to become polarised or change their 
morphology and exhibit no signs of gel contraction. 
The 3D rendered images and bee swarm plot data suggest that HDF cells become 
polarised and invade through mini-organotypic gels when co-cultured with VB6 cells. 
Contrarily, FSF and MRC5 cells displayed no or little signs of invasion when co-
cultured with VB6 cells. The HDF: VB6 combination exhibits a large degree of gel 
contraction (gel height approximately 400µm thick), compared to the gels containing 
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Figure 3.15: 3D rendered and quantified z-stacks of fluorescently labelled HDF, 
FSF and MRC5 cells co-cultured with fluorescently labelled VB6 cells in mini-
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Figure 3.15: rendered and quantified z-stacks of fluorescently 
labelled HDF, FSF and MRC5 cells co-cultured with fluorescently 
labelled VB6 cells in mini-organotypic gels imaged at 72 hours post 
plating 
The figure displays Imaris XT rendered and analysed 3D z-stack images of 
fluorescently labelled green HDF, FSF and MRC5 fibroblast cells co-cultured with 
fluorescently labelled red VB6 OSCC cancer cells After 72 hours post cell seeding, 
all cells type are vibrant with colour and easily identifiable. A) HDF and VB6 cells 
appear attached and spread on to the surface of the gel. HDF cells have changed 
their polarity to that favouring a downward vertical invasion. The bee swarm plot 
displays a population of VB6 cells migrating in to the gels. Gel thickness is 
approximately 400µm. B) FSF and VB6 cells appear attached and spread on the 
surface of the gel. FSF cells do not appear to become polarised or invade into the 
gel. Gel thickness is approximately 800µm. C) MRC5 and VB6 cells appear to be 
settled, attached and homogenously spread on the surface of the gel. Neither cell 
type display signs of invasion. Both cell types appear densely packed together in 
a layer no more than 100µm in thickness. Overall gel thickness is approximately 
1050µm. One representative image for the 72 hour time point from triplicate gels 
belonging to one of two independent experiments. 
 
  




The primary aim of this study was to develop a novel 3D organotypic invasion model 
aided by fluorescence to capture, monitor and study live cancer cell invasion. This 
was achieved by combining use of transient cellular dyes, Transwell® inserts with 
optically clear PET membranes, a long working distance 20x objective and confocal 
microscopy. Thus, I have developed a new reproducible robust method to visualise 
tumour cells interacting with stromal fibroblasts within a 3D microenvironment in situ. 
Furthermore with the aid of image analysis we have found a suitable representation 
to measure and quantify cellular invasion. This assay will speed up the analysis of 
tumour-stromal interactions that have previously required many days of histological 
processing. However the assay has revealed much more about the dynamic 
behaviour and interactions between tumour and fibroblast cells within mini-
organotypic gels. 
Many labs now use the in vitro organotypic gel assay systems (Coleman et al., 2014b; 
Froeling et al., 2010; Froeling et al., 2009; Gaggioli et al., 2007; Mackenzie, 2004; 
Schneider et al., 2008)  as they are meant to more closely mimic the in vivo invasive 
tumour front. Almost all other groups use histology to assess the invasiveness of the 
tumour cell component of the organotypic gel and then do so at a pre-determined 
end-point. However, here with the aid of confocal microscopy, we have attempted to 
quantify tumour and fibroblast cell invasion within a 3D gel. A similar imaging 
technique was used by Vial and colleagues to examine colon carcinoma cell invasion 
through Matrigel®-coated 8µm pore size Transwell® inserts (Vial et al., 2003). Few 
groups have examined the inherent invasiveness of the fibroblasts used in the assay. 
The data in this chapter shows that one must be very careful to monitor the invasive 
activity of the fibroblasts in isolation as they may be the principal determinant of 
cancer cell invasiveness.  
Observations from this study suggest that some stromal fibroblasts cells are highly 
invasive through the collagen: Matrigel® substrate, in particular our HDFs (Figure 
3.8), whereas, VB6 cancer cells are not (Figure 3.7). Only when combined with 
HDFs, do VB6 cells have the ability to ‘invade’ (Figure 3.9). This capacity to follow 
into the fibroblast pre-modelled matrix has been reported to occur in vivo during 
collective cell invasion (Alexander et al., 2008; Hegerfeldt et al., 2002). A study in 
2007 described co-cultures containing carcinoma cells and stromal fibroblasts 
resulted in the leading cells always to be a fibroblast (Gaggioli et al., 2007). The 
authors used multi-photon microscopy to examine invasion through large organotypic 
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gels (designed by Nystrom et al., 2005). Gaggioli and colleagues reported that 
carcinoma cells move through the tracks and channels in the ECM behind the 
fibroblasts, such tracks required protease- and force- mediated matrix remodelling. 
The data presented here are consistent with that of Gaggioli, that the fibroblast cells 
within our 3D model create tracks and channels through the mini-organotypic gel, 
perhaps by use of enzymes. It is widely established that MMPs have a key role in 
matrix degradation and remodelling by fibroblast cells (Egeblad et al., 2005; Egeblad 
and Werb, 2002; Raeber et al., 2007; Rhee, 2009; Yamaguchi et al., 2014). Stromal 
fibroblasts have been shown to participate in tumour invasion by secretion of matrix-
degrading enzymes (Sreenath et al., 1992; Wernert, 1997). However the Gaggioli 
study failed to acknowledge the dynamic signalling between cancer cells and 
fibroblasts that modifies this invasive response. 
Thus combining the highly invasive HDF cells with the poorly invasive MDA-468 
resulted in only a moderately invasive co-culture. The HDF cells have not invaded as 
deeply as they are able when plated on their own and the MDA-468s have shown 
evidence of invasion in contrast to when they are plated on their own (compare Figure 
3.11B and Figure 3.14A). 
The combination of H1299 and HDF cells appears to have had an intermediate effect 
in-between that of the MDA-468 and HDF co-culture. When one examines the other 
tumour; fibroblast combinations, again there is a distinct difference in behaviour of 
the combined cells. This can be seen clearly in the quantitation data. It appears that, 
when plated alone, the FSFs and MRC5s polarise and invade slower compared to 
HDFs (Figure 3.12). Moreover, FSFs and MRC5s cell combinations with H1299, 
MDA-468 and VB6 cancer cells show little and in some cases, no signs of invasion, 
at least within the initial 72 hours (Figure 3.13B & C, Figure 3.14B & C and Figure 
3.15B & C).   
Initial interpretation of the VB6: HDF data might be that this is just an assay that 
measures fibroblast invasion, however, the assay is measuring the dynamic 
interactions between cancer cells and stromal fibroblasts that result in a modified 
behaviour of both cell types. Which signals are exchanged between the cancer cells 
and fibroblasts to result in these specific 3D behaviours remain unknown but are likely 
to be valuable to identify since they can completely change the behaviour of an 
invasive front. Moreover, it is likely that modifying the extracellular matrix gel 
composition may also modify the behaviour observed in the experiments displayed in 
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this chapter.  Both suggestions will have to be investigated by others as it is beyond 
the scope of this study. 
As mentioned earlier, the large organotypic gels which were previously used (Nystrom 
et al., 2005) are more time consuming, expensive and arduous to create than the 
mini-organotypic gels. However there are significant differences between the Nystrom 
large organotypic gels and the in situ analysed fluorescent mini-organotypic gels 
described here. Plating gels into a Transwell® insert may exert additional mediated 
forces on to the gel, changing its overall stiffness which could feedback and change 
the motility, migration and invasive capabilities of cells  (Ehrbar et al., 2011; Lang et 
al., 2015; Zaman et al., 2006).  
Additionally the large organotypic gels had fibroblasts embedded within the gel prior 
to the polymerisation incubation step, however Figure 3.10 displays fluorescently 
labelled HDF cells residing at the bottom of the gel post polymerisation. This could be 
due to collagen fibril formation and mechanism. Collagen fibrils are a homogenous 
collection of thin rod shaped molecules before polymerisation. Polymerisation 
generates heterogeneous cross-linked lattice-like structures when conditions are 
adjusted to near physiological values (i.e., between temperatures 20-37°C and pH 
6.5-8.5) producing collagen fibres >200nm wide (McPherson et al., 1985; Sung et al., 
2009; Wood, 1960). Additionally, studies have reported the kinetics of in vitro collagen 
fibril development is effected by temperature, pH and integrins (Gelman et al., 1979; 
Velling et al., 2002; Williams et al., 1978). Perhaps the collagen fibres form at a 
greater rate than the rate of HDF cell polarisation and spreading.  
Moreover, in the large organotypic gels, the plated tumour cells would not physically 
encounter as many fibroblasts as they do in the mini-organotypic assay and therefore 
would not have such a high cross-talk. However, as cancer cells in vivo do encounter 
fibroblasts at their invasive front the mini-organotypic gels might be considered as 
exaggerating the tumour: fibroblast interaction.  
Overall the fluorescent mini-organotypic gels offers a reproducible, robust, and 
quantitative assay that allows researchers to investigate tumour-stroma interactions 
of any cell type in an affordable manner. Furthermore, measurable changes can be 
observed within 72 hours. This opens doors to conduct drug and gene library screens 
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4.0 An siRNA screen investigating the role of 
fibroblast proteases in regulating tumour cell 
invasion using a novel 3D fluorescent mini-
organotypic invasion assay 
 
4.1 Background 
4.1.1 Small interfering RNA (siRNA) 
Gene silencing through a sequence specific manner is triggered by the introduction 
of double stranded RNA via a post-transcriptional process (known as RNA 
interference (RNAi)) (Elbashir et al., 2001). Since the discovery of genetic 
interference in 1998 (Fire et al., 1998),  siRNA technology has become a powerful 
tool for temporarily silencing the expression of any target gene.  
Studies have revealed that RNAi induced signalling is a two-step mechanism; (1) the 
first step involves the degradation of double stranded RNA (dsRNA) into siRNA 
(approximately 20-25 nucleotides long) by the enzyme Dicer (DCR); (2) the second 
step involves the siRNA being incorporated into a RNA-induced silencing complex 
(RISC), which subsequently identifies and silences complementary messenger RNA 
(mRNA) (Agrawal et al., 2003; Hannon and Rossi, 2004). 
Several factors can affect the efficiency of RNAi, one of the major factor determine 
silencing efficiency is the length of the siRNA duplex. It was reported that a 17-
nucldeotide duplex was not effective in silencing the target, however a 19-nucleuotide 
duplex mediated efficient silencing (Czauderna et al., 2003). Additionally, the amount 
of siRNA that is delivered to the host cells can effect siRNA transfection efficiency 
and reduce knockdown rates. Usually the siRNA duplexes are transfected using 
standard techniques and become diluted due to cell proliferation, thus only effective 
when concentration levels are sufficient (Alshamsan et al., 2009; Kim et al., 2007).  
To achieve stable gene targeting is it possible to use a viral or non-viral transduction 
of short-hairpin (shRNA) nucleic acid that encodes the dsRNA that is then cut with 
DCR. Once inserted into genome each insert should produce siRNA for the life span 
of the cell (Huang et al., 2015). 
  




4.1.2 Uses of siRNA technology in 2D screening methods 
In published reports, siRNA and RNAi screens have been widely performed for a 
variety of biological studies using 2D adherent cell culture systems. Some examples 
include, the identification of novel targets for effective treatment of triple negative 
breast cancer (Lee et al., 2015), regulators of cell invasion and migration (Smolen et 
al., 2010) and mechanisms of resistance to drugs in liver cancer (Rudalska et al., 
2014). However, the detriment of such assays lies within their incapacity to mimic a 
physiological microenvironment similar to that of native tissue. 3D cultures display a 
higher degree of structural complexity, analogous to native tissue (Hess et al., 2010) 
and are currently used in biological studies of tumour biology (Pampaloni et al., 2007). 
High throughput siRNA screening using 2D microplate based methods are not 
hindered by readout limitations and are compatible with many liquid handling 
instruments typically available in most HTS laboratories. 2D high-throughput siRNA 
screens have been performed in 96-well plates (Ovcharenko et al., 2005), to 384-well 
microplates (Chung et al., 2008; Petrocca et al., 2013) and impressively, 1536-well 
nanoplates (Chung et al., 2010). However, all lacking the important significance of 
the third dimension (z-plane). 
The appeal of screening in 3D is due to the ability to produce a variety of phenotypic 
data that are more physiologically relevant than those obtained in 2D screens. To 
ensure access of siRNA reagents to all cells within a 3D culture, they are typically 
transfected on a 2D substrate before being introduced into the 3D scaffold of choice. 
Current technological advances have enabled gene silencing of cancer cells in 3D 
models using BioChip (Abbud-Antaki et al., 2012; Marhefka and Abbud-Antaki, 2012), 
microfluidic platforms (Chen and Yoon, 2017) and implemented via 96-well hanging 
drop spheroids (InSphero AG, Switzerland) (Thoma et al., 2013). The abundance of 
diverse studies using RNAi technology illustrates how popular this silencing method 
has become over the past 20 years.  
Development of a 3D screening system can be problematic in comparison to its 2D 
counterpart, caused by various factors, such as; (1) appointing a scaffold material 
and assay design that suitably represents an ECM environment with regards to the 
experimental question; (2) optimising an appropriate plate format to ensure optimal 
throughput with minimal experimental variations; (3) taking into consideration costs 
of consumables and reagents; (4) sourcing an appropriate microscope system, 
capable of imaging through z-depths with speed and consistency to produce high 
content phenotypic data for image analysis; and (5) data management; having a 




system in place whereby high content multiple parameter data can be analysed via 
batch processing from an integrated software. 
Cancer cells, have been the principal target cell of interest for the majority of in vitro 
cancer related drug and gene screens. Such screens include, targeting cancer stem 
cells via chemotherapeutic agents (Dragu et al., 2015), discovering potential cancer 
drug targets by clustered regularly interspaced short palindromic repeats (CRISP-
Cas9) screening (Shi et al., 2015) or determining correlations between drug sensitivity 
and mutation by means of screening lung cancer cell lines for an EGFR kinase 
inhibitor (McDermott et al., 2008).  
However, a dominant and yet often neglected component of the tumour stroma 
environment are the fibroblasts. Studies have suggested the prominent functional 
roles of these cells in cancer metastasis and progression (Gaggioli et al., 2007; Kalluri 
and Zeisberg, 2006; Liao et al., 2009). In this section, my aim was to investigate any 
changes in phenotypic behaviour of fibroblast and cancer cells when transfecting 
fibroblasts with siRNA that targeted proteases. 
In the previous chapter, I screened three strains of fibroblasts and showed that HDFs 
are the most invasive cell type within 3D mini-organotypic gels, more so when plated 
alone, however also when co-cultured with cancer cells. Here, I focus especially on 
HDF cells, to perform a loss of function (LOF) siRNA screen, to observe and record 
any phenotypic changes when a single protease is knocked-down. 
  




4.2 SMARTpool siRNA screen – targeting a panel of proteases in HDF 
cells 
To examine whether gene silencing in HDF cells had any effect on invasion and 
matrix degradation, HDF cells were transfected with a custom library of SMARTpool 
siRNA and plated in co-culture with non-treated VB6 cells on to mini-organotypic gels. 
The custom SMARTpool siRNA library (listed in Table 2.5) was delivered within the 
inner 60 wells of a 96-well U-bottomed plate. 
The siRNA transfection screen was conducted in 15 individual experiments; each 
experiment contained triplicate samples of four pooled siRNAs with the addition of a 
siGENOME non-targeting siRNA control (denoted as NT) and a transfection reagent-
only treated control (listed in Table 2.6 and displayed in Appendix Figures 7.1 – 
7.15). The detailed experimental method is described in Section 2.6.1, but briefly, 
the concept was to use the newly optimised fluorescent 3D mini-organotypic invasion 
assay to identify which, if any, siRNAs inhibited HDF and VB6 cell invasion when the 
protease was knocked down solely in HDF cells. 
HDF cells were plated into 6-well plates (1.5 x 105 cells/well) and the next day 
transfected with SMARTpool siRNA (20nM final concentration). Three days post 
transfection, HDF and VB6 cells were fluorescently labelled with CellTracker™ Green 
(10µM) and Red (5µM) respectively, counted and seeded in a 2:1 ratio of fibroblast: 
tumour cells on top of mini-organotypic gels. Three days post plating (six days post 
transfection) end point analysis z-stack images were acquired via CLSM. A 
smoothened, rendered 3D representation of the raw .lsm confocal z-stack was 
generated for each of the samples via Imaris XT image analysis software. Distance 
Transformation analysis was performed on the rendered 3D volumes producing .csv 
data files. Graphical plots of invasive depth were generated in Prism using data 
extrapolated from the .csv files (as described in Section 2.5). 
Due to the cost of consumables, reagents and limited confocal microscopy usage 
time, the primary siRNA knockdown screen could only be conducted once and on one 
strain of fibroblasts (HDFs). 
 
4.2.1  SMARTpool primary siRNA screen  
Here I investigated, the effects, of siRNA knockdown in fibroblast cells of 
intracellularly expressed proteases using the fluorescent 3D mini-organotypic 
invasion assay. The series of figures that follow display 3D Imaris rendered images 




of the 60 SMARTpool siRNA (arranged alphanumerically) compared against a non-
targeting siRNA control (NT) at the end point of the assay (Figure 4.1 - Figure 4.5). 
The invasive depth data, of HDF (Figure 4.6A) and VB6 cells (Figure 4.6B), was 
measured and plotted, compared against the NT control. 
 
4.2.1.1 SMARTpool primary siRNA screen: calpains 
(CAPNs) 
Calpains are a unique class of intracellular Ca2+ dependent cysteine proteases, with 
a wide array of functionalities, including, cytoskeletal remodelling, cellular signalling, 
cell survival and apoptosis. In mammals the calpain family is comprised of 15 
members, of which nine are ubiquitously expressed in all tissues, specifically CAPN-
1, -2, -4, -7 and -10 (Ono and Sorimachi, 2012; Storr et al., 2011). CAPN-3 has been 
identified within the skeletal muscles, whereas CAPN-5 has been expressed in the 
brain and CAPN-8 and -9 in the stomach (Sorimachi and Suzuki, 2001). 
Figure 4.1 displays a series of 3D images containing fluorescently labelled HDF 
(green) cells transfected with SMARTpool CAPN-1, -2, -3, -5, -6, -7, -9, -10, -11, -13 
and CAPN small subunit-1 (also known as CAPN-4) siRNA, co-cultured with 
fluorescently labelled VB6 cells (red). Transwells® were imaged six days post 
transfection via CLSM. 
Image analysis shows that siRNA knockdown of CAPN-1, -2, -9, -10 and CAPNS-1 
in HDFs reduces the invasion of the fibroblasts and contraction of the gels in relation 
to the NT sample. In contrast, HDF cells transfected with CAPN-3, -5, -6, -11 and -13 
display more polarisation, changing their orientation and invading vertically through 
the gel, as similarly observed with the NT sample. Interestingly, CAPN-7 displays 
signs of gel contraction (gel height approximately 450µm), however, HDF and VB6 
cells appear to be attached and spread out on to the gel. HDF cells exhibit no 
polarisation, change in morphology or invasion. The gel contraction displayed may be 
a product of matrix remodelling and evaporation of gels during incubation. 
  











Figure 4.1: End point 3D rendered z-stacks of fluorescently labelled 
HDF cells transfected with siRNA to different calpains plated in mini-
organotypic gels with fluorescently labelled VB6 cells 
The series of images above displays 3D Imaris rendered z-stacks of mini-
organotypic gels containing siRNA transfected HDF and non-transfected VB6 
cells, six days post transfection. HDF cells were plated into a 6-well plate (1.5 x 
105 cells/well) and after 24 hours, HDFs were transfected with siRNA (20nM) in 
triplicate wells. 72 hours post transfection, HDF and VB6 cells were fluorescently 
labelled with CellTracker™ Green (10µM) and Red (5µM) respectively. Next, HDF 
and VB6 cells were counted and plated (2:1 ratio of fibroblast: tumour in a 
suspension containing 105 cells in total) on to mini-organotypic gels and 
incubated. 72 hours post incubation (six days post transfection) z-stack volumes 
were obtained via CLSM. Images were rendered using Imaris image analysis 
software. Image analysis revealed HDF cells transfected with CAPN-1, -2, -10 and 
CAPNS-1 siRNA reduced gel contraction and HDF: VB6 cell invasion into the gel 
in relation to the non-targeting siRNA (NT) sample. Whereas, HDF cells 
transfected with CAPN-3, -5, -6, -7, -9, -11 and -13 polarised and invade into the 
gel. Gels appear diminished and contracted to a degree similar to that compared 
with observation from the NT sample. One representative image of triplicate gels 
belonging to one independent experiment. 
 
  




4.2.1.2 SMARTpool primary siRNA screen: caspases 
(CASPs) 
Caspases (cysteine-aspartic proteases) are a family of Ca2+ independent enzymes 
essential for maintaining homeostasis through programmed cell death (apoptosis, 
necrosis and pyroptosis) and are categorised as initiators or effectors based on their 
apoptotic signalling cascade positions (McIlwain et al., 2013; Zhivotovsky, 2003). 
Figure 4.2 displays a series of 3D rendered images containing fluorescently labelled 
HDF (green) cells transfected with SMARTpool CASP-1, -2, -3, -4, -5, -6, -7, -8, -9, -
10 and -14 siRNA, co-cultured with fluorescently labelled VB6 cells (red). Transwells® 
were imaged six days post transfection via CLSM. 
Image analysis suggests that siRNA knockdown of CASP-1 and -8 in HDFs reduces 
the number of cells which that have become polarised, correlating with reduced 
invasion and gel contraction compared with the NT sample. Whereas, HDF cells 
transfected with CASP-2 and -5 display HDF cells polarising, changing their 
orientation and invading vertically through the gel, as similarly observed with the NT 
sample. Interestingly, CASP-7 displays signs of gel contraction (gel height 
approximately 450µm), however, HDF and VB6 cells appear to be attached and 
spread on to the surface of the gel. HDF cells display no signs of polarisation, change 
in morphology or invasion. The gel contraction observed may be products of matrix 
remodelling, gel contraction and evaporation during incubation. It’s possible that 
knockdown of CASP-7 has inhibited invasion of fibroblasts cells. Furthermore, the 
VB6 cells plated alongside the CASP-9 and -14 transfected HDFs appear to have 
changed their morphology, from a spherical to an elongated form. The reasons for 
this are unknown and could possibly be due to signalling changes between the cells 
within the co-culture. Additionally, the VB6 cells in the CASP-9 and -14 samples 
appear less in number, suggesting that there is maybe cell death or diminished levels 
of the transient fluorescent dye.  











Figure 4.2: End point 3D rendered z-stacks of fluorescently labelled 
HDF cells transfected with siRNA to different caspases plated in mini-
organotypic gels with fluorescently labelled VB6 cells 
The series of images above displays 3D Imaris rendered z-stacks of mini-
organotypic gels containing siRNA transfected HDF and non-transfected VB6 
cells, six days post transfection. HDF cells were plated in to a 6-well plate (1.5 x 
105 cells/well) and after 24 hours, HDFs were transfected with siRNA (20nM) in 
triplicate wells. 72 hours post transfection, HDF and VB6 cells were fluorescently 
labelled with CellTracker™ Green (10µM) and Red (5µM) respectively. Next, HDF 
and VB6 cells were counted and plated (2:1 ratio of fibroblast: tumour in a 
suspension containing 105 cells in total) on to mini-organotypic gels and 
incubated. 72 hours post incubation (six days post transfection) z-stack volumes 
were obtained via CLSM. Images were rendered using Imaris image analysis 
software. Image analysis revealed HDF cells transfected with CASP-1 and -8 
siRNA reduced gel contraction and HDF: VB6 cell invasion into the gel in relation 
to the NT sample. Whereas, HDF cells transfected with CASP-3, -4, -5, -6, -7, -9, 
-10 and -14 show varying levels of  polarisation and invasion into the gel. Gels 
appear diminished and contracted to a degree similar to that compared with 
observation from the NT sample. One representative image of triplicate gels 
belonging to one independent experiment. 
 
  




4.2.1.3 SMARTpool primary siRNA screen: matrix 
metalloproteinases (MMPs) 
Matrix metalloproteinases (or matrixins) are a family of zinc-containing 
metalloendopeptidase enzymes that are known to degrade and remodel various 
components of the ECM (Egeblad and Werb, 2002).  Studies have identified a variety 
of functions and roles involving MMPs, such as, degradation of ECM proteins 
(Alexander et al., 1996), collagen production during wound healing (Saarialho-Kere 
et al., 1993) and in 2001 our laboratory revealed that the integrin αvβ6, upregulated 
MMP-9 and promoted migration of oral keratinocytes (Thomas et al., 2001c). 
Figure 4.3 displays a series of 3D images containing fluorescently labelled HDF 
(green) cells transfected with SMARTpool MMP-1, -2, -3, -7, -8, -9, -10, -12, -13, -14, 
-15, -16, -17, -19, -20, -21, -24, -25, -26, -27 and -28 siRNA, co-cultured with 
fluorescently labelled VB6 cells (red). Transwells® were imaged six days post 
transfection via CLSM. 
Image analysis suggests that siRNA knockdown of MMP-3, -9, -10, -11, -17, -20 and 
-21 in HDFs reduces the number of cells which become polarised, associated with 
reduced invasion and gel contraction in relation to the NT sample. HDF cells 
transfected with MMP-1, -2, -7, -12, -13, -19, -24 and -25 all display HDF polarisation, 
changing their orientation and invading vertically through the gel, as similarly 
observed with the NT sample.  
Interestingly, HDF cells transfected with MMP-14, -15, -26 and -27 displays signs of 
gel contraction, however, HDF and VB6 cells appear to remain at the top of the gel. 
These HDF cells display no signs of polarisation, change in morphology or invasion. 
The gel contraction observed within these samples (MMP-14, -15, -26 and -27) may 
be products of matrix remodelling and evaporation of gels during incubation. 
Additionally, the knockdown of MMP-14, -15, -26 and -27 may have inhibited the 
ability of HDF cell to migrate or invade. In fact Stephen Weiss’ group published the 
necessity of MMP-14 (MT1-MMP) to mediate cell invasion (Hotary et al., 2002). 
Furthermore, MMP-8, -16, and -28 exhibit medium levels of gel contraction, however 
also display signs of fibroblast cell polarisation and invasion into the gel. This may be 
due to diminishing siRNA effects or inefficient knockdown during the transfection 
process. 
  
















Figure 4.3: End point 3D rendered z-stacks of fluorescently labelled HDF cells 
transfected with siRNA to different matrix metalloproteinases plated in mini-
organotypic gels with fluorescently labelled VB6 cells 
 
  




Figure 4.3: End point 3D rendered z-stacks of fluorescently labelled 
HDF cells transfected with siRNA to different matrix 
metalloproteinases plated in mini-organotypic gels with 
fluorescently labelled VB6 cells 
The series of images above displays 3D Imaris rendered z-stacks of mini-
organotypic gels containing siRNA transfected HDF and non-transfected VB6 
cells, six days post transfection. HDF cells were plated in to a 6-well plate (1.5 x 
105 cells/well) and after 24 hours, HDFs were transfected with siRNA (20nM) in 
triplicate wells. 72 hours post transfection, HDF and VB6 cells were fluorescently 
labelled with CellTracker™ Green (10µM) and Red (5µM) respectively. Next, HDF 
and VB6 cells were counted and plated (2:1 ratio of fibroblast: tumour in a 
suspension containing 105 cells in total) on to mini-organotypic gels and 
incubated. 72 hours post incubation (six days post transfection) z-stack volumes 
were obtained via CLSM. Images were rendered using Imaris image analysis 
software. Image analysis revealed HDF cells transfected with MMP-3, -9, -10, -
11, -17, -20 and -21 siRNA reduced gel contraction and HDF: VB6 cell invasion 
into the gel in relation to the NT sample. Whereas, HDF cells transfected with 
MMP-1, -2, -7, -12, -13,-14, -15, -19, -24, -25, -26 and -27 show varying levels of 
polarisation and invasion into the gel. Gels appear diminished and contracted to 
a degree similar to that compared with observation from the NT sample. One 
representative image of triplicate gels belonging to one independent experiment. 
  




4.2.1.4 SMARTpool primary siRNA screen: serine 
protease inhibitors (SERPINs) and sonic 
hedgehog (SHH) 
Serine protease inhibitors (known as SERPINs) are a superfamily of inhibitors that 
use a conformational change to inhibit target enzymes. Over 1,500 SERPIN-like 
genes have been identified in animals, bacteria, plants and poxviruses. However in 
humans, 36 SERPINs have been identified as extracellular molecules (Law et al., 
2006).  
SHH is one of three hedgehog homologues present in mammals, the others being 
Desert (DHH) and Indian (IHH).  The SHH pathway has been reported during early 
embryonic cortical (Rash and Grove, 2007) and neuronal development (Lewis and 
Eisen, 2001). It has also been implicated with regulating stromal fibroblast behaviour 
in cancers (Fendrich et al., 2011; Thayer et al., 2003) and was the target for clinical 
trials in pancreatic cancer (Kim et al., 2014). It was included in the screen as a non-
protease target likely to affect fibroblast promoted invasion. 
Figure 4.4 displays a series of 3D images containing fluorescently labelled HDF 
(green) cells transfected with SMARTpool SERPIN-A1, -A3, -B2, -B12, -D1, E1, -F1 
and SHH co-cultured with fluorescently labelled VB6 cells (red). Transwells® were 
imaged six days post transfection via CLSM. 
Image analysis shows that siRNA knockdown of SERPIN-D1 and -F1 in HDFs 
reduces the number of HDF cells that become polarised, thus inhibiting invasion and 
gel contraction in relation to the NT sample. Whereas, HDF cells transfected with 
SERPIN-A3 and SHH display HDF cell polarisation, changing their orientation and 
invading vertically through the gel, as similarly observed with the NT sample. 
Interestingly, SERPIN-A1, -B2, -B12 and -E1 displays medium levels of gel 
contraction, however, also display early levels of fibroblast cell polarisation and 
invasion into the gel. This may be due to diminishing siRNA effects or inefficient 
knockdown during the transfection process. 
  





Figure 4.4: End point 3D rendered z-stacks of fluorescently labelled HDF cells 
transfected with siRNA to different serpins and sonic hedgehog in mini-
organotypic gels with fluorescently labelled VB6 cells 





Figure 4.4: End point 3D rendered z-stacks of fluorescently labelled 
HDF cells transfected with siRNA to different serpins and sonic 
hedgehog in mini-organotypic gels with fluorescently labelled VB6 
cells 
The series of images above displays 3D Imaris rendered z-stacks of mini-
organotypic gels containing siRNA transfected HDF and non-transfected VB6 
cells, six days post transfection. HDF cells were plated in to a 6-well plate (1.5 x 
105 cells/well) and after 24 hours, HDFs were transfected with siRNA (20nM) in 
triplicate wells. 72 hours post transfection, HDF and VB6 cells were fluorescently 
labelled with CellTracker™ Green (10µM) and Red (5µM) respectively. Next, HDF 
and VB6 cells were counted and plated (2:1 ratio of fibroblast: tumour in a 
suspension containing 105 cells in total) on to mini-organotypic gels and 
incubated. 72 hours post incubation (six days post transfection) z-stack volumes 
were obtained via CLSM. Images were rendered using Imaris image analysis 
software. Image analysis revealed HDF cells transfected with SERPIN-D1 and -
F1 siRNA reduced gel contraction and HDF: VB6 cell invasion into the gel in 
relation to the NT sample. Whereas, HDF cells transfected with SERPIN-A1, -A3, 
-B2, -B12, -E1 and SHH show varying levels of polarisation and invasion into the 
gel. Gels appear diminished and contracted to a degree similar to that compared 
with observation from the NT sample. One representative image of triplicate gels 
belonging to one independent experiment. 
 
  




4.2.1.5 SMARTpool primary siRNA screen: 
transmembrane serine proteases (TMPRSSs) 
Transmembrane serine proteases are a class of membrane-bound proteolytic 
enzymes, which have been identified to play roles in activation of virus entry within in 
acute respiratory syndromes (Shulla et al., 2011), hearing loss (Guipponi et al., 2008) 
and cancer (Tuhkanen et al., 2013).  
Figure 4.5 displays a series of 3D images containing fluorescently labelled HDF 
(green) cells transfected with SMARTpool TMPRSS-2, -3, -4, -5, -6, -9, -11A and -13 
co-cultured with fluorescently labelled VB6 cells (red). Transwells® were imaged six 
days post transfection via CLSM. 
Results show that siRNA knockdown of TMPRSS-13 in HDFs reduces the number of 
cells that become polarised correlating with reduced invasion and gel contraction in 
relation to the NT sample. Whereas, HDF cells transfected with TMPRSS-2, -3, -5, -
9 and -11A display HDF cells polarising, changing their orientation and invading 
vertically through the gel, as similarly observed with the NT sample. Interestingly, 
TMPRSS-4 and -6 displays medium levels of gel contraction, however, also display 
early levels of fibroblast cell polarisation and invasion into the gel. This may be due 
to diminishing siRNA effects or inefficient knockdown during the transfection process. 





Figure 4.5: End point 3D rendered z-stacks of fluorescently labelled HDF cells 
transfected with siRNA to different transmembrane serine proteases in mini-
organotypic gels with fluorescently labelled VB6 cells 




Figure 4.5: End point 3D rendered z-stacks of fluorescently labelled 
HDF cells transfected with siRNA to different transmembrane serine 
proteases in mini-organotypic gels with fluorescently labelled VB6 
cells 
The series of images above displays 3D Imaris rendered z-stacks of mini-
organotypic gels containing siRNA transfected HDF and non-transfected VB6 
cells, six days post transfection. HDF cells were plated in to a 6-well plate (1.5 x 
105 cells/well) and after 24 hours, HDFs were transfected with siRNA (20nM) in 
triplicate wells. 72 hours post transfection, HDF and VB6 cells were fluorescently 
labelled with CellTracker™ Green (10µM) and Red (5µM) respectively. Next, HDF 
and VB6 cells were counted and plated (2:1 ratio of fibroblast: tumour in a 
suspension containing 105 cells in total) on to mini-organotypic gels and 
incubated. 72 hours post incubation (six days post transfection) z-stack volumes 
were obtained via CLSM. Images were rendered using Imaris image analysis 
software. Image analysis revealed HDF cells transfected with TMPRSS-13 siRNA 
reduced gel contraction and HDF: VB6 cell invasion into the gel in relation to the 
NT sample. Whereas, HDF cells transfected with TMPRSS-2, -3, -4, -5, -6, -9 and 
-11A show varying levels of polarisation and invasion into the gel. Gels appear 
diminished and contracted to a degree similar to that compared with observation 
from the NT sample. One representative image of triplicate gels belonging to one 
independent experiment. 
 
4.2.1.6 Identification of hits from SMARTpool primary 
siRNA screen 
To determine whether knockdown of siRNA from the SMARTpool library had any 
significant effect on fibroblast cell invasion when compared against the NT sample, 
data were collected and plotted in prism. A waterfall histogram plot, displays the HDFs 
(Figure 4.6A) and VB6s (Figure 4.6B) average distance from the PET membrane for 
all 60 siRNAs relative to the NT control sample. Statistical analysis identified 16 gene 
candidates that reduced HDF and VB6 cell invasion when knocked down in HDF cells.  
  



















Figure 4.6: Analysing the effects of siRNA knockdown of proteases 
in HDF cells within 3D mini-organotypic gels plated with fluorescent 
VB6 cells 
The figure displays average cell distance from the PET membrane for all 60 
siRNAs. The height of each bar signifies depth of invasion, therefore, the shorter 
the bar the great the invasion.  Z-position data of HDF cells within the mini-
organotypic gels six days post transfection were collected and plotted in Prism 
and compared to the NT siRNA control. A) HDF cell waterfall plot displaying 
average height of cells six days post transfection. The green dashed line 
represents the average for the NT sample HDF cells. B) VB6 cell average height 
plotted in the same arrangement HDF siRNA treatment. Red dashed line 
represents the average for the NT sample VB6 cells Results display the mean and 
s.d of triplicate samples from one biological experiment. One-way ANOVA, *** p 
< 0.001, ** p < 0.01, * p < 0.05. 
 
4.2.2 Summary of hits from SMARTpool primary siRNA screen 
The results of the siRNA screen identified 16 siRNAs that significantly reduced 
(p<0.05) HDF and VB6 cell invasion as well as gel shrinkage when knocked down in 
HDF cells (summarised in Table 4.1). Figure 4.6 provides a unique insight to the five 
main protease families that comprise the screen (calpains, caspases, matrix 
metalloproteinases, serine peptidase inhibitors and transmembrane serine 
proteases).  
The 16 hits comprise of; six matrix metalloproteinases (MMP-9, -10, -11, -17, -20 and 
-21); four calpains (CAPN-1, -2, -10 and sub-unit 1); two caspases (CASP-2 and -8); 
two serine peptidase inhibitors (SERPIN-D1 and -F1); and two transmembrane serine 
proteases (TMPRSS-6 and -13) (displayed in Figure 4.7). The data show multiple 
protease families appear to have a substantial role in fibroblast biology, which, in turn 
is having a direct effect on invasion and migration of cancer cells in 3D mini-
organotypic gels. 
  








References Function in cancer 
CAPN-1 *** 







(Ho et al., 2012; Mamoune et al., 
2003) 
CAPN-10 ** 
(Ling et al., 2009; Moreno-Luna et 
al., 2011) 
CAPNS-1 *** (Bertoli et al., 2009) 
CASP-2 *** 
(Ho et al., 2009; McIlwain et al., 
2013; Shin et al., 2005) Apoptosis 
Necrosis 
CASP-8 *** 
(Kolenko et al., 1999; McIlwain et 
al., 2013; Shivapurkar et al., 2002) 
MMP-9 *** 
(P et al., 2000; Simon et al., 1998; 







(Regala et al., 2011; Zhang et al., 
2014) 
MMP-11 *** (Kou et al., 2013) 
MMP-17 *** (Chabottaux et al., 2006) 
MMP-20 *** (Saxena et al., 2015) 
MMP-21 ** (Wu et al., 2013) 





(Dawson et al., 1999; Fitzgerald et 
al., 2012; Yang et al., 2009) 
TMPRSS-6 ** 
(Hartikainen et al., 2006; Tuhkanen 
et al., 2013) Tumourigenesis 
TMPRSS-13 *** - 
 *** p < 0.001, ** p < 0.01, * p < 0.05 
 
  







Figure 4.7: Summary of hits from primary SMARTpool siRNA screen 
The figure displays the significant hits (One-way ANOVA, *** p < 0.001, ** p < 
0.01, * p < 0.05) from the primary siRNA screen. The solid orange bars indicate 
the five selected siRNA hits I choose to follow up. The green dashed line 








4.3 Investigation of hits from primary SMARTpool siRNA screen 
Due to cost and time factors, all of the 16 siRNA hits could not be investigated. 
Therefore five siRNA were chosen to pursue and validate based on; (1) their 
relevance, if any, towards cancer progression; (2) their novelty as potential targets; 
and (3) commercial availability of known working antibodies.  
The chosen siRNA to pursue were calpain-10 (CAPN-10), caspase-8 (CASP-8), 
matrix metalloproteinase-17 (MMP-17), serine peptidase inhibitor clade-F (SERPIN-
F1) and transmembrane protease, serine-13 (TMPRSS-13) (highlighted by orange 
filled bars in Figure 4.7). 
To confirm observations from the SMARTpool primary screen, the five selected hits 
were re-tested. HDF cells were once again, plated, transfected with pooled siRNA, 
alongside a NT control and a transfection reagent-only treated control (denoted as 
Control) and imaged in the same manner as described above. Unfortunately, at the 
end point of the assay the confocal microscope was unavailable due to technical 
issues. Therefore mini-organotypic gels containing siRNA treated HDF cells were 
fixed and stained with H&E and the level of gene knockdown was confirmed via qPCR 
(Figure 4.8).   
 
4.3.1 Repeating siRNA knockdown on pooled; CAPN-10, CASP-
8, MMP-17, SERPIN-F1 and TMPRSS-13 
The H&E stained images (Figure 4.8A) show HDF and VB6 cells invading as 
expected within the NT siRNA control and non-transfected HDF (denoted as Control) 
samples, with clear signs of both cell types invading through the mini-organotypic gel 
towards the bottom of the Transwell®. Conversely, the gels with siRNA treated HDFs 
appear not to have invaded in comparison to NT and Control samples. Thus, probably 
reducing the HDFs ability to remodel the gel and create channels which cancer cells 
migrate through.  
The siRNA within the HDF cells may also have an effect on the surrounding VB6 cells 
when plated together on top of the gels. Within the siRNA treated samples, a small 
number of cells appear to start invading through the gel; I believe these could be 
fibroblast cells (due to their spindle-like appearance) that have polarised and started 
to initially invade. This could be due to low knockdown efficiency during transfection 
stage, or diminished siRNA effects. Figure 4.8B demonstrates at least 70% gene 
silencing was induced for all five pooled siRNA. Overall these results, firstly suggest 




via H&E and qPCR data, that each of the selected siRNAs may have an effect on 
mediating fibroblast cell invasion in 3D gels. Secondly, the 24-well mini-organotypic 
invasion assay is a suitable, reliable and reproducible method for siRNA studies.




















Figure 4.8: Representative H&E stained sections of 3D-
miniorganotypic gels with siRNA knockdown HDF cells and 
confirmation via qPCR 
A) HDF were pre-treated with five chosen pooled siRNA, 6 days post transfection, 
mini-organotypic gels were fixed and H&E stained. NT and Control (top left and 
right panel) display fibroblast and cancer cell collectively invading (indicated by 
white arrows). siRNA knockdown samples show reduced fibroblast and cancer cell 
invasion. A small number of fibroblast cells can be seen invading vertically 
(indicated by green arrows). One representative of triplicate samples. Scale bar 
100µm, x20 objective. B) siRNA knockdown examined using qPCR (NT = non 
targeting siRNA control); *** p<0.001 students paired t-test. Data shown represents 
s.d from triplicate samples from one independent experiment. 
 
  




4.4 Hit validation of SMARTpool siRNA using individual deconvoluted 
siRNAs 
The approach to test pooled siRNA duplexes that can target a single given gene 
maximises resources and increases throughput. However pooled screens do not 
provide any insight into the activity of the individual siRNAs contributing to a given 
change in phenotypic behaviour. On the contrary, individual siRNA duplex 
experiments, do require considerable commitments in terms of consumables, 
however permitting stratification of the hits into groups based on particular phenotypic 
discoveries.  
Here, investigation into the pooled siRNAs was performed, via LOF validation screen. 
Therefore each of the four individual siRNA duplexes of CAPN-10 (Figure 4.9), 
CASP-8 (Figure 4.10), MMP-17 (Figure 4.11), SERPIN-F1 (Figure 4.12) and 
TMPRSS-13 (Figure 4.13) were purchased and knocked down in HDF cells 
(summarised in Table 2.7).  
(Figure 4.9A - Figure 4.13A) display 3D rendered Imaris images of the siRNA 
knocked down in HDF cells. Graphical bee swarm plots, indicating exact z-positions 
of HDF and VB6 cells within the gel were plotted to display invasive capability 
compared against the NT (Figure 4.9B - Figure 4.13B). At least two siRNA molecules 
are expected to recapitulate phenotypic changes induced by the pool and be 
confirmed by clear correlations in protein level depletion to establish a relationship 
between the gene and the response. 
 
4.4.1 Hit validation of pooled siRNA using individual molecules 
to identify active species for CAPN-10 
To determine which four, if any, of the individual CAPN-10 constituents (represented 
as 1, 2, 3 and 4) had any effect whatsoever on  the phenotypic properties of HDF 
cells or gel integrity, HDF cells were, plated, transfected (in triplicate) with the single 
siRNA duplexes (after 24 hours), fluorescently labelled and co-cultured with 
fluorescent VB6 cells on to mini-organotypic gels (after 72 hours) and imaged via 
CLSM (after another 72 hours) as previously described in Section 2.6.1 (Figure 4.9). 
Figure 4.9A displays a panel of 3D Imaris rendered images containing a NT siRNA 
control sample and the individual siRNA duplexes transfected into HDF cells. 
Image analysis observations suggest the HDF cells do not become polarised or 
invade through the organotypic gel compared with the NT sample. With the exception 




of siRNA number 1 and 2, a small number of HDFs can be identified breaking away 
from the main cluster of cells and invading into the gel in siRNA 3 and 4. This may be 
due to diminished siRNA effects. The NT sample displays large populations of HDF 
cells becoming polarised, changing their morphology to favour a vertical orientation, 
thus, invading downward through the gel. Additionally all gels appear to exhibit the 
same level of gel contraction as observed with the NT sample.  
Figure 4.9B illustrates a graphical plot of each HDF and VB6 cells z-position within 
the mini-organotypic gel at the end point of the assay. The plot displays that HDFs 
within the NT sample cover an invasive range of approximately 250µm. Within the 
core of the invading HDF cells, a small cluster of VB6 cells are identified following 
closely behind. Perhaps migrating through the channels made by the HDF cells. 
Transfection of the four individual siRNAs for CAPN-10 in HDF cells demonstrated 
inhibition of HDF and VB6 cell growth and invasion compared with the NT control.  
However, the siRNA transfected gels have shrunk to the same height as the NT 
sample which was not expected.











Figure 4.9: 3D rendered and invasion distance quantification of individual CAPN-
8 siRNA knockdown in HDF cells 
 
  




Figure 4.9: 3D rendered and invasion distance quantification of 
individual CAPN-8 siRNA knockdown in HDF cells 
The series of images above displays 3D Imaris XT rendered and analysed z-
stacks of mini-organotypic gels containing siRNA transfected HDF and non-
transfected VB6 cells, six days post transfection. HDF cells were plated in to a 6-
well plate (1.5 x 105 cells/well), after 24 hours, HDFs were transfected with 
individual oligonucleotides of CAPN-10 siRNA (denoted as 1, 2, 3 and 4) (20nM) 
in triplicate wells. 72 hours post transfection, HDF and VB6 cells were 
fluorescently labelled with CellTracker™ Green (10µM) and Red (5µM) 
respectively. Next, HDF and VB6 cells were counted and plated (2:1 ratio of 
fibroblast: tumour in a suspension containing 105 cells in total) on to mini-
organotypic gels and incubated. A) 72 hours post incubation (six days post 
transfection) z-stack volumes were obtained via CLSM. Images were rendered 
using Imaris image analysis software. NT and siRNA samples 1, 2, 3 and 4 display 
brightly fluorescent populations of both cell types. HDFs and VB6 cells appear 
attached and spread on to the gel surface. Gel height for all samples is similar to 
observations of the NT sample (all samples approximately between 700-600µm 
in thickness). Image and distance quantification analysis show that HDF cells 
become polarised, change their morphology and invade vertically downward 
through the gel, whereas, siRNA 1 and 2 treated HDFs do not become polarised 
or invade. Analysis of siRNA 3 and 4 suggest a small population of HDF cells start 
to become polarised and begin their initial invasion. B) Invasion data were 
measured and plotted in Prism and compared against the NT control. One 
representative series of images from triplicate gels belonging to one of two 
independent experiments. 
  




4.4.2 Hit validation of pooled siRNA using individual duplexes 
to identify active species for CASP-8 
HDF cells were transfected with the individual CASP-8 constituents represented as 
1, 2, 7 and 25. Figure 4.10A displays a panel of 3D Imaris rendered images 
containing a NT sample and the individual siRNA duplexes transfected into HDF cells.  
Image analysis observations suggest HDF cells transfected with CASP-8 
oligonucleotides appear to display minimal polarisation and changes in morphology, 
compared to the more polarised appearing HDFs within the NT sample. siRNA 1, 2 
and 7 displayed a small number of HDF breaking away from the main cluster of cells, 
polarised and invading through the gel. This may be due to diminishing siRNA effects. 
Additionally all gels appear to exhibit the same level of gel contraction as observed 
with the NT sample, with gel heights for all samples approximately between 700-
600µm.   
Figure 4.10B illustrates a graphical plot of each HDF cells z-position within the mini-
organotypic gel at the end point of the assay. Treatment of the four individual siRNA 
duplexes for CAPN-8 demonstrated an inhibition of growth and invasion of HDF and 
VB6 cells, relative to the NT control. However the gel has contracted to a height 
similar to that of the NT control (as observed in Figure 4.9).










Figure 4.10: 3D rendered and invasion distance quantification of individual 
CASP-8 siRNA knockdown in HDF cells 
 
  




Figure 4.10: 3D rendered and invasion distance quantification of 
individual CASP-8 siRNA knockdown in HDF cells 
The series of images above displays 3D Imaris XT rendered and analysed z-
stacks of mini-organotypic gels containing siRNA transfected HDF and non-
transfected VB6 cells, six days post transfection. HDFs were transfected with 
individual oligonucleotides of CASP-8 siRNA (denoted as 1, 2, 7 and 25) (20nM) 
in triplicate wells. 72 hours post transfection, HDF and VB6 cells were 
fluorescently labelled with CellTracker™ Green (10µM) and Red (5µM) 
respectively. Next, HDF and VB6 cells were counted and plated (2:1 ratio of 
fibroblast: tumour in a suspension containing 105 cells in total) on to mini-
organotypic gels and incubated. A) 72 hours post incubation (six days post 
transfection) z-stack volumes were obtained via CLSM. Images were rendered 
using Imaris image analysis software. NT and siRNA samples 1, 2, 3 and 4 display 
brightly fluorescent populations of both cell types. HDFs and VB6 cells appear 
attached and spread on to the gel surface. Gel height for all samples is similar to 
observations of the NT sample (all samples approximately between 700-600µm 
in thickness). Image and distance quantification analysis show that HDF cells 
become polarised, change their morphology and invade vertical downward 
through the gel. Whereas siRNA 1 and 2 treated HDFs do not come polarised or 
invade. Analysis of siRNA 3 and 4 suggest a small population of HDF cells start 
to become polarised and begin their initial invasion. B) Invasion data were 
measured and plotted in Prism and compared against the NT control. One 
representative series of images from triplicate gels belonging to one of two 
independent experiments. 
  




4.4.3 Hit validation of pooled siRNA using individual duplexes 
to identify active species for MMP-17 
HDF cells were transfected with MMP-17 constituents represented as 1, 4, 5 and 19. 
Figure 4.11A displays a panel of 3D Imaris rendered images containing a NT sample 
and the individual siRNA duplexes transfected into HDF cells.  
Interestingly siRNA 1 and 4 displayed signs of increased gel thickness compared to 
the NT sample, which is approximately 600µm. siRNA 1 – approximately 1100µm 
thick with HDF cells covering an invasive range between 1100µm and 850µm, siRNA 
2 – approximately 1000µm thick with HDF cells covering an invasive range between 
1000µm and 700µm. Additionally within these two samples HDF cells have begun to 
start invading, however, have not reached the same invasive depth as siRNA 5 
(300µm) and 19 (600µm). All samples exhibited increased gel thickness when 
compared with, not only, the NT sample but also the CAPN-10 (Figure 4.9) and 
CASP-8 (Figure 4.10) samples.  
Figure 4.11B illustrates a graphical plot of each HDF cells z-position within the mini-
organotypic gel at the end point of the assay. Treatment of the four individual siRNA 
duplexes for MMP-17 demonstrated an inhibition of HDF and VB6 growth and 
invasion for siRNA 1 and 4 with decreased levels of gel contraction, however, siRNA 
samples 5 and 19 display signs of increased gel contraction and HDF cell invasion, 
but not as extensively as observed with the NT control. 
  










Figure 4.11: 3D rendered and invasion distance quantification of individual 
MMP-17 siRNA knockdown in HDF cells 
 
  




Figure 4.11: 3D rendered and invasion distance quantification of 
individual MMP-17 siRNA knockdown in HDF cells 
The series of images above displays 3D Imaris XT rendered and analysed z-
stacks of mini-organotypic gels containing siRNA transfected HDF and non-
transfected VB6 cells, six days post transfection. HDFs were transfected with 
individual oligonucleotides of MMP-17 siRNA (denoted as 1, 4, 5 and 19) (20nM) 
in triplicate wells. 72 hours post transfection, HDF and VB6 cells were 
fluorescently labelled with CellTracker™ Green (10µM) and Red (5µM) 
respectively. Next, HDF and VB6 cells were counted and plated (2:1 ratio of 
fibroblast: tumour in a suspension containing 105 cells in total) on to mini-
organotypic gels and incubated. A) 72 hours post incubation (six days post 
transfection) z-stack volumes were obtained via CLSM. Images were rendered 
using Imaris image analysis software. NT and siRNA samples 1, 4, 5 and 19 
display brightly fluorescent populations of both cell types. HDFs and VB6 cells 
appear attached and spread on to the gel surface. Image and distance 
quantification analysis suggest that HDF cells from all siRNA treated samples 
become polarised, change their morphology and invade vertical downward 
through the gel at different rates. Samples 1 and 4 gels have contracted much 
less than the NT sample and display signs of HDF cell invasion. Samples 5 and 
19 shows a lesser degree of contraction when compared to samples 1 and 4, but 
possess thicker gels than the NT control. B) Invasion data were measured and 
plotted in Prism and compared against the NT control. One representative series 
of images from triplicate gels belonging to one of two independent experiments. 
 




4.4.4 Hit validation of pooled siRNA using individual duplexes 
to identify active species for SERPIN-F1 
HDF cells were transfected with SERPIN-F1 constituents represented as 1, 2, 3 and 
4. Figure 4.12A displays a panel of 3D Imaris rendered images containing a NT 
siRNA control sample and the individual siRNA duplexes transfected into HDF cells. 
Image analysis observations suggest the HDF cells treated with siRNA 1 and 2 do 
not become polarised or invade through the organotypic gel compared with the NT 
sample. However, siRNA samples 3 and 4, a small number of HDFs can be identified 
breaking away from the main cluster of cells and invading into the gel. This may be 
due to diminished siRNA effects. The NT sample displays large populations of HDF 
cells becoming polarised, changing their morphology to favour a vertical orientation, 
thus, invading downward through the gel. Additionally all gels appear to exhibit the 
same level of gel contraction as observed with the NT sample. 
Figure 4.12B illustrates a graphical plot of each HDF cells z-position within the mini-
organotypic gel at the end point of the assay. The plot displays that HDFs within the 
NT sample cover an invasive range of approximately 200µm. Within the core of the 
invading HDF cells, a small cluster of VB6 cells are identified following closely behind. 
Perhaps migrating through the channels made by the HDF cells. Transfection of the 
four individual siRNA duplexes for SERPIN-F1 in HDF cells demonstrated an 
inhibition of HDF and VB6 cell growth and invasion, compared with the NT control. 
As observed with CAPN-10 (Figure 4.9) and CASP-8 (Figure 4.10) the SERPIN-F1 
siRNA treated gels have contracted vertically almost to the same thickness as the NT 
control samples.










Figure 4.12: 3D rendered and invasion distance quantification of individual 
SERPIN-F1 siRNA knockdown in HDF cells 
 
  




Figure 4.12: 3D rendered and invasion distance quantification of 
individual SERPIN-F1 siRNA knockdown in HDF cells 
The series of images above displays 3D Imaris XT rendered and analysed z-
stacks of mini-organotypic gels containing siRNA transfected HDF and non-
transfected VB6 cells, six days post transfection. HDF cells were plated in to a 6-
well plate (1.5 x 105 cells/well), after 24 hours, HDFs were transfected with 
individual oligonucleotides of SERPIN-F1 siRNA (denoted as 1, 2, 3 and 4) (20nM) 
in triplicate wells. 72 hours post transfection, HDF and VB6 cells were 
fluorescently labelled with CellTracker™ Green (10µM) and Red (5µM) 
respectively. Next, HDF and VB6 cells were counted and plated (2:1 ratio of 
fibroblast: tumour in a suspension containing 105 cells in total) on to mini-
organotypic gels and incubated. A) 72 hours post incubation (six days post 
transfection) z-stack volumes were obtained via CLSM. Images were rendered 
using Imaris image analysis software. NT and siRNA samples 1, 2, 3 and 4 display 
brightly fluorescent populations of both cell types. HDFs and VB6 cells appear 
attached and spread on to the gel surface. Gel height for NT sample is 
approximately 450µm in thickness, whereas, samples 1-4 are approximately 
between 600-500µm in thickness. Image analysis of NT sample displays HDF 
cells become polarised, change their morphology and invade vertical downward 
through the gel. Whereas siRNA 1 and 2 treated HDFs do not come polarised or 
invade. Analysis of siRNA 3 and 4 suggest a small population of HDF cells start 
to become polarised and begin their initial invasion. B) Invasion data were 
measured and plotted in Prism and compared against the NT control. One 
representative series of images from triplicate gels belonging to one of two 
independent experiments. 
  




4.4.5 Hit validation of pooled siRNA using individual duplexes 
to identify active species for TMPRSS-13 
HDF cells were transfected with TMPRSS-13 constituents represented as 1, 2, 3 and 
4. Figure 4.13A displays a panel of 3D Imaris rendered images containing a NT 
sample and the individual siRNA duplexes transfected into HDF cells.  
NT control and all siRNA samples suggest HDF cells appear to become polarised 
and being invading through the gel. The NT sample shows large populations of HDF 
cells invading vertically downward through the gel and VB6 cells follow closely behind. 
Interestingly siRNA 1, 2 and 3 displayed signs of increased gel thickness compared 
to the NT sample, which his approximately 650µm. siRNA 1 and 2 are both 
approximately 900µm thick with HDF cells covering an invasive range between 
900µm and 850µm, siRNA 3 being approximately 1000µm thick with HDF cells 
covering an invasive range between 1000µm and 850µm. siRNA 4 displays levels of 
contraction in between that of the NT control and its siRNA members. siRNA samples 
1, 2 and 3 display similar levels of increased gel thickness compared with observation 
from MMP-17.  The images also display reduced invasion and growth of HDF and 
VB6 cells when treated with siRNAs 1, 2 and 3 compared with the NT samples. 
Figure 4.13B illustrates a graphical plot of each HDF cells z-position within the mini-
organotypic gel at the end point of the assay. Treatment of the four individual siRNA 
duplexes for TMPRSS-13 demonstrated a slight inhibition of HDF and VB6 invasive 
capabilities for siRNA 1, 2 and 3 with decreased levels of gel contraction, however, 
siRNA sample 4 display signs of increased gel contraction and HDF cell invasion, but 
not as extensively as observed with the NT control. 
 
  










Figure 4.13: 3D rendered and invasion distance quantification of individual 
TMPRSS-13 siRNA knockdown in HDF cells 
 
  




Figure 4.13: 3D rendered and invasion distance quantification of 
individual TMPRSS-13 siRNA knockdown in HDF cells 
The series of images above displays 3D Imaris XT rendered and analysed z-
stacks of mini-organotypic gels containing siRNA transfected HDF and non-
transfected VB6 cells, six days post transfection. HDF cells were plated in to a 6-
well plate (1.5 x 105 cells/well), after 24 hours, HDFs were transfected with 
individual oligonucleotides of TMPRSS-13 siRNA (denoted as 1, 2, 3 and 4) 
(20nM) in triplicate wells. 72 hours post transfection, HDF and VB6 cells were 
fluorescently labelled with CellTracker™ Green (10µM) and Red (5µM) 
respectively. Next, HDF and VB6 cells were counted and plated (2:1 ratio of 
fibroblast: tumour in a suspension containing 105 cells in total) on to mini-
organotypic gels and incubated. A) 72 hours post incubation (six days post 
transfection) z-stack volumes were obtained via CLSM. Images were rendered 
using Imaris image analysis software. NT and siRNA samples 1, 2, 3 and 4 display 
brightly fluorescent populations of both cell types. HDFs and VB6 cells appear 
attached and spread on to the gel surface. Gel height for NT sample is 
approximately 450µm in thickness, whereas, samples 1 and 2 are approximately 
between 900µm in thickness. Sample 3 is approximately 1000µm and sample 4 
being approximately 580µm. Image analysis of NT sample displays large 
populations of HDF cells become polarised, change their morphology and invade 
vertical downward through the gel. Whereas siRNA samples 1-4 display a varying 
degree of HDF cell polarisation and invasion.   B) Invasion data were measured 
and plotted in Prism and compared against the NT control. One representative 
series of images from triplicate gels belonging to one of two independent 
experiments. 
  




4.4.6 Summary of hit validation screen from individual siRNA 
The knock down of CAPN-10, CASP-8 and SERPIN-F1 individual siRNA in HDF cells 
appears to have decreased the number of HDF cells that have polarised, change their 
morphology and invade into mini-organotypic gels. However there was a similar 
reduction in gel height which was not expected. These effects are unlikely to be just 
evaporation of gels during incubation, since other siRNA experiments run at the same 
time and biological repeats did not shrink. In contrast, individual siRNA from MMP-17 
and TMPRSS-13 both displayed a similar responses to the SMARTpool. 
Thus, invasion and growth of the HDFs and VB6 were reduced and gel thickness 
remained similar to the starting height. Figure 4.14 displays a summarised plot of 
individual siRNA invasion data. As we could not deduce why the CAPN-10, CASP-8 
and SERPIN-F1 samples displayed reduced growth and invasion, but still displayed 







Figure 4.14: Invasion distance quantification of individual siRNA  




Figure 4.14: Invasion distance quantification of individual siRNA  
The bee swarm plot displays invasive spread of HDF and VB6 cells of the 
individual siRNA from the five chosen hits identified from the primary screen. Z-
position data of HDF and VB6 cells within the mini-organotypic gels six days post 
transfection were collected and plotted in Prism and compared to the NT control. 
Results display the mean and s.d of triplicate repeats from one of two biological 
experiments. One-way ANOVA, ** p < 0.01, * p < 0.05. 
 
 




4.5 Protein expression of selected siRNA targets 
Western blotting was conducted to determine the protein expression level of the 
individual oligonucleotides from MMP-17 and TMPRSS-13. HDF cells were plated 
and transfected as previously described, before protein lysates were collected and 
samples were prepared for western blotting (as described in Section 2.2). Western 
blots were quantified by densitometry analysis of three independent biological 
experiments, relative to non-targeting siRNA control (denoted at NT). 
 
4.5.1 Protein expression level of MMP-17 in response to siRNA 
Figure 4.15 suggests that HDF cells transfected with the individual MMP-17 siRNA, 
numbers 5 and 19, produced higher levels of MMP-17 protein expression when 
compared to the NT sample. However, on the contrary, numbers 1 and 4, significantly 






Figure 4.15: Western blot analysis of HDF cells transfected with MMP-17 
individual oligonucleotides 




Figure 4.15:  Western blot analysis of HDF cells transfected with 
MMP-17 individual oligonucleotides 
The four individual siRNA constituents of MMP-17 were knocked down in HDF 
cells (20nM), alongside a non-targeting (NT) siRNA control and a transfection 
reagent only treated sample (No siRNA Ctl). 6 days post transfection lysates were 
collected and blotted for MMP-17 protein expression. A) Cell lysates from HDF 
cells transfected with MMP-17 individual siRNA (numbered 1,4, 5 and 19), NT, 
and No siRNA Ctl were analysed for MMP-17 expression (MMP-17 antibody) and 
HSC-70 loading control by western blotting. B) Triplicate western blot samples 
were analysed by densitometry and data were normalised to NT. Data display the 
mean and s.d of three independent biologically repeated experiments. Student t-
test, ** p<0.01. 
 
  




4.5.2 Protein expression level of TMPRSS-13 oligonucleotides 
Figure 4.16 suggests that HDF cells transfected with the individual TMPRSS-13 
siRNA, numbers 1-4, had no significant effect on protein expression of TMPRSS-13 
when compare to the NT. Conversely, increasing protein expression level in siRNA 






Figure 4.16: Western blot analysis of HDF cells transfection with 
TMPRSS-13 individual oligonucleotides 
The four individual siRNA constituents of TMPRSS-13 were knocked down in HDF 
cells (20nM), alongside a non-targeting (NT) siRNA control and a transfection 
reagent only treated sample (No siRNA Ctl). 6 days post transfection lysates were 
collected and blotted for TMPRSS-13 protein expression. A) Cell lysates from 
HDF cells transfected with TMPRSS-13 individual siRNA (numbered 1,2, 3 and 
4), NT, and No siRNA Ctl were analysed for TMPRSS-13 expression (TMPRSS-
13 antibody) and HSC-70 loading control by western blotting. B) Triplicate western 
blot samples were analysed by densitometry and data were normalised to NT. 
Data display the mean and s.d of three independent biologically repeated 
experiments. 




4.6 Summary of data 
Here, I have validated the robustness, reproducibility and reliability of the fluorescent 
mini-organotypic invasion assay by performing a primary siRNA SMARTpool library 
screen. Image and data analysis identified 16 hits that significantly reduced gel 
contraction and cancer and fibroblast invasion. From those 16 hits, five were selected 
to follow up. Repetition of the five SMARTpool hits confirmed observations and results 
obtained from the primary screen.  
Validation of the selected hits was performed via individual deconvolution 
experiments which identified MMP-17 and TMPRSS-13 candidates for further 
investigation. Protein level expression of MMP-17 was significantly reduced in two of 
the four individual siRNA when knocked down in HDF cells. Conversely, protein levels 
reduction of TMPRSS-13 was not observed. It is possible that the antibody used was 
not specific for TMPRSS-13, despite the manufacturers’ claims. With more time and 
funds I could have tested other reagents for TMPRSS-13 but this was not possible. 
  




4.7 High-content multi-parameter data analysis 
3D Image analysis of confocal z-stacks via Imaris XT produced .csv data files for a 
variety of parameters for every fluorescent particle (a cell or group of cells) within 
each colour channel (area, elipticity oblate and prolate, intensity, invasion, sphericity 
and volume). So far, I have investigated invasive depth against time and treatment 
parameters for HDF and VB6 cells. However, multi-parameter phenotypic analysis 
may provide important insights into assessing changes in cell dynamics and the 
biological responses to siRNA transfection on both HDF and VB6 cell behaviour. 
Traditionally, from a screening point of view, the end point goal was to identify 
compounds or small molecules which had a desirable effect and eliminate those that 
did not. Primary screening assays were designed with a single read-out (commonly 
time-resolved fluorescence resonance energy transfer (TR-FRET)) to aid selection of 
active molecules. However, recently the pharmaceutical and biotechnology industry 
have adopted a multi-parameter high-content phenotypic screening and data analysis 
approach. 
With the vast advances in high-content capturing automated microscopes, intelligent 
data management systems and automated batch and image processing analysis 
software; the rate of target identification of new therapeutic agents may increase. 
Therefore, screening of therapeutic interfering molecules (such as compounds or 
RNAi) along with efficient multi-parameter high-content data analysis has become an 
achievable and desirable objective (Hulkower and Herber, 2011). 
Here, with the aid of MatLab® (Matrix Laboratory, MathWork, USA), an interactive, 
multi-paradigm mathematical programming language; manipulation, extrapolation 
and plotting of data was performed automatically via a custom designed script named 
‘multi-parameter analysis algorithm’. Data for invasion vs sphericity, invasion vs 
volume and effect of elipticity prolate vs elipticity oblate were determined and plotted 
via MatLab®. 
The customised script was developed in collaboration with Joseph Brook 
(Sosabowski group, Centre for Molecular Oncology – Barts Cancer Institute) who 
wrote the algorithm (Appendix Figure 7.16). 
  




4.7.1 High-content multi-parameter data analysis: SMARTpool 
primary screen 
As described previously in this chapter, HDFs were plated into 6-well plates, 
transfected with SMARTpool or NT siRNA control, fluorescently labelled with 
CellTracker™ Green and co-cultured into mini-organotypic gels containing 
CellTracker™ Red labelled VB6 cells. Six days post transfection gels were imaged 
via CLSM and z-stack data files (.lsm) were analysed and rendered using Imaris XT. 
Analysis of the 3D volumes produced multi-parameter data files (.csv), of which, each 
could be plotted and analysed in comparison against each other. To efficiently extract 
this data the custom MatLab® algorithm was used to collate and plot HDF and VB6 
cell data from a range of phenotypic parameters (elipticity prolate, elipticity oblate, 
invasion, sphericity and volume).  
Sphericity (ѱ), defined by Wadell in 1932, is the measure of how mathematically 
spherical an object is on a scale of 0 to 1 (0 being flat to 1 being perfectly spherical) 
(Wadell, 1932). An example of multi-parameter analysis, shown below, displays 
invasion vs sphericity data for NT control siRNA transfected HDFs co-cultured with 
VB6 cells from three technical repeat samples (Figure 4.17A). In all three samples it 
is evident that the fibroblast cells with the deepest invasion have a spherical value 
between 0.55 – 1.0. This may suggest medium to high level spherical cells invade 
further into the gels, thus, potentially being the invasive cell type for tumour cells to 
follow.  
Additionally, all samples appear to exhibit apparent signs of gel contraction (gel 
heights all within a range approximately between 380-500µm). Furthermore, the 
invading HDF and VB6 cells appear to have a greater sphericity value compared to 
the cells which do not appear to invade and remain at the surface of the gel. Thus 
suggesting that sphericity of fibroblast and tumour cells may affect their ability to 
invade within a 3D environment. Interestingly, all samples display different cell 
numbers, this may be due to differences in proliferative rates, cell death or dissipation 
of the transient fluorescent dye. Furthermore, cell number may be affected by 
sphericity, an increase in sphericity suggests a decrease in available surface area, 
thus prohibiting cell adhering and spreading. 
Figure 4.17B displays invasion vs sphericity data for HDFs transfected with MMP-10 
SMARTpool siRNA and co-cultured with VB6 cells. Each sample from three technical 
repeats is plotted alongside a NT siRNA control. Immediately, we observe differences 
not only, in gel height (MMP-10 treated gels are within a range approximately between 




1100-1200µm in height) but also, level of invasion of both cell types. Suggesting, 
knockdown of MMP-10 in HDF cells effects the ability of these fibroblasts to polarise, 
remodel and invade through 3D gels, thus, also reducing invasiveness of the tumour 
cells. Similarly to Figure 4.17A, the number each cell type varies within all samples, 
probably due to the reasons mentioned above. However, this does not appear to 
influence or negate the possible deductions these data show as the sample size 
within every repeat is high. 
I have focused on the five selected hits identified from the SMARTpool screen (CAPN-
10, CASP-8. MMP-17, SERPIN-F1 and TMPRSS-13) to further analyse multi-
parameter data for Invasion vs sphericity, volume and elipticity (Figure 4.18, Figure 













Figure 4.17: Multi-parameter analysis of HDFs transfected with NT control and MMP-10 siRNA co-cultured with VB6 cells: Invasion vs 
sphericity 




Figure 4.17: Multi-parameter analysis of HDFs transfected with NT 
control and MMP-10 siRNA co-cultured with VB6 cells: Invasion vs 
sphericity 
The figures above illustrate invasion vs sphericity data, which were compiled and 
plotted via the custom designed MatLab® algorithm. HDFs were transfected with 
SMARTpool MMP-10 or NT siRNA, fluorescently labelled green and co-cultured 
into mini-organotypic gels alongside fluorescently labelled red VB6 cells. Z-stacks 
were collected six days post transfection via CLSM and analysed by Imaris XT. A) 
HDFs transfected with NT control siRNA () co-cultured with VB6 cells (). In all 
repeats HDF cells appear to become polarised and invade into the mini-
organotypic gel. All gels exhibit signs of gel contraction to a similar degree (gel 
heights range between 380-500µm). All gels suggest invading HDF and VB6 cells 
have an increased spherical value. B) Combined plot of MMP-10 transfected 
HDFs (O) co-cultured with VB6 cells (O) and NT control siRNA transfected HDFs 
(X) co-cultured with VB6 cells (X) (NT sample is the same in all MMP-10 repeats). 
All gels appear to have contracted less compared to the NT sample. Additionally, 
HDFs and VB6s do not appear to invade throughout the gel.  Series of invasion 
vs sphericity data from triplicate technical repeats from one independent 
experiment. 
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4.7.2 High-content multi-parameter data analysis of hits from 
primary screen 
The five selected targets identified from the primary SMARTpool siRNA screen 
(CAPN-10, CASP-8, MMP-17, SERPIN-F1 and TMPRSS-13) significantly (p<0.05) 
reduced HDF and VB6 cell invasion and gel shrinkage relative to a NT siRNA control 
(Figure 4.7). However, to determine if siRNA knockdown had any effect on polarity, 
sphericity as well as invasion, data from Imaris XT was analysed using the ‘multi-
parameter analysis algorithm’ via MatLab®. 
Data from fluorescently labelled HDFs (transfected with target or NT control siRNA) 
and fluorescently labelled VB6 cells were extrapolated from .csv files and plotted for 
invasion vs sphericity (Figure 4.18), invasion vs volume (Figure 4.19) and invasion 
vs elipticity (oblate and prolate) (Figure 4.20).  
In mathematical terms, a spheroid is a shape that closely resembles a sphere, but, is 
not perfectly spherical (also known as an ellipse). When the ellipse is rotated along 
its major axis, it produces an elongated ‘pointy’ shape, the extent of elongation is 
referred to as elipticity prolate. On the contrary, elipticity oblate is when an ellipse is 
rotated along its minor axis resulting in a compressed ‘squashed’ disk-like shape 
(Teitze, 1965). Effectively, oblate is more horizontal, whereas prolate favours the 
vertical plane.  
Volume data for each cell type were filtered to background noise. The selection 
process involved excluding data that did not meet a specific criteria based on cell 
diameter of single and clusters of cells. Volumes between 1000 - 15000µm3 on the 
basis that a single VB6 cell has a diameter of 18µm ± 2µm and a single HDF cell 





    
4.7.2.1 Multi-parameter data analysis: Invasion vs 
sphericity 
Figure 4.18 shows plots of cell invasiveness versus sphericity for each of the hits 
against the NT siRNA control. In each case the data confirm that the NT control cells 
have all invaded further into the gels more than the CAPN-10, CASP-8, MMP-17, 
SERPIN-F1 and TMPRSS-13 siRNA transfected cells. One can also see that the 
depth of invasion varies in the NT control, with the surface of the VB6 cells varying 
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from 400-850µm. The change in sphericity of siRNA treated HDFs is predominantly 
between 0.6 – 0.9. Thus, these are mainly HDF cells that are near spherical, as well 
as those that have medium sphericity to be amongst the most invasive cell.  
A similar spread of sphericity values are seen for most of the VB6 population within 
these samples. The data may suggest that HDFs exhibit both mesenchymal and 
amoeboid invasive migration patterns. The change in shape, sphericity and response 
to gene knockdown in HDFs appears different for each gene target. For example, 
CASP-8 (Figure 4.18B) and SERPIN-F1 (Figure 4.18D) show a wider range of 
change with a higher number of cells being less spherical (values at >0.5). 
In contrast TMPRSS-13 knockdown (Figure 4.18E) shift the HDF population towards 
a more spherical nature. CAPN-10 (Figure 4.18A) and MMP-17 (Figure 4.18C) seem 
to have a similar shape distribution to that of the NT control cells. Since cell shape in 
3D is a complex interplay between regulation of the cell cytoskeleton and the ECM, 
these data suggest that the effect of the siRNA targeting may be more complex than 
just modifying the ECM. 
 
4.7.2.2 Multi-parameter data analysis: invasion vs 
volume 
Figure 4.19 displays plots comparing invasiveness versus volume for each of the hits 
against a NT siRNA control. In each case the data confirm that NT HDFs have 
invaded further into the gel relative to the CAPN-10, CASP-8, MMP-17, SERPIN-F1 
and TMPRSS-13 transfected HDFs. Additionally, the depth of invasion of the NT 
HDFs and VB6 cells varies with volume size, cells between 1000-5000µm3 (probably 
single cells) appear to invade the deepest.  
However NT HDFs and VB6 cell cover a broad range of volume between 1000-
15,000µm3, cells of a greater volume appear to remain at the surface of the gels. The 
siRNA treated HDFs, in general, the volume exhibits a broad range for all samples 
compared to the NT controls. The VB6 cells co-cultured with the siRNA HDFs also 
have a broad range of volumes. 
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4.7.2.3 Multi-parameter data analysis: invasion vs 
elipticity (oblate and prolate) 
In Figure 4.20 I compared invasiveness with oblate (horizontal, flattened shape) and 
prolate (vertical, elongated shape) elipticity. If we compare the NT control samples in 
each of the five pairs of data in Figure 4.20, In general, the trend is toward a more 
elongated (higher values for elipticity prolate) and a less flattened (lower values for 
elipticity oblate) polarisation in the invasive NT HDFs. Generally the VB6 cells show 
a spread of oblate and prolate elipticity values between 0.2 – 0.6. For the siRNA 
treated HDFs, in general, the elipticity values exhibit a broader range for both oblate 
and prolate for all samples compared with the NT control. The VB6 cells associated 
with the siRNA treated HDFs also have a broad range of elipticities.  
  

















Figure 4.18: Multi-parameter analysis of the five selected siRNA 
targets: Invasion vs sphericity 
The figure illustrates invasion vs sphericity data from the five chosen siRNA 
targets alongside a NT control. Fluorescently labelled HDF cells were transfected 
with SMARTpool target or NT siRNA control, co-cultured with fluorescently 
labelled VB6s and plated into mini-organotypic gels. Z-stacks were collected six 
days post transfection via CLSM and analysed by Imaris XT. A custom designed 
MatLab® algorithm extrapolated invasion and sphericity data from .csv files 
produced by Imaris XT. O represent fluorescent HDF cells transfected with target 
siRNA and O represent fluorescent VB6 cells co-cultured with target transfected 
HDFs. X represent fluorescent HDF cells transfected with NT siRNA control and 
X represent fluorescent VB6 cells co-cultured with NT transfected HDFs. A) 
CAPN10 vs NT. B) CASP-8 vs NT. C) MMP-17 vs NT. D) SERPIN-F1 vs NT. E) 
TMPRSS-13 vs NT. One representative plot of triplicate samples belonging to one 
independent experiment. 

















Figure 4.19: Multi-parameter analysis of the five selected siRNA 
targets: Invasion vs volume 
The figure illustrates invasion vs volume data from the five chosen siRNA targets 
alongside a NT siRNA control. Fluorescently labelled HDF cells were transfected 
with SMARTpool or NT siRNA, co-cultured with fluorescently labelled VB6s and 
plated into mini-organotypic gels. Z-stacks were collected six days post 
transfection via CLSM and analysed by Imaris XT. A custom designed MatLab® 
algorithm extrapolated invasion and volume data from .csv files produced by 
Imaris XT. O represent fluorescent HDF cells transfected with target siRNA and O 
represent fluorescent VB6 cells co-cultured with target transfected HDFs. X 
represent fluorescent HDF cells transfected with NT siRNA control and X 
represent fluorescent VB6 cells co-cultured with NT transfected HDFs. A) 
CAPN10 vs NT. B) CASP-8 vs NT. C) MMP-17 vs NT. D) SERPIN-F1 vs NT. E) 
TMPRSS-13 vs NT. One representative plot of triplicate samples belonging to one 
independent experiment. 
 




















Figure 4.20: Multi-parameter analysis of the five selected siRNA 
targets: Invasion vs elipticity (oblate and prolate) 
The figure illustrates invasion vs elipticity (oblate and prolate) data from the five 
chosen siRNA targets alongside an NT siRNA control. Elipticity oblate is a 
measure of compression of spherical objects when rotated along their minor axis, 
thus forming flattened disk-like shapes. Elipticity prolate is a measure of 
elongation of spherical objects when rotated along their major axis, thus, forming 
a rugby ball-like shape. A custom designed MatLab® algorithm extrapolated data 
from invasion and elipticity .csv files produced by Imaris XT. O represent 
fluorescent HDF cells transfected with target siRNA and O represent fluorescent 
VB6 cells co-cultured with target transfected HDFs. X represent fluorescent HDF 
cells transfected with NT siRNA control and X represent fluorescent VB6 cells co-
cultured with NT transfected HDFs. A) CAPN10 vs NT. B) CASP-8 vs NT. C) 
MMP-17 vs NT. D) SERPIN-F1 vs NT. E) TMPRSS-13 vs NT. One representative 
plot of triplicate samples belonging to one independent experiment. 
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4.7.3 Summary of multi-parameter analysis 
Here, I have presented the value of 3D multi-parametric phenotypic data that can be 
obtained from Imaris XT image analysis with aid of a custom designed MatLab® 
algorithm. Graphical data representation of invasion vs elipticity, sphericity and 
volume further suggests that siRNA knockdown of specific proteases on HDFs, co-
cultured with VB6 tumour cells reduces cell polarisation, gel shrinkage and collective 
cell invasion into 3D gels.  
With more time I could have developed an algorithm to perform statistical analysis in 
MatLab® on the multi-parameter data sets. For example, to determine any significance 
between cells within a sub-group of the majority population that may be more 
polarised. Additionally, to determine if there is any significance between the level of 
sphericity and invasion.  
 
  




Cancer cell metastasis in vivo can be influenced by an interactive 3D ECM. However, 
the majority of drug and RNAi primary and validation screens to identify potential 
therapeutic targets have been performed in 2D mono-layer culture systems (Chung 
et al., 2010; Jansen et al., 2017; Lee et al., 2015; Petrocca et al., 2013). A large 
number of studies have suggested that cellular cues, protein and gene expression, 
invasion and shape may all change in a 3D physiomimetic spatial architecture (Bissell 
et al., 2003; Nyga et al., 2011; Petersen et al., 1992; von der Mark et al., 1977).  
Thus, 3D siRNA screening methods are becoming increasingly more prevalent; for 
example, the Cancer Biochip System has been used to study anchorage-independent 
breast cancer growth (Marhefka and Abbud-Antaki, 2012). Additionally, Bauer and 
colleagues used 3D mammospheres to perform an RNAi screen which identified 
several growth factors that increased breast cancer cells sensitivity to paclitaxel 
(Bauer et al., 2010). Furthermore, Thoma and colleagues developed a 3D hanging 
droplet spheroid assay to assess phenotypic growth effects of siRNA gene depletions 
in colon cancer cells (Thoma et al., 2013). 
Here, I used the novel fluorescent 3D mini-organotypic co-culture invasion assay to 
perform a LOF siRNA screen from a custom library of intracellularly expressed 
proteases (Figure 4.1 - Figure 4.5).  Statistical analysis from the primary screen 
identified 16 hit targets which significantly (p<0.05) reduced fibroblast and cancer cell 
invasion six days post transfection compared to the NT control (Figure 4.6).  
 
4.8.1 Investigation of hits from primary SMARTpool siRNA 
screen 
The 16 hits from the primary screen (listed in Table 4.1 and displayed in Figure 4.7) 
were categorised by their families and investigated for their relevance, if any, in 
cancer progression (described in detail below). 
 
4.8.1.1 Investigation of proteases from primary 
SMARTpool siRNA screen – CAPNs 
Investigations have highlighted the importance of several calpains in processes 
crucial to cancer development and progression.  A study published in 2009 identified 
two splice variants of CAPN-3 that could be responsible for degrading cytoplasmic β-
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catenin, thus having control on the translocation to the nucleus, where β-catenin 
regulates transcription factors involved in cell proliferation and motility in melanoma 
development (Moretti et al., 2009).  
Additionally, increased expression of CAPN-6 was observed during progression of 
uterine cervical neoplasia (Lee et al., 2008b). Furthermore, the regulatory role of 
CAPNs has been identified in apoptotic death in malignant brain tumours (Ray et al., 
2002) and induce apoptosis in human prostate cancer cells (Zhu et al., 1995). CAPN-
10 expression is ubiquitous (Sorimachi and Suzuki, 2001) and  has been associated 
with type 2 diabetes (Horikawa et al., 2000; Ling et al., 2009).  
However there is very little evidence to suggest that CAPN-10 plays a role in cancer 
progression, with the exception of Moreno-Luna and colleagues, whom analysed the 
contribution of CAPN-10 alleles in laryngeal cancer survivors (Moreno-Luna et al., 
2011). Furthermore, the study of an association between variants in the diabetes 
susceptibility gene (CAPN-10) with pancreatic cancer amongst smokers (Fong et al., 
2010). Moreover, I did not identify evidence of CAPN-10 having been used in a 3D 
model, thus, making CAPN-10 an interesting target for further pursuit. 
 
4.8.1.2 Investigation of proteases from primary 
SMARTpool siRNA – CASPs 
During normal development (embryogenesis, angiogenesis and organogenesis) 
excess cells are eliminated by various cell death modalities, amongst them, apoptosis 
is the most investigated. In 1972 it was first described as a major defence strategy, 
preventing cells from acquiring tumourigenic potential (Kerr et al., 1972). 
Caspases (cysteine-aspartic proteases) are a family of Ca2+ independent enzymes 
essential for maintaining homeostasis through programmed cell death (apoptosis, 
necrosis and pyroptosis) and are categorised as initiators or effectors based on their 
apoptotic signalling cascade positions. Caspases can be subdivided into three 
functional groups; executioner CASPs (-3, -6 and -7) initiator CASPs (-2, -8, -9 and -
10) and inflammatory CASPs (-1, -4, -5, -11 and -12) (Zhivotovsky, 2003). 
Interestingly, the regulation of apoptosis is controlled by the initiator CASPs (-2, -8, -
9 and -10) (Olsson and Zhivotovsky, 2011; Parrish et al., 2013).  
Groups have investigated the role of CASP-8 within neuroendocrine lung carcinomas 
and suggested that loss of CASP-8 expression in lung cancer cells (NCI-H82) 
correlates with activation of the MYCN oncogene (Shivapurkar et al., 2002). 
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Additionally, inactivation of CASP-8 has been considered to be involved in the 
pathogenesis of childhood neuroblastoma tumours (Takita et al., 2000; Teitz et al., 
2000).  
Furthermore the loss of protein and mRNA CASP-8 expression and enzyme activity 
are common in rhabdomyosarcomas, medulloblastomas, retinoblastomas and 
neuroblastomas (Harada et al., 2002). Interestingly, CASP-8 activity has been 
suggested to promote cell invasion in neuroblastoma cells (NB7 and NB5) (Barbero 
et al., 2009) and inhibition of CASP-8 suppressed cell migration of breast cancer cells 
(Lopez et al., 2011). This evidence suggests CASP-8 may have function as a potential 
future therapeutic target, however, increased understanding of its molecular 
mechanisms would be desired, thus making CASP-8 a suitable candidate for further 
investigation. 
 
4.8.1.3 Investigation of chosen proteases from siRNA 
screen – MMPs 
MMPs are a clan within a larger metzincin superfamily, which include other members 
such as astacins, reprolysins (a disintegrin and metalloproteinase (ADAMs)) and 
serralysins (Page-McCaw et al., 2007; Ra and Parks, 2007). MMPs are widely 
expressed and cleave a variety of extracellular substrates including, but not limited 
to, proteoglycans and protein components of the ECM. Thus, MMPs catalyse 
hydrolysis of ECM proteins, including, collagens, fibronectin and laminins, thus 
modifying the integrity of the connective tissue (Nagase et al., 2006). Moreover, MMP 
activation is regulated by tissue inhibitors of metalloproteinases (TIMPs) (Brew and 
Nagase, 2010).  
This protease family includes secreted and soluble MMPs, or membrane type MMPs 
(MT-MMP) that are anchored to the cell surface through transmembrane domains, 
called glycosyl-phosphatidyl inositol (GPI) anchors (Host et al., 2012). There are 25 
distinct family members of MMPs,  humans having 24 of the matrixin genes including 
the duplicated MMP-23 gene, which can be organised into six groups based on 
substrate preference: Collagenases (MMP-1, -8, -13 and -18), gelatinases (MMP-2 
and -9), stromelysins (MMP-3, -10 and -11), matrilysin (MMP-7 and -26), membrane 
type (MT)-MMPs (MMP-14, -15, -16, -17, -24 and -25) and others include MMP-12, -
19, -20, -21, -23A -23B, -27 and -28.  
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Several studies have described the presence of MMPs in many types of cancer, 
Kohrmann and colleagues identified increased expression of MMP-1, -2, -8, -9, -10, -
11, -12, -13, -15, -19, -23, -24, -27, and -28 on human breast cancer tissue compared 
to normal breast tissue (Kohrmann et al., 2009). Additionally, MMP-10 was suggested 
to be more highly expressed in lung cancer tumours with high metastatic potential 
(Regala et al., 2011). Interestingly, MMP-2, -9 and -14 (MT1-MMP) have been 
reported to mechanistically become involved in tumour angiogenesis (Littlepage et 
al., 2010). Moreover, our laboratory reported MMP-2 and -9 promote invasion of 
OSCC when upregulated via an increased expression of the integrin αvβ6 (Thomas 
et al., 2001a).  
The MT-MMPs are affixed to the plasma membrane via a GPI anchor, enabling these 
enzymes to contain a unique set of functional and regulatory mechanisms that 
distinguish them from the rest of the MMP family (Itoh et al., 1999). MMP-17 is a 
member of the MT subfamily (MT4-MMP), it was cloned from human breast 
carcinoma cDNA and its mRNA has been expressed in breast cancer tissue 
(Chabottaux et al., 2006; Puente et al., 1996). The role of MMP-17 is currently 
unknown and there is little literature evidence describing its roll its role in cancer, with 
the exception of its expression being observed in multiple breast cancers, suggesting 
it plays a role in tumour invasion and metastasis (Puente et al., 1996). Thus, making 
MMP-17 (MT4-MMP) an interesting target for further investigation. 
 
4.8.1.4 Investigation of chosen proteases from siRNA 
screen – SERPINs 
SERPINs are a broadly distributed superfamily of serine proteinase inhibitors that use 
a conformational change to inhibit target enzymes. Over 1,500 SERPIN-like genes 
have been identified in animals, bacteria, plants and poxviruses. However in humans, 
36 SERPINs have been identified as extracellular molecules (13 members of Clade 
A) and intracellular molecules (13 members of Clade B) and play a significant role in 
inflammation and cancer metastasis (Law et al., 2006; Silverman et al., 2001). 
SERPIN-F1 (also known as pigment epithelium derived factor, PEDF) was discovered 
in the early 1990s as a differentiation factor for retinoblastoma cells (Steele et al., 
1993; Tombran-Tink et al., 1991). Soon after it was reported that expression of PEDF 
is highly increased in young lung fibroblasts cells related to senescent cells and has 
since been associated with growth arrest and ageing in fibroblasts (Doggett et al., 
1992; Pignolo et al., 1993).  
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Almost a decade after its initial discovery, PEDF was described as an inhibitor of 
angiogenesis (Dawson et al., 1999) and thereafter been reported, to delay tumour 
growth in retinoblastomas (Yang et al., 2009), inhibit tumour cell proliferation in 
prostate cancer (Zhang et al., 2007) and act as both, a metastatic suppressor and 
neuroprotectant in brain metastasis from breast tumours (Fitzgerald et al., 2012). 
These observations show that PEDF (SERPIN-F1) has been implicated within diverse 
biological processes and is prominently emerging as an area of interest as an 
anticancer target, thus, making an interesting target to pursue. 
 
4.8.1.5 Investigation of chosen proteases from siRNA 
screen – TMPRSS13 
TMPRSS are one of four sub-family groups under the umbrella of type II 
transmembrane serine proteases (TTSPs) family.  Several members of the TTSPs 
family have been shown to play a critical role in cancer progression. Hepsin (sub-
family member of TTSPs) a cell surface serine protease, has been reported to be 
upregulated in prostate cancer (Klezovitch et al., 2004; Wu and Parry, 2007). 
Matriptase, also known as membrane-type serine protease 1, is widely, but not 
ubiquitously expressed at the cell surface of epithelia and expression of this protease 
correlates with the progression of ovarian (Oberst et al., 2002) and head and neck 
cancer (Cheng et al., 2006).  
Moreover, Matriptase-2 (TMPRSS-6) has been linked to breast cancer (Hartikainen 
et al., 2006; Tuhkanen et al., 2013). TMPRSS-13 is a splice variant of the mosaic 
serine protease large forms and is a member of the hepsin sub-family (Hashimoto et 
al., 2010; Kido and Okumura, 2008). However the precise physiological and 
pathological function of TMPRSS-13 and its role, if any, in cancer progression remain 
to be investigated.  
A biological repeat of the siRNA SMARTpool knockdown and qPCR data from the 
five chosen hits (CAPN-10, CASP-8, MMP-17, SERPIN-F1 and TMPRSS-13) 
confirmed observations from the primary screen, whereby, knockdown of the target 
siRNA in HDF cells reduced gel contraction, HDF cell polarisation and HDFs and VB6 
cell invasion (Figure 4.8). Thus overall with the exception of SERPIN-F1 the other 
hits have all been associated with cancer but not through expression in the 
mesenchymal cells. My data suggested that many fibroblast proteases represent 
important components of tumour progression and invasion. 
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4.8.2 Summary of multi-parametric phenotypic analysis 
3D high-content phenotypic screens are being widely implemented within early stage 
drug discovery research. For example, Di and colleagues used a 3D micro tissue 
assay cultured with mouse breast cancer cells (4T1 cells) to perform a phenotypic 
drug screen profiling against 598 parameters via ImageJ analysis (Di et al., 2014). 
Additionally, earlier this year, Ott and colleagues used high content image analysis 
and automated liquid handling robotics to not only plate, but also to dose 3D liver 
spheroids to deduce drug-drug interactions in hepatotoxicity studies (Ott et al., 2017).  
The success of such assays depend on a variety of factors, such as; (1) developing 
a repeatable, reliable and robust 3D assay; (2) producing a suitable 3D physiomimetic 
environment to address the experimental question; (3) sourcing an appropriate 
imaging platform to ensure, not only speed, but sufficient resolution of image capture; 
and (4) ease of data analysis, having an image analysis system in place whereby 
multi-parametric phenotypic profiling can be efficiently determined. Here, we have 
adopted an efficient, user friendly programmable interface to extrapolate and deduce 
multi-parametric data from previous image analysis. 
In the previous chapter I described the development of a novel, physiomimetic 
fluorescent invasion assay which offers reproducible, robust and quantitative 3D 
analysis. Development of the assay identified that fibroblasts (in this case HDFs) 
appear to be the leading invasive cell type. However, cancer cells appear to follow 
closely behind, probably migrating through the channels created from matrix 
degradation and remodelling by enzymatic secretions from the HDFs.  
These data fit with observations from other studies in which fibroblast invasion led to 
collective cancer cell invasion (Gaggioli et al., 2007). With this information, we thought 
rather than focusing solely on trying to reduce cancer cell invasion, we would focus 
on targeting fibroblast activity.  Here, I have utilised the assay to perform a siRNA 
screen of proteases, targeting specifically the HDF cells.  
The objective of this screen was to identify, if any, targets whose silencing by siRNA 
significantly reduced HDF and consequently VB6 cell collective invasion. Image and 
quantitative invasion analysis identified 16 hits which significantly (p<0.05) reduced 
fibroblasts (HDF) and cancer (VB6) cell invasion six days post transfection. 
Interestingly, I observed changes in phenotypic characteristics (cell shape and 
polarity) within each cell type from different treatments.  
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To further examine these characteristics, we employed aid of a high-performance 
mathematical programming language (MatLab®) to measure and plot multi-parameter 
high-content data produced during Imaris XT image analysis. Analysis of invasion vs 
elipticity, sphericity and volume suggests knockdown of specific proteases in our HDF 
cells may lead to reductions in gel contraction, HDF polarisation and ultimately HDF 
and VB6 cell collective invasion in 3D gels when compared to a NT control treated 
sample.  
Interestingly, phenotypic multi-parametric data analysis has also revealed different 
levels of variation between triplicate repeats. Suggesting that the amount of variation 
between cells from one experiment to another (performed 1-2 weeks apart) could 
potentially effect cellular behaviour within the 3D gels (such as cell adhesion, shape, 
and polarity). This may be due to the passage number of the HDF and VB6 cells, 
although lower passages were continually used. Additionally, the degree of variation 
may also be related to position of each Transwells® within the 24-well source plate 
during incubation; those situated at the plate periphery could be subject to greater 
levels of evaporation thus changing cell morphology.  
However, the use of high-content multi-parameter phenotypic data analysis via 
MatLab® has proved to be a useful ally in the 3D fluorescent mini-organotypic invasion 
assay, in terms of; (1) extracting and plotting large amounts of data efficiently; (2) 
diversity, the algorithm can be easily modified by users with an intermediate level of 
expertise; (3) integration, MatLab® can be partnered with batch analysis software 
(such as SnowPlow and Pipeline Pilot) to perform ‘on-the-fly’ data migration and 
analysis, thus increasing the rate of result delivery.  
Further investigation into these data would require more time. However, the use of 
MatLab® to determine these data provides greater support to earlier observations, 
thus, further validating the reliability and robustness of the assay. 
The challenge now was to miniaturise and optimise the 24-well assay, to a 96-well 
microtiter plate format, thus enabling higher-throughput of small molecules and 
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5.0 Development of a fluorescent 96-well micro-
organotypic invasion assay 
 
5.1 Background 
Over the last 15 years the majority of in vitro cell based drug discovery screening has 
been performed within 2D culture systems on flat and rigid substrata. However, 
culturing cells in 2D conditions may not be physiologically relevant with translation in 
vivo for reasons previously mentioned. Tissue-specific spatial architecture and 
biochemical and biomechanical elements surrounding the stromal microenvironment 
are all essential components of a developing tumour microenvironment and can be, 
at least in part, recapitulated within 3D culture systems. Earlier I described (Section 
1.3) and summarised (Table 1.1) the main differences between 2D and 3D culture 
systems. 
For example, endometrial cancer cells (Ishikawa, KLE and RL95-2) displayed lower 
proliferative rates in 2D monolayer cultures, compared to 3D spheroids supplemented 
with Matrigel® (Chitcholtan et al., 2012). Additionally, Gudjonsson and colleagues 
showed that mammary epithelial cells can form functional acini as observed in vivo 
when cultured on 3D collagen type I: laminin-1 rich gels (Gudjonsson et al., 2002).  
With this in mind, many groups around the world have pioneered 3D cancer models 
to recapitulate the tumour-stromal microenvironment. Some examples include the 
use of organotypic culture models to study progression of pancreatic ductal 
adenocarcinoma (PDAC) (Carapuca et al., 2016; Froeling et al., 2009). Multicellular 
tumour spheroids used investigate the invasion, proliferation and viability of NSCLC 
line (Colo699) dosed with Afatinib (a tyrosine kinase inhibitor which targets EGFR) 
(Huber et al., 2016); and more advanced technologies, such as, 3D organ-on-a-chip 
microsystems, which have been used to successfully  recreate and mimic human lung 
function (Benam et al., 2016) and identify gene targets for breast cancer via siRNA 
screening (Marhefka and Abbud-Antaki, 2012). 
As advanced and unique as these 3D technologies are, they all share one common 
drawback, which is their inability to be integrated into a HTS automated workflow. 
This may be due to several factors, such as; (1) their incapacity to be miniaturised; 
(2) the need for human input during the assay protocol; (3) the high cost of 
consumables and reagents per experiment prohibiting higher-throughput; and (4) the 




amount of time needed to complete the assay, analyse the data and measure 
significant changes. 
Previously, I described the development of a novel 3D fluorescent invasion assay 
which produced reproducible, robust quantitative analysis and was also utilised to 
perform a siRNA screen of proteases. The screen identified MMP-17 may be required 
for the promotion of cancer cell invasion. Here I sought to develop and miniaturise 
the 24-well 3D mini-organotypic invasion assay, to engineer a one-step assay system, 
whereby initial cell and gel seeding, live image capture and final analysis is not only 
within the same culture vessel, but also compatible with laboratory HTS automation 
and high-content data analysis. 
  




5.2 96-well micro-organotypic Transwell® invasion assay 
The fluorescent 24-well mini-organotypic invasion assay revealed that not only do 
certain types of fibroblasts become polarised and rapidly invade down through a 
collagen: Matrigel® substrate, but also that they are the most invasive cell type. 
Previously, I have shown that this assay was used to perform a siRNA protease 
screen and revealed that knockdown of MMP-17 in HDF cells changed cell shape, 
gel contraction and significantly reduced invasion of HDF and VB6 cells (relative to a 
non-targeting siRNA control).  
However, the entire screen, from tissue culture, to image capture, image rendering 
and data analysis took over 18 months to complete. This was in part due to; (1) 
procuring the correct microscope parts (LWD objective and plate stage); (2) obtaining 
an appropriate image analysis software; (3) time lost during delivery of reagents and 
consumables; and (4) limited use of the confocal microscope. This highlights the need 
to develop a novel 3D organotypic based model which would allow for higher-
throughput of samples. Thus, I aimed to downsize the assay by increasing sample 
numbers with the use of a 96-well plate format. 
Described in Section 2.10.1, Corning produce a variety of 96-well Transwell® insert 
plates covering a range of pore sizes between 0.4-8.0µm. Each plate includes a 
Transwell® unit (96-well insert), a reservoir plate and 96-well receiver plate with oval 
shaped wells. However all of the Transwell® insert units possess an opaque 
polycarbonate membrane which not suitable for imaging purposes (Figure 2.2A).  
During a secondment with my collaborators, AstraZeneca, I contacted Corning 
requesting the need of a 96-well Transwell® insert with 0.4µm pore sizes and a PET 
(transparent) membrane. Corning sent free samples to me (Figure 2.2B), presumably 
having specifically manufactured them and now commercially produce these plates 
at a cost of £884.61 per case (five plates) (Corning, #7369). 
 
5.2.1 96-well vs 24-well Transwell® insert invasion assay 
To determine if the 96-well Transwell® insert could be used in a higher-throughput 
manner, this plate type was used to perform a comparison study against the 24-well 
mini-organotypic Transwell® invasion assay. Organotypic gel was prepared as 
described in Section 2.3.1 and added to wells of the 96-well Transwell® insert plate 
(50µl/well) before being placed into an incubator to polymerise. Meanwhile, HDF and 
VB6 cells were fluorescently labelled with CellTracker™ Green (10µM) and Red 




(5µM) respectively (described in Section 2.4). The fluorescently labelled cells were 
counted and seeded on top of the polymerised organotypic gels in 50µl suspensions 
of VB6s or HDFs alone (5 x 103 cells total), or in a 2:1 co-culture ratio of fibroblast 
(3.3 x 103 cells) and tumour (1.7 x 103 cells). 3D z-stack images were obtained over 
a 72 hour period via CLSM and raw .lsm confocal z-stacks were rendered and 
analysed via Imaris XT (described in Section 2.5) (Figure 5.1, Figure 5.2 and Figure 
5.3). 
 
5.2.1.1 96-well micro-organotypic Transwell® cultured 
with fluorescently labelled VB6 cells imaged at 24, 
48 & 72 hour time points 
To compare the 96-well micro-organotypic Transwell® assay against the 24-well mini-
organotypic invasion assay (Figure 3.7); fluorescently labelled, CellTracker™ Red 
(5µM) VB6 cells were plated alone on top of the gels and imaged every 24 hours for 
three days via CLSM 710, producing z-stack volumes. 
Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated for the 24, 48 and 72-hour time points 
(Figure 5.1A-C). Distance Transformation analysis was performed on the rendered 
3D volumes producing .csv data files. Graphical plots of invasive depth were 
generated in Prism using data extrapolated from the .csv files (Figure 5.1D). 
At the 24 hour time point image analysis revealed the VB6 cells appear adhered and 
homogeneously spread on to the surface of the gel. Throughout the 72 hour time 
points VB6s do not exhibit signs of invasion into the organotypic gel. Additionally, over 
a 72 hour period the VB6s display proliferation and reside within tightly packed layers 
spanning 80µm (24 hours), 100µm (48 hours) and 120µm (72 hours). Gel height does 
appear to reduce over the 72 hour period, possible due to evaporation of the exposed 
surface of the gels during incubation (gel height at 24 hours is approximately 1450µm, 
shrinking to approximately 1080µm by 72 hours). 
These data are consistent with the observations from Figure 3.7, where VB6 cells 
were plated on top of organotypic gels housed within the 24-well Transwell® format. 
In the 24-well format, 100µl of organotypic gel was plated into each Transwell® and 
once polymerised, this produced a gel 1400-1500µm in thickness when imaged at the 
24 hour time point. Similarly, the gel thickness within the 96-well format is also 
between 1400-1500µm in thickness despite only plating 50µl of gel. This is due to the 




diameter differences between both Transwell® inserts. The 24-well Transwells® are 
wide, containing parallel vertical walls and a diameter of 6.5mm whereas, the 96-well 
Transwells® have narrow non-parallel walls and a diameter of 4.26mm. Both formats 
permit a 700µm x 700µm x 1500µm field of view and show increased proliferation, 
gel shrinkage and no invasion of VB6 cells over a 72 hour period. 
  






Figure 5.1: 3D rendered and quantified z-stacks of fluorescently labelled 
VB6 cells plated alone on top of 96-well Transwell® micro-organotypic 
gels 
 





Figure 5.1: 3D rendered and quantified z-stacks of fluorescently 
labelled VB6 cells plated alone on top of 96-well Transwell® micro-
organotypic gels 
The figure displays Imaris XT rendered and analysed 96-well micro-organotypic 
gels plated with CellTracker™ Red labelled VB6 cells (5µM). Confocal microscope 
obtained z-stacks were segmented, rendered and analysed by Imaris XT. Images 
were rendered using a surface segmentation tool that accurately detects particles 
of specific diameters and intensity. Distance Transformation calculations were 
performed via Imaris XT and plotted in Prism. A, B, C) 24, 48 and 72 hour time 
point.VB6 cells appear vibrant with colour and are easily identifiable. VB6 cells do 
not invade throughout the micro-organotypic gel over a 72 hour period. However 
the average height of the gels reduces. This contraction is probably due to 
evaporation during incubation. Serum-free medium was not placed above each 
gel when incubated, thus exposing the upper surface of the gels. D) Graphical 
depiction of individual VB6 cells z-position in relation to the PET membrane 
(position 0). Each red dot represents one cell within the 700µm square field of 
view. The cells stack tightly together and on top of each other in a layer that is 
between 80-120µm in depth. One representative image for each time point from 
one of two independent experiments. 
 
  




5.2.1.2 96-well micro-organotypic Transwell® cultured 
with fluorescently labelled HDF cells imaged at 24, 
48 & 72 hour time points 
To compare the 96-well micro-organotypic Transwell® assay against the 24-well mini-
organotypic invasion assay (Figure 3.8); fluorescently labelled, CellTracker™ Green 
(10µM) HDF cells were plated alone on top of the gels and imaged every 24 hours for 
three days via CLSM 710, producing z-stack volumes. 
Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated for the 24, 48 and 72-hour time points 
(Figure 5.2A-C). Distance Transformation analysis was performed on the rendered 
3D volumes producing .csv data files. Graphical plots of invasive depth were 
generated in Prism using data extrapolated from the .csv files (Figure 5.2D). 
At the 24 hour time point HDF cells appeared to be adhered and homogeneously 
spread on to the surface of the gel using image analysis. In addition, a number of 
HDF cells are seen to change their morphology and adopt a vertical orientation, thus 
invading vertically downward through the gel. At the 48 hour time point, increased 
numbers of HDFs have changed their orientation and invade further into the gel. This 
is probably due to enzymatic secretions from the fibroblasts which may have 
degraded the ECM proteins and remodelled the gels. Interestingly, at the 72 hour time 
point, the gel has drastically contracted vertically, however, there also appears to be 
signs of lateral contraction and the upper portion of the gel appears disfigured. This 
may be due to the narrowing walls of the 96-Transwell® insert exerting an inward force 
on to the gel and/or also the HDFs may have physically contracted the gel.  
Between the 24 and 72 hour period the HDFs display increased proliferation and 
cover a z-range spanning 160µm (24 hours, Figure 5.2A), 250µm (48 hours, Figure 
5.2B). Determining the range for the 72 hour time point (Figure 5.2C) accurately 
cannot be done due to the uneven surface. Gel height does appear to reduce over 
the 72 hour period, possible due to evaporation of the exposed surface of the gels 
during incubation and gel contraction via the fibroblasts (gel height at 24 hours is 
approximately 1700µm, shrinking to approximately 1000µm by 72 hours). 
These data display some similarities with the observations from Figure 3.8 where 
HDF cells were plated on top of organotypic gels housed within the 24-well Transwell® 
format. Both formats display levels of increased HDF proliferation and change in 
shape and orientation, resulting in invasion of HDFs into the gels. However, the 24-




well format displayed gel shrinkage 24 hours after cell-seeding (approximately 
600µm, Figure 3.8A), whereas Figure 5.2A (96-well format 24 hour time point) gel 
height is 1700µm. This could be due to the rate of evaporation being less in the 96-
well format than in the 24-well format, possibly to the reduced surface area of exposed 
gel.  
Furthermore, data from Figure 3.8C suggest that HDFs polarise and invade very 
rapidly through 24-well mini-organotypic wells and by the 72 hour time have invaded 
into the entirety of the gel. However, the HDFs have not invaded as deeply into the 
gel by the 72 hour time point in this 96-well assay (Figure 5.2C). This may be due to 
the reduction in cell numbers plated per Transwell® (5 x 103 cells/well for 96-well, 105 
cells/well for 24-well), or due to the fact that the volume of gel available for the cells 
to invade into is greatly reduced in the 96-well format, thus, not allowing them to 
invade as freely in all directions compared to the 24-well format. 
  






Figure 5.2: 3D rendered and quantified z-stacks of fluorescently labelled 
HDF cells plated alone on top of 96-well Transwell® micro-organotypic gels 
 




Figure 5.2: 3D rendered and quantified z-stacks of fluorescently 
labelled HDF cells plated alone on top of 96-well Transwell® micro-
organotypic gels 
The figure displays Imaris XT rendered and analysed 96-well micro-organotypic 
gels plated with CellTracker™ Green labelled HDF cells (5µM). Confocal 
microscope obtained z-stacks were segmented, rendered and analysed by Imaris 
XT. Images were rendered using a surface segmentation tool that accurately 
detects particles of specific diameters and intensity. Distance Transformation 
calculations were performed via Imaris XT and plotted in Prism. HDF cells appear 
vibrant with colour and are easily identifiable. A) 24 hour time point, HDFs change 
shape and morphology and begin invading vertically downward through the gel. 
B) 48 hour time point, increased number of cells changing shape observed and 
cells invade further into the gel. C) After 72 hours gels display horizontal and 
perhaps lateral contraction and degradation, probably through evaporation during 
incubation and matrix remodelling from fibroblast secretions. D) Graphical 
depiction of individual HDF cells z-position in relation to the PET membrane 
(position 0). Each green dot represents one cell within the 700µm square field of 








5.2.1.3 96-well micro-organotypic Transwell® co-cultured 
with fluorescently labelled VB6 and HDF cells 
imaged at 24, 48 & 72 hour time points 
To compare the 96-well micro-organotypic Transwell® assay against the 24-well mini-
organotypic invasion assay (Figure 3.9); HDF and VB6 cells were labelled with 
CellTracker™ Green (10µM) and Red (5µM) respectively and co-cultured in a 2:1 
ratio on top of the gels and imaged every 24 hours for three days via CLSM 710. 
 Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated for the 24, 48 and 72-hour time points 
(Figure 5.3A-C). Distance Transformation analysis was performed on the rendered 
3D volumes producing .csv data files. Graphical plots of invasive depth were 
generated in Prism using data extrapolated from the .csv files (Figure 5.3D). 
After 24 hours both cell types appear to have attached and spread uniformly on the 
surface of the gel and display no signs of invasion at this time point. However, 
noticeably the HDF cells have started to change their shape and orientation to 
facilitate invasion.  
At the 48 hour time point a large population of HDF and VB6 cell remain at the surface 
of the gel, however, a small number of HDFs are observed invading vertically through 
the gel and a small number of VB6 tumour cells are also observed breaking away the 
main layer. Gel height between these two time points is very similar, both 
approximately 1400µm, however, at the 72 hour time point, the gel has contracted 
vertically (now approximately 850µm) and HDF cells are observed invading through 
the gel. I also observed that the most invasive cell type was a fibroblast and often 
followed closely behind by VB6 tumour cells. 
These data show resemblance similar to that of Figure 3.9, where HDF and VB6 cells 
were co-cultured into the 24-well format. In both formats, the leading invasive cell type 
always appears to be a fibroblast, which are followed by tumour cells probably 
migrating through the channels created by the fibroblasts during matrix remodelling. 
Additionally, data from Figure 3.9 suggested that the rate at which the HDF cells 
invade through the gels when co-cultured with VB6 cells is reduced and results in a 
slower initial rate of polarisation and invasion when compared to HDFs plated alone 
(Figure 3.8).  
 




This also appears to be a similar observation between Figure 5.2 and Figure 5.3. 
Furthermore, I observed a large difference in gel contraction and invasion between 
the 48 and 72 hour time points, whereas, data from Figure 3.9 suggests gradual gel 
shrinkage over 72 hours. This may be due to evaporation, matrix remodelling or even 
an inward force being exerting on to the gels from the 96-well format.  






Figure 5.3: 3D rendered and quantified z-stacks of fluorescently labelled 
VB6s and HDF cells co-cultured in 96-well Transwell® micro-organotypic 
gels 





Figure 5.3: 3D rendered and quantified z-stacks of fluorescently 
labelled VB6s and HDF cells co-cultured in 96-well Transwell® micro-
organotypic gels 
The figure displays Imaris XT rendered and analysed mini-organotypic gels co-
cultured with CellTracker™ Green and Red labelled HDF (10µM) and VB6 (5µM) 
respectively. Confocal microscope obtained z-stacks were segmented, rendered 
and analysed by Imaris XT. Images were rendered using a surface segmentation 
tool that accurately detects particles of specific diameters and intensity. Distance 
Transformation calculations were performed via Imaris XT and plotted in Prism. 
HDF and VB6 cells appear vibrant with colour and are easily identifiable. A) At the 
24 hour time point, HDFs show initial signs of polarisation and begin invading 
vertically downward through the gel. B) At the 48 hour time point, increased 
number of cells changing shape observed and cells invade further into the gel. A 
small number of VB6s can also be observed breaking away from the main cell 
layer. C) After 72 hours gels displays horizontal contraction and degradation, 
probably through evaporation during incubation and matrix remodelling from 
fibroblast secretions. D) Graphical depiction of individual HDF cells z-position in 
relation to the PET membrane (position 0). Each dot represents one cell within the 
700µm square field of view. One representative image for each time point from 
one of two independent experiments. 
  




5.2.1.4 Summary of 96-Transwell® insert 
The 96 well Transwell® assay displays many similar features to the 24-well assay 
described in Chapter III, namely; both formats produce very similar 3D rendered 
images (red fluorescent PET membrane and 700µm x 700 µm x 1500 µm volumes)  
and quantitative data after 72 hours post cell seeding. Additionally, both assays 
revealed that VB6 OSCC do not invade through organotypic gels over a 72 hour 
period without the presence of HDFs. Furthermore, HDFs appear to be the most 
invasive cell type regardless of plate format or Transwell® size. Whilst, both formats 
display gel contraction and degradation, albeit to a varying degree in the 96-well 
assay I also observed lateral contraction of the gels.  
The assay was set up with relative ease and advantageously requires less volume of 
expensive organotypic gel and a lower seeding density of cells. Image capture via 
CLSM was approximately the same time per gel as with the 24-well format (typically 
20 minutes for gels approximately 1500µm in thickness), however, media 
replenishment without the use of liquid handling robotics was problematic.  
Furthermore, the aim was always to develop an assay which was not only cost 
efficient to enable HTS within the pharmaceutical and biotechnology industry but also 
could be manually performed with ease by the majority of biological research 
laboratories. Owing to plate costs and technical difficulties of manual handling, this 
assay therefore is not suitable.  
Thus, I asked the following; ‘is it possible to measure and quantify fibroblast and 
cancer cell 3D invasion without the use of a Transwell® organotypic culture system?’ 
To address this I began to develop a 96-well plate multicellular 3D invasion assay 
where the cells invaded upward through the gel toward a chemotactic gradient. In 
addition, for development of an HTS screen I needed to ensure that cells would be 
permanently fluorescent. 
  




5.3 Generation of stable fluorescent cell lines via use of lentiviral 
particles 
In the previous chapters, cancer cells (VB6, H1299 and MDA-468) and fibroblast cells 
(HDF, FSF and MRC5) were labelled with transient fluorescent dyes (CellTracker™ 
Red and Green, respectively). The advantage of such transient dyes is that they allow 
for multigenerational tracking of cellular movements, they are easy to use and 
compatible with almost all cell types. However, the disadvantages are that the 
fluorescent probes (supplied as a desiccated sample) must be dissolved in DMSO 
which although further diluted could affect the health of cells. Additionally, the dye is 
not permanent, the retention time is approximately 72 hours (dependent on 
concentration used and cell type) and effectively fluorescent intensity halves per each 
proliferation cycle.  
Furthermore, there is no way of accurately confirming fluorescent efficiency, whilst 
sell sorting on fluorescent populations can be performed via FACs analysis, this 
process would take a few days in which the tracker would dissipate. Thus, to ensure 
permanent, stable and uniform fluorescence expression, a lentiviral transduction 
system was used to insert fluorescent proteins into the target cells. 
 
5.3.1 Viral mediated generation of H2B-RFP expressing VB6 
cells and H2B-GFP and EGFP expressing HDF cells 
The lentiviral transduction system is based on the HIV and utilises a packaging, 
vehicle and vector plasmids (Dull et al., 1998). Section 2.11 describes in detail the 
production of lentiviral particles encoding for fluorescent histone H2B-RFP, -GFP and 
whole cell EGFP. Briefly, HEK293T were seeded into a 6-well plate (105 cells/well) 
and grown to approximately 80% confluency before the lentiviral constructs 
(comprised of packaging plasmids pMD2.G and pCMVR8.74 with pLV-H2B-RFP or –
GFP or EGFP vector and FuGENE transfection reagent) were added to the HEK293T 
cells and incubated for 48 hours. The resulting viral containing cell culture medium 
was collected and frozen at -80°C until use. VB6s were infected with virus carrying 
H2B-RFP (Figure 5.4A), whereas HDFs were infected with virus carrying H2B-GFP 
(Figure 5.4B) or EGFP (Figure 5.4C). Both cell types were sorted by FACS to recover 
and re-culture highly positive fluorescent populations. 
  











Figure 5.4: FACS analysis and expression of H2B-RFP infected into VB6 








Figure 5.4: FACS analysis and expression of H2B-RFP infected into 
VB6 cells and H2B-GFP and EGFP infected into HDF cells 
VB6 cells infected with lentivirus particles encoded for H2B-RFP and HDF cells 
infected with H2B-GFP or EGFP. FACS analysis was performed to select the 
highest expressing cells (>95% positive). Highly expressing cells were efficiently 
recovered and placed back into culture before another round of cell sorting was 
performed. A) Left panel displays VB6 control sample, middle panel gated region 
for H2B-RFP positive VB6 cells. Right panel displays a confocal microscopic 
image of live VB6 cells constitutively expressing nuclear histone H2B-RFP. B) Left 
panel displays HDF control sample, middle displays gated region of H2B-GFP 
positive HDF cells. Right panel displays a confocal microscopic image of live HDF 
cells constitutively expressing nuclear histone H2B-GFP. C) Left panel displays 
HDF control samples, middle panel displays gated region of EGFP positive HDF 
cells. Right panel displays a confocal microscopic image of live HDF cells 
constitutively expressing whole cell EGFP. FACS experiment was performed by 
the Flow Cytometry Department at BCI. Data shown is from the first of three 
rounds of FACS analysis. Scale bar 50µm. 
 
  




5.4 96-well micro-organotypic reverse invasion assay 
Due to the high cost and laborious process of preparing the 96-well Transwell® 
invasion assay, I sought to develop a 96-well micro-organotypic invasion assay that 
did not require the use of a Transwell® insert. In 2008, Sanz-Mareno and colleagues 
reported the use of a 3D 96-well invasion assay to examine roles of NEDD9-DOCK3-
Rac and ROCK-ARHGAP22 signalling pathways, whereby cells were suspended in 
collagen type I and plated into 96-well plates coated with BSA. The plates were then 
centrifuged and incubated for 30 minutes before serum-containing media were added 
to each well. After 24 hours cells were fixed and stained with Hoechst before confocal 
z-slices were collected (Sanz-Moreno et al., 2008).  
Like Sanz-Mareno, the assay described here uses a similar 96-well reverse invasion 
format, described in Section 2.10.3. Briefly, stably fluorescent HDFs expressing H2B-
GFP and VB6s expressing H2B-RFP were suspended in organotypic gel and added 
to a low-binding 96-well plate either alone (7.5 x 103 cells/well in total) or in a 2:1 co-
culture of fibroblast (5.0 x 103 cells) to tumour (2.5 x 103 cells) respectively. The plate 
was then centrifuged, forcing cells to the bottom of the gel before incubation at 37°C 
for one hour. Next, serum-containing media were added on top of the gels and 
returned for incubation. 3D live z-stack images were obtained daily over a period of 
72 hours. Fluorescent microspheres (10µm diameter) were added to each well 20 
minutes prior to imaging the 24 hour time point, thus identifying the surface of the gel. 
 
5.4.1 96-well micro-organotypic reverse invasion assay 
cultured alone with stably expressing H2B-RFP VB6 cells 
imaged at 24, 48 & 72 hour time points 
To examine whether VB6 tumour cells invade upward through micro-organotypic 
gels, VB6 cells stably expressing H2B-RFP were incorporated into organotypic gel 
before being plated alone into 96-well low binding plates and imaged every 24 hours 
for three days via CLSM 710. Using Imaris XT image analysis software a rendered, 
smoothened 3D representation of the raw .lsm confocal z-stack was generated and 
Distance Transformation analysis was performed on the rendered 3D volumes 
producing .csv data files. Graphical plots of invasive depth were generated in Prism 
using data extrapolated from the .csv files for the 24, 48 and 72-hour time points. The 
z-positions of each fluorescent microsphere were measured and averaged to 
determine approximate gel height (Figure 5.5). 




At the 24 hour time point Image analysis revealed fluorescent red VB6 cells at the 
bottom of the gel forming a layer of cells approximately 30µm thick. The blue 
microspheres can be observed settled at the surface of the gel (approximately 
450µm). At the 48 hour time point VB6 cell numbers appear to have increased and 
tightly packed together, now within approximately a 50µm layer. Additionally, VB6s 
do not appear to invade through the organotypic gel and gel height has remained 
similar to that observed at the 24 hour time point. By the 72 hour time point VB6 cell 
numbers appear to have increased further and produce a 100µm cell layer.  
Interestingly gel height is now approximately 290µm, this may be due to evaporation 
and gel shrinkage. Throughout the three time points cell size does appear to vary, 
however, this may be due to groups or clusters of cells joined together or within close 
proximity of each other. Furthermore, these data are consistent with the observations 
from Figure 3.7 and Figure 5.1, suggesting VB6 cells do not invade through 





Figure 5.5: 3D rendered and quantified z-stacks of VB6 cells expressing H2B-RFP embedded alone in 96-well 
reverse micro-organotypic gels 




Figure 5.5: 3D rendered and quantified z-stacks of VB6 cells 
expressing H2B-RFP embedded alone in 96-well reverse micro-
organotypic gels 
The figure displays Imaris XT rendered and analysed 96-well reverse invasion 
micro-organotypic gels embedded with VB6 cells stably expressing H2B-RFP. 
Confocal microscope obtained z-stacks were segmented, rendered and analysed 
by Imaris XT. Images were rendered using a surface segmentation tool that 
accurately detects particles of specific diameters and intensity. Distance 
Transformation calculations, relative to the base of the well, were performed using 
Imaris XT and plotted in Prism. A, B, C) 24, 48 and 72 hour time point images and 
quantified invasion distance plots. VB6 cells appear vibrant with colour and are 
easily identifiable. VB6 cells do not appear to invade throughout the micro-
organotypic gel over a 72 hour period. However the average height of the gels 
reduces between 48 and 72 hour time points. This contraction is probably due to 
evaporation during incubation. One representative image for each time point from 
three independent experiments. 
  




5.4.2 96-well micro-organotypic reverse invasion assay 
cultured alone with stably expressing H2B-GFP HDF cells 
imaged at 24, 48 & 72 hour time points 
To examine whether HDF cells invade upward through micro-organotypic gels; HDFs 
stably expressing H2B-GFP were incorporated into organotypic gel before being 
plated alone into 96-well low binding plates and imaged every 24 hours for three days 
via CLSM 710.  
Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated and Distance Transformation analysis 
was performed on the rendered 3D volumes producing .csv data files. Graphical plots 
of invasive depth were generated in Prism using data extrapolated from the .csv files 
for the 24, 48 and 72-hour time points. The z-positions of each fluorescent 
microsphere were measured and averaged to determine approximate gel height 
(Figure 5.6). 
Image analysis from the 24 hour time point revealed fluorescently green labelled HDF 
cells at the bottom of the gel forming a layer of cells approximately 30-40µm thick. 
The blue microspheres can be observed settled at the surface of the gel 
(approximately 390µm). The graphical plot suggests one HDF cell is observed 
breaking away from the main population and invading through the organotypic gel 
(identified with a white arrow). At the 48 hour time point there notable differences to 
24 hour time point, such as, a profuse increase in the number of HDF cells. 
Additionally, a large population of HDF cells can be observed invading almost through 
the entire gel. Thus, perhaps contributing to the reduction in gel height, which is now 
approximately 270µm thick. Furthermore, gel height reduction may be due to matrix 
remodelling from the HDFs. The 72 hour time suggests that HDF cells have now 
reached the top of the gel. Gel height appears to have slightly increased from 270µm 
to 305µm, this may be due to the fibroblast cells secretions at the top of the gel forcing 
the gel surface to expand.  
Interestingly, the level of change between 24 and 48 hours is vast in comparison to 
48 and 72 hours. Perhaps this may be due to a larger chemotactic effect between the 
initial few hours and the 48 hour time point. These data may suggest the chemotactic 
gradient is lost after 36-48 hours. However, these data are still consistent with 
observations from Figure 3.8 and Figure 5.2, suggesting that HDF cells not only 





Figure 5.6: 3D rendered and quantified z-stacks of HDF cells expressing H2B-GFP embedded alone in 96-well 
reverse micro-organotypic gels 




Figure 5.6: 3D rendered and quantified z-stacks of HDF cells 
expressing H2B-GFP embedded alone in 96-well reverse micro-
organotypic gels 
The figure displays Imaris XT rendered and analysed 96-well reverse invasion 
micro-organotypic gels embedded with HDF cells stably expressing H2B-GFP. 
Confocal microscope obtained z-stacks were segmented, rendered and analysed 
by Imaris XT. Images were rendered using a surface segmentation tool that 
accurately detects particles of specific diameters and intensity. Distance 
Transformation calculations, relative to the base of the well, were performed using 
Imaris XT and plotted in Prism. A) 24 hour time point displays vibrant HDF cells, 
distributed at the bottom of the gel. The 3D image and invasion distance graph 
displays one invading cell moving away from the main population towards the top 
of the gel. Gel height is approximately 390µm.  B) 48 hour time point displays 
increased levels of cell number and invasion. HDF cells invade the entirety of the 
gel. In addition, gel height was reduced to approximately 270µm, probably due to 
gel contraction and degradation. C) The 72 hour time point displays similar 
features to that of the 48 hour time point, in that, HDFs have invaded the entire 
gel and increased in cell number. One representative image for each time point 
from three independent experiments. 
  




5.4.3 96-well micro-organotypic reverse invasion assay co-
cultured with stably expressing H2B-GFP HDFs and H2B-
RFP expressing VB6 cells imaged at 24, 48 & 72 hour time 
points  
To examine the invasion of VB6s in the presence of HDF cells in inverted micro-
organotypic gels, HDFs expressing H2B-GFP and VB6s expressing H2B-RFP were 
incorporated into organotypic gel before being plated alone into 96-well low binding 
plates and imaged every 24 hours for three days via CLSM 710.  
Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated and Distance Transformation analysis 
was performed on the rendered 3D volumes producing .csv data files. Graphical plots 
of invasive depth were generated in Prism using data extrapolated from the .csv files 
for the 24, 48 and 72-hour time points. The z-positions of each fluorescent 
microsphere were measured and averaged to determine approximate gel height 
(Figure 5.7). 
Image analysis from the 24 hour time point revealed bright populations of both cell 
types forming layers approximately 30-40µm thick. The blue microspheres can be 
observed settled at the surface of the gel (approximately 390µm). The graphical plot 
suggests a small population of HDFs may have broken away from the main layer, 
followed by VB6 cells. At the 48 hour time point there are notable differences to the 
24 hour time point, such as, increased cell numbers in both populations. Additionally, 
at the 48 hour time point, large populations of HDF cells can be observed invading 
through the entire gel. Followed closely by VB6 cells, which may have migrated into 
the channels created by the fibroblasts.  
The graphical plot from the 48 hour time point suggests that the HDFs invade in a 
wave like pattern through the gel and both cell types appear to have a wide variation 
in the degree of invasive activity of individual cells. The gel height between the 24 
and 48 hour time point does not change, thus suggesting that HDFs and VB6s 
invaded approximately 200µm in 24 hours. The 72 hour time point reveals increased 
cell numbers within both populations. Strikingly, the plot for the 72 hour time point 
suggests that HDFs and VB6 have retreated on themselves compared to the 48 hour 
time point, however I do not believe this to be the case. Rather, as the gel has 
contracted and degraded the overall gel height has reduced (now approximately 
240µm), thus, bringing the cells closer in proximity to one another. 




The level of change between the 24 and 48 hour time points is very informative and 
further suggests that, the invasive behaviour is largely based on chemotaxis. Similarly 
to the 72 hour HDF alone gel (Figure 5.6C) this sample also appears withered and 
contracted. This further suggests that quantitative behaviour changes can be 
collected and measured within the first 36, if not 24, hours of this experiment. These 
data are consistent with observations from Figure 3.9 and Figure 5.3, suggesting 
that HDFs are the leading invasive cells type, probably degrading the organotypic gel, 






Figure 5.7: 3D rendered and quantified z-stacks of HDFs expressing H2B-GFP co-cultured with VB6s 
expressing H2B-RGP in 96-well reverse micro-organotypic gels 




Figure 5.7: 3D rendered and quantified z-stacks of HDFs 
expressing H2B-GFP co-cultured with VB6s expressing H2B-RGP 
in 96-well reverse micro-organotypic gels 
The figure displays Imaris XT rendered and analysed 96-well reverse invasion 
micro-organotypic gels co-cultured with embedded HDFs stably expressing 
H2B-GFP and VB6s stably expressing H2B-RFP. Confocal microscope 
obtained z-stacks were segmented, rendered and analysed by Imaris XT. 
Images were rendered using a surface segmentation tool that accurately 
detects particles of specific diameters and intensity. Distance Transformation 
calculations, relative to the base of the well, were performed using Imaris XT 
and plotted in Prism. A) 24 hour time point displays vibrant HDF and VB6 cells, 
distributed at the bottom of the gel. The invasion distance graph displays a 
small cluster of HDFs may have broken away from the main population, 
followed by VB6 cells. Gel height is approximately 390µm.  B) 48 hour time 
point displays increased levels of cell proliferation of both cell types. HDFs 
have invaded further into the gel (200µm deeper than 24 hour time point) and 
appear to be followed closely by migrating tumour cells. Probably through the 
channels created by fibroblasts during matrix remodelling. Gel height remains 
similar to the previous time point (approximately 390µm). C) The 72 hour time 
point displays drastic gel contraction and degradation compared to the 48 hour 
time point. Gel is approximately 240µm in thickness. Both cell types display 
increased levels of proliferation. One representative image for each time point 
from three independent experiments. 
 
  




5.4.4 siRNA knockdown of five selected hits from primary 
SMARTpool siRNA screen in 96-well reverse micro-
organotypic invasion assay 
To determine whether gene silencing in HDF cells had a similar or any effect on 
fibroblast/cancer cell invasion and gel contraction in the 96-well reverse format as 
observed in the 24-well format, HDFs were transfected with SMARTpool siRNA or 
non-targeting siRNA control (described in Section 2.6.1) and seeded into organotypic 
gels.  
Briefly, HDF cells (H2B-GFP expressing) were plated into 24-well plates (2.0 x 104 
cells/well) and the next day transfected with the five SMARTpool siRNA selected hits 
identified from the primary screen and NT siRNA control, described in Section 4.3 
(CAPN-10, CASP-8, MMP-17, SERPIN-F1, TMRPSS-13) (20nM). Three days post 
transfection, HDFs and VB6 cells (H2B-RFP expressing) were counted and 
incorporated into organotypic gel in a 2:1 ratio of fibroblast: tumour cells before being 
plated into 96-well low binding plates. The plate was then centrifuged at 4°C before 
being incubated. Post polymerisation, 100µl of serum-containing medium were added 
to each well and re-incubated. Three days post plating (six days post transfection), 
10µm fluorescent microspheres were added to each well and end point z-stack 
images were acquired via CLSM 710.  
Using Imaris XT image analysis software a rendered, smoothened 3D representation 
of the raw .lsm confocal z-stack was generated and Distance Transformation analysis 
was performed on the rendered 3D volumes producing .csv data files. Graphical plots 
of invasive depth were generated in Prism. The z-positions of each fluorescent 
microsphere were measured and averaged to determine approximate gel height 
(Figure 5.8). 
Image analysis revealed vibrant populations of both cell types across all treatments. 
Interestingly, the NT sample displays similar levels of invasion of HDFs and VB6 cells 
and gel height (approximately 450µm) as observed in the 48 hour time point co-
culture sample (Figure 5.7B).  
The CAPN-10 and SERPIN-F1 images and invasion data from the invasion distance 
plots suggest similar levels of invasion to the NT sample, whereby HDFs are observed 
breaking away from the main population and begin to invade into the gels. As 
previously noticed, HDFs appear to be the leading invasive cell type and are closely 
followed by the VB6 tumour cells. The CAPN-10 (770µm) and SERPIN-F1 (660µm) 




gel height is greater than that of the NT sample (450 µm). Furthermore, MMP-17 
(1100µm) and TMPRSS-13 (1200µm) gels are even greater than CAPN-10, SERPIN-
F1 and the NT sample. One possible explanation of the thicker gels might be via 
increased ECM secretions by the cells. I also considered whether it may be due to 
swelling of the gels from the medium placed above the gel but it was not observed in 
others treatments or in earlier experiments (Figure 5.6 and Figure 5.8). The exact 
reasons for this increased size are yet to be identified.  
To address the increase in gel size, I tested control wells where no cells were 
included, only the 10µm fluorescent beads were added to the top of the gel (Figure 
5.9). Surprisingly the gel containing beads only (gel height 440µm) shrank to a similar 
height to that of the NT control (450µm). Since there were no cells, gel degradation 
and contraction may not be the explanation for the reduction in height, only 
evaporation. Thus explaining why the siRNA treated samples had taller gels remains 
unconfirmed. 
The CASP-8 image and invasion plot reveal no evident signs of invasion of either cell 
type (Figure 5.8). More interestingly, the data displays the lowest numbers of both 
cell types compared against all samples, suggesting that CASP-8 knockdown in the 
HDFs may cause cell death or decrease proliferative rates. Gel height is similar to 
that of the NT sample (approximately 450µm). 
Data from the invasion plot suggests samples containing HDFs with silenced MMP-
17 and TMPRSS-13 do not appear to break away from the main population as 
observed with the NT, CAPN-10 and SERPIN-F1 transfected HDFs. Thus not 
invading into the gels but rather appear to settle in a large population at the bottom of 
the gel in a layer approximately 210µm thick. Secondly, the VB6 cells also remain at 
the bottom of the gel and do not invade into the gels. This may be due to the MMP-
17 and TMPRSS-13 knockdown on the fibroblasts, thus, affecting the ability of matrix 
remodelling, motility or invasion to occur within the HDF population.  
A consistent change that compares with the 24-well assay is the thickness of the gel 
at the end of the experiment. In both the 96-well and 24-well formats the gels 
containing MMP-17 and TMPRSS-13 treated HDF are thicker. In future improvements 
to this assay it would be ideal to use a fluorescent collagen or second-harmonic 
imaging to observe the distribution of collagen fibres within the gel. 
Overall the fluorescent images in Figure 5.8 show that there are large differences in 
the distribution and numbers of cells in each treatment, however given the 




conclusions above, it was likely that chemotactic gradient had probably vanished by 
36-48 hours and it may have been more informative to have analysed this assay in a 





Figure 5.8: 3D rendered and quantified z-stacks of siRNA KD in HDFs expressing H2B-GFP co-cultured with VB6s expressing H2B-
RGP in 96-well reverse micro-organotypic gels 
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Figure 5.8: End point 3D rendered and quantified z-stacks of siRNA 
KD in HDFs expressing H2B-GFP co-cultured with VB6s expressing 
H2B-RGP in 96-well reverse micro-organotypic gels 
The figure displays Imaris XT rendered and analysed 96-well reverse invasion 
micro-organotypic gels co-cultured with embedded siRNA transfected HDFs 
(expressing H2B-GFP) and non-transfected VB6s (expressing H2B-RFP) six days 
post transfection. HDF cells were plated into a 24-well plate (2.0 x 104 cells/well) 
and after 24 hours transfected with the top five selected SMARTpool hits from the 
primary screen (CAPN-10, CASP-8, MMP-17, SERPIN-F1 and TMPRSS13) 
(20nM) along with a non-targeting siRNA control(NT) in triplicate wells. 72 hours 
post transfection HDF and VB6 cells were counted and embedded into 
organotypic gel before seeding into 96-well low binding plates and centrifuged at 
4°C. The plate was incubated for one hour until polymerised before 100µl of serum 
media were added to each well. 72 hours post incubation (six days post 
transfection) z-stack volumes were obtained via CLSM. 20 minutes prior to 
imaging 10µm fluorescent (blue) microspheres were added in each well to identify 
the surface of the gel. Raw confocal data were segmented, rendered and analysed 
by Imaris XT and invasion data plotted in Prism. The NT sample displays similar 
results as observed with the 48 hour time point co-culture displayed in Figure 
5.7B, whereby, the gel has not completely withered or diminished and HDFs can 
be observed invading through the gel followed closely by the VB6 cells. The 
CAPN-10 gel displays a degree of HDF and VB6 invasion similar to that of the NT 
sample, however, also exhibits and an increase in gel height (770µm). CASP-8 
sample displays similar gel height to NT sample, however, both cell types appear 
lower in number compared with other samples. MMP-17 sample displays large 
populations of both cell types remain at the bottom of the gel in a layer 
approximately 210µm thick, moreover, the HDFs and VB6s show no signs of 
invasion as observed with the NT, CAPN-10 and SERPIN-F1 sample. SERPIN-
F1 sample displays similar levels of invasion as observed with CAPN-10 and NT, 
however, also exhibits an increase in gel height (660µm). TMPRSS-13 sample 
displays similar features observed with MMP-17 sample, such as, increased gel 
thickness (1200µm) and no signs of HDF or VB6 invasion. One representative 
image for each treatment from one independent experiment. 
 
  






Figure 5.9: Comparison of gel height 72 hours post plating 
Left figure displays Imaris XT rendered reverse invasion micro-organotypic gels 
co-cultured with embedded NT transfected HDFs (expressing H2B-GFP) and non-
transfected VB6s (expressing H2B-RFP) at 72 hour end point (gel height 450 µm). 
Right panel displays 72 hours end point containing 10µm fluorescent (blue) 
microspheres only (gel height 440µm). 
  




5.4.5 Summary – 96-well reverse 
The 96-well reverse micro-organotypic invasion assay has revealed that not only are 
the fibroblast component of the ECM probably the most invasive but also one of the 
most crucial elements when trying to model in vitro tumour metastasis using 
organotypic cultures. Here I observed similarities between the reverse invasion 
format and the Transwell® insert formats, such as, the fibroblast component in both 
formats appear to be the leading invasive cell. In addition, regardless of well or insert 
size, the organotypic gels can experience contraction, degradation and/or 
evaporation. Furthermore, VB6 cells alone do not appear to invade through 
organotypic gels in either format, whereas, when co-cultured with HDFs, both cell 
types display signs of invasion and migration. Thus, both formats provide a robust 
method to monitor chemotaxis driven invasion.  
However, the 96-well reverse format displayed increased gel thickness when cultured 
with MMP-17 and TMPRSS-13 siRNA transfected HDFs.   
The 96-well reverse assay can be easily performed and is unique and versatile, 
producing 3D images and quantitative data for analysis. Nonetheless, regardless of 
the cost advantages and speed of the assay there are questionable observations 
which have been identified and discussed within the next section. 
  





It is recognised that 3D culture systems better reflect the in vivo behaviour of cellular 
characteristics in comparison to 2D monolayer cultures (Itano et al., 2003; Lee et al., 
2007; McBeath et al., 2004). Additionally, the tumour microenvironment has been 
reported to play an important role within the process of metastasis and drug 
resistance (Correia and Bissell, 2012; Hanahan and Coussens, 2012; Quail and 
Joyce, 2013). However, HTS drug discovery programs still primarily use 2D cancer 
culture methods (Grozinger et al., 2006; Inglese et al., 2006) neglecting the 
importance of stromal cells and ECM components.  
Therefore there is a desire for the pharmaceutical industry to implement 3D cancer 
screening assays for the identification of potential therapeutic targets. However, there 
is not a universal standardised 3D HTS model whereby manipulation, treatment, 
imaging and analysis can be up-scaled due to the vast focus on specific applications. 
Some groups have reported the use of 3D single cell tumour spheroids as a potential 
3D model to identify anticancer agents (Chen and Yoon, 2017; Huber et al., 2016; Ott 
et al., 2017; Zanoni et al., 2016). Although these models can recapitulate some 
aspects of cancer cell growth in 3D, their lack of stromal microenvironment 
components prohibits crucial in vivo interactions, thus making them an unsuitable 3D 
assay for industry. Thus, 3D multicellular spheroids have been developed to study 
the differences in drug sensitivity when comparing cancer cells grown in single and 
multi-cellular 3D cultures (Vorsmann et al., 2013).  
 
5.5.1 Investigation of 96-well Transwell® invasion assay 
The aim of this part of the study was to develop a higher-throughput novel 3D 
organotypic invasion model based on the previously described fluorescent 24-well 
mini-organotypic assay. This was achieved by miniaturising the 24-well assay via use 
of a 96-well Transwell® insert with optically clear PET membranes (Figure 2.2B), 
transient cellular dyes, a LWD 20x objective and confocal microscopy. Thus, I have 
developed and optimised a higher-throughput, reproducible and robust method to 
visualise fibroblast and tumour cell interaction within a 3D microenvironment. 
Observations from the 96-well Transwell® pilot experiments revealed that when VB6 
cancer cells are plated alone (Figure 5.1) there appear to be no signs of invasion 
when monitored over a 72 hour period. These observations are representative of the 
24-well assay (Figure 3.7) and confirm that VB6 cells do not invade through 




organotypic gels when plated alone. In addition, both formats display gel shrinkage 
over a 72 hour period, probably due to evaporation during incubation.  
When HDFs were plated alone in the 96-well Transwell® format (Figure 5.2) they 
appear to change their morphology and orientation and invade into the organotypic 
gel within the first 48 hours as observed in the 24-well format (Figure 3.8). Thus 
confirming that HDFs can invade through collagen: Matrigel® based gels. However, 
the 72 hour time point images from the 96-well format display a reduction in invasion 
of the fibroblasts compared to that of the 24-well format and a disfigured gel. The 96-
well data suggests that the gels experience vast contraction, horizontally and 
vertically. This may be due to the stiffness of the gels in the smaller inserts or possible 
degradation and remodelling of the gel through fibroblast secretions.  
HDFs and VB6 cells co-cultured in the 96-well format (Figure 5.3) displayed reduced 
polarisation of the HDF cells and invasive depth reached was less than when plated 
alone. This may be result of signalling interference by the VB6 cells or also reduced 
cell numbers. Furthermore, invasive depth may have been prohibited by gel stiffness 
(Lang et al., 2015; Zaman et al., 2006), thus adding to the reduction in invasion. 
Nevertheless, the 72 hour time point image displays HDF cells invading through the 
gel followed by migrating tumour cells, as observed in the 24-well format (Figure 3.9).  
The major differences between the both assay formats include; (1) differing surface 
area of exposed gel during incubation, thus, varying the rate and type of gel 
contraction and shrinkage (vertical and lateral); (2) 72 hour time point in the 96-well 
format appears to display physiologically disfigurement to gels, perhaps due to matrix 
remodelling action or gel contraction (perhaps performing this assay for 36-48 instead 
of 72 hour could be a solution); and (3) cost of consumables; one case (five plates) 
of the 96-well Transwell® Insert plates costs £884.61 (£1.84 per Transwell®), however 
one case (four plates, 12 inserts/plate) of the 24-well Transwell® inserts costs £271.60 
(£5.69 per Transwell®). Thus per individual insert, the 24-well format is three times 
more expensive, excluding the cost of reagents. However, the advantage of the 
costlier 24-well format is that all of the Transwells® are individual, therefore, do not all 
need to be used at the same time.  
The 96-well Transwell® micro-organotypic invasion assay has the potential to 
increase throughput and perform HTS, by reducing the volume of required reagents 
(collagen, Matrigel®, culture medium) and number of cells for those wishing to perform 
high-throughput assays. Interestingly, this plate format has been designed and can 
be integrated into an automated HTS workflow due to its barcoded plates and oval 




shaped wells, thus facilitating medium exchange via liquid handling robotics, 
nonetheless, working by hand with this assay format proved to be very arduous and 
time consuming. 
 
5.5.2 Investigation of 96-well reverse micro-organotypic 
invasion assay 
In order to further reduce cost and decrease assay set up time, I developed 96-well 
reverse invasion assay similar to that used in 2008 (Sanz-Moreno et al., 2008). This 
group used A375M2 and WM1361 melanoma cells expressing GFP and measured 
invasion through collagen type I gels 24 hours post seeding, after fixation. Cells were 
cultured alone and those had invaded by 50µm from the base of the well were 
considered invasive. However, the assay described here uses two different stably 
fluorescent cell populations, imaged live via confocal microscopy.  
The 96-well reverse assay pilot experiments displayed several similarities when 
compared to the 24- and 96-well Transwell® methods, such as, VB6 cells plated alone 
in the 96-well reverse assay (Figure 5.5) do not invade through organotypic gels over 
a period of 72 hours. Additionally, HDF cells plated alone (Figure 5.6) invade rapidly 
through organotypic gels, thus degrading the gels, causing them to shrink after 48 
hours. Furthermore, HDFs and VB6s co-cultured (Figure 5.7) revealed that HDFs 
invade and remodel organotypic gels, thus, providing means of passage for migrating 
VB6 cells. Interestingly the 96-well reverse assay displays rapid behavioural changes. 
The 72 hour time point data shows that cell movement is not different between the 
siRNA treated wells and the cells in the non-targeting control wells.  
These data suggested that the chemotactic gradient may be lost between 36-48 
hours. Thus, ideally, microscope permitting, it may be of interest to image every hour 
for 24-36 hours. 
The reverse invasion assay format has several advantages over the 96-well 
Transwell® assay, including; (1) reduced cost, the 96-well reverse format only 
requires 100µl of cell culture medium per well, whereas the 96-Transwell® format 
requires 150µl and the cost of an individual 96-well Transwell® plate is £176 whereas 
the low binding µClear® 96-well plates are £2.92 each; (2) overall assay set up time 
is reduced when using the reverse format due to the cells being embedded into the 
organotypic gel prior to polymerisation; (3) medium replenishment is simplified when 
using the reverse invasion assay, the process involves use of a multi-channel pipette 




to exchange medium across all wells. Whereas, for the 96-well Transwell® format the 
user is required to manually remove the insert by hand and then replenish medium; 
(4) 3D image capture of the reverse assay gels is much faster as the gels are much 
thinner in comparison to those in the 96-well Transwell®, thus, reducing overall assay 
time. 
Conversely, the data from (Figure 5.8) revealed that gel thickness increased after a 
72 hour time period when gels were embedded with MMP-17 and TMPRSS-13 siRNA 
transfected HDFs. While the exact reasons for this are unclear, one suggestion may 
be due to the increased production of GAGs. Due to their strong hydrophilic 
properties, GAGs are highly negatively charged therefore attract osmotically active 
Na+ ions, which in turn, draws large volume of water into surrounding ECM in which 
the GAGs reside. This influx of water can cause a form of swelling pressure (Frantz 
et al., 2010; Gandhi and Mancera, 2008), thus leading to an increased in gel 
thickness. 
Additionally, perhaps the increase in gel thickness is a result of increased collagen 
production from HDF cells. For example, during fibrosis and wound healing, 
myofibroblasts are known to secrete exaggerated levels of ECM proteins (collagen 
type I and fibronectin) (Darby et al., 2014; Li et al., 2007b). With more time I would 
like to have investigated the secretome of the MMP-17 and TMPRSS-13 treated cells. 
Overall, these results have demonstrated that miniaturisation of the 24-well mini-
organotypic invasion does not compromise the value of the assay. Both formats are 
robust and reproducible despite differences in costs and 3D image readout. Whilst no 
3D assay can fully mimic the in vivo tumour-stroma microenvironment, both 96-well 
versions have several important advances, such as; (1) modular design facilitates 
incorporation of any cell type; (2) permit live imaging and can produce  measurable 
3D data within 24 hours; (3) primary human and tumour cells can be integrated, thus, 
cultures can be customised to screen for target specific treatments; (4) ease of 
transfection or drug dosing during the experiment; and (5) integration into an 
automated screening work flow, thus, permitting HTS.   




Whilst these data provide a useful insight into the development of a 3D micro-
organotypic invasion assay, it should be noted that there remains much to validate 
and address. I have not performed siRNA transfection experiments within the 96-well 
Transwell® assay, nor repeated the top five siRNA knockdown in the 96-well reverse 
method. This was due to insufficient time and depletion of all siRNA reagents. 
Furthermore, I have not positively identified the mechanisms by which increased gel 
thickness occurs with some siRNA knockdowns and this is likely to be important in 











CHAPTER VI: FINAL CONCLUSIONS 
  




6.0 Final Conclusions 
 
It has been estimated that number of globally reported cancer cases will rise to over 
20 million per annum by 2025 (Bray and Soerjomataram, 2015). Cancer is becoming 
increasingly more prominent around the world, despite the progress being made 
towards reducing incidence and mortality rates. Metastases formation, the ability of 
cancer cells to spread to distant organs within the body, has been reported to be 
responsible for approximately 90% of cancer-related deaths (Chang et al., 2005). 
Thus, understanding the complex processes involved in tumour metastasis has been 
a major area of focus for over a century (Friberg and Nystrom, 2015; Hart and Fidler, 
1980b; Paget, 1889; Paget, 1989; Rous, 1910).  
With over 200 FDA approved anti-cancer drugs available for clinical application 
(Buffery, 2015), the majority of these drugs only target anti-proliferative properties of 
tumour cells and not their metastatic behaviour (migration and invasion). Metastasis 
still demands a high therapeutic focus, however major obstacles effect treatment of 
cancer patients who may develop or already have metastases, such as; (1) the 
heterogeneity of tumour cells, containing subpopulations of different geno- and 
phenotypic cells. Meaning each variation has its own invasive, migratory and 
proliferative properties, therefore could be uninhibited by drugs; (2) lack of 
standardised physiomimetic models which recapitulate the metastasis process. The 
pharmaceutical industry desire a 3D model that can be used to perform HTS for their  
potential anti-metastatic compound libraries (Fidler and Kripke, 2015). 
Studies have attempted to inhibit various steps of the metastatic process, starting with 
Lance Liotta’s earlier research, which reported the  degradation of basement 
membrane by murine tumour cells (Liotta et al., 1977). Followed by the discovery of 
MMP-2 as a collagen type IV degrading enzyme (Liotta et al., 1979). In addition, the 
role of proteases within tumour cells to prohibit invasion was reported by Fayard and 
colleagues, who described a reduction in breast cancer cell invasion via inhibition of 
serine proteases (Fayard et al., 2009). Other proteases, such as MMPs have also 
been reported to have an inhibiting effect on tumour cell migration and proliferation. 
For example, Adachi and colleagues reported that MMP-7 overexpression in colon 
cancer cells (CHC-Y1) altered the invasive potential in vivo (Adachi et al., 1999). 
Adding further, up regulation of the integrin αvβ6 generated a tumour promoting 
function of myoepithelial cells in ductal carcinoma in situ (DCIS) through TGF-β 
upregulation of MMP-9 (Allen et al., 2014). 




Additionally, inhibiting angiogenesis, more specifically VEGF, reduces the formation 
of blood vessels surrounding the tumour, thus blocking the supply of nutrients to 
cancer cells, leading to vascular collapse, hypoxia and eventually cell death (Bohn et 
al., 2017; Potente et al., 2011). However, cancer cells have the ability to proliferate 
around existing blood vessels in a process known as vessel co-option (Qian, 2013) 
thus antiangiogenic therapy is likely to be ineffective. 
All of this is clearly not enough to prevent metastasis and perhaps this is an 
unpreventable occurrence. However, targeting a specific stage of the metastatic 
process with the use of a functional standardised assay is highly desirable. Moreover, 
focusing solely only on the cancer cells as a target completely neglects and misses 
the opportunity to manipulate the stromal host microenvironment. The host organ 
environment represents a stable target that could be manipulated in vitro and in vivo 
to produce an anti-invasive, uninhabitable environment for the unpredictable and 
unstable tumour cells. 
Designing an in vitro 3D assay that provides a physiomimetic microenvironment to 
monitor and recapitulate the tumour-stromal interactions is highly required. To date, 
there are many different 3D cancer modelling methods, including spheroid cultures 
(Amann et al., 2014; Huber et al., 2016; Ott et al., 2017; Vorsmann et al., 2013; Ware 
et al., 2016), synthetic gels (DeVolder and Kong, 2012; Loessner et al., 2010; 
Sawhney et al., 1994) and organ-on-a-chip (Bhise et al., 2014; Huh et al., 2010; 
Marhefka and Abbud-Antaki, 2012). 
In this study I have developed an in vitro 3D fluorescent mini-organotypic invasion 
assay based on the organotypic skin culture model originally developed by Fusenig 
(Fusenig et al., 1983). Adaptations of this model have been widely used (Carapuca 
et al., 2016; Froeling et al., 2011; Gaggioli et al., 2007; Mackenzie, 2004; Nystrom et 
al., 2005) to culture cancer cells (with or without fibroblast cells) in a polymerised 
collagen (type I) based gel. The assay (referred to as ‘large organotypic gels’) 
provides a unique scaffold to successfully cultivate cells on top of, or embedded, 
within the gel at an air-liquid interface to study cancer invasion. However, the assay 
lasts for 2-3 weeks, followed by several days of sample processing before being 
available for analysis. Additionally, the assay demands large volumes of costly 
reagents (collagen and Matrigel®) and large numbers of cells per experiment, 
therefore, prohibiting large scale functional drug or gene screening. 
With the use of a transient fluorescent cell permeable dye (CellTracker™), a confocal 
microscope fitted with a LWD x20 objective and image analysis software; I produced 




3D rendered z-stack volumes of cancer and fibroblast cell invasion within a 24-well 
mini-organotypic assay using Transwell® inserts. Data revealed that when 
fluorescently labelled (CellTracker™ Red) VB6 cancer cells were plated alone on top 
of mini-organotypic gels there were no signs of invasion over a 72 hour period (Figure 
3.7). VB6 cells adhere and reside at the top of the gel, however, the gels displayed a 
slight reduction in gel height, suggesting that the exposed surface of the gel 
experiences evaporation. Probably during incubation thus causing the gels to shrink.  
Conversely, 24 hours after our fluorescently labelled (CellTracker™ Green), HDFs 
were plated alone on top of the gels, fibroblasts became polarised, change their 
morphology to favour that of a vertical orientation and begin to invade downward 
through the gel (Figure 3.8). At the 72 hour time point large populations of spindle-
shaped fibroblast cells were observed invading throughout the entirety of the gel 
probably towards a chemotactic gradient. Furthermore, the gel height has drastically 
reduced in comparison to observations with VB6 cells alone. The reduction in gel 
height maybe in part due to the evaporation witnessed with VB6 gels. However, I 
believe that it is also due to degradation and contraction of the gels via fibroblast cell 
activity. This is supported within the literature, that fibroblast cells remodel and 
destroy fibrous proteins in the ECM via enzymatic secretions (Frantz et al., 2010; 
Page-McCaw et al., 2007) and that fibroblast movement within the ECM can re-
organise and contract collagen fibres in tissues in vivo (Ehrlich and Hunt, 2012). In 
addition, the discovery that stromelysin-3 promoted breast cancer but was located in 
the fibroblast component, further suggests that protease-dependent invasion of 
cancer cells may not require the cancer to express the protease (Basset et al., 1990). 
When fluorescently labelled HDFs and VB6s were co-cultured into mini-organotypic 
gels (Figure 3.9); the 24 hour time point revealed that both cell types were 
homogenously spread and adhered on to the surface of the gel. However, HDFs did 
not display any signs of invasion as when plated alone after 24 hours. At the 48 hour 
time point, HDFs were observed invading through the gel in a polarised vertical 
morphology and VB6 cells appeared to follow closely behind. By the 72 hour time 
point the organotypic gel displayed signs of gel contraction, degradation and perhaps 
evaporation. Interestingly HDFs had invaded through the gel and were pursued by 
VB6 cells. This data suggests that not only are the HDFs the leading invasive cell 
type in this assay, but also, that when co-cultured, VB6 cells may slow down the rate 
at which HDFs polarise and invade. Furthermore, VB6 cells presumably migrate down 
through the channels created by the HDFs (Figure 6.1).  




Furthermore, I examined different fibroblast and tumour cells to gather data on 
invasive behaviour and to test robustness of the assay. Breast (MDA-468) and lung 
(H1299) cancer cells were labelled using CellTracker™ Red and plated alone z-
stacks obtained 72 hours post seeding (Figure 3.11).  The data revealed that MDA-
468, H1299 or VB6 cells invade into organotypic gels over a 72 hour time period.  
Skin (FSF) and lung (MRC-5) fibroblasts were labelled using CellTracker™ Green 
and plated alone z-stacks obtained 72 hours post seeding (Figure 3.12).  The data 
revealed that neither FSFs nor MRC-5s polarised or invaded into the gels to the extent 
observed with the HDF cells when plated alone. FSF cells do become polarised and 
displayed early signs of morphological changes and invasion after 72 hours. 
However, the reduced numbers of invading cells may be due to age and passage 
numbers of the fibroblast cells or that these cells possess a phenotype that has a 
slow rate of initial invasion. Thus longer time point images would be needed to confirm 
the extent of invasion.   
HDF, FSF and MRC-5 fibroblast cells were co-cultured with either H1299, MDA-48 
and VB6 cancer cells (Figure 3.13 – Figure 3.15) and imaged 72 hours post seeding. 
Data revealed that VB6 cancer cells co-cultured with HDF fibroblasts displayed the 
largest amounts of fibroblast and cancer cell invasion as well as the most amount of 
gel degradation and contraction. 
Overall, these data showed that, the newly developed fluorescent in vitro 3D mini-
organotypic invasion assay permits, live in situ imaging of 3D gels and the assay 
produces measurable changes within 72 hours. Furthermore, image analysis 
provides 3D rendered and smoothened images, along with quantifiable cellular 
invasion data. This will speed up the analysis of mini-organotypic samples compared 
to the lengthy time constraints of the large gels. 
Furthermore, I identified that not only are fibroblasts the leading invasive cell type 
within 3D mini-organotypic gels, in particular HDFs, but also that they can facilitate 
invasion of cancer cells. Thus implying that the stromal fibroblasts are a key element 
in the invasion of certain types of cancers and may facilitate collective cell invasion, 

















Figure 6.1: 3D rendered z-stack of 72 hour time point fluorescently 
labelled HDFs and VB6 cells co-cultured in mini-organotypic gels 
The figure displays 72 hour time point Imaris rendered image of fluorescently 
labelled (CellTracker™ Green) HDFs co-cultured with fluorescently labelled 
(CellTracker™ Red) VB6 cells co-cultured in mini-organotypic gels. A) 72 hour time 
point image of co-culture. HDFs observed as leading invasive cell type followed 
by VB6 cells. B) Enlarged image of VB6 cells closely following behind HDF cells. 








To validate the 24-well fluorescent mini-organotypic invasion assay and examine 
gene silencing effects in 3D; I performed a siRNA SMARTpool library screen using a 
panel of proteases and targeted solely the fibroblast component of the tumour-stroma 
environment. Within the large organotypic gel studies, the tumour cells were 
predominantly the main cell of interest when performing data analysis and deducing 
conclusions. However, here I have chosen to focus on the often neglected fibroblast 
component of the stroma. 
Since its original discovery in the late 90’s (Fire et al., 1998), siRNA technology has 
become a powerful and commonly used tool for silencing the expression of target 
genes in many 2D in vitro siRNA screens (Lee et al., 2015; Rudalska et al., 2014; 
Smolen et al., 2010). Advances in liquid handling automation instruments, microscopy 
imaging platforms and plastics have made 2D siRNA HTS achievable in 384 
(Petrocca et al., 2013) and even 1,536-well microtiter plates (Chung et al., 2010). 
However, all lacking the important significance of the 3D spatial architecture as 
observed in vivo.  
Here, using a small protease target library, I focused on fibroblast component of the 
ECM via a SMARTpool siRNA knockdown. Target and NT siRNA control transfected 
fluorescently labelled HDFs were co-cultured with non-transfected fluorescently 
labelled VB6 cells, plated into mini-organotypic gels and imaged at a 72 hour end 
point. The purpose of this screen was to identify, if any, pooled proteases that show 
change in phenotypic behaviour of fibroblast and cancer cells via LOF screen.  
The results of the siRNA screen (Figure 4.6) identified 16 genes that significantly 
(p<0.05) reduced fibroblast and cancer cell invasion as well as gel contraction, 
relative to a NT siRNA control. Image analysis revealed that fibroblast polarisation 
and changes in morphology were not observed and perhaps somewhat impeded or 
temporarily disengaged, thus, unable to invade through the gels. Therefore, ultimately 
leading to the reduction in cancer cell invasion. Furthermore, gel contraction and 
degradation was not as extensively observed. 
Due to cost and time factors all 16 siRNA hits could not be investigated, thus, five 
siRNA were chosen to pursue and validate based on; (1) their relevance, if any, 
towards cancer progression; (2) their novelty as potential targets and; (3) the 
commercial availability of known working antibodies. The chosen genes of interest 
were CAPN-10, CASP-8, MMP-17, SERPIN-F1 and TMPRSS-13. A repeat 
transfection experiment confirmed that each of the selected siRNA reduced HDF and 




VB6 cell invasion six days post transfection and was confirmed by H&E staining and 
qPCR (Figure 4.8). 
SMARTpool siRNA of a single given gene consists of four siRNA duplexes that have 
been combined together. Thus, the individual siRNA of the five hits were purchased 
to investigate which, if any, of the individual siRNA duplexes provided any insight into 
the activity which contributed to the change in phenotypic behaviour. 
The knockdown of CAPN-10 (Figure 4.9), CASP-8 (Figure 4.10) and SERPIN-F1 
(Figure 4.12) individual siRNA in HDF cells decreased the number of polarising and 
invading HDF cells and reduction in gel height relative to a NT siRNA control. 
However, the individual siRNA of MMP-17 (constituent numbers one and two) (Figure 
4.11) and TMPRSS-13 (constituent numbers 1 and 4) (Figure 4.13) significantly 
(p<0.05) showed limited change in gel height possible suggesting reduced gel 
degradation and contraction, as well as displaying reduced levels of HDF and VB6 
cell invasion relative to a NT siRNA control. Therefore MMP-17 and TMPRSS-13 
were further investigated. Western blotting confirmed reduction in protein level 
expression for MMP-17 (Figure 4.15). However, reduction in the protein expression 
of TMPRSS-13 was not observed via western blot. It is possible that the antibody 
used was not specific for TMPRSS-13 and would require further testing of other 
reagents. Further investigation included antibody staining on tissue sections, 
however, the results displayed large areas of non-specific staining and was not 
conclusive. Therefore alternative reagents would need to be identified and tested. 
The mechanism of how MMP-17 and TMPRSS-13 knockdown in HDFs reduced 
cancer and fibroblast cell invasion still needs to be identified. 
In summary in vitro 3D fluorescent mini-organotypic invasion assay provided a 
reliable and repeatable method to perform a LOF siRNA screen via measurement of 
invasive depth. However, Imaris XT image analysis generated data for other 
measureable parameters from both cell types, such as volume, sphericity, and 
elipticity. These high-content phenotypic parameters may also be useful in providing 
information regarding fibroblast and cancer cell behaviour in 3D mini-organotypic 
gels. 
With the use of a custom designed MatLab® algorithm (Appendix 7.16), phenotypic 
data of both cell types were extracted, organised and plotted to produce graphical 
plots for invasion vs sphericity of NT siRNA control samples (Figure 4.17A) and 
MMP-10 transfected HDF samples (Figure 4.17B). The data revealed that the leading 
invasive cells (mainly the HDFs) have a spherical value between 0.5-0.9. Suggesting 




that in order to invade through the gels, the cells maybe slightly less spherical and 
possess a flatter shape. Invading VB6 cells display a similar range of spherical values 
suggesting that they may also change shape slightly if they are to migrate into and 
through the channel created by the HDFs. Resting VB6 cells (those at the surface of 
the gel) display a broad range of spherical values ranging from 0.4-1.0. Further 
MatLab® analysis was performed on the five SMARTpool selected siRNA hits; 
Invasion vs sphericity (Figure 4.18), Invasion vs volume (Figure 4.19) and invasion 
vs elipticity (oblate and prolate) (Figure 4.20). Data revealed that not only do smaller 
volume, but also, less oblate and more prolate shaped cells invade further into 
organotypic gels. 
Overall, with the use of a novel in vitro 3D fluorescent mini-organotypic invasion assay 
and image analysis, I have performed and validated a siRNA screen that identified 16 
SMARTpool hit proteases which significantly reduced cancer and fibroblast cell 
invasion. Further investigation revealed that two of these hits significantly reduced 
invasion when performing a validation screen using the individual siRNA. 
Furthermore, with the aid of MatLab® we have shown that this assay can provide 3D 
high-content multi-parametric data analysis. Thus further increasing the rate of result 
delivery and making this assay format a relatively easy 3D invasion assay for other 
laboratories to use. 
The need to identify potential therapeutic targets using in vitro 3D HTS platforms has 
become increasingly more desirable within drug discovery (Mayr and Fuerst, 2008). 
Academic and industrial labs are developing 3D HTS assays which they feel can 
provide a suitable in vitro-like model. Here, I presented two potential HTS models that 
can be adopted by both academia and industry to perform HTS drug or gene 
screening in a 3D physiomimetic in vitro organotypic based model.  
The 96-Transwell® insert micro-organotypic invasion assay has revealed similarities 
in invasive behaviour of VB6 and HDF cells and also shown to be more cost efficient 
than its 24-well counterpart. With oval shaped wells, for ease of medium exchange 
via integration with liquid handling systems and barcoded plates, this assay format 
would be fully supported on an automated platform. However working manually with 
this format was cumbersome. 
The 96-well reverse assay, provides a simpler assay format which requires less 
preparation time and is more cost efficient than the 96-Transwell® method. Here I 
have shown that both assays can be performed manually from preparation to data 




analysis, however going forward the 96-well reverse assay would be a more cost 
efficient model to use but it still requires further optimisation. 
Despite these reservation, to investigate whether the 96-well reverse invasion assay 
could be used to; (1) perform a manually prepared drug screen; (2) deliver high-
content multi-parameter data analysis; (3) be integrated into a robotic imaging 
system. I performed a manual  small preliminary drug screen consisting of an ALK5, 
ERK and MEK inhibitors as well as two known MMP inhibitors (Doxycycline 
(Stechmiller et al., 2010)  and Marimastat, which has been reported to prevent 
fibroblast-mediated collagen contraction (Scott et al., 1998).  
The experiment, which took place in August 2017 at AstraZeneca (Cambridge) 
involved the manual preparation of organotypic gels containing transiently labelled 
fluorescent HDFs and VB6 cells. 24-hours post seeding compound dosing was 
performed automatically using a Bravo™ Velocity 11 liquid handling platform (Agilent, 
USA) before being incubated in an automated microplate carousel incubator 
(SteriStore, HighRes biosolutions, USA). 24-hours post drug dosing, plates were 
imaged automatically using a high-content screening confocal microscope system 
(Cell Voyager 7000 (CV7000), Yokogawa, Japan) (Figure 6.2). 
 Overall the process of plate preparation was the most time consuming aspect, 
compound dosing was quick and automated plate imaging was even more rapid. A z-
stack of one well, with four field of views, containing a 500µm gel in three colours took 
approximately between 1-2 minute to scan. Unfortunately the experiment 
experienced some technical issues and even though high-content data were 
captured, complete analysis could not be completed. However the most important 
aspect is that the 96-well reverse assay can deliver high-content data for multi-
parameter analysis aided by integration into an automated screening and imaging 
platforms.  
















£137 100,000 100-120µl 
CLSM 710 – 20-23 mins 
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Figure 6.2: CV7000 – high content screening automated confocal 
scanner unit 
A) CV7000 main confocal scanning unit, temperature and CO2, controlled with 
built-in liquid handler to enable long term live cell image and rapid kinetic analysis. 
B) CV7000 set up at AstraZeneca. Integrated with SteriStore microplate incubator 
and plate hotel with loading robotic arm. Images provided by AstraZeneca. 
 




My studies have allowed me to develop a novel and robust in vitro fluorescent 3D 
mini-organotypic invasion assay which can be used to perform siRNA screens and 
produce quantitative high-content phenotypic data for analysis. Furthermore, the 
miniaturisation has produced two smaller assays which can be integrated into a HTS 
platform. However there are several experiment that could be addressed to further 
validate this work: 
1) Introduction of CAFs into the organotypic invasion assays order to further assess 
cancer and fibroblast cell invasion, but also to mimic more closely the tumour-stromal 
microenvironment. While the HDFs probably behaved has CAFs (high invasive) they 
were not derived from a tumour. 
2) Gel contraction assays with fibroblast and cancer cell combinations, in the 
presence of pan-protease inhibitors may help to identify how much reduction in gel 
size is due to physical contraction by cells versus enzyme destruction. 
3) To examine organotypic gel degradation and invasion of cancer and fibroblast 
cells, future work should involve the use of fluorescent collagen or second-harmonic 
imaging. Additionally, regular imaging of the gels (every few hours rather than once 
per day) via confocal or spinning disk microscopy, to understand the dynamic 
changes in collagen: Matrigel® gel remodelling. 
4) To confirm the value of MMP-17 and TMPRSS-13 as targets for suppressing the 
pro-invasive activity of HDFs, these genes should be knocked-down in a series of 
CAFs from multiple cancers within the fluorescent 3D organotypic model described 
here. Furthermore, we could make cell line models which contain a more efficient 
knockdown of MMP-17 and TMPRSS-13. Thus future work may involve the 
development CRISPR-Cas9 cell lines. 
5) The mechanisms of MMP-17 and TMPRSS-13 suppression of fibroblast and thus 
cancer cell invasion are not known. It is not established whether degradation of one 
or more proteins in the extracellular collagen: Matrigel® matrix is the target, or a 
consequence of siRNA knockdown within some other aspect of the fibroblast biology 
is affected. Some groups have established mass spectrometry methods for identifying 
protease degradome (Butler et al., 2009; Shen et al., 2012) and such studies may 
determine if the target is extracellular. We could perform mass spectrometry protease 
degradome analysis to identify the specific targets of MMP-17 and TMPRSS-13. 
 




Advances in 3D culturing systems have enabled rapid development of an array of 
new in vitro tumour models and also variations of existing traditional models, through 
new innovations (detailed in Section 1.3). 3D models can partly recapitulate the in 
vivo tumour-stromal microenvironment, thus having the potential to reduce the 
number of animal experiments. In 2013 the EU banned the use of animal models 
within the cosmetics industry and experts stated that it would take at least 7-10 years 
to replace the current in vivo animal tests (Leist et al., 2014). Thus driving engineers 
and researchers to innovate new in vitro 3D modelling techniques. 
To summarise, I have developed an in vitro 3D fluorescent organotypic invasion 
assay that not only mimics the in vivo tumour-stromal microenvironment and allows 
live in situ imaging of fluorescently labelled cell populations, but also produces 
quantitative multi-parametric data. The assay was used to perform a siRNA library 
screen and revealed promising avenues for potentially new therapeutic targets. 
Furthermore, the assay was miniaturised in to two different assay methods, having 
the potential to be suitable for higher-throughput studies of drug and gene therapies 
within academia and industry.  
As no 3D in vitro assay can ever fully mimic the in vivo host environment; I believe 
the assays developed in this study provide an affordable and reliable model to 
produce a clearer insight to the early stages of cancer metastasis by means of 
targeting the stromal fibroblasts in order to reduce cancer cell invasion and migration. 
The assay can be used to rapidly identify potential targets and may be considered a 
positive aspect of the 3Rs (reduction, replacement, refinement) for in vivo studies. I 
believe the next generation of in vitro models will need to incorporate infiltrating cells 
from the innate and immune systems to move closer to mimicking the true in vivo 
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Appendix Figure 7.1: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with NT siRNA control, 
CAPN-5, MMP-15, CASP-4 and CASP-8 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels  
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, CAPN-
5, MMP-15, CASP-4 and CASP-8 SMARTpool siRNA (20nM), co-cultured with 
fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained via 
CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
  











Appendix Figure 7.2: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
SERPIN-E1, MMP-3, CAPN-10 and CASP-1 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, SERPIN-
E1, MMP-3, CAPN-10 and CASP-1 SMARTpool siRNA (20nM), co-cultured with 
fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained via 
CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.3: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
CASP-9, MMP-7, MMP-19 and SHH SMARTpool siRNA co-cultured 
with fluorescently labelled VB6 cells in mini-organotypic gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, CASP-
9, MMP-7, MMP-19 and SHH SMARTpool siRNA (20nM), co-cultured with 
fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained via 
CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.4: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
CAPN-11, CASP-10, MMP-1 and MMP-2 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, CAPN-
11, CASP-10, MMP-1 and MMP-2 SMARTpool siRNA (20nM), co-cultured with 
fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained via 
CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.5: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
CASP-14, CAPN-13, MMP-8 and TMPRSS-11A SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, CASP-
14, CAPN-13, MMP-8 and TMPRSS-11A SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.6: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
CASP-6, MMP-10, SERPIN-A1 and TMPRSS-13 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, CASP-
6, MMP-10, SERPIN-A1 and TMPRSS-13 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 











Appendix Figure 7.7: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
MMP-24, CASP-2, TMPRSS-3 and MMP-21 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, MMP-
24, CASP-2, TMPRSS-3 and MMP-21 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.8: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
MMP-20, TMPRSS-2, CAPN-3 and CASP-3 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, MMP-
20, TMPRSS-2, CAPN-3 and CASP-3 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.9: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
MMP-12, CAPN-2, SERPIN-A3 and MMP-11 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, MMP-
12, CAPN-2, SERPIN-A3 and MMP-11 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.10: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
MMP-17, MMP-13, MMP-25 and CAPN-1 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, MMP-
17, MMP-13, MMP-25 and CAPN-1 SMARTpool siRNA (20nM), co-cultured with 
fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained via 
CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.11: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
SERPIN-B12, TMPRSS-4, CAPN-6 and CASP-5 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, SERPIN-
B12, TMPRSS-4, CAPN-6 and CASP-5 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.12: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
MMP-14, MMP-26, SERPIN-B2 and TMPRSS-5 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, MMP-
14, MMP-26, SERPIN-B2 and TMPRSS-5 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.13: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
CAPN-7, MMP-9, CAPNS-1 and MMP-27 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, CAPN-
7, MMP-9, CAPNS-1 and MMP-27 SMARTpool siRNA (20nM), co-cultured with 
fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained via 
CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 











Appendix Figure 7.14: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
SERPIN-D1, TMPRSS-6, CAPN-9 and CASP-7 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, SERPIN-
D1, TMPRSS-6, CAPN-9 and CASP-7 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
 
  











Appendix Figure 7.15: Primary SMARTpool siRNA screen; 
fluorescently labelled HDFs transfected with a NT siRNA control, 
MMP-16, MMP-28, SERPIN-F1 and TMPRSS-9 SMARTpool siRNA co-
cultured with fluorescently labelled VB6 cells in mini-organotypic 
gels 
3D Imaris rendered z-stacks of mini-organotypic gels containing fluorescently 
labelled HDFs (CellTracker™ Green) transfected with NT siRNA control, MMP-
16, MMP-28, SERPIN-F1 and TMPRSS-9 SMARTpool siRNA (20nM), co-cultured 
with fluorescently labelled VB6 cells (CellTracker™ Red). Z-stacks were obtained 
via CLSM 72 hours post seeding (six days post transfection). One representative 
image of triplicate gels belonging to one independent experiment. 
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7.2 MatLab® algorithm for high-content multi-parameter analysis 
 
//multi-parameter analysis algorithm  
 
function [ContGreenOut,ContRedOut,IDgrOut,IDreOut]= CompPlot( 
input1,input2 ) 
% Scatter plots of siRNA transfected HDF cells and non-treated VB6  
cancer cells and non targeting siRNA control 
% input1 and input2 are the choice of filter 
% the choices are in order: 
%   Area, Elipticity_(oblate), Elipticity_(prolate),Invasion, 
Sphericity, Volume, 
%  The outputs are the from the plots 
close all 
 
d = '*.csv'; %find csvs in directory 
D = dir(d); 
Key = {'Area', 'Elipticity (oblate)', 'Elipticity (prolate)', 
'Sphericity', 'Volume', 'Invasion'}; %Names of the filters 
 
%% Find the names of the compounds 
for i = 1:size(D,1) 
    place = regexp(D(i).name,'(','split'); %Split the name 
    place = place(:,1); 
    DD(i) = cellstr(place); %Save names in cells 
end 
C = unique(DD); %Find the unique names 
 
%% Get the control data 
index = strfind(C,'Control'); 
idx = find(not(cellfun('isempty', index)));  
C(idx) = []; %Remove it from consideration of comparison 
 
ContGreen = csvread('Control(green).csv'); %Load in controls 
ContRed = csvread('Control(red).csv'); 
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K1 = char(Key(:,input1)); %Find first filter 
K2 = char(Key(:,input2)); %Find first filter 
 
%% Get data and plot scatter graphs 
for j = 1:size(C,2) 
    %Get name of compound and find file 
    e = char(C(j)); 
    f = sprintf('%s*.csv',e); 
    F = dir(f); 
 
    %Load in green and red data 
    gr = sprintf('%s(green).csv',e); 
    re = sprintf('%s(red).csv',e); 
    IDgr = csvread(gr); 
    IDre = csvread(re); 
 
    %Plot red and green compound vs red and green control 
    figure(j) 
    scatter(IDgr(:,input1),IDgr(:,input2),'g') 
    hold on 
    scatter(IDre(:,input1),IDre(:,input2),'r') 
    scatter(ContGreen(:,input1),ContGreen(:,input2),'x','g') 
    scatter(ContRed(:,input1),ContRed(:,input2),'x','r') 
 
    %Label plot 
    CompNameG = sprintf('%s Green',e); 
    CompNameR = sprintf('%s Red',e); 
    legend(CompNameG,CompNameR,'Control Green','Control Red') 
    lh=findall(gcf,'tag','legend'); 
    set(lh,'location','northeastoutside'); 
    title(e) 
    xlabel(Key(:,input1)) 
    ylabel(Key(:,input2)) 
 
    %Save plot 
    Name = sprintf('%s (%s Vs %s).png',e,K1,K2); 
    fName = sprintf('-f%d',j); 
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    print(fName,Name,'-dpng') 
end 
ContGreenOut = ContGreen(:,[input1,input2]); 
ContRedOut = ContRed(:,[input1,input2]); 
IDgrOut = IDgr(:,[input1,input2]); 
IDreOut = IDre(:,[input1,input2]); 
end 
 
Appendix Figure 7.16: MatLab® multi-parameter analysis algorithm  
Raw .lsm CLSM z-stacks were rendered and analysed using Imaris XT. Distance 
Transformation analysis generated .csv data files for a variety of measureable 
parameters.  A ‘multi-parameter analysis algorithm’ was created and used to 
extract and plot invasion, sphericity, volume and elipticity (prolate and oblate) via 
MatLab®. The customised algorithm was developed in collaboration with Joseph 
Brook, who wrote the algorithm. 
 




Abbud-Antaki, R.A., Marhefka, J.N., DeLuca, A.L., and Zuromskis, M.P. (2012). The 
Cancer BioChip System: a functional genomic assay for anchorage-independent 
three-dimensional breast cancer cell growth. Horm Cancer 3, 261-270. 
Acker, H., Carlsson, J., Mueller-Klieser, W., and Sutherland, R.M. (1987). 
Comparative pO2 measurements in cell spheroids cultured with different techniques. 
Br J Cancer 56, 325-327. 
Adachi, Y., Yamamoto, H., Itoh, F., Hinoda, Y., Okada, Y., and Imai, K. (1999). 
Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal 
cancers. Gut 45, 252-258. 
Adzhubei, A.A., Sternberg, M.J., and Makarov, A.A. (2013). Polyproline-II helix in 
proteins: structure and function. J Mol Biol 425, 2100-2132. 
Agrawal, N., Dasaradhi, P.V., Mohmmed, A., Malhotra, P., Bhatnagar, R.K., and 
Mukherjee, S.K. (2003). RNA interference: biology, mechanism, and applications. 
Microbiol Mol Biol Rev 67, 657-685. 
Ahmed, E.M. (2015). Hydrogel: Preparation, characterization, and applications: A 
review. J Adv Res 6, 105-121. 
Al-Bahlani, S.M., Al-Rashdi, R.M., Kumar, S., Al-Sinawi, S.S., Al-Bahri, M.A., and 
Shalaby, A.A. (2017). Calpain-1 Expression in Triple-Negative Breast Cancer: A 
Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index. Biomed 
Res Int 2017, 9290425. 
Alberts, B., Johnson, A., and Lewis, J. (2002). Molecular Biology of the Cell. 4th 
Edition - The Extracellular Matrix of Animals, 4th edn (Garlend Science). 
Albini, A., and Benelli, R. (2007). The chemoinvasion assay: a method to assess 
tumor and endothelial cell invasion and its modulation. Nat Protoc 2, 504-511. 
Alexander, C.M., Howard, E.W., Bissell, M.J., and Werb, Z. (1996). Rescue of 
mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of 
metalloproteinases-1 transgene. The Journal of cell biology 135, 1669-1677. 
Alexander, S., Koehl, G.E., Hirschberg, M., Geissler, E.K., and Friedl, P. (2008). 
Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. 
Histochem Cell Biol 130, 1147-1154. 
Allen, M.D., Thomas, G.J., Clark, S., Dawoud, M.M., Vallath, S., Payne, S.J., Gomm, 
J.J., Dreger, S.A., Dickinson, S., Edwards, D.R., et al. (2014). Altered 
microenvironment promotes progression of preinvasive breast cancer: myoepithelial 
expression of alphavbeta6 integrin in DCIS identifies high-risk patients and predicts 
recurrence. Clin Cancer Res 20, 344-357. 
Allocca, G., Kusumbe, A.P., Ramasamy, S.K., and Wang, N. (2016). Confocal/two-
photon microscopy in studying colonisation of cancer cells in bone using xenograft 
mouse models. BoneKEy Rep 5. 
Alshamsan, A., Haddadi, A., Incani, V., Samuel, J., Lavasanifar, A., and Uludag, H. 
(2009). Formulation and delivery of siRNA by oleic acid and stearic acid modified 
polyethylenimine. Mol Pharm 6, 121-133. 
Chapter VIII: References 
288 
 
Amann, A., Zwierzina, M., Gamerith, G., Bitsche, M., Huber, J.M., Vogel, G.F., 
Blumer, M., Koeck, S., Pechriggl, E.J., Kelm, J.M., et al. (2014). Development of an 
innovative 3D cell culture system to study tumour--stroma interactions in non-small 
cell lung cancer cells. PloS one 9, e92511. 
Andersen, T., Auk-Emblem, P., and Dornish, M. (2015). 3D Cell Culture in Alginate 
Hydrogels. Microarrays (Basel) 4, 133-161. 
Anlar, B., and Gunel-Ozcan, A. (2012). Tenascin-R: role in the central nervous 
system. Int J Biochem Cell Biol 44, 1385-1389. 
Artym, V.V., Zhang, Y., Seillier-Moiseiwitsch, F., Yamada, K.M., and Mueller, S.C. 
(2006). Dynamic interactions of cortactin and membrane type 1 matrix 
metalloproteinase at invadopodia: defining the stages of invadopodia formation and 
function. Cancer Res 66, 3034-3043. 
Ashworth, T. (1869). A case of cancer in which cells similar to those in the tumors 
were seen in the blood after death. Australian Medical Journal 14, 146-149. 
Astrof, S., Crowley, D., and Hynes, R.O. (2007). Multiple cardiovascular defects 
caused by the absence of alternatively spliced segments of fibronectin. Dev Biol 311, 
11-24. 
Aumailley, M., Bruckner-Tuderman, L., Carter, W.G., Deutzmann, R., Edgar, D., 
Ekblom, P., Engel, J., Engvall, E., Hohenester, E., Jones, J.C., et al. (2005). A 
simplified laminin nomenclature. Matrix biology : journal of the International Society 
for Matrix Biology 24, 326-332. 
Baker, B.M., and Chen, C.S. (2012). Deconstructing the third dimension: how 3D 
culture microenvironments alter cellular cues. J Cell Sci 125, 3015-3024. 
Baraniak, P.R., and McDevitt, T.C. (2012). Scaffold-free culture of mesenchymal 
stem cell spheroids in suspension preserves multilineage potential. Cell Tissue Res 
347, 701-711. 
Barbero, S., Mielgo, A., Torres, V., Teitz, T., Shields, D.J., Mikolon, D., Bogyo, M., 
Barila, D., Lahti, J.M., Schlaepfer, D., et al. (2009). Caspase-8 association with the 
focal adhesion complex promotes tumor cell migration and metastasis. Cancer Res 
69, 3755-3763. 
Barczyk, M., Carracedo, S., and Gullberg, D. (2010). Integrins. Cell Tissue Res 339, 
269-280. 
Barsky, S.H., Rao, C.N., Grotendorst, G.R., and Liotta, L.A. (1982). Increased content 
of Type V Collagen in desmoplasia of human breast carcinoma. Am J Pathol 108, 
276-283. 
Basset, P., Bellocq, J.P., Wolf, C., Stoll, I., Hutin, P., Limacher, J.M., Podhajcer, O.L., 
Chenard, M.P., Rio, M.C., and Chambon, P. (1990). A novel metalloproteinase gene 
specifically expressed in stromal cells of breast carcinomas. Nature 348, 699-704. 
Bauer, J.A., Ye, F., Marshall, C.B., Lehmann, B.D., Pendleton, C.S., Shyr, Y., 
Arteaga, C.L., and Pietenpol, J.A. (2010). RNA interference (RNAi) screening 
approach identifies agents that enhance paclitaxel activity in breast cancer cells. 
Breast Cancer Res 12, R41. 
Baum, J., and Duffy, H.S. (2011). Fibroblasts and myofibroblasts: what are we talking 
about? J Cardiovasc Pharmacol 57, 376-379. 
Chapter VIII: References 
289 
 
Bell, E., Ehrlich, H.P., Buttle, D.J., and Nakatsuji, T. (1981). Living tissue formed in 
vitro and accepted as skin-equivalent tissue of full thickness. Science 211, 1052-
1054. 
Bell, E., Ivarsson, B., and Merrill, C. (1979). Production of a tissue-like structure by 
contraction of collagen lattices by human fibroblasts of different proliferative potential 
in vitro. Proc Natl Acad Sci U S A 76, 1274-1278. 
Bell, E.M., C; Solomon, D (1979). characteristics of a tissue equivalent formed by 
fibroblasts cast in a collagen gel. Journal of Cell Biology 83. 
Benam, K.H., Villenave, R., Lucchesi, C., Varone, A., Hubeau, C., Lee, H.H., Alves, 
S.E., Salmon, M., Ferrante, T.C., Weaver, J.C., et al. (2016). Small airway-on-a-chip 
enables analysis of human lung inflammation and drug responses in vitro. Nat 
Methods 13, 151-157. 
Bernerd, F., and Asselineau, D. (2008). An organotypic model of skin to study 
photodamage and photoprotection in vitro. J Am Acad Dermatol 58, S155-159. 
Bertoli, C., Copetti, T., Lam, E.W., Demarchi, F., and Schneider, C. (2009). Calpain 
small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A. Oncogene 28, 
721-733. 
Bhadriraju, K., and Chen, C.S. (2002). Engineering cellular microenvironments to 
improve cell-based drug testing. Drug Discov Today 7, 612-620. 
Bhise, N.S., Ribas, J., Manoharan, V., Zhang, Y.S., Polini, A., Massa, S., Dokmeci, 
M.R., and Khademhosseini, A. (2014). Organ-on-a-chip platforms for studying drug 
delivery systems. J Control Release 190, 82-93. 
Bialkowska, A.B., and Yang, V.W. (2012). High-throughput screening strategies for 
targeted identification of therapeutic compounds in colorectal cancer. Future Oncol 8, 
259-272. 
Bissell, M.J., and Hines, W.C. (2011). Why don't we get more cancer? A proposed 
role of the microenvironment in restraining cancer progression. Nat Med 17, 320-329. 
Bissell, M.J., Rizki, A., and Mian, I.S. (2003). Tissue architecture: the ultimate 
regulator of breast epithelial function. Curr Opin Cell Biol 15, 753-762. 
Bledzka, K., Liu, J., Xu, Z., Perera, H.D., Yadav, S.P., Bialkowska, K., Qin, J., Ma, 
Y.Q., and Plow, E.F. (2012). Spatial coordination of kindlin-2 with talin head domain 
in interaction with integrin beta cytoplasmic tails. The Journal of biological chemistry 
287, 24585-24594. 
Bohn, K.A., Adkins, C.E., Nounou, M.I., and Lockman, P.R. (2017). Inhibition of VEGF 
and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden. Front 
Pharmacol 8, 193. 
Boolell, M., Allen, M.J., Ballard, S.A., Gepi-Attee, S., Muirhead, G.J., Naylor, A.M., 
Osterloh, I.H., and Gingell, C. (1996). Sildenafil: an orally active type 5 cyclic GMP-
specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. 
Int J Impot Res 8, 47-52. 
Bosse, Y., Postma, D.S., Sin, D.D., Lamontagne, M., Couture, C., Gaudreault, N., 
Joubert, P., Wong, V., Elliott, M., van den Berge, M., et al. (2012). Molecular signature 
of smoking in human lung tissues. Cancer Res 72, 3753-3763. 
Chapter VIII: References 
290 
 
Boukamp, P., Tilgen, W., Dzarlieva, R.T., Breitkreutz, D., Haag, D., Riehl, R.K., 
Bohnert, A., and Fusenig, N.E. (1982). Phenotypic and genotypic characteristics of a 
cell line from a squamous cell carcinoma of human skin. J Natl Cancer Inst 68, 415-
427. 
Bourdon, M.A., Wikstrand, C.J., Furthmayr, H., Matthews, T.J., and Bigner, D.D. 
(1983). Human glioma-mesenchymal extracellular matrix antigen defined by 
monoclonal antibody. Cancer Res 43, 2796-2805. 
Boyden, S. (1962). The chemotactic effect of mixtures of antibody and antigen on 
polymorphonuclear leucocytes. J Exp Med 115, 453-466. 
Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L.A., 
Knuechel, R., and Kirchner, T. (2001). Variable beta-catenin expression in colorectal 
cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad 
Sci U S A 98, 10356-10361. 
Brandenburger, M., Wenzel, J., Bogdan, R., Richardt, D., Nguemo, F., Reppel, M., 
Hescheler, J., Terlau, H., and Dendorfer, A. (2012). Organotypic slice culture from 
human adult ventricular myocardium. Cardiovasc Res 93, 50-59. 
Brandish, P.E., Chiu, C.S., Schneeweis, J., Brandon, N.J., Leech, C.L., Kornienko, 
O., Scolnick, E.M., Strulovici, B., and Zheng, W. (2006). A cell-based ultra-high-
throughput screening assay for identifying inhibitors of D-amino acid oxidase. J 
Biomol Screen 11, 481-487. 
Bray, F., and Soerjomataram, I. (2015). The Changing Global Burden of Cancer: 
Transitions in Human Development and Implications for Cancer Prevention and 
Control. In Cancer: Disease Control Priorities, Third Edition (Volume 3), H. Gelband, 
P. Jha, R. Sankaranarayanan, and S. Horton, eds. (Washington (DC)). 
Breslin, S., and O'Driscoll, L. (2013). Three-dimensional cell culture: the missing link 
in drug discovery. Drug Discov Today 18, 240-249. 
Brew, K., and Nagase, H. (2010). The tissue inhibitors of metalloproteinases (TIMPs): 
an ancient family with structural and functional diversity. Biochim Biophys Acta 1803, 
55-71. 
Brock, A., Chang, E., Ho, C.C., LeDuc, P., Jiang, X., Whitesides, G.M., and Ingber, 
D.E. (2003). Geometric determinants of directional cell motility revealed using 
microcontact printing. Langmuir 19, 1611-1617. 
Bryant, S.J., and Anseth, K.S. (2002). Hydrogel properties influence ECM production 
by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed 
Mater Res 59, 63-72. 
Buchser, W., Collins, M., Garyantes, T., Guha, R., Haney, S., Lemmon, V., Li, Z., and 
Trask, O.J. (2004). Assay Development Guidelines for Image-Based High Content 
Screening, High Content Analysis and High Content Imaging. In Assay Guidance 
Manual, G.S. Sittampalam, N.P. Coussens, K. Brimacombe, A. Grossman, M. Arkin, 
D. Auld, C. Austin, J. Baell, B. Bejcek, T.D.Y. Chung, et al., eds. (Bethesda (MD)). 
Buffery, D. (2015). The 2015 Oncology Drug Pipeline: Innovation Drives the Race to 
Cure Cancer. Am Health Drug Benefits 8, 216-222. 
 
Chapter VIII: References 
291 
 
Burke, J.F., Yannas, I.V., Quinby, W.C., Jr., Bondoc, C.C., and Jung, W.K. (1981). 
Successful use of a physiologically acceptable artificial skin in the treatment of 
extensive burn injury. Ann Surg 194, 413-428. 
Butler, G.S., Dean, R.A., Smith, D., and Overall, C.M. (2009). Membrane protease 
degradomics: proteomic identification and quantification of cell surface protease 
substrates. Methods in molecular biology 528, 159-176. 
Caicedo-Carvajal, C.E., Liu, Q., Remache, Y., Goy, A., and Suh, K.S. (2011). Cancer 
Tissue Engineering: A Novel 3D Polystyrene Scaffold for In Vitro Isolation and 
Amplification of Lymphoma Cancer Cells from Heterogeneous Cell Mixtures. J Tissue 
Eng 2011, 362326. 
Cailleau, R., Olive, M., and Cruciger, Q.V. (1978). Long-term human breast 
carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911-
915. 
Cairns, D.M., Chwalek, K., Moore, Y.E., Kelley, M.R., Abbott, R.D., Moss, S., and 
Kaplan, D.L. (2016). Expandable and Rapidly Differentiating Human Induced Neural 
Stem Cell Lines for Multiple Tissue Engineering Applications. Stem Cell Reports 7, 
557-570. 
Cairns, J. (1975). Mutation selection and the natural history of cancer. Nature 255, 
197-200. 
Camenisch, T.D., Schroeder, J.A., Bradley, J., Klewer, S.E., and McDonald, J.A. 
(2002). Heart-valve mesenchyme formation is dependent on hyaluronan-augmented 
activation of ErbB2-ErbB3 receptors. Nat Med 8, 850-855. 
Carapuca, E.F., Gemenetzidis, E., Feig, C., Bapiro, T.E., Williams, M.D., Wilson, A.S., 
Delvecchio, F.R., Arumugam, P., Grose, R.P., Lemoine, N.R., et al. (2016). Anti-
stromal treatment together with chemotherapy targets multiple signalling pathways in 
pancreatic adenocarcinoma. The Journal of pathology 239, 286-296. 
Carlson, M.W., Alt-Holland, A., Egles, C., and Garlick, J.A. (2008). Three-dimensional 
tissue models of normal and diseased skin. Curr Protoc Cell Biol Chapter 19, Unit 19 
19. 
Carlsson, J., and Acker, H. (1988). Relations between pH, oxygen partial pressure 
and growth in cultured cell spheroids. Int J Cancer 42, 715-720. 
Carpenter, P.M., Dao, A.V., Arain, Z.S., Chang, M.K., Nguyen, H.P., Arain, S., Wang-
Rodriguez, J., Kwon, S.Y., and Wilczynski, S.P. (2009). Motility induction in breast 
carcinoma by mammary epithelial laminin 332 (laminin 5). Mol Cancer Res 7, 462-
475. 
Caswell, P.T., Chan, M., Lindsay, A.J., McCaffrey, M.W., Boettiger, D., and Norman, 
J.C. (2008). Rab-coupling protein coordinates recycling of alpha5beta1 integrin and 
EGFR1 to promote cell migration in 3D microenvironments. The Journal of cell biology 
183, 143-155. 
Caswell, P.T., Spence, H.J., Parsons, M., White, D.P., Clark, K., Cheng, K.W., Mills, 
G.B., Humphries, M.J., Messent, A.J., Anderson, K.I., et al. (2007). Rab25 associates 
with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. 
Dev Cell 13, 496-510. 
 
Chapter VIII: References 
292 
 
Cavallaro, U., and Christofori, G. (2004). Multitasking in tumor progression: signaling 
functions of cell adhesion molecules. Ann N Y Acad Sci 1014, 58-66. 
Chabottaux, V., Sounni, N.E., Pennington, C.J., English, W.R., van den Brule, F., 
Blacher, S., Gilles, C., Munaut, C., Maquoi, E., Lopez-Otin, C., et al. (2006). 
Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and 
metastases. Cancer Res 66, 5165-5172. 
Chambers, A.F., Groom, A.C., and MacDonald, I.C. (2002). Dissemination and 
growth of cancer cells in metastatic sites. Nat Rev Cancer 2, 563-572. 
Chang, H.Y., Nuyten, D.S., Sneddon, J.B., Hastie, T., Tibshirani, R., Sorlie, T., Dai, 
H., He, Y.D., van't Veer, L.J., Bartelink, H., et al. (2005). Robustness, scalability, and 
integration of a wound-response gene expression signature in predicting breast 
cancer survival. Proc Natl Acad Sci U S A 102, 3738-3743. 
Chen, B., Kumar, G., Co, C.C., and Ho, C.C. (2013). Geometric control of cell 
migration. Sci Rep 3, 2827. 
Chen, C.S., Mrksich, M., Huang, S., Whitesides, G.M., and Ingber, D.E. (1997). 
Geometric control of cell life and death. Science 276, 1425-1428. 
Chen, Y.C., and Yoon, E. (2017). High-Throughput Cancer Cell Sphere Formation for 
3D Cell Culture. Methods in molecular biology 1612, 281-291. 
Cheng, M.F., Tzao, C., Tsai, W.C., Lee, W.H., Chen, A., Chiang, H., Sheu, L.F., and 
Jin, J.S. (2006). Expression of EMMPRIN and matriptase in esophageal squamous 
cell carcinoma: correlation with clinicopathological parameters. Dis Esophagus 19, 
482-486. 
Chia, N.Y., Chan, Y.S., Feng, B., Lu, X., Orlov, Y.L., Moreau, D., Kumar, P., Yang, 
L., Jiang, J., Lau, M.S., et al. (2010). A genome-wide RNAi screen reveals 
determinants of human embryonic stem cell identity. Nature 468, 316-320. 
Chiquet-Ehrismann, R. (1995). Tenascins, a growing family of extracellular matrix 
proteins. Experientia 51, 853-862. 
Chiquet-Ehrismann, R., and Tucker, R.P. (2004). Connective tissues: signalling by 
tenascins. Int J Biochem Cell Biol 36, 1085-1089. 
Chitcholtan, K., Sykes, P.H., and Evans, J.J. (2012). The resistance of intracellular 
mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. 
J Transl Med 10, 38. 
Choy, A., and McCulloch, P.G. (1993). Detection and enumeration of circulating 
tumour cells in colorectal cancer. Br J Surg 80, 1490. 
Chung, N., Locco, L., Huff, K.W., Bartz, S., Linsley, P.S., Ferrer, M., and Strulovici, 
B. (2008). An efficient and fully automated high-throughput transfection method for 
genome-scale siRNA screens. J Biomol Screen 13, 142-148. 
Chung, N., Marine, S., Smith, E.A., Liehr, R., Smith, S.T., Locco, L., Hudak, E., 
Kreamer, A., Rush, A., Roberts, B., et al. (2010). A 1,536-well ultra-high-throughput 
siRNA screen to identify regulators of the Wnt/beta-catenin pathway. Assay Drug Dev 
Technol 8, 286-294. 
Clark, A.G., and Vignjevic, D.M. (2015). Modes of cancer cell invasion and the role of 
the microenvironment. Curr Opin Cell Biol 36, 13-22. 
Chapter VIII: References 
293 
 
Coleman, S.J., Chioni, A.M., Ghallab, M., Anderson, R.K., Lemoine, N.R., Kocher, 
H.M., and Grose, R.P. (2014a). Nuclear translocation of FGFR1 and FGF2 in 
pancreatic stellate cells facilitates pancreatic cancer cell invasion. EMBO Mol Med 6, 
467-481. 
Coleman, S.J., Watt, J., Arumugam, P., Solaini, L., Carapuca, E., Ghallab, M., Grose, 
R.P., and Kocher, H.M. (2014b). Pancreatic cancer organotypics: High throughput, 
preclinical models for pharmacological agent evaluation. World J Gastroenterol 20, 
8471-8481. 
Condeelis, J., and Segall, J.E. (2003). Intravital imaging of cell movement in tumours. 
Nat Rev Cancer 3, 921-930. 
Corning (2016). Corning Matrigel Matrix. 
Correia, A.L., and Bissell, M.J. (2012). The tumor microenvironment is a dominant 
force in multidrug resistance. Drug Resist Updat 15, 39-49. 
Cristofanilli, M., Budd, G.T., Ellis, M.J., Stopeck, A., Matera, J., Miller, M.C., Reuben, 
J.M., Doyle, G.V., Allard, W.J., Terstappen, L.W., et al. (2004). Circulating tumor cells, 
disease progression, and survival in metastatic breast cancer. N Engl J Med 351, 
781-791. 
Croft, D.R., Sahai, E., Mavria, G., Li, S., Tsai, J., Lee, W.M., Marshall, C.J., and Olson, 
M.F. (2004). Conditional ROCK activation in vivo induces tumor cell dissemination 
and angiogenesis. Cancer Res 64, 8994-9001. 
Cukierman, E., Pankov, R., Stevens, D.R., and Yamada, K.M. (2001). Taking cell-
matrix adhesions to the third dimension. Science 294, 1708-1712. 
Cukierman, E., Pankov, R., and Yamada, K.M. (2002). Cell interactions with three-
dimensional matrices. Curr Opin Cell Biol 14, 633-639. 
Czauderna, F., Fechtner, M., Dames, S., Aygun, H., Klippel, A., Pronk, G.J., Giese, 
K., and Kaufmann, J. (2003). Structural variations and stabilising modifications of 
synthetic siRNAs in mammalian cells. Nucleic Acids Res 31, 2705-2716. 
Darby, I.A., Laverdet, B., Bonte, F., and Desmouliere, A. (2014). Fibroblasts and 
myofibroblasts in wound healing. Clin Cosmet Investig Dermatol 7, 301-311. 
David, L., Dulong, V., Le Cerf, D., Cazin, L., Lamacz, M., and Vannier, J.P. (2008). 
Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of 
anticancer drug sensitivity. Acta Biomater 4, 256-263. 
Davidson, L.A., and Keller, R.E. (1999). Neural tube closure in Xenopus laevis 
involves medial migration, directed protrusive activity, cell intercalation and 
convergent extension. Development 126, 4547-4556. 
Dawson, D.W., Volpert, O.V., Gillis, P., Crawford, S.E., Xu, H., Benedict, W., and 
Bouck, N.P. (1999). Pigment epithelium-derived factor: a potent inhibitor of 
angiogenesis. Science 285, 245-248. 
De Wever, O., Nguyen, Q.D., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., 
and Mareel, M. (2004). Tenascin-C and SF/HGF produced by myofibroblasts in vitro 
provide convergent pro-invasive signals to human colon cancer cells through RhoA 
and Rac. FASEB J 18, 1016-1018. 
 
Chapter VIII: References 
294 
 
Dean, D.D., Martel-Pelletier, J., Pelletier, J.P., Howell, D.S., and Woessner, J.F., Jr. 
(1989). Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in 
human osteoarthritic cartilage. J Clin Invest 84, 678-685. 
Degen, M., Brellier, F., Kain, R., Ruiz, C., Terracciano, L., Orend, G., and Chiquet-
Ehrismann, R. (2007). Tenascin-W is a novel marker for activated tumor stroma in 
low-grade human breast cancer and influences cell behavior. Cancer Res 67, 9169-
9179. 
Degen, M., Brellier, F., Schenk, S., Driscoll, R., Zaman, K., Stupp, R., Tornillo, L., 
Terracciano, L., Chiquet-Ehrismann, R., Ruegg, C., et al. (2008). Tenascin-W, a new 
marker of cancer stroma, is elevated in sera of colon and breast cancer patients. Int 
J Cancer 122, 2454-2461. 
Denis Semwogerere, E.R.W. (2005). Confocal Microscopy (Taylor & Francis). 
DeVolder, R., and Kong, H.J. (2012). Hydrogels for in vivo-like three-dimensional 
cellular studies. Wiley Interdiscip Rev Syst Biol Med 4, 351-365. 
Di, Z., Klop, M.J., Rogkoti, V.M., Le Devedec, S.E., van de Water, B., Verbeek, F.J., 
Price, L.S., and Meerman, J.H. (2014). Ultra high content image analysis and 
phenotype profiling of 3D cultured micro-tissues. PloS one 9, e109688. 
Doggett, D.L., Rotenberg, M.O., Pignolo, R.J., Phillips, P.D., and Cristofalo, V.J. 
(1992). Differential gene expression between young and senescent, quiescent WI-38 
cells. Mech Ageing Dev 65, 239-255. 
Downer, C.S., Watt, F.M., and Speight, P.M. (1993). Loss of alpha 6 and beta 4 
integrin subunits coincides with loss of basement membrane components in oral 
squamous cell carcinomas. The Journal of pathology 171, 183-190. 
Dragu, D.L., Necula, L.G., Bleotu, C., Diaconu, C.C., and Chivu-Economescu, M. 
(2015). Therapies targeting cancer stem cells: Current trends and future challenges. 
World J Stem Cells 7, 1185-1201. 
Dreher, F., Patouillet, C., Fouchard, F., Zanini, M., Messager, A., Roguet, R., Cottin, 
M., Leclaire, J., and Benech-Kieffer, F. (2002). Improvement of the experimental 
setup to assess cutaneous bioavailability on human skin models: dynamic protocol. 
Skin Pharmacol Appl Skin Physiol 15 Suppl 1, 31-39. 
Dull, T., Zufferey, R., Kelly, M., Mandel, R.J., Nguyen, M., Trono, D., and Naldini, L. 
(1998). A third-generation lentivirus vector with a conditional packaging system. J 
Virol 72, 8463-8471. 
Dvorak, H.F. (1986). Tumors: wounds that do not heal. Similarities between tumor 
stroma generation and wound healing. N Engl J Med 315, 1650-1659. 
Dvorak, H.F. (2015). Tumors: wounds that do not heal-redux. Cancer Immunol Res 
3, 1-11. 
Dvorak, H.F., Dvorak, A.M., Manseau, E.J., Wiberg, L., and Churchill, W.H. (1979). 
Fibrin gel investment associated with line 1 and line 10 solid tumor growth, 
angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, 
myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. J 
Natl Cancer Inst 62, 1459-1472. 
 
Chapter VIII: References 
295 
 
Edmondson, R., Broglie, J.J., Adcock, A.F., and Yang, L. (2014). Three-dimensional 
cell culture systems and their applications in drug discovery and cell-based 
biosensors. Assay Drug Dev Technol 12, 207-218. 
Egeblad, M., Littlepage, L.E., and Werb, Z. (2005). The fibroblastic coconspirator in 
cancer progression. Cold Spring Harb Symp Quant Biol 70, 383-388. 
Egeblad, M., and Werb, Z. (2002). New functions for the matrix metalloproteinases in 
cancer progression. Nat Rev Cancer 2, 161-174. 
Ehrbar, M., Sala, A., Lienemann, P., Ranga, A., Mosiewicz, K., Bittermann, A., Rizzi, 
S.C., Weber, F.E., and Lutolf, M.P. (2011). Elucidating the role of matrix stiffness in 
3D cell migration and remodeling. Biophys J 100, 284-293. 
Ehrlich, H.P., and Hunt, T.K. (2012). Collagen Organization Critical Role in Wound 
Contraction. Adv Wound Care (New Rochelle) 1, 3-9. 
Elbashir, S.M., Lendeckel, W., and Tuschl, T. (2001). RNA interference is mediated 
by 21- and 22-nucleotide RNAs. Genes Dev 15, 188-200. 
Erickson, H.P. (1993). Tenascin-C, tenascin-R and tenascin-X: a family of talented 
proteins in search of functions. Curr Opin Cell Biol 5, 869-876. 
Eves, P., Layton, C., Hedley, S., Dawson, R.A., Wagner, M., Morandini, R., Ghanem, 
G., and Mac Neil, S. (2000). Characterization of an in vitro model of human melanoma 
invasion based on reconstructed human skin. Br J Dermatol 142, 210-222. 
Ewing, J. (1928). Neoplastic Diseases: A Treatise on Tumours.   Third edition. Royal 
8vo. Pp. 1127, with 546 illustrations. 1928. Philadelphia and London: W. B. Saunders 
Co. Ltd. 63s. net. British Journal of Surgery 16, 174-175. 
Falkenberg, K.J., Gould, C.M., Johnstone, R.W., and Simpson, K.J. (2014). Genome-
wide functional genomic and transcriptomic analyses for genes regulating sensitivity 
to vorinostat. Sci Data 1, 140017. 
Fayard, B., Bianchi, F., Dey, J., Moreno, E., Djaffer, S., Hynes, N.E., and Monard, D. 
(2009). The serine protease inhibitor protease nexin-1 controls mammary cancer 
metastasis through LRP-1-mediated MMP-9 expression. Cancer Res 69, 5690-5698. 
Fendrich, V., Oh, E., Bang, S., Karikari, C., Ottenhof, N., Bisht, S., Lauth, M., Brossart, 
P., Katsanis, N., Maitra, A., et al. (2011). Ectopic overexpression of Sonic Hedgehog 
(Shh) induces stromal expansion and metaplasia in the adult murine pancreas. 
Neoplasia 13, 923-930. 
Fidler, I.J. (2003). The pathogenesis of cancer metastasis: the 'seed and soil' 
hypothesis revisited. Nat Rev Cancer 3, 453-458. 
Fidler, I.J., and Kripke, M.L. (2015). The challenge of targeting metastasis. Cancer 
Metastasis Rev 34, 635-641. 
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998). 
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis 
elegans. Nature 391, 806-811. 
 
 
Chapter VIII: References 
296 
 
Fitzgerald, D.P., Subramanian, P., Deshpande, M., Graves, C., Gordon, I., Qian, Y., 
Snitkovsky, Y., Liewehr, D.J., Steinberg, S.M., Paltan-Ortiz, J.D., et al. (2012). 
Opposing effects of pigment epithelium-derived factor on breast cancer cell versus 
neuronal survival: implication for brain metastasis and metastasis-induced brain 
damage. Cancer Res 72, 144-153. 
Fleming, A. (1929). On the antibacterial action of cultures of a penicillium, with special 
reference to their use in the isolation of B. influenzae. The British Journal of 
Experimental Pathology 10, 226-236. 
Fong, E.L., Santoro, M., Farach-Carson, M.C., Kasper, F.K., and Mikos, A.G. (2014). 
Tissue Engineering Perfusable Cancer Models. Curr Opin Chem Eng 3, 112-117. 
Fong, P.Y., Fesinmeyer, M.D., White, E., Farin, F.M., Srinouanprachanh, S., 
Afsharinejad, Z., Mandelson, M.T., Brentnall, T.A., Barnett, M.J., Goodman, G.E., et 
al. (2010). Association of diabetes susceptibility gene calpain-10 with pancreatic 
cancer among smokers. J Gastrointest Cancer 41, 203-208. 
Foty, R. (2011). A simple hanging drop cell culture protocol for generation of 3D 
spheroids. J Vis Exp. 
Foulds, L. (1954). The experimental study of tumor progression: a review. Cancer 
Res 14, 327-339. 
Frantz, C., Stewart, K.M., and Weaver, V.M. (2010). The extracellular matrix at a 
glance. J Cell Sci 123, 4195-4200. 
Frazier, K.S., and Grotendorst, G.R. (1997). Expression of connective tissue growth 
factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol 29, 
153-161. 
Friberg, S., and Nystrom, A. (2015). Cancer Metastases: Early Dissemination and 
Late Recurrences. Cancer Growth Metastasis 8, 43-49. 
Friedl, P. (2004). Prespecification and plasticity: shifting mechanisms of cell 
migration. Curr Opin Cell Biol 16, 14-23. 
Friedl, P., Hegerfeldt, Y., and Tusch, M. (2004). Collective cell migration in 
morphogenesis and cancer. Int J Dev Biol 48, 441-449. 
Friedl, P., and Wolf, K. (2003). Tumour-cell invasion and migration: diversity and 
escape mechanisms. Nat Rev Cancer 3, 362-374. 
Friedland, J.C., Lee, M.H., and Boettiger, D. (2009). Mechanically activated integrin 
switch controls alpha5beta1 function. Science 323, 642-644. 
Froeling, F.E., Feig, C., Chelala, C., Dobson, R., Mein, C.E., Tuveson, D.A., Clevers, 
H., Hart, I.R., and Kocher, H.M. (2011). Retinoic acid-induced pancreatic stellate cell 
quiescence reduces paracrine Wnt-beta-catenin signaling to slow tumor progression. 
Gastroenterology 141, 1486-1497, 1497 e1481-1414. 
Froeling, F.E., Marshall, J.F., and Kocher, H.M. (2010). Pancreatic cancer 
organotypic cultures. Journal of biotechnology 148, 16-23. 
Froeling, F.E., Mirza, T.A., Feakins, R.M., Seedhar, A., Elia, G., Hart, I.R., and 
Kocher, H.M. (2009). Organotypic culture model of pancreatic cancer demonstrates 
that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor 
cells. Am J Pathol 175, 636-648. 
Chapter VIII: References 
297 
 
Fusenig, N.E. (1971). Isolation and cultivation of epidermal cells from embryonic 
mouse skin. Naturwissenschaften 58, 421. 
Fusenig, N.E., Breitkreutz, D., Dzarlieva, R.T., Boukamp, P., Bohnert, A., and Tilgen, 
W. (1983). Growth and differentiation characteristics of transformed keratinocytes 
from mouse and human skin in vitro and in vivo. J Invest Dermatol 81, 168s-175s. 
Gabbiani, G., Ryan, G.B., and Majne, G. (1971). Presence of modified fibroblasts in 
granulation tissue and their possible role in wound contraction. Experientia 27, 549-
550. 
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J.F., Harrington, 
K., and Sahai, E. (2007). Fibroblast-led collective invasion of carcinoma cells with 
differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9, 1392-
1400. 
Gahwiler, B.H. (1981a). Morphological differentiation of nerve cells in thin organotypic 
cultures derived from rat hippocampus and cerebellum. Proc R Soc Lond B Biol Sci 
211, 287-290. 
Gahwiler, B.H. (1981b). Organotypic monolayer cultures of nervous tissue. J 
Neurosci Methods 4, 329-342. 
Gahwiler, B.H. (1988). Organotypic cultures of neural tissue. Trends Neurosci 11, 
484-489. 
Gandhi, N.S., and Mancera, R.L. (2008). The structure of glycosaminoglycans and 
their interactions with proteins. Chem Biol Drug Des 72, 455-482. 
Gelman, R.A., Williams, B.R., and Piez, K.A. (1979). Collagen fibril formation. 
Evidence for a multistep process. The Journal of biological chemistry 254, 180-186. 
Gelse, K., Poschl, E., and Aigner, T. (2003). Collagens--structure, function, and 
biosynthesis. Adv Drug Deliv Rev 55, 1531-1546. 
Geuijen, C.A., and Sonnenberg, A. (2002). Dynamics of the alpha6beta4 integrin in 
keratinocytes. Mol Biol Cell 13, 3845-3858. 
Ghajar, C.M., and Bissell, M.J. (2010). Tumor engineering: the other face of tissue 
engineering. Tissue Eng Part A 16, 2153-2156. 
Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C.S., and Sahai, E. (2009). 
Localized and reversible TGFbeta signalling switches breast cancer cells from 
cohesive to single cell motility. Nat Cell Biol 11, 1287-1296. 
Gligorijevic, B., Wyckoff, J., Yamaguchi, H., Wang, Y., Roussos, E.T., and Condeelis, 
J. (2012). N-WASP-mediated invadopodium formation is involved in intravasation and 
lung metastasis of mammary tumors. J Cell Sci 125, 724-734. 
Gordon, M.K., and Hahn, R.A. (2010). Collagens. Cell Tissue Res 339, 247-257. 
Griffiths, M., Ojeh, N., Livingstone, R., Price, R., and Navsaria, H. (2004). Survival of 
Apligraf in acute human wounds. Tissue Eng 10, 1180-1195. 
Grozinger, K., Proudfoot, J., and Hargrave, K. (2006). Discovery and Development of 
Nevirapine. In Drug Discovery and Development (John Wiley & Sons, Inc.), pp. 353-
363. 
Chapter VIII: References 
298 
 
Gudjonsson, T., Ronnov-Jessen, L., Villadsen, R., Rank, F., Bissell, M.J., and 
Petersen, O.W. (2002). Normal and tumor-derived myoepithelial cells differ in their 
ability to interact with luminal breast epithelial cells for polarity and basement 
membrane deposition. J Cell Sci 115, 39-50. 
Guipponi, M., Toh, M.Y., Tan, J., Park, D., Hanson, K., Ballana, E., Kwong, D., 
Cannon, P.Z., Wu, Q., Gout, A., et al. (2008). An integrated genetic and functional 
analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing 
loss. Hum Mutat 29, 130-141. 
Han, W., Chen, S., Yuan, W., Fan, Q., Tian, J., Wang, X., Chen, L., Zhang, X., Wei, 
W., Liu, R., et al. (2016). Oriented collagen fibers direct tumor cell intravasation. Proc 
Natl Acad Sci U S A 113, 11208-11213. 
Hanahan, D., and Coussens, L.M. (2012). Accessories to the crime: functions of cells 
recruited to the tumor microenvironment. Cancer Cell 21, 309-322. 
Hanley, C.J., Noble, F., Ward, M., Bullock, M., Drifka, C., Mellone, M., 
Manousopoulou, A., Johnston, H.E., Hayden, A., Thirdborough, S., et al. (2016). A 
subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber 
elongation, which is prognostic in multiple cancers. Oncotarget 7, 6159-6174. 
Hannon, G.J., and Rossi, J.J. (2004). Unlocking the potential of the human genome 
with RNA interference. Nature 431, 371-378. 
Harada, K., Toyooka, S., Shivapurkar, N., Maitra, A., Reddy, J.L., Matta, H., Miyajima, 
K., Timmons, C.F., Tomlinson, G.E., Mastrangelo, D., et al. (2002). Deregulation of 
caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 62, 5897-
5901. 
Harburger, D.S., Bouaouina, M., and Calderwood, D.A. (2009). Kindlin-1 and -2 
directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-
specific activation effects. The Journal of biological chemistry 284, 11485-11497. 
Harma, V., Virtanen, J., Makela, R., Happonen, A., Mpindi, J.P., Knuuttila, M., 
Kohonen, P., Lotjonen, J., Kallioniemi, O., and Nees, M. (2010). A comprehensive 
panel of three-dimensional models for studies of prostate cancer growth, invasion and 
drug responses. PloS one 5, e10431. 
Hart, I.R. (1982). 'Seed and soil' revisited: mechanisms of site-specific metastasis. 
Cancer Metastasis Rev 1, 5-16. 
Hart, I.R., and Fidler, I.J. (1980a). Cancer invasion and metastasis. Q Rev Biol 55, 
121-142. 
Hart, I.R., and Fidler, I.J. (1980b). Role of organ selectivity in the determination of 
metastatic patterns of B16 melanoma. Cancer Res 40, 2281-2287. 
Hartikainen, J.M., Tuhkanen, H., Kataja, V., Eskelinen, M., Uusitupa, M., Kosma, 
V.M., and Mannermaa, A. (2006). Refinement of the 22q12-q13 breast cancer--
associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish 
population. Clin Cancer Res 12, 1454-1462. 
Hashimoto, T., Kato, M., Shimomura, T., and Kitamura, N. (2010). TMPRSS13, a type 
II transmembrane serine protease, is inhibited by hepatocyte growth factor activator 
inhibitor type 1 and activates pro-hepatocyte growth factor. FEBS J 277, 4888-4900. 
 
Chapter VIII: References 
299 
 
Hauw, J.J., Berger, B., and Escourolle, R. (1972). [Presence of synapses in 
organotypic culture in vitro of human cerebellum]. C R Acad Sci Hebd Seances Acad 
Sci D 274, 264-266. 
Haycock, J.W. (2011). 3D cell culture: a review of current approaches and techniques. 
Methods in molecular biology 695, 1-15. 
Hegerfeldt, Y., Tusch, M., Brocker, E.B., and Friedl, P. (2002). Collective cell 
movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-
integrin function, and migration strategies. Cancer Res 62, 2125-2130. 
Helbling-Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, 
J., Tome, F.M., Schwartz, K., Fardeau, M., Tryggvason, K., et al. (1995). Mutations 
in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital 
muscular dystrophy. Nat Genet 11, 216-218. 
Herold-Mende, C., Mueller, M.M., Bonsanto, M.M., Schmitt, H.P., Kunze, S., and 
Steiner, H.H. (2002). Clinical impact and functional aspects of tenascin-C expression 
during glioma progression. Int J Cancer 98, 362-369. 
Hess, M.W., Pfaller, K., Ebner, H.L., Beer, B., Hekl, D., and Seppi, T. (2010). 3D 
versus 2D cell culture implications for electron microscopy. Methods Cell Biol 96, 649-
670. 
Hinz, B., Phan, S.H., Thannickal, V.J., Prunotto, M., Desmouliere, A., Varga, J., De 
Wever, O., Mareel, M., and Gabbiani, G. (2012). Recent developments in 
myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 180, 
1340-1355. 
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J.M., 
Senior, R.M., and Shibuya, M. (2002). MMP9 induction by vascular endothelial growth 
factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2, 289-300. 
Ho, L.H., Taylor, R., Dorstyn, L., Cakouros, D., Bouillet, P., and Kumar, S. (2009). A 
tumor suppressor function for caspase-2. Proc Natl Acad Sci U S A 106, 5336-5341. 
Ho, W.C., Pikor, L., Gao, Y., Elliott, B.E., and Greer, P.A. (2012). Calpain 2 regulates 
Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma. The Journal 
of biological chemistry 287, 15458-15465. 
Hofmann, A., Ritz, U., Verrier, S., Eglin, D., Alini, M., Fuchs, S., Kirkpatrick, C.J., and 
Rommens, P.M. (2008). The effect of human osteoblasts on proliferation and neo-
vessel formation of human umbilical vein endothelial cells in a long-term 3D co-culture 
on polyurethane scaffolds. Biomaterials 29, 4217-4226. 
Horikawa, Y., Oda, N., Cox, N.J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., 
Lindner, T.H., Mashima, H., Schwarz, P.E., et al. (2000). Genetic variation in the gene 
encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26, 163-
175. 
Host, L., Paye, A., Detry, B., Blacher, S., Munaut, C., Foidart, J.M., Seiki, M., Sounni, 
N.E., and Noel, A. (2012). The proteolytic activity of MT4-MMP is required for its pro-
angiogenic and pro-metastatic promoting effects. Int J Cancer 131, 1537-1548. 
 
 
Chapter VIII: References 
300 
 
Hotary, K.B., Yana, I., Sabeh, F., Li, X.Y., Holmbeck, K., Birkedal-Hansen, H., Allen, 
E.D., Hiraoka, N., and Weiss, S.J. (2002). Matrix metalloproteinases (MMPs) regulate 
fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp 
Med 195, 295-308. 
Hou, J.M., Krebs, M.G., Lancashire, L., Sloane, R., Backen, A., Swain, R.K., Priest, 
L.J., Greystoke, A., Zhou, C., Morris, K., et al. (2012). Clinical significance and 
molecular characteristics of circulating tumor cells and circulating tumor microemboli 
in patients with small-cell lung cancer. J Clin Oncol 30, 525-532. 
Huang, G., Gao, Q., Zhao, Y., Dong, Z., Li, T., Guan, X., and Jiang, J. (2015). A novel 
siRNA validation system for functional screening of effective RNAi targets in 
mammalian cells and development of a derivative lentivirus delivery system. Gene 
558, 278-286. 
Hubbell, J.A. (1995). Biomaterials in tissue engineering. Biotechnology (N Y) 13, 565-
576. 
Huber, J.M., Amann, A., Koeck, S., Lorenz, E., Kelm, J.M., Obexer, P., Zwierzina, H., 
and Gamerith, G. (2016). Evaluation of assays for drug efficacy in a three-dimensional 
model of the lung. J Cancer Res Clin Oncol 142, 1955-1966. 
Hughes, J.P., Rees, S., Kalindjian, S.B., and Philpott, K.L. (2011). Principles of early 
drug discovery. Br J Pharmacol 162, 1239-1249. 
Huh, D., Hamilton, G.A., and Ingber, D.E. (2011). From 3D cell culture to organs-on-
chips. Trends Cell Biol 21, 745-754. 
Huh, D., Matthews, B.D., Mammoto, A., Montoya-Zavala, M., Hsin, H.Y., and Ingber, 
D.E. (2010). Reconstituting organ-level lung functions on a chip. Science 328, 1662-
1668. 
Hulkower, K.I., and Herber, R.L. (2011). Cell migration and invasion assays as tools 
for drug discovery. Pharmaceutics 3, 107-124. 
Husemann, Y., Geigl, J.B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, 
G., Eils, R., Fehm, T., Riethmuller, G., et al. (2008). Systemic spread is an early step 
in breast cancer. Cancer Cell 13, 58-68. 
Hwang, C.M., Khademhosseini, A., Park, Y., Sun, K., and Lee, S.H. (2008). 
Microfluidic chip-based fabrication of PLGA microfiber scaffolds for tissue 
engineering. Langmuir 24, 6845-6851. 
Hynes, R.O. (1987). Integrins: a family of cell surface receptors. Cell 48, 549-554. 
Hynes, R.O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. 
Cell 69, 11-25. 
Hynes, R.O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 
673-687. 
Hynes, R.O. (2009). The extracellular matrix: not just pretty fibrils. Science 326, 1216-
1219. 
Hynes, R.O., Bader, B.L., and Hodivala-Dilke, K. (1999). Integrins in vascular 
development. Braz J Med Biol Res 32, 501-510. 
 
Chapter VIII: References 
301 
 
Ibbetson, S.J., Pyne, N.T., Pollard, A.N., Olson, M.F., and Samuel, M.S. (2013). 
Mechanotransduction pathways promoting tumor progression are activated in 
invasive human squamous cell carcinoma. Am J Pathol 183, 930-937. 
Igarashi, M., Irwin, C.R., Locke, M., and Mackenzie, I.C. (2003). Construction of large 
area organotypical cultures of oral mucosa and skin. J Oral Pathol Med 32, 422-430. 
Imamura, T., Iguchi, H., Manabe, T., Ohshio, G., Yoshimura, T., Wang, Z.H., Suwa, 
H., Ishigami, S., and Imamura, M. (1995). Quantitative analysis of collagen and 
collagen subtypes I, III, and V in human pancreatic cancer, tumor-associated chronic 
pancreatitis, and alcoholic chronic pancreatitis. Pancreas 11, 357-364. 
Inglese, J., Auld, D.S., Jadhav, A., Johnson, R.L., Simeonov, A., Yasgar, A., Zheng, 
W., and Austin, C.P. (2006). Quantitative high-throughput screening: a titration-based 
approach that efficiently identifies biological activities in large chemical libraries. Proc 
Natl Acad Sci U S A 103, 11473-11478. 
Ishiwata, T., Takahashi, K., Shimanuki, Y., Ohashi, R., Cui, R., Takahashi, F., 
Shimizu, K., Miura, K., and Fukuchi, Y. (2005). Serum tenascin-C as a potential 
predictive marker of angiogenesis in non-small cell lung cancer. Anticancer Res 25, 
489-495. 
Itano, N., Okamoto, S., Zhang, D., Lipton, S.A., and Ruoslahti, E. (2003). Cell 
spreading controls endoplasmic and nuclear calcium: a physical gene regulation 
pathway from the cell surface to the nucleus. Proc Natl Acad Sci U S A 100, 5181-
5186. 
Itoh, Y., Kajita, M., Kinoh, H., Mori, H., Okada, A., and Seiki, M. (1999). Membrane 
type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a 
glycosylphosphatidylinositol-anchored proteinase. The Journal of biological 
chemistry 274, 34260-34266. 
Jain, M.P., Choi, A.O., Neibert, K.D., and Maysinger, D. (2009). Probing and 
preventing quantum dot-induced cytotoxicity with multimodal alpha-lipoic acid in 
multiple dimensions of the peripheral nervous system. Nanomedicine (Lond) 4, 277-
290. 
Jansen, V.M., Bhola, N.E., Bauer, J.A., Formisano, L., Lee, K.M., Hutchinson, K.E., 
Witkiewicz, A.K., Moore, P.D., Estrada, M.V., Sanchez, V., et al. (2017). Kinome-Wide 
RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 
Inhibition in ER-Positive Breast Cancer. Cancer Res 77, 2488-2499. 
Jensen, D.H., Reibel, J., Mackenzie, I.C., and Dabelsteen, E. (2015). Single cell 
migration in oral squamous cell carcinoma - possible evidence of epithelial-
mesenchymal transition in vivo. J Oral Pathol Med 44, 674-679. 
Jiang, W.G., Sanders, A.J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., 
Thompson, S.K., Zollo, M., Spano, D., Dhawan, P., et al. (2015). Tissue invasion and 
metastasis: Molecular, biological and clinical perspectives. Semin Cancer Biol 35 
Suppl, S244-S275. 
Kadaba, R., Birke, H., Wang, J., Hooper, S., Andl, C.D., Di Maggio, F., Soylu, E., 
Ghallab, M., Bor, D., Froeling, F.E., et al. (2013). Imbalance of desmoplastic stromal 
cell numbers drives aggressive cancer processes. The Journal of pathology 230, 107-
117. 
 
Chapter VIII: References 
302 
 
Kalluri, R. (2016). The biology and function of fibroblasts in cancer. Nat Rev Cancer 
16, 582-598. 
Kalluri, R., and Weinberg, R.A. (2009). The basics of epithelial-mesenchymal 
transition. J Clin Invest 119, 1420-1428. 
Kalluri, R., and Zeisberg, M. (2006). Fibroblasts in cancer. Nat Rev Cancer 6, 392-
401. 
Karlsson, H., Fryknas, M., Larsson, R., and Nygren, P. (2012). Loss of cancer drug 
activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D 
spheroid cell culture system. Exp Cell Res 318, 1577-1585. 
Kats-Ugurlu, G., Roodink, I., de Weijert, M., Tiemessen, D., Maass, C., Verrijp, K., 
van der Laak, J., de Waal, R., Mulders, P., Oosterwijk, E., et al. (2009). Circulating 
tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell 
carcinoma. The Journal of pathology 219, 287-293. 
Kenny, H.A., Krausz, T., Yamada, S.D., and Lengyel, E. (2007). Use of a novel 3D 
culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular 
matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J 
Cancer 121, 1463-1472. 
Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-
257. 
Khetan, S., Guvendiren, M., Legant, W.R., Cohen, D.M., Chen, C.S., and Burdick, 
J.A. (2013). Degradation-mediated cellular traction directs stem cell fate in covalently 
crosslinked three-dimensional hydrogels. Nat Mater 12, 458-465. 
Kiani, C., Chen, L., Wu, Y.J., Yee, A.J., and Yang, B.B. (2002). Structure and function 
of aggrecan. Cell Res 12, 19-32. 
Kido, H., and Okumura, Y. (2008). Mspl/Tmprss13. Front Biosci 13, 754-758. 
Kim, E.J., Sahai, V., Abel, E.V., Griffith, K.A., Greenson, J.K., Takebe, N., Khan, G.N., 
Blau, J.L., Craig, R., Balis, U.G., et al. (2014). Pilot clinical trial of hedgehog pathway 
inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with 
metastatic pancreatic adenocarcinoma. Clin Cancer Res 20, 5937-5945. 
Kim, J.B., Stein, R., and O'Hare, M.J. (2004). Three-dimensional in vitro tissue culture 
models of breast cancer-- a review. Breast Cancer Res Treat 85, 281-291. 
Kim, W.J., Chang, C.W., Lee, M., and Kim, S.W. (2007). Efficient siRNA delivery 
using water soluble lipopolymer for anti-angiogenic gene therapy. J Control Release 
118, 357-363. 
Kimlin, L.C., Casagrande, G., and Virador, V.M. (2013). In vitro three-dimensional 
(3D) models in cancer research: an update. Mol Carcinog 52, 167-182. 
Klein, C.A. (2009). Parallel progression of primary tumours and metastases. Nat Rev 
Cancer 9, 302-312. 
Kleinman, H.K., and Martin, G.R. (2005). Matrigel: basement membrane matrix with 
biological activity. Semin Cancer Biol 15, 378-386. 
 
Chapter VIII: References 
303 
 
Klezovitch, O., Chevillet, J., Mirosevich, J., Roberts, R.L., Matusik, R.J., and 
Vasioukhin, V. (2004). Hepsin promotes prostate cancer progression and metastasis. 
Cancer Cell 6, 185-195. 
Klumpp, M., Boettcher, A., Becker, D., Meder, G., Blank, J., Leder, L., Forstner, M., 
Ottl, J., and Mayr, L.M. (2006). Readout technologies for highly miniaturized kinase 
assays applicable to high-throughput screening in a 1536-well format. J Biomol 
Screen 11, 617-633. 
Kohrmann, A., Kammerer, U., Kapp, M., Dietl, J., and Anacker, J. (2009). Expression 
of matrix metalloproteinases (MMPs) in primary human breast cancer and breast 
cancer cell lines: New findings and review of the literature. BMC Cancer 9, 188. 
Kolenko, V., Uzzo, R.G., Bukowski, R., Bander, N.H., Novick, A.C., Hsi, E.D., and 
Finke, J.H. (1999). Dead or dying: necrosis versus apoptosis in caspase-deficient 
human renal cell carcinoma. Cancer Res 59, 2838-2842. 
Kou, Y.B., Zhang, S.Y., Zhao, B.L., Ding, R., Liu, H., and Li, S. (2013). Knockdown of 
MMP11 inhibits proliferation and invasion of gastric cancer cells. Int J Immunopathol 
Pharmacol 26, 361-370. 
Kramer, N., Walzl, A., Unger, C., Rosner, M., Krupitza, G., Hengstschlager, M., and 
Dolznig, H. (2013). In vitro cell migration and invasion assays. Mutat Res 752, 10-24. 
Kumar, C.C., Malkowski, M., Yin, Z., Tanghetti, E., Yaremko, B., Nechuta, T., Varner, 
J., Liu, M., Smith, E.M., Neustadt, B., et al. (2001). Inhibition of angiogenesis and 
tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin 
receptor antagonist. Cancer Res 61, 2232-2238. 
Kunz-Schughart, L.A., Freyer, J.P., Hofstaedter, F., and Ebner, R. (2004). The use of 
3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol 
Screen 9, 273-285. 
Lam, J., Truong, N.F., and Segura, T. (2014a). Design of cell-matrix interactions in 
hyaluronic acid hydrogel scaffolds. Acta Biomater 10, 1571-1580. 
Lam, P.Y., Fischer, R.S., Shin, W.D., Waterman, C.M., and Huttenlocher, A. (2014b). 
Spinning disk confocal imaging of neutrophil migration in zebrafish. Methods in 
molecular biology 1124, 219-233. 
Lang, N.R., Skodzek, K., Hurst, S., Mainka, A., Steinwachs, J., Schneider, J., Aifantis, 
K.E., and Fabry, B. (2015). Biphasic response of cell invasion to matrix stiffness in 
three-dimensional biopolymer networks. Acta Biomater 13, 61-67. 
Langley, R.R., and Fidler, I.J. (2011). The seed and soil hypothesis revisited--the role 
of tumor-stroma interactions in metastasis to different organs. Int J Cancer 128, 2527-
2535. 
Languino, L.R., Gehlsen, K.R., Wayner, E., Carter, W.G., Engvall, E., and Ruoslahti, 
E. (1989). Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. The 
Journal of cell biology 109, 2455-2462. 
Larue, L., and Bellacosa, A. (2005). Epithelial-mesenchymal transition in 
development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. 
Oncogene 24, 7443-7454. 
 
Chapter VIII: References 
304 
 
Laurie, G.W., Leblond, C.P., and Martin, G.R. (1982). Localization of type IV collagen, 
laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of 
basement membranes. The Journal of cell biology 95, 340-344. 
Law, R.H., Zhang, Q., McGowan, S., Buckle, A.M., Silverman, G.A., Wong, W., 
Rosado, C.J., Langendorf, C.G., Pike, R.N., Bird, P.I., et al. (2006). An overview of 
the serpin superfamily. Genome Biol 7, 216. 
LeBleu, V.S., Macdonald, B., and Kalluri, R. (2007). Structure and function of 
basement membranes. Exp Biol Med (Maywood) 232, 1121-1129. 
Lee, G.Y., Kenny, P.A., Lee, E.H., and Bissell, M.J. (2007). Three-dimensional culture 
models of normal and malignant breast epithelial cells. Nat Methods 4, 359-365. 
Lee, H.K., Velazquez Sanchez, C., Chen, M., Morin, P.J., Wells, J.M., Hanlon, E.B., 
and Xia, W. (2016). Three Dimensional Human Neuro-Spheroid Model of Alzheimer's 
Disease Based on Differentiated Induced Pluripotent Stem Cells. PloS one 11, 
e0163072. 
Lee, J., Cuddihy, M.J., and Kotov, N.A. (2008a). Three-dimensional cell culture 
matrices: state of the art. Tissue Eng Part B Rev 14, 61-86. 
Lee, J., Galloway, R., Grandjean, G., Jacob, J., Humphries, J., Bartholomeusz, C., 
Goodstal, S., Lim, B., Bartholomeusz, G., Ueno, N.T., et al. (2015). Comprehensive 
Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a 
Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-
Negative Breast Cancer. J Cancer 6, 1306-1319. 
Lee, S.J., Kim, B.G., Choi, Y.L., and Lee, J.W. (2008b). Increased expression of 
calpain 6 during the progression of uterine cervical neoplasia: immunohistochemical 
analysis. Oncol Rep 19, 859-863. 
Leist, M., Hasiwa, N., Rovida, C., Daneshian, M., Basketter, D., Kimber, I., Clewell, 
H., Gocht, T., Goldberg, A., Busquet, F., et al. (2014). Consensus report on the future 
of animal-free systemic toxicity testing. ALTEX 31, 341-356. 
Leong, D.T., and Ng, K.W. (2014). Probing the relevance of 3D cancer models in 
nanomedicine research. Adv Drug Deliv Rev 79-80, 95-106. 
Levental, K.R., Yu, H., Kass, L., Lakins, J.N., Egeblad, M., Erler, J.T., Fong, S.F., 
Csiszar, K., Giaccia, A., Weninger, W., et al. (2009). Matrix crosslinking forces tumor 
progression by enhancing integrin signaling. Cell 139, 891-906. 
Lewis, K.E., and Eisen, J.S. (2001). Hedgehog signaling is required for primary 
motoneuron induction in zebrafish. Development 128, 3485-3495. 
Li, H., Fan, X., and Houghton, J. (2007a). Tumor microenvironment: the role of the 
tumor stroma in cancer. J Cell Biochem 101, 805-815. 
Li, J., Chen, J., and Kirsner, R. (2007b). Pathophysiology of acute wound healing. 
Clin Dermatol 25, 9-18. 
Li, L., Zhou, Q., Voss, T.C., Quick, K.L., and LaBarbera, D.V. (2016). High-throughput 
imaging: Focusing in on drug discovery in 3D. Methods 96, 97-102. 
Liang, C.C., Park, A.Y., and Guan, J.L. (2007). In vitro scratch assay: a convenient 
and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2, 329-333. 
Chapter VIII: References 
305 
 
Liao, D., Luo, Y., Markowitz, D., Xiang, R., and Reisfeld, R.A. (2009). Cancer 
associated fibroblasts promote tumor growth and metastasis by modulating the tumor 
immune microenvironment in a 4T1 murine breast cancer model. PloS one 4, e7965. 
Ling, C., Groop, L., Guerra, S.D., and Lupi, R. (2009). Calpain-10 expression is 
elevated in pancreatic islets from patients with type 2 diabetes. PloS one 4, e6558. 
Liotta, L.A. (1984). Tumor invasion and metastases: role of the basement membrane. 
Warner-Lambert Parke-Davis Award lecture. Am J Pathol 117, 339-348. 
Liotta, L.A., Abe, S., Robey, P.G., and Martin, G.R. (1979). Preferential digestion of 
basement membrane collagen by an enzyme derived from a metastatic murine tumor. 
Proc Natl Acad Sci U S A 76, 2268-2272. 
Liotta, L.A., Kleinerman, J., Catanzaro, P., and Rynbrandt, D. (1977). Degradation of 
basement membrane by murine tumor cells. J Natl Cancer Inst 58, 1427-1431. 
Liotta, L.A., and Rao, C.N. (1986). Tumor invasion and metastasis. Monogr Pathol, 
183-192. 
Liotta, L.A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C.M., and Shafie, S. (1980). 
Metastatic potential correlates with enzymatic degradation of basement membrane 
collagen. Nature 284, 67-68. 
Littlepage, L.E., Sternlicht, M.D., Rougier, N., Phillips, J., Gallo, E., Yu, Y., Williams, 
K., Brenot, A., Gordon, J.I., and Werb, Z. (2010). Matrix metalloproteinases contribute 
distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and 
angiogenesis progression. Cancer Res 70, 2224-2234. 
Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data 
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 
402-408. 
Loessner, D., Stok, K.S., Lutolf, M.P., Hutmacher, D.W., Clements, J.A., and Rizzi, 
S.C. (2010). Bioengineered 3D platform to explore cell-ECM interactions and drug 
resistance of epithelial ovarian cancer cells. Biomaterials 31, 8494-8506. 
Lopez, J., John, S.W., Tenev, T., Rautureau, G.J., Hinds, M.G., Francalanci, F., 
Wilson, R., Broemer, M., Santoro, M.M., Day, C.L., et al. (2011). CARD-mediated 
autoinhibition of cIAP1's E3 ligase activity suppresses cell proliferation and migration. 
Mol Cell 42, 569-583. 
Lu, P., Takai, K., Weaver, V.M., and Werb, Z. (2011). Extracellular matrix degradation 
and remodeling in development and disease. Cold Spring Harb Perspect Biol 3. 
Luo, W., Ren, Z., Gao, S., Jin, H., Zhang, G., Zhou, L., and Zheng, S. (2016). Clinical 
correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma. Oncol 
Lett 11, 1345-1352. 
Luzzi, K.J., MacDonald, I.C., Schmidt, E.E., Kerkvliet, N., Morris, V.L., Chambers, 
A.F., and Groom, A.C. (1998). Multistep nature of metastatic inefficiency: dormancy 
of solitary cells after successful extravasation and limited survival of early 
micrometastases. Am J Pathol 153, 865-873. 
Maatta, M., Soini, Y., Paakko, P., Salo, S., Tryggvason, K., and Autio-Harmainen, H. 
(1999). Expression of the laminin gamma2 chain in different histological types of lung 
carcinoma. A study by immunohistochemistry and in situ hybridization. The Journal 
of pathology 188, 361-368. 
Chapter VIII: References 
306 
 
Macarron, R., Banks, M.N., Bojanic, D., Burns, D.J., Cirovic, D.A., Garyantes, T., 
Green, D.V., Hertzberg, R.P., Janzen, W.P., Paslay, J.W., et al. (2011). Impact of 
high-throughput screening in biomedical research. Nat Rev Drug Discov 10, 188-195. 
Mackenzie, I.C. (2004). Growth of malignant oral epithelial stem cells after seeding 
into organotypical cultures of normal mucosa. J Oral Pathol Med 33, 71-78. 
Mackenzie, I.C., and Fusenig, N.E. (1983). Regeneration of organized epithelial 
structure. J Invest Dermatol 81, 189s-194s. 
Macmillan, B.G. (1962). Homograft skin--a valuable adjunct to the treatment of 
thermal burns. J Trauma 2, 130-141. 
Makarovskiy, A.N., Ackerley, W., 3rd, Wojcik, L., Halpert, G.K., Stein, B.S., Carreiro, 
M.P., and Hixson, D.C. (1997). Application of immunomagnetic beads in combination 
with RT-PCR for the detection of circulating prostate cancer cells. J Clin Lab Anal 11, 
346-350. 
Mamoune, A., Luo, J.H., Lauffenburger, D.A., and Wells, A. (2003). Calpain-2 as a 
target for limiting prostate cancer invasion. Cancer Res 63, 4632-4640. 
Marhefka, J.N., and Abbud-Antaki, R.A. (2012). Validation of the Cancer BioChip 
System as a 3D siRNA screening tool for breast cancer targets. PloS one 7, e46086. 
Marsh, D., Dickinson, S., Neill, G.W., Marshall, J.F., Hart, I.R., and Thomas, G.J. 
(2008). alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell 
carcinoma through stromal modulation. Cancer Res 68, 3295-3303. 
Marshall, J. (2011). Transwell((R)) invasion assays. Methods in molecular biology 
769, 97-110. 
Martina, E., Chiquet-Ehrismann, R., and Brellier, F. (2010). Tenascin-W: an 
extracellular matrix protein associated with osteogenesis and cancer. Int J Biochem 
Cell Biol 42, 1412-1415. 
Mathes, S.H., Wohlwend, L., Uebersax, L., von Mentlen, R., Thoma, D.S., Jung, R.E., 
Gorlach, C., and Graf-Hausner, U. (2010). A bioreactor test system to mimic the 
biological and mechanical environment of oral soft tissues and to evaluate substitutes 
for connective tissue grafts. Biotechnol Bioeng 107, 1029-1039. 
Mayr, L.M., and Fuerst, P. (2008). The future of high-throughput screening. J Biomol 
Screen 13, 443-448. 
McAnulty, R.J. (2007). Fibroblasts and myofibroblasts: their source, function and role 
in disease. Int J Biochem Cell Biol 39, 666-671. 
McBeath, R., Pirone, D.M., Nelson, C.M., Bhadriraju, K., and Chen, C.S. (2004). Cell 
shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev 
Cell 6, 483-495. 
McDermott, U., Sharma, S.V., and Settleman, J. (2008). High-throughput lung cancer 
cell line screening for genotype-correlated sensitivity to an EGFR kinase inhibitor. 
Methods Enzymol 438, 331-341. 
McGurk, L., Morrison, H., Keegan, L.P., Sharpe, J., and O'Connell, M.A. (2007). 
Three-dimensional imaging of Drosophila melanogaster. PloS one 2, e834. 
 
Chapter VIII: References 
307 
 
McIlwain, D.R., Berger, T., and Mak, T.W. (2013). Caspase functions in cell death 
and disease. Cold Spring Harb Perspect Biol 5, a008656. 
McPherson, J.M., Wallace, D.G., Sawamura, S.J., Conti, A., Condell, R.A., Wade, S., 
and Piez, K.A. (1985). Collagen fibrillogenesis in vitro: a characterization of fibril 
quality as a function of assembly conditions. Coll Relat Res 5, 119-135. 
Mecham, R.P. (2008). Methods in elastic tissue biology: elastin isolation and 
purification. Methods 45, 32-41. 
Mehta, G., Hsiao, A.Y., Ingram, M., Luker, G.D., and Takayama, S. (2012). 
Opportunities and challenges for use of tumor spheroids as models to test drug 
delivery and efficacy. J Control Release 164, 192-204. 
Meng, W., Kallinteri, P., Walker, D.A., Parker, T.L., and Garnett, M.C. (2007). 
Evaluation of poly (glycerol-adipate) nanoparticle uptake in an in vitro 3-D brain tumor 
co-culture model. Exp Biol Med (Maywood) 232, 1100-1108. 
Miller, E.J. (1985). The structure of fibril-forming collagens. Ann N Y Acad Sci 460, 1-
13. 
Miyazono, K. (2009). Transforming growth factor-beta signaling in epithelial-
mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol 
Sci 85, 314-323. 
Moore, K.M., Thomas, G.J., Duffy, S.W., Warwick, J., Gabe, R., Chou, P., Ellis, I.O., 
Green, A.R., Haider, S., Brouilette, K., et al. (2014). Therapeutic targeting of integrin 
alphavbeta6 in breast cancer. J Natl Cancer Inst 106. 
Moreno-Luna, R., Abrante, A., Esteban, F., Gonzalez-Moles, M.A., Delgado-
Rodriguez, M., Saez, M.E., Gonzalez-Perez, A., Ramirez-Lorca, R., Real, L.M., and 
Ruiz, A. (2011). Calpain 10 gene and laryngeal cancer: a survival analysis. Head 
Neck 33, 72-76. 
Moretti, D., Del Bello, B., Cosci, E., Biagioli, M., Miracco, C., and Maellaro, E. (2009). 
Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-
induced changes in vitro and differential expression in melanocytic lesions. 
Carcinogenesis 30, 960-967. 
Moutasim, K.A., Nystrom, M.L., and Thomas, G.J. (2011). Cell migration and invasion 
assays. Methods in molecular biology 731, 333-343. 
Mu, D., Cambier, S., Fjellbirkeland, L., Baron, J.L., Munger, J.S., Kawakatsu, H., 
Sheppard, D., Broaddus, V.C., and Nishimura, S.L. (2002). The integrin 
alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent 
activation of TGF-beta1. The Journal of cell biology 157, 493-507. 
Mueller, D., Kramer, L., Hoffmann, E., Klein, S., and Noor, F. (2014). 3D organotypic 
HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. 
Toxicol In Vitro 28, 104-112. 
Nagase, H., Visse, R., and Murphy, G. (2006). Structure and function of matrix 
metalloproteinases and TIMPs. Cardiovasc Res 69, 562-573. 
Nelson, C.M., and Bissell, M.J. (2006). Of extracellular matrix, scaffolds, and 
signaling: tissue architecture regulates development, homeostasis, and cancer. Annu 
Rev Cell Dev Biol 22, 287-309. 
Chapter VIII: References 
308 
 
Nicolson, G.L. (1982). Cancer metastasis. Organ colonization and the cell-surface 
properties of malignant cells. Biochim Biophys Acta 695, 113-176. 
Nishiyama, T., Amano, S., Tsunenaga, M., Kadoya, K., Takeda, A., Adachi, E., and 
Burgeson, R.E. (2000). The importance of laminin 5 in the dermal-epidermal 
basement membrane. J Dermatol Sci 24 Suppl 1, S51-59. 
Noel, J.C., Fernandez-Aguilar, S., Fayt, I., Buxant, F., Ansion, M.H., Simon, P., and 
Anaf, V. (2005). Laminin-5 gamma 2 chain expression in cervical intraepithelial 
neoplasia and invasive cervical carcinoma. Acta Obstet Gynecol Scand 84, 1119-
1123. 
Nyga, A., Cheema, U., and Loizidou, M. (2011). 3D tumour models: novel in vitro 
approaches to cancer studies. J Cell Commun Signal 5, 239-248. 
Nystrom, M.L., Thomas, G.J., Stone, M., Mackenzie, I.C., Hart, I.R., and Marshall, 
J.F. (2005). Development of a quantitative method to analyse tumour cell invasion in 
organotypic culture. The Journal of pathology 205, 468-475. 
Oberst, M.D., Johnson, M.D., Dickson, R.B., Lin, C.Y., Singh, B., Stewart, M., 
Williams, A., al-Nafussi, A., Smyth, J.F., Gabra, H., et al. (2002). Expression of the 
serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: 
correlation with clinical outcome and tumor clinicopathological parameters. Clin 
Cancer Res 8, 1101-1107. 
Olivier, M., Langerod, A., Carrieri, P., Bergh, J., Klaar, S., Eyfjord, J., Theillet, C., 
Rodriguez, C., Lidereau, R., Bieche, I., et al. (2006). The clinical value of somatic 
TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 12, 1157-
1167. 
Olsson, M., and Zhivotovsky, B. (2011). Caspases and cancer. Cell Death Differ 18, 
1441-1449. 
Ono, Y., and Sorimachi, H. (2012). Calpains: an elaborate proteolytic system. Biochim 
Biophys Acta 1824, 224-236. 
Orend, G., and Chiquet-Ehrismann, R. (2006). Tenascin-C induced signaling in 
cancer. Cancer Lett 244, 143-163. 
Orimo, A., Gupta, P.B., Sgroi, D.C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, 
R., Carey, V.J., Richardson, A.L., and Weinberg, R.A. (2005). Stromal fibroblasts 
present in invasive human breast carcinomas promote tumor growth and 
angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348. 
Orkin, R.W., Gehron, P., McGoodwin, E.B., Martin, G.R., Valentine, T., and Swarm, 
R. (1977). A murine tumor producing a matrix of basement membrane. J Exp Med 
145, 204-220. 
Orloff, J., Douglas, F., Pinheiro, J., Levinson, S., Branson, M., Chaturvedi, P., Ette, 
E., Gallo, P., Hirsch, G., Mehta, C., et al. (2009). The future of drug development: 
advancing clinical trial design. Nat Rev Drug Discov 8, 949-957. 
Ott, L.M., Ramachandran, K., and Stehno-Bittel, L. (2017). An Automated Multiplexed 
Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D. SLAS 
Discov 22, 614-625. 
 
Chapter VIII: References 
309 
 
Ovcharenko, D., Jarvis, R., Hunicke-Smith, S., Kelnar, K., and Brown, D. (2005). 
High-throughput RNAi screening in vitro: from cell lines to primary cells. RNA 11, 985-
993. 
P, O.c., Modjtahedi, H., Rhys-Evans, P., Court, W.J., Box, G.M., and Eccles, S.A. 
(2000). Epidermal growth factor-like ligands differentially up-regulate matrix 
metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res 60, 
1121-1128. 
Page-McCaw, A., Ewald, A.J., and Werb, Z. (2007). Matrix metalloproteinases and 
the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8, 221-233. 
Paget, S. (1889). The Distribution Of Secondary Growths In Cancer Of The Breast. 
THE LANCET 133, 571-573. 
Paget, S. (1989). The distribution of secondary growths in cancer of the breast. 1889. 
Cancer Metastasis Rev 8, 98-101. 
Pampaloni, F., Reynaud, E.G., and Stelzer, E.H. (2007). The third dimension bridges 
the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8, 839-845. 
Pan, T., Fong, E.L., Martinez, M., Harrington, D.A., Lin, S.H., Farach-Carson, M.C., 
and Satcher, R.L. (2015). Three-dimensional (3D) culture of bone-derived human 
786-O renal cell carcinoma retains relevant clinical characteristics of bone 
metastases. Cancer Lett 365, 89-95. 
Pankov, R., and Yamada, K.M. (2002). Fibronectin at a glance. J Cell Sci 115, 3861-
3863. 
Pantel, K., Brakenhoff, R.H., and Brandt, B. (2008). Detection, clinical relevance and 
specific biological properties of disseminating tumour cells. Nat Rev Cancer 8, 329-
340. 
Parenteau, N.L., Bilbo, P., Nolte, C.J., Mason, V.S., and Rosenberg, M. (1992). The 
organotypic culture of human skin keratinocytes and fibroblasts to achieve form and 
function. Cytotechnology 9, 163-171. 
Parrish, A.B., Freel, C.D., and Kornbluth, S. (2013). Cellular mechanisms controlling 
caspase activation and function. Cold Spring Harb Perspect Biol 5. 
Paszek, M.J., Zahir, N., Johnson, K.R., Lakins, J.N., Rozenberg, G.I., Gefen, A., 
Reinhart-King, C.A., Margulies, S.S., Dembo, M., Boettiger, D., et al. (2005). 
Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241-254. 
Paulus, W., Baur, I., Beutler, A.S., and Reeves, S.A. (1996). Diffuse brain invasion of 
glioma cells requires beta 1 integrins. Lab Invest 75, 819-826. 
Perrimon, N., and Bernfield, M. (2001). Cellular functions of proteoglycans--an 
overview. Semin Cell Dev Biol 12, 65-67. 
Petersen, O.W., Ronnov-Jessen, L., Howlett, A.R., and Bissell, M.J. (1992). 
Interaction with basement membrane serves to rapidly distinguish growth and 
differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl 
Acad Sci U S A 89, 9064-9068. 
 
 
Chapter VIII: References 
310 
 
Petrocca, F., Altschuler, G., Tan, S.M., Mendillo, M.L., Yan, H., Jerry, D.J., Kung, 
A.L., Hide, W., Ince, T.A., and Lieberman, J. (2013). A genome-wide siRNA screen 
identifies proteasome addiction as a vulnerability of basal-like triple-negative breast 
cancer cells. Cancer Cell 24, 182-196. 
Phelps, R.M., Johnson, B.E., Ihde, D.C., Gazdar, A.F., Carbone, D.P., McClintock, 
P.R., Linnoila, R.I., Matthews, M.J., Bunn, P.A., Jr., Carney, D., et al. (1996). NCI-
Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl 24, 32-91. 
Pickup, M.W., Mouw, J.K., and Weaver, V.M. (2014). The extracellular matrix 
modulates the hallmarks of cancer. EMBO Rep 15, 1243-1253. 
Pietras, K., Pahler, J., Bergers, G., and Hanahan, D. (2008). Functions of paracrine 
PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological 
targeting. PLoS Med 5, e19. 
Pignolo, R.J., Cristofalo, V.J., and Rotenberg, M.O. (1993). Senescent WI-38 cells 
fail to express EPC-1, a gene induced in young cells upon entry into the G0 state. 
The Journal of biological chemistry 268, 8949-8957. 
Ponten, F., Ren, Z., Nister, M., Westermark, B., and Ponten, J. (1994). Epithelial-
stromal interactions in basal cell cancer: the PDGF system. J Invest Dermatol 102, 
304-309. 
Potente, M., Gerhardt, H., and Carmeliet, P. (2011). Basic and therapeutic aspects of 
angiogenesis. Cell 146, 873-887. 
Poujade, M., Grasland-Mongrain, E., Hertzog, A., Jouanneau, J., Chavrier, P., 
Ladoux, B., Buguin, A., and Silberzan, P. (2007). Collective migration of an epithelial 
monolayer in response to a model wound. Proc Natl Acad Sci U S A 104, 15988-
15993. 
Provenzano, P.P., Eliceiri, K.W., Campbell, J.M., Inman, D.R., White, J.G., and Keely, 
P.J. (2006). Collagen reorganization at the tumor-stromal interface facilitates local 
invasion. BMC Med 4, 38. 
Provenzano, P.P., Inman, D.R., Eliceiri, K.W., Knittel, J.G., Yan, L., Rueden, C.T., 
White, J.G., and Keely, P.J. (2008). Collagen density promotes mammary tumor 
initiation and progression. BMC Med 6, 11. 
Puente, X.S., Pendas, A.M., Llano, E., Velasco, G., and Lopez-Otin, C. (1996). 
Molecular cloning of a novel membrane-type matrix metalloproteinase from a human 
breast carcinoma. Cancer Res 56, 944-949. 
Pyke, C., Salo, S., Ralfkiaer, E., Romer, J., Dano, K., and Tryggvason, K. (1995). 
Laminin-5 is a marker of invading cancer cells in some human carcinomas and is 
coexpressed with the receptor for urokinase plasminogen activator in budding cancer 
cells in colon adenocarcinomas. Cancer Res 55, 4132-4139. 
Qian, C.N. (2013). Hijacking the vasculature in ccRCC--co-option, remodelling and 
angiogenesis. Nat Rev Urol 10, 300-304. 
Quail, D.F., and Joyce, J.A. (2013). Microenvironmental regulation of tumor 
progression and metastasis. Nat Med 19, 1423-1437. 
Ra, H.J., and Parks, W.C. (2007). Control of matrix metalloproteinase catalytic 
activity. Matrix biology : journal of the International Society for Matrix Biology 26, 587-
596. 
Chapter VIII: References 
311 
 
Raeber, G.P., Lutolf, M.P., and Hubbell, J.A. (2007). Mechanisms of 3-D migration 
and matrix remodeling of fibroblasts within artificial ECMs. Acta Biomater 3, 615-629. 
Raghunath, J., Rollo, J., Sales, K.M., Butler, P.E., and Seifalian, A.M. (2007). 
Biomaterials and scaffold design: key to tissue-engineering cartilage. Biotechnol Appl 
Biochem 46, 73-84. 
Rash, B.G., and Grove, E.A. (2007). Patterning the dorsal telencephalon: a role for 
sonic hedgehog? J Neurosci 27, 11595-11603. 
Ray, S.K., Patel, S.J., Welsh, C.T., Wilford, G.G., Hogan, E.L., and Banik, N.L. (2002). 
Molecular evidence of apoptotic death in malignant brain tumors including 
glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res 69, 
197-206. 
Regala, R.P., Justilien, V., Walsh, M.P., Weems, C., Khoor, A., Murray, N.R., and 
Fields, A.P. (2011). Matrix metalloproteinase-10 promotes Kras-mediated bronchio-
alveolar stem cell expansion and lung cancer formation. PloS one 6, e26439. 
Rhee, S. (2009). Fibroblasts in three dimensional matrices: cell migration and matrix 
remodeling. Exp Mol Med 41, 858-865. 
Ricard-Blum, S. (2011). The collagen family. Cold Spring Harb Perspect Biol 3, 
a004978. 
Rizki, A., Weaver, V.M., Lee, S.Y., Rozenberg, G.I., Chin, K., Myers, C.A., Bascom, 
J.L., Mott, J.D., Semeiks, J.R., Grate, L.R., et al. (2008). A human breast cell model 
of preinvasive to invasive transition. Cancer Res 68, 1378-1387. 
Ropponen, K., Tammi, M., Parkkinen, J., Eskelinen, M., Tammi, R., Lipponen, P., 
Agren, U., Alhava, E., and Kosma, V.M. (1998). Tumor cell-associated hyaluronan as 
an unfavorable prognostic factor in colorectal cancer. Cancer Res 58, 342-347. 
Rous, P. (1910). A Transmissible Avian Neoplasm. (Sarcoma of the Common Fowl.). 
J Exp Med 12, 696-705. 
Rudalska, R., Dauch, D., Longerich, T., McJunkin, K., Wuestefeld, T., Kang, T.W., 
Hohmeyer, A., Pesic, M., Leibold, J., von Thun, A., et al. (2014). In vivo RNAi 
screening identifies a mechanism of sorafenib resistance in liver cancer. Nat Med 20, 
1138-1146. 
Ryan, S.L., Baird, A.M., Vaz, G., Urquhart, A.J., Senge, M., Richard, D.J., O'Byrne, 
K.J., and Davies, A.M. (2016). Drug Discovery Approaches Utilizing Three-
Dimensional Cell Culture. Assay Drug Dev Technol 14, 19-28. 
Saarialho-Kere, U.K., Kovacs, S.O., Pentland, A.P., Olerud, J.E., Welgus, H.G., and 
Parks, W.C. (1993). Cell-matrix interactions modulate interstitial collagenase 
expression by human keratinocytes actively involved in wound healing. J Clin Invest 
92, 2858-2866. 
Sadikot, T., Swink, M., Eskew, J.D., Brown, D., Zhao, H., Kusuma, B.R., Rajewski, 
R.A., Blagg, B.S., Matts, R.L., Holzbeierlein, J.M., et al. (2013). Development of a 
high-throughput screening cancer cell-based luciferase refolding assay for identifying 
Hsp90 inhibitors. Assay Drug Dev Technol 11, 478-488. 
Sahai, E., and Marshall, C.J. (2003). Differing modes of tumour cell invasion have 
distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell 
Biol 5, 711-719. 
Chapter VIII: References 
312 
 
Santiago-Walker, A., Li, L., Haass, N.K., and Herlyn, M. (2009). Melanocytes: from 
morphology to application. Skin Pharmacol Physiol 22, 114-121. 
Sanz-Moreno, V., Gadea, G., Ahn, J., Paterson, H., Marra, P., Pinner, S., Sahai, E., 
and Marshall, C.J. (2008). Rac activation and inactivation control plasticity of tumor 
cell movement. Cell 135, 510-523. 
Sarrazin, S., Lamanna, W.C., and Esko, J.D. (2011). Heparan sulfate proteoglycans. 
Cold Spring Harb Perspect Biol 3. 
Sawhney, A.S., Pathak, C.P., van Rensburg, J.J., Dunn, R.C., and Hubbell, J.A. 
(1994). Optimization of photopolymerized bioerodible hydrogel properties for 
adhesion prevention. J Biomed Mater Res 28, 831-838. 
Saxena, G., Koli, K., de la Garza, J., and Ogbureke, K.U. (2015). Matrix 
metalloproteinase 20-dentin sialophosphoprotein interaction in oral cancer. J Dent 
Res 94, 584-593. 
Schneider, R.K., Neuss, S., Stainforth, R., Laddach, N., Bovi, M., Knuechel, R., and 
Perez-Bouza, A. (2008). Three-dimensional epidermis-like growth of human 
mesenchymal stem cells on dermal equivalents: contribution to tissue organization 
by adaptation of myofibroblastic phenotype and function. Differentiation 76, 156-167. 
Schroeder, A., Heller, D.A., Winslow, M.M., Dahlman, J.E., Pratt, G.W., Langer, R., 
Jacks, T., and Anderson, D.G. (2011). Treating metastatic cancer with 
nanotechnology. Nat Rev Cancer 12, 39-50. 
Scott, K.A., Wood, E.J., and Karran, E.H. (1998). A matrix metalloproteinase inhibitor 
which prevents fibroblast-mediated collagen lattice contraction. FEBS Letters 441, 
137-140. 
Senger, D.R., Perruzzi, C.A., Feder, J., and Dvorak, H.F. (1986). A highly conserved 
vascular permeability factor secreted by a variety of human and rodent tumor cell 
lines. Cancer Res 46, 5629-5632. 
Serra, M., Brito, C., Correia, C., and Alves, P.M. (2012). Process engineering of 
human pluripotent stem cells for clinical application. Trends Biotechnol 30, 350-359. 
Shen, Y., Tolic, N., Purvine, S.O., and Smith, R.D. (2012). Improving collision induced 
dissociation (CID), high energy collision dissociation (HCD), and electron transfer 
dissociation (ETD) fourier transform MS/MS degradome-peptidome identifications 
using high accuracy mass information. J Proteome Res 11, 668-677. 
Shi, J., Wang, E., Milazzo, J.P., Wang, Z., Kinney, J.B., and Vakoc, C.R. (2015). 
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat 
Biotechnol 33, 661-667. 
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., and Takeyama, H. (2015). 
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor 
Growth. Cancers (Basel) 7, 2443-2458. 
Shin, S., Lee, Y., Kim, W., Ko, H., Choi, H., and Kim, K. (2005). Caspase-2 primes 
cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 24, 
3532-3542. 
 
Chapter VIII: References 
313 
 
Shivapurkar, N., Toyooka, S., Eby, M.T., Huang, C.X., Sathyanarayana, U.G., 
Cunningham, H.T., Reddy, J.L., Brambilla, E., Takahashi, T., Minna, J.D., et al. 
(2002). Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther 1, 65-
69. 
Shoulders, M.D., and Raines, R.T. (2009). Collagen structure and stability. Annu Rev 
Biochem 78, 929-958. 
Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., and Gallagher, 
T. (2011). A transmembrane serine protease is linked to the severe acute respiratory 
syndrome coronavirus receptor and activates virus entry. J Virol 85, 873-882. 
Silverman, G.A., Bird, P.I., Carrell, R.W., Church, F.C., Coughlin, P.B., Gettins, P.G., 
Irving, J.A., Lomas, D.A., Luke, C.J., Moyer, R.W., et al. (2001). The serpins are an 
expanding superfamily of structurally similar but functionally diverse proteins. 
Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. The 
Journal of biological chemistry 276, 33293-33296. 
Simian, M., Hirai, Y., Navre, M., Werb, Z., Lochter, A., and Bissell, M.J. (2001). The 
interplay of matrix metalloproteinases, morphogens and growth factors is necessary 
for branching of mammary epithelial cells. Development 128, 3117-3131. 
Simon, C., Nemechek, A.J., Boyd, D., O'Malley, B.W., Jr., Goepfert, H., Flaitz, C.M., 
and Hicks, M.J. (1998). An orthotopic floor-of-mouth cancer model allows 
quantification of tumor invasion. Laryngoscope 108, 1686-1691. 
Simpson, K.J., Selfors, L.M., Bui, J., Reynolds, A., Leake, D., Khvorova, A., and 
Brugge, J.S. (2008). Identification of genes that regulate epithelial cell migration using 
an siRNA screening approach. Nat Cell Biol 10, 1027-1038. 
Singhvi, R., Kumar, A., Lopez, G.P., Stephanopoulos, G.N., Wang, D.I., Whitesides, 
G.M., and Ingber, D.E. (1994). Engineering cell shape and function. Science 264, 
696-698. 
Smolen, G.A., Zhang, J., Zubrowski, M.J., Edelman, E.J., Luo, B., Yu, M., Ng, L.W., 
Scherber, C.M., Schott, B.J., Ramaswamy, S., et al. (2010). A genome-wide RNAi 
screen identifies multiple RSK-dependent regulators of cell migration. Genes Dev 24, 
2654-2665. 
Sorimachi, H., and Suzuki, K. (2001). The structure of calpain. J Biochem 129, 653-
664. 
Sreenath, T., Matrisian, L.M., Stetler-Stevenson, W., Gattoni-Celli, S., and Pozzatti, 
R.O. (1992). Expression of matrix metalloproteinase genes in transformed rat cell 
lines of high and low metastatic potential. Cancer Res 52, 4942-4947. 
Stark, H.J., Baur, M., Breitkreutz, D., Mirancea, N., and Fusenig, N.E. (1999). 
Organotypic keratinocyte cocultures in defined medium with regular epidermal 
morphogenesis and differentiation. J Invest Dermatol 112, 681-691. 
Stechmiller, J., Cowan, L., and Schultz, G. (2010). The role of doxycycline as a matrix 
metalloproteinase inhibitor for the treatment of chronic wounds. Biol Res Nurs 11, 
336-344. 
Steele, F.R., Chader, G.J., Johnson, L.V., and Tombran-Tink, J. (1993). Pigment 
epithelium-derived factor: neurotrophic activity and identification as a member of the 
serine protease inhibitor gene family. Proc Natl Acad Sci U S A 90, 1526-1530. 
Chapter VIII: References 
314 
 
Storr, S.J., Carragher, N.O., Frame, M.C., Parr, T., and Martin, S.G. (2011). The 
calpain system and cancer. Nat Rev Cancer 11, 364-374. 
Strovel, J., Sittampalam, S., Coussens, N.P., Hughes, M., Inglese, J., Kurtz, A., 
Andalibi, A., Patton, L., Austin, C., Baltezor, M., et al. (2004). Early Drug Discovery 
and Development Guidelines: For Academic Researchers, Collaborators, and Start-
up Companies. In Assay Guidance Manual, G.S. Sittampalam, N.P. Coussens, K. 
Brimacombe, A. Grossman, M. Arkin, D. Auld, C. Austin, J. Baell, B. Bejcek, T.D.Y. 
Chung, et al., eds. (Bethesda (MD)). 
Suh, H., and Lee, J.E. (2002). Behavior of fibroblasts on a porous hyaluronic acid 
incorporated collagen matrix. Yonsei Med J 43, 193-202. 
Sung, K.E., Su, G., Pehlke, C., Trier, S.M., Eliceiri, K.W., Keely, P.J., Friedl, A., and 
Beebe, D.J. (2009). Control of 3-dimensional collagen matrix polymerization for 
reproducible human mammary fibroblast cell culture in microfluidic devices. 
Biomaterials 30, 4833-4841. 
Sutherland, R.M., and Durand, R.E. (1984). Growth and cellular characteristics of 
multicell spheroids. Recent Results Cancer Res 95, 24-49. 
Sutherland, R.M., Inch, W.R., McCredie, J.A., and Kruuv, J. (1970). A multi-
component radiation survival curve using an in vitro tumour model. Int J Radiat Biol 
Relat Stud Phys Chem Med 18, 491-495. 
Sutherland, R.M., McCredie, J.A., and Inch, W.R. (1971). Growth of multicell 
spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 46, 
113-120. 
Takita, J., Yang, H.W., Bessho, F., Hanada, R., Yamamoto, K., Kidd, V., Teitz, T., 
Wei, T., and Hayashi, Y. (2000). Absent or reduced expression of the caspase 8 gene 
occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or 
rhabdomyosarcoma. Med Pediatr Oncol 35, 541-543. 
Tanaka, K., Hiraiwa, N., Hashimoto, H., Yamazaki, Y., and Kusakabe, M. (2004). 
Tenascin-C regulates angiogenesis in tumor through the regulation of vascular 
endothelial growth factor expression. Int J Cancer 108, 31-40. 
Teitz, T., Wei, T., Valentine, M.B., Vanin, E.F., Grenet, J., Valentine, V.A., Behm, 
F.G., Look, A.T., Lahti, J.M., and Kidd, V.J. (2000). Caspase 8 is deleted or silenced 
preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6, 
529-535. 
Teitze, H. (1965). Famous Problems of Mathematics: Solved and Unsolved 
Mathematical Problems from Antiquity to Modern Times (New York: Graylock Press). 
Thayer, S.P., di Magliano, M.P., Heiser, P.W., Nielsen, C.M., Roberts, D.J., Lauwers, 
G.Y., Qi, Y.P., Gysin, S., Fernandez-del Castillo, C., Yajnik, V., et al. (2003). 
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 
425, 851-856. 
Thiery, J.P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat 
Rev Cancer 2, 442-454. 
Thiery, J.P., Acloque, H., Huang, R.Y., and Nieto, M.A. (2009). Epithelial-
mesenchymal transitions in development and disease. Cell 139, 871-890. 
 
Chapter VIII: References 
315 
 
Thoma, C.R., Stroebel, S., Rosch, N., Calpe, B., Krek, W., and Kelm, J.M. (2013). A 
high-throughput-compatible 3D microtissue co-culture system for phenotypic RNAi 
screening applications. J Biomol Screen 18, 1330-1337. 
Thomas, G.J., Lewis, M.P., Hart, I.R., Marshall, J.F., and Speight, P.M. (2001a). 
AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-
regulation of matrix metalloproteinase-9. Int J Cancer 92, 641-650. 
Thomas, G.J., Lewis, M.P., Whawell, S.A., Russell, A., Sheppard, D., Hart, I.R., 
Speight, P.M., and Marshall, J.F. (2001b). Expression of the alphavbeta6 integrin 
promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 
117, 67-73. 
Thomas, G.J., Nystrom, M.L., and Marshall, J.F. (2006). Alphavbeta6 integrin in 
wound healing and cancer of the oral cavity. J Oral Pathol Med 35, 1-10. 
Thomas, G.J., Poomsawat, S., Lewis, M.P., Hart, I.R., Speight, P.M., and Marshall, 
J.F. (2001c). alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and 
promotes migration of normal oral keratinocytes. J Invest Dermatol 116, 898-904. 
Timpl, R., Rohde, H., Robey, P.G., Rennard, S.I., Foidart, J.M., and Martin, G.R. 
(1979). Laminin--a glycoprotein from basement membranes. The Journal of biological 
chemistry 254, 9933-9937. 
Tolboom, T.C., and Huizinga, T.W. (2007). In vitro matrigel fibroblast invasion assay. 
Methods Mol Med 135, 413-421. 
Tombran-Tink, J., Chader, G.G., and Johnson, L.V. (1991). PEDF: a pigment 
epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 53, 
411-414. 
Tompkins, R.G., and Burke, J.F. (1990). Progress in burn treatment and the use of 
artificial skin. World J Surg 14, 819-824. 
Torisawa, Y.S., Mosadegh, B., Cavnar, S.P., Ho, M., and Takayama, S. (2011). 
Transwells with microstamped membranes produce micropatterned two-dimensional 
and three-dimensional co-cultures. Tissue Eng Part C Methods 17, 61-67. 
Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., and Jemal, A. (2015). 
Global cancer statistics, 2012. CA Cancer J Clin 65, 87-108. 
Tuhkanen, H., Hartikainen, J.M., Soini, Y., Velasco, G., Sironen, R., Nykopp, T.K., 
Kataja, V., Eskelinen, M., Kosma, V.M., and Mannermaa, A. (2013). Matriptase-2 
gene (TMPRSS6) variants associate with breast cancer survival, and reduced 
expression is related to triple-negative breast cancer. Int J Cancer 133, 2334-2340. 
Tzu, J., and Marinkovich, M.P. (2008). Bridging structure with function: structural, 
regulatory, and developmental role of laminins. Int J Biochem Cell Biol 40, 199-214. 
Usui, T., Sakurai, M., Kawasaki, H., Ohama, T., Yamawaki, H., and Sato, K. (2017). 
Establishment of a novel three-dimensional primary culture model for hippocampal 
neurogenesis. Physiol Rep 5. 
Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szasz, A.M., Wang, Z.C., 
Brock, J.E., Richardson, A.L., and Weinberg, R.A. (2009). A pleiotropically acting 
microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046. 
 
Chapter VIII: References 
316 
 
Valastyan, S., and Weinberg, R.A. (2011). Tumor metastasis: molecular insights and 
evolving paradigms. Cell 147, 275-292. 
Valcourt, U., Alcaraz, L.B., Exposito, J.Y., Lethias, C., and Bartholin, L. (2015). 
Tenascin-X: beyond the architectural function. Cell Adh Migr 9, 154-165. 
van der Flier, A., and Sonnenberg, A. (2001). Function and interactions of integrins. 
Cell Tissue Res 305, 285-298. 
van Roy, F., and Berx, G. (2008). The cell-cell adhesion molecule E-cadherin. Cell 
Mol Life Sci 65, 3756-3788. 
van Zijl, F., Krupitza, G., and Mikulits, W. (2011). Initial steps of metastasis: cell 
invasion and endothelial transmigration. Mutat Res 728, 23-34. 
Velling, T., Risteli, J., Wennerberg, K., Mosher, D.F., and Johansson, S. (2002). 
Polymerization of type I and III collagens is dependent on fibronectin and enhanced 
by integrins alpha 11beta 1 and alpha 2beta 1. The Journal of biological chemistry 
277, 37377-37381. 
Vial, E., Sahai, E., and Marshall, C.J. (2003). ERK-MAPK signaling coordinately 
regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4, 67-79. 
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, 
C., Mendiola, M., Hardisson, D., and Eccles, S.A. (2012). Advances in establishment 
and analysis of three-dimensional tumor spheroid-based functional assays for target 
validation and drug evaluation. BMC Biol 10, 29. 
von der Mark, K., Gauss, V., von der Mark, H., and Muller, P. (1977). Relationship 
between cell shape and type of collagen synthesised as chondrocytes lose their 
cartilage phenotype in culture. Nature 267, 531-532. 
Vorsmann, H., Groeber, F., Walles, H., Busch, S., Beissert, S., Walczak, H., and 
Kulms, D. (2013). Development of a human three-dimensional organotypic skin-
melanoma spheroid model for in vitro drug testing. Cell Death Dis 4, e719. 
Vracko, R. (1974). Basal lamina scaffold-anatomy and significance for maintenance 
of orderly tissue structure. Am J Pathol 77, 314-346. 
Wadell, H. (1932). Volume, Shape, and Roundness of Rock Particles. The Journal of 
Geology 40, 443-451. 
Wagenseil, J.E., and Mecham, R.P. (2007). New insights into elastic fiber assembly. 
Birth Defects Res C Embryo Today 81, 229-240. 
Wakeling, A.E., Guy, S.P., Woodburn, J.R., Ashton, S.E., Curry, B.J., Barker, A.J., 
and Gibson, K.H. (2002). ZD1839 (Iressa): an orally active inhibitor of epidermal 
growth factor signaling with potential for cancer therapy. Cancer Res 62, 5749-5754. 
Wang, C., Tang, Z., Zhao, Y., Yao, R., Li, L., and Sun, W. (2014). Three-dimensional 
in vitro cancer models: a short review. Biofabrication 6, 022001. 
Ware, M.J., Colbert, K., Keshishian, V., Ho, J., Corr, S.J., Curley, S.A., and Godin, B. 
(2016). Generation of Homogenous Three-Dimensional Pancreatic Cancer Cell 
Spheroids Using an Improved Hanging Drop Technique. Tissue Eng Part C Methods 
22, 312-321. 
 
Chapter VIII: References 
317 
 
Waymack, P., Duff, R.G., and Sabolinski, M. (2000). The effect of a tissue engineered 
bilayered living skin analog, over meshed split-thickness autografts on the healing of 
excised burn wounds. The Apligraf Burn Study Group. Burns 26, 609-619. 
Weaver, V.M., Petersen, O.W., Wang, F., Larabell, C.A., Briand, P., Damsky, C., and 
Bissell, M.J. (1997). Reversion of the malignant phenotype of human breast cells in 
three-dimensional culture and in vivo by integrin blocking antibodies. The Journal of 
cell biology 137, 231-245. 
Weber, P., Montag, D., Schachner, M., and Bernhardt, R.R. (1998). Zebrafish 
tenascin-W, a new member of the tenascin family. J Neurobiol 35, 1-16. 
Weiss, L. (1990). Metastatic inefficiency. Adv Cancer Res 54, 159-211. 
Wells, A., Grahovac, J., Wheeler, S., Ma, B., and Lauffenburger, D. (2013). Targeting 
tumor cell motility as a strategy against invasion and metastasis. Trends Pharmacol 
Sci 34, 283-289. 
Wernert, N. (1997). The multiple roles of tumour stroma. Virchows Arch 430, 433-
443. 
West, D.C., Shaw, D.M., Lorenz, P., Adzick, N.S., and Longaker, M.T. (1997). Fibrotic 
healing of adult and late gestation fetal wounds correlates with increased 
hyaluronidase activity and removal of hyaluronan. Int J Biochem Cell Biol 29, 201-
210. 
Wilhelmsen, K., Litjens, S.H., and Sonnenberg, A. (2006). Multiple functions of the 
integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. Mol Cell Biol 26, 
2877-2886. 
Williams, B.R., Gelman, R.A., Poppke, D.C., and Piez, K.A. (1978). Collagen fibril 
formation. Optimal in vitro conditions and preliminary kinetic results. The Journal of 
biological chemistry 253, 6578-6585. 
Wise, S.G., and Weiss, A.S. (2009). Tropoelastin. Int J Biochem Cell Biol 41, 494-
497. 
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U.H., Deryugina, E.I., 
Strongin, A.Y., Brocker, E.B., and Friedl, P. (2003). Compensation mechanism in 
tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular 
proteolysis. The Journal of cell biology 160, 267-277. 
Wolf, K., Wu, Y.I., Liu, Y., Geiger, J., Tam, E., Overall, C., Stack, M.S., and Friedl, P. 
(2007). Multi-step pericellular proteolysis controls the transition from individual to 
collective cancer cell invasion. Nat Cell Biol 9, 893-904. 
Wolf, M.K. (1970). Anatomy of cultured mouse cerebellum. II. Organotypic migration 
of granule cells demonstrated by silver impregnantion of normal and mutant cultures. 
J Comp Neurol 140, 281-298. 
Wood, G.C. (1960). The formation of fibrils from collagen solutions. 2. A mechanism 
of collagen-fibril formation. Biochem J 75, 598-605. 
Worst, P.K., Mackenzie, I.C., and Fusenig, N.E. (1982). Reformation of organized 
epidermal structure by transplantation of suspensions and cultures of epidermal and 
dermal cells. Cell Tissue Res 225, 65-77. 
 
Chapter VIII: References 
318 
 
Worst, P.K., Valentine, E.A., and Fusenig, N.E. (1974). Formation of epidermis after 
reimplantation of pure primary epidermal cell cultures from perinatal mouse skin. J 
Natl Cancer Inst 53, 1061-1064. 
Wu, Q., and Parry, G. (2007). Hepsin and prostate cancer. Front Biosci 12, 5052-
5059. 
Wu, T., Li, Y., Lu, J., Qiao, Q., Bao, G., Wang, N., He, X., and Du, X. (2013). Increased 
MMP-21 expression is associated with poor overall survival of patients with gastric 
cancer. Med Oncol 30, 323. 
Yamada, K.M., and Cukierman, E. (2007). Modeling tissue morphogenesis and 
cancer in 3D. Cell 130, 601-610. 
Yamaguchi, H., Lorenz, M., Kempiak, S., Sarmiento, C., Coniglio, S., Symons, M., 
Segall, J., Eddy, R., Miki, H., Takenawa, T., et al. (2005). Molecular mechanisms of 
invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and 
cofilin. The Journal of cell biology 168, 441-452. 
Yamaguchi, H., Yoshida, N., Takanashi, M., Ito, Y., Fukami, K., Yanagihara, K., 
Yashiro, M., and Sakai, R. (2014). Stromal fibroblasts mediate extracellular matrix 
remodeling and invasion of scirrhous gastric carcinoma cells. PloS one 9, e85485. 
Yanagishita, M. (1993). Function of proteoglycans in the extracellular matrix. Acta 
Pathol Jpn 43, 283-293. 
Yang, H., Cheng, R., Liu, G., Zhong, Q., Li, C., Cai, W., Yang, Z., Ma, J., Yang, X., 
and Gao, G. (2009). PEDF inhibits growth of retinoblastoma by anti-angiogenic 
activity. Cancer Sci 100, 2419-2425. 
Yee, D., Rosen, N., Favoni, R.E., and Cullen, K.J. (1991). The insulin-like growth 
factors, their receptors, and their binding proteins in human breast cancer. Cancer 
Treat Res 53, 93-106. 
Zaman, M.H., Trapani, L.M., Sieminski, A.L., Mackellar, D., Gong, H., Kamm, R.D., 
Wells, A., Lauffenburger, D.A., and Matsudaira, P. (2006). Migration of tumor cells in 
3D matrices is governed by matrix stiffness along with cell-matrix adhesion and 
proteolysis. Proc Natl Acad Sci U S A 103, 10889-10894. 
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., 
and Tesei, A. (2016). 3D tumor spheroid models for in vitro therapeutic screening: a 
systematic approach to enhance the biological relevance of data obtained. Sci Rep 
6, 19103. 
Zelenka, P.S., and Arpitha, P. (2008). Coordinating cell proliferation and migration in 
the lens and cornea. Semin Cell Dev Biol 19, 113-124. 
Zhang, G., Miyake, M., Lawton, A., Goodison, S., and Rosser, C.J. (2014). Matrix 
metalloproteinase-10 promotes tumor progression through regulation of angiogenic 
and apoptotic pathways in cervical tumors. BMC Cancer 14, 310. 
Zhang, K., and Kramer, R.H. (1996). Laminin 5 deposition promotes keratinocyte 
motility. Exp Cell Res 227, 309-322. 
Zhang, S., Gelain, F., and Zhao, X. (2005). Designer self-assembling peptide 
nanofiber scaffolds for 3D tissue cell cultures. Semin Cancer Biol 15, 413-420. 
 
Chapter VIII: References 
319 
 
Zhang, T., Guan, M., Xu, C., Chen, Y., and Lu, Y. (2007). Pigment epithelium-derived 
factor inhibits glioma cell growth in vitro and in vivo. Life Sci 81, 1256-1263. 
Zhivotovsky, B. (2003). Caspases: the enzymes of death. Essays Biochem 39, 25-
40. 
Zhou, Z., Wang, J., Cao, R., Morita, H., Soininen, R., Chan, K.M., Liu, B., Cao, Y., 
and Tryggvason, K. (2004). Impaired angiogenesis, delayed wound healing and 
retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 64, 
4699-4702. 
Zhu, W., Murtha, P.E., and Young, C.Y. (1995). Calpain inhibitor-induced apoptosis 
in human prostate adenocarcinoma cells. Biochem Biophys Res Commun 214, 1130-
1137. 
Zimmermann, W.H., Melnychenko, I., Wasmeier, G., Didie, M., Naito, H., Nixdorff, U., 
Hess, A., Budinsky, L., Brune, K., Michaelis, B., et al. (2006). Engineered heart tissue 
grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12, 452-
458. 
 
